var title_f27_49_28432="GHVD rates with prophylaxis";
var content_f27_49_28432=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F79413&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F79413&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 611px\">",
"   <div class=\"ttl\">",
"    Rates of acute and chronic graft-versus-host disease following prophylaxis with cyclosporin and methotrexate with or without anti-T-cell globulin",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 591px; height: 545px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The figures depict crude and adjusted incidence rates of graft-versus-host disease (GVHD) in 202 patients with hematologic malignancies randomly assigned to receive GVHD prophylaxis with cyclosporin and methotrexate with or without anti-T cell globulin (ATG-F). Incidence rates are given for grade III-IV acute GVHD (A), grade II-IV acute GVHD (B), limited or extensive chronic GVHD (C), and extensive chronic GVHD (D). Adjusted rates are adjusted for disease status and stem-cell source.",
"    <div class=\"footnotes\">",
"     Lim/ext: limited/extensive.",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced from: Finke J, Bethge WA, Schmoor C, et al. Standard graft-versus-host disease prophylaxis with or without anti-T-cell globulin in haematopoietic cell transplantation from matched unrelated donors: a randomised, open-label, multicentre phase 3 trial. Lancet Oncol 2009; 10:855. Illustration used with the permission of Elsevier Inc. All rights reserved.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f27_49_28432=[""].join("\n");
var outline_f27_49_28432=null;
var title_f27_49_28433="Ectopic ureter pathogenesis";
var content_f27_49_28433=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F68944&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F68944&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 522px\">",
"   <div class=\"ttl\">",
"    Embryology of a complete uretal duplication and ectopic ureter",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 502px; height: 698px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Schematic embryologic development of a complete duplex renal system with the formation of two ureteral buds. Note that the cranial ureteral bud drains the lower pole of the kidney and the caudal ureter bud the upper renal unit. In general, pathology occurs when the caudal ureteral bud inserts in an abnormal distal ectopic location in the bladder (ie, ectopic ureter) or caudal to the bladder causing upper pole ureteral obstruction. When the cranial ureter inserts abnormally, lower pole ureteral reflux can occur.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f27_49_28433=[""].join("\n");
var outline_f27_49_28433=null;
var title_f27_49_28434="Ultrasound axial image of the wrist";
var content_f27_49_28434=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEURO%2F56630&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEURO%2F56630&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 525px\">",
"   <div class=\"ttl\">",
"    Ultrasound axial image of the wrist",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 505px; height: 241px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This is an ultrasound axial image of the wrist at the distal wrist crease. The image on the left is obtained with the probe perpendicular to the flexor carpi radialis tendon (T); note that it is hyperechoic in this image. In the right image, at the same level, the probe is tilted just off the perpendicular axis by aiming the probe slightly proximal. Note that this shift of just a few degrees causes the tendon to become hypoechoic. The median nerve (N) varies less in echogenicity because the tendon exhibits a higher degree of anisotropy. Note that some of the flexor tendons below the nerve, which are not precisely parallel to the flexor carpi radialis tendon, also show marked variations in echogenicity with the slight shift of probe angle. (The numeral \"-1\" to the right indicates a depth of 1 cm, and the dot below it represents an additional 0.5 cm.)",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Francis O Walker, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f27_49_28434=[""].join("\n");
var outline_f27_49_28434=null;
var title_f27_49_28435="Secretin: Drug information";
var content_f27_49_28435=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Secretin: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?17/24/17795?source=see_link\">",
"    see \"Secretin: Patient drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_pediatric\" href=\"UTD.htm?19/45/20179?source=see_link\">",
"    see \"Secretin: Pediatric drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F220255\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      ChiRhoStim&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F220269\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Diagnostic Agent",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F220257\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Note:",
"     </b>",
"     A test dose of 0.1 mL (0.2-0.4 mcg) is injected to test for possible allergy. Dosing may be completed if no reaction occurs after 1 minute.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Diagnosis of pancreatic dysfunction, facilitation of ERCP:",
"     </b>",
"     I.V.: 0.2 mcg/kg over 1 minute",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Diagnosis of gastrinoma:",
"     </b>",
"     I.V.: 0.4 mcg/kg over 1 minute",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F220258\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F220238\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Injection, powder for reconstitution [human derived]:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     ChiRhoStim&reg;: 16 mcg",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F220223\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F220240\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Administer by direct I.V. injection slowly over 1 minute",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F220239\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Secretin-stimulation testing to aid in diagnosis of pancreatic exocrine dysfunction; diagnosis of gastrinoma (Zollinger-Ellison syndrome); facilitation of endoscopic retrograde cholangiopancreatography (ERCP) visualization",
"    </p>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F220267\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     1% to 10%:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Cardiovascular: Flushing (1%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Gastrointestinal: Nausea (1% to 2%), abdominal discomfort (&le;1%), abdominal pain (&le;1%), vomiting (&le;1%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Miscellaneous: Bleeding (sphincterectomy, &le;1%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     &lt;1% (Limited to important or life-threatening): Abdominal cramps, anxiety, bloating, bradycardia (mild), diaphoresis, diarrhea, dyspepsia, faintness, fatigue, fever, headache, heart rate increased, hypotension, leukocytoplastic vasculitis, lightheadedness, numbness/tingling in the extremities, oral secretions increased, oxygen saturation decreased, pallor, pancreatitis (mild), rash (abdominal), respiratory distress (transient), sedation, seizure, warm sensation (abdomen/face)",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F220243\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to secretin or any component of the formulation; acute pancreatitis",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F220227\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Allergic reaction: Potential for allergic reactions exists; test dose is recommended. Medications for the treatment of hypersensitivity should be available for immediate use. Patients with a history of asthma or atopy are at higher risk for reaction.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Disease-related concerns:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hepatic impairment: Use with caution in patients with hepatic impairment (including ethanol-induced disease); volume response to secretin may be exaggerated.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Inflammatory bowel disease: Response may be blunted in the presence of inflammatory bowel disease; blunted response is not indicative of pancreatic disease.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concurrent drug therapy issues:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Anticholinergics: Response may be blunted in the presence of anticholinergic agents; blunted response is not indicative of pancreatic disease.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Special populations:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Pediatrics: Safety and efficacy have not been established in children.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Other warnings/precautions:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Vagotomy: Response may be blunted following vagotomy; blunted response is not indicative of pancreatic disease.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13300032\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F220231\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Anticholinergic Agents: May diminish the therapeutic effect of Secretin.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F220233\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C (",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F220244\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Reproduction studies have not been conducted.",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F220260\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excretion in breast milk unknown/use caution",
"    </p>",
"   </div>",
"   <div class=\"block brc drugH1Div\" id=\"F16571116\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Breast-Feeding Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     It is not known if secretin is excreted in breast milk. The manufacturer recommends that caution be exercised when administering secretin to nursing women.",
"    </p>",
"   </div>",
"   <div class=\"block dic drugH1Div\" id=\"F220245\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dietary Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     SecreFlo&trade;: Patients should be in a fasting state (12- to 15-hour fast) prior to testing for gastrinoma.",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F16323825\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution (reconstituted)",
"     </b>",
"     (ChiRhoStim Intravenous)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     16 mcg (1): $498.00",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution (reconstituted)",
"     </b>",
"     (SecreFlo Intravenous)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     16 mcg (1): $510.00",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F220236\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to protocols for collection of pancreatic secretion and/or serum gastrin.",
"    </p>",
"   </div>",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F6038825\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Secrepan (JP);",
"     </li>",
"     <li>",
"      Secretin Ferring (FI);",
"     </li>",
"     <li>",
"      Sekretolin (CZ)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F220226\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Human and porcine secretin are both synthetically derived products and are equally potent on an osmolar basis. Secretin is a hormone which is normally secreted by duodenal mucosa and upper jejunal mucosa. It increases the volume and bicarbonate content of pancreatic juice; stimulates the flow of hepatic bile with a high bicarbonate concentration; stimulates gastrin release in patients with Zollinger-Ellison syndrome.",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F220242\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Onset of action: Peak output of pancreatic secretions: ~30 minutes",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Duration: Human: 1.5-2 hours; Porcine: 1-1.5 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Distribution: V",
"     <sub>",
"      d",
"     </sub>",
"     : Human: 2.7 L; Porcine: 2 L",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life elimination: Human: 45 minutes; Porcine: 27 minutes",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Metz DC, Buchanan M, Purich E, et al, &ldquo;A Randomized Controlled Crossover Study Comparing Synthetic Porcine and Human Secretins With Biologically Derived Porcine Secretin to Diagnose Zollinger-Ellison Syndrome,&rdquo;",
"      <i>",
"       Aliment Pharmacol Ther",
"      </i>",
"      , 2001, 15(5):669-76.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?27/49/28435/abstract-text/11328261/pubmed\" id=\"11328261\" target=\"_blank\">",
"        11328261",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 10259 Version 31.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0505-217.16.9.173-D52E307D49-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f27_49_28435=[""].join("\n");
var outline_f27_49_28435=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F220255\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F220269\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F220257\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F220258\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F220238\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F220223\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F220240\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F220239\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F220267\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F220243\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F220227\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13300032\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F220231\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F220233\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F220244\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F220260\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16571116\">",
"      Breast-Feeding Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F220245\">",
"      Dietary Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16323825\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F220236\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6038825\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F220226\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F220242\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/10259\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/10259|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?17/24/17795?source=related_link\">",
"      Secretin: Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?19/45/20179?source=related_link\">",
"      Secretin: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f27_49_28436="Sonogram short umbilical cord";
var content_f27_49_28436=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F75623&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F75623&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Sonogram of short umbilical cord",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 403px; height: 253px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f27_49_28436=[""].join("\n");
var outline_f27_49_28436=null;
var title_f27_49_28437="Hepatitis B immune globulin: Drug information";
var content_f27_49_28437=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Hepatitis B immune globulin: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?27/42/28323?source=see_link\">",
"    see \"Hepatitis B immune globulin: Patient drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_pediatric\" href=\"UTD.htm?23/39/24181?source=see_link\">",
"    see \"Hepatitis B immune globulin: Pediatric drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F178933\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      HepaGam B&reg;;",
"     </li>",
"     <li>",
"      HyperHEP B&trade; S/D;",
"     </li>",
"     <li>",
"      Nabi-HB&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F178934\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      HepaGam B&reg;;",
"     </li>",
"     <li>",
"      HyperHEP B&trade; S/D",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F178944\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Blood Product Derivative;",
"     </li>",
"     <li>",
"      Immune Globulin",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F178935\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Postexposure prophylaxis:",
"     </b>",
"     I.M.: 0.06 mL/kg as soon as possible after exposure (ie, within 24 hours of needlestick, ocular, or mucosal exposure or within 14 days of sexual exposure); repeat at 28-30 days after exposure  in nonresponders to hepatitis B vaccine or in patients who refuse vaccination",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Note:",
"     </b>",
"     HBIG may be administered at the same time (but at a different site) or up to 1 month preceding hepatitis B vaccination without impairing the active immune response",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;text-align:justify;\">",
"     <b>",
"      Prevention of hepatitis B virus recurrence after liver transplantation (HepaGam B&trade;):",
"     </b>",
"     I.V.: 20,000 units/dose according to the following schedule:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-top:0em;text-align:justify;\">",
"     Anhepatic phase (Initial dose): One dose given with the liver transplant",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-top:0em;text-align:justify;\">",
"     Week 1 postop: One dose daily for 7 days (days 1-7)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-top:0em;text-align:justify;\">",
"     Weeks 2-12 postop: One dose every 2 weeks starting day 14",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-top:0em;text-align:justify;\">",
"     Month 4 onward: One dose monthly starting on month 4",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Dose adjustment: Adjust dose to reach anti-HBs levels of 500 units/L within the first week after transplantation. In patients with surgical bleeding, abdominal fluid drainage &gt;500 mL or those undergoing plasmapheresis, administer 10,000 units/dose every 6 hours until target anti-HBs levels are reached.",
"    </p>",
"   </div>",
"   <div class=\"block dop drugH1Div\" id=\"F178941\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Pediatric",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?23/39/24181?source=see_link\">",
"      see \"Hepatitis B immune globulin: Pediatric drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Infants born to HBsAg-positive mothers:",
"     </b>",
"     I.M.: 0.5 mL as soon after birth as possible (within 12 hours); active vaccination with hepatitis B vaccine may begin at the same time in a different site (if not contraindicated). If first dose of hepatitis B vaccine is delayed for as long as 3 months, dose may be repeated. If hepatitis B vaccine is refused, dose may be repeated at 3 and 6 months.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Infants born to mothers with unknown HBsAg status at birth (CDC, 2005):",
"     </b>",
"     I.M.:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Birth weight &lt;2 kg: 0.5 mL within 12 hours of birth (along with hepatitis B vaccine) if unable to determine maternal HBsAg status within that time",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Birth weight &ge;2 kg: If the mother is determined to be HBsAg positive, administer 0.5 mL as soon as possible, but within 7 days of birth",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Household exposure prophylaxis in infants &lt;12 months:",
"     </b>",
"     I.M.: 0.5 mL (to be administered if mother or primary caregiver has acute HBV infection).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Postexposure prophylaxis:",
"     </b>",
"     I.M.: Children &ge;12 months: Refer  to adult dosing.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Note:",
"     </b>",
"     HBIG may be administered at the same time (but at a different site) or up to 1 month preceding hepatitis B vaccination without impairing the active immune response",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F178936\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block dor drugH1Div\" id=\"F15897466\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Renal Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No dosage adjustment provided in manufacturer&rsquo;s labeling.",
"    </p>",
"   </div>",
"   <div class=\"block doh drugH1Div\" id=\"F15897467\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Hepatic Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No dosage adjustment provided in manufacturer&rsquo;s labeling.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F178920\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Injection, solution [preservative free]:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     HepaGam B&reg;: Anti-HBs &gt; 312 units/mL (1 mL, 5 mL) [contains maltose, polysorbate 80]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     HyperHEP B&trade; S/D: Anti-HBs &gt; 220 units/mL (0.5 mL, 1 mL, 5 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Nabi-HB&reg;: Anti-HBs &gt; 312 units/mL (1 mL, 5 mL) [contains polysorbate 80]",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F178907\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F178923\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:-4em;margin-left:4em;\">",
"     I.M.: Postexposure prophylaxis: I.M. injection only in anterolateral aspect of upper thigh and deltoid muscle of upper arm; to prevent injury from injection, care should be taken when giving to patients with thrombocytopenia or bleeding disorders",
"    </p>",
"    <p style=\"text-indent:-4em;margin-left:4em;\">",
"     I.V.:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     HepaGam B&trade;: Liver transplant: Administer at 2 mL/minute. Decrease infusion to &le;1 mL/minute for patient discomfort or infusion-related adverse events. Actual volume of infusion is dependent upon potency labeled on each individual vial.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Nabi-HB&reg;: Although not FDA-approved for this purpose, Nabi-HB&reg; has been administered intravenously in hepatitis B-positive liver transplant patients (Dickson, 2006)",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F178921\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Passive prophylactic immunity to hepatitis B following: Acute exposure to blood containing hepatitis B surface antigen (HB",
"     <sub>",
"      s",
"     </sub>",
"     Ag); perinatal exposure of infants born to HB",
"     <sub>",
"      s",
"     </sub>",
"     Ag-positive mothers; sexual exposure to HB",
"     <sub>",
"      s",
"     </sub>",
"     Ag-positive persons; household exposure to persons with acute HBV infection",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Prevention of hepatitis B virus recurrence after liver transplantation in HB",
"     <sub>",
"      s",
"     </sub>",
"     Ag-positive transplant patients",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Note:",
"     </b>",
"     Hepatitis B immune globulin is not indicated for treatment of active hepatitis B infection and is ineffective in the treatment of chronic active hepatitis B infection.",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F6052749\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       HBIG may be confused with BabyBIG",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F178942\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Reported with postexposure prophylaxis. Adverse events reported in liver transplant patients included tremor and hypotension, were associated with a single infusion during the first week of treatment, and did not recur with additional infusions.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;\">",
"     Central nervous system: Dizziness, fainting, headache, lightheadedness, malaise",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Dermatologic: Angioedema, bruising, urticaria",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Gastrointestinal: Nausea, vomiting",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Hematologic: WBC decreased",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Hepatic: Alkaline phosphatase increased, AST increased",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Local: Ache, erythema, pain, and/or tenderness at injection site",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Neuromuscular &amp; skeletal: Arthralgia, joint stiffness, myalgia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Renal: Creatinine increased",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Respiratory: Cold symptoms",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Miscellaneous: Anaphylaxis, flu-like syndrome",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F178926\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     HepaGam B&reg;: Anaphylactic or severe systemic reaction to human globulin preparations; postexposure prophylaxis in patients with severe thrombocytopenia or other coagulation disorders which would contraindicate I.M. injections (administer only if benefit outweighs the risk)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     HyperHEP B&trade; S/D: No contraindications listed in manufacturer's labeling",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Nabi-HB&reg;: Anaphylactic or severe systemic reaction to human globulin preparations",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F178911\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Anaphylaxis/hypersensitivity reactions: Hypersensitivity and anaphylactic reactions can occur; immediate treatment (including epinephrine 1:1000) should be available. Use with caution in patients with isolated immunoglobulin A deficiency or a history of systemic hypersensitivity to human immunoglobulins.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Infusion reactions: When administered I.V., do not exceed recommended infusion rates; may increase risk of adverse events. Patients should be monitored for adverse events during and after the infusion.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Thrombotic events: Thrombotic events have been reported with administration of intravenous immune globulin; use with caution in patients of advanced age, with a history of atherosclerosis or cardiovascular and/or thrombotic risk factors, patients with impaired cardiac output, coagulation disorders, prolonged immobilization, or patients with known/suspected hyperviscosity. Consider a baseline assessment of blood viscosity in patients at risk for hyperviscosity.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Disease-related concerns:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Bleeding disorders: Use with caution in patients with thrombocytopenia or coagulation disorders; I.M. injections may be contraindicated.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Dosage form specific issues:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Human plasma: Product of human plasma; may potentially contain infectious agents which could transmit disease. Screening of donors, as well as testing and/or inactivation or removal of certain viruses, reduces the risk. Infections thought to be transmitted by this product should be reported to the manufacturer.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Maltose: Some products may contain maltose, which may result in falsely-elevated blood glucose readings.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13299441\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F178915\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Vaccines (Live): Immune Globulins may diminish the therapeutic effect of Vaccines (Live).  Management: Live organism vaccination should be withheld for up to 6 months following immune globulin administration.  Live vaccine given immediately prior to immune globulin may require repeat vaccination.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Yellow Fever Vaccine.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F178917\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C (",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F2530309\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Animal reproduction studies have not been conducted. Use of HBIG is not contraindicated in pregnant women and may be used for postexposure prophylaxis when indicated (CDC, 2001). In addition, use of HBIG has been evaluated to reduce maternal to fetal transmission of hepatis B virus during pregnancy (ACOG, 2007)",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F2530311\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excretion in breast milk unknown/use caution",
"    </p>",
"   </div>",
"   <div class=\"block brc drugH1Div\" id=\"F4603416\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Breast-Feeding Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Infants born to HBsAg-positive mothers may be breast fed (CDC, 2005). Use of HBIG is not contraindicated in breast-feeding women (CDC, 2001).",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F4603420\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Liver transplant: Serum HBsAg; infusion-related adverse events",
"    </p>",
"   </div>",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F178928\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Bayhep (PK);",
"     </li>",
"     <li>",
"      Euvax-B (KP);",
"     </li>",
"     <li>",
"      Hebagam IM (ZA);",
"     </li>",
"     <li>",
"      Hepabig (IN, KP, MY, PH);",
"     </li>",
"     <li>",
"      Hepacaf (BE);",
"     </li>",
"     <li>",
"      Hepagam B (IL);",
"     </li>",
"     <li>",
"      Hepatect (AT, CH, CO, DE, EE, HN, IE, PL, PT, TR, TW);",
"     </li>",
"     <li>",
"      Hepatitis B Immunoglobulin-VF (AU);",
"     </li>",
"     <li>",
"      HepBQuin (NL);",
"     </li>",
"     <li>",
"      Hepuman Berna (PE);",
"     </li>",
"     <li>",
"      HyperHEP B (HK, IL, NZ, TW);",
"     </li>",
"     <li>",
"      Igantibe (TH);",
"     </li>",
"     <li>",
"      IMMUNOHBs (TH);",
"     </li>",
"     <li>",
"      IVheBex (FR, GR);",
"     </li>",
"     <li>",
"      NEOHepatect (CZ);",
"     </li>",
"     <li>",
"      VENBIG (DK, TH);",
"     </li>",
"     <li>",
"      Zutectra (GB)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F178910\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hepatitis B immune globulin (HBIG) is a nonpyrogenic sterile solution containing  immunoglobulin G (IgG) specific to hepatitis B surface antigen (HB",
"     <sub>",
"      s",
"     </sub>",
"     Ag). HBIG differs from immune globulin in the amount of anti-HB",
"     <sub>",
"      s",
"     </sub>",
"     . Immune globulin is prepared from plasma that is not preselected for anti-HB",
"     <sub>",
"      s",
"     </sub>",
"     content. HBIG is prepared from plasma preselected for high titer anti-HB",
"     <sub>",
"      s",
"     </sub>",
"     . In the U.S., HBIG has an anti-HB",
"     <sub>",
"      s",
"     </sub>",
"     high titer &gt;1:100,000 by IRA.",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F178925\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Duration: Postexposure prophylaxis: 3-6 months",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Absorption: I.M.: Slow",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life: 17-25 days",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Distribution: V",
"     <sub>",
"      d",
"     </sub>",
"     : 7-15 L",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Time to peak, serum: I.M.: 2-10 days",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      American College of Obstetricians and Gynecologists, ACOG Practice Bulletin No. 86: &ldquo;Viral Hepatitis in Pregnancy,&rdquo;",
"      <i>",
"       Obstet Gynecol",
"      </i>",
"      , 2007, 110(4):941-56.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?27/49/28437/abstract-text/17906043/pubmed\" id=\"17906043\" target=\"_blank\">",
"        17906043",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Centers for Disease Control and Prevention (CDC), &ldquo;A Comprehensive Immunization Strategy to Eliminate Transmission of Hepatitis B Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices (ACIP) Part I: Immunization of Infants, Children, and Adolescents,&rdquo;",
"      <i>",
"       MMWR Recomm Rep",
"      </i>",
"      , 2005, 54(RR-16):1-31.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Centers for Disease Control and Prevention (CDC), &ldquo;A Comprehensive Immunization Strategy to Eliminate Transmission of Hepatitis B Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: Immunization of Adults,&rdquo;",
"      <i>",
"       MMWR Recomm Rep",
"      </i>",
"      , 2006, 54(RR-16):1-33.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?27/49/28437/abstract-text/17159833/pubmed\" id=\"17159833\" target=\"_blank\">",
"        17159833",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Centers for Disease Control and Prevention (CDC), U.S. Public Health Service, \"Updated U.S. Public Health Service Guidelines for the Management of Occupational Exposures to HBV, HCV, and HIV and Recommendations for Postexposure Prophylaxis,\"",
"      <i>",
"       MMWR Recomm Rep",
"      </i>",
"      , 2001, 50(RR-11):1-52.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?27/49/28437/abstract-text/11442229/pubmed\" id=\"11442229\" target=\"_blank\">",
"        11442229",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Cohen V, Jellinek SP, Teperikidis L, et al, &ldquo;Room-Temperature Storage of Medications Labeled for Refrigeration,&rdquo;",
"      <i>",
"       Am J Health-Syst Pharm",
"      </i>",
"      , 2007, 64(16):1711-15.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?27/49/28437/abstract-text/17687059/pubmed\" id=\"17687059\" target=\"_blank\">",
"        17687059",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Dickson RC, Terrault NA, Ishitani M, et al, &ldquo;Protective Antibody Levels and Dose Requirements for IV 5% Nabi Hepatitis B Immune Globulin Combined With Lamivudine in Liver Transplantation for Hepatitis B-Induced End Stage Liver Disease,&rdquo;",
"      <i>",
"       Liver Transpl",
"      </i>",
"      , 2006,  12(1):124-33.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?27/49/28437/abstract-text/16382463/pubmed\" id=\"16382463\" target=\"_blank\">",
"        16382463",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Tung BY and Kowdley KV, &ldquo;Hepatitis B and Liver Transplantation,&rdquo;",
"      <i>",
"       Clin Infect Dis",
"      </i>",
"      , 2005, 41(10):1461-6.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?27/49/28437/abstract-text/16231258/pubmed\" id=\"16231258\" target=\"_blank\">",
"        16231258",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 8520 Version 40.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1003-61.234.146.186-A7177AF1CA-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f27_49_28437=[""].join("\n");
var outline_f27_49_28437=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F178933\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F178934\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F178944\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F178935\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F178941\">",
"      Dosing: Pediatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F178936\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F15897466\">",
"      Dosing: Renal Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F15897467\">",
"      Dosing: Hepatic Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F178920\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F178907\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F178923\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F178921\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6052749\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F178942\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F178926\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F178911\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13299441\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F178915\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F178917\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2530309\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2530311\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F4603416\">",
"      Breast-Feeding Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F4603420\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F178928\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F178910\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F178925\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/8520\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/8520|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?27/42/28323?source=related_link\">",
"      Hepatitis B immune globulin: Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?23/39/24181?source=related_link\">",
"      Hepatitis B immune globulin: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f27_49_28438="Pemphigus vulgaris extensive lesions";
var content_f27_49_28438=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F74842&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F74842&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Pemphigus vulgaris",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Widespread erosions are present on the skin in this patient with pemphigus vulgaris.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f27_49_28438=[""].join("\n");
var outline_f27_49_28438=null;
var title_f27_49_28439="Sodium label PI";
var content_f27_49_28439=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PI%2F53229&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PI%2F53229&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 559px\">",
"   <div class=\"ttl\">",
"    Food labels can be tricky",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 539px; height: 550px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    To figure out how much sodium you are eating, check the label to find out how much sodium is in one serving. If you are having more than one serving, multiply that amount by the number of servings you plan to eat. For instance, if you are going to eat this whole can of soup, you should multiply 850 by 2. That means that you will be having 1700 milligrams of sodium. That's more sodium than many people are supposed to have in one day.",
"    <div class=\"footnotes\">",
"     %: percent.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f27_49_28439=[""].join("\n");
var outline_f27_49_28439=null;
var title_f27_49_28440="Xanthrogranulomatous chol Light";
var content_f27_49_28440=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F75696&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F75696&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Xanthogranulomatous cholecystitis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 417px; height: 276px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAEUAaEDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD0/wATDS/in4MaXQ9Ymu7Bb+J7q1SLEgCsMxlSAVP8WT2596STwVaW3iC18SJJqc1lauJdJ0d8xWtk2zDMUxleckcdSO1bugaaulSarZeGdKGkW4lKny4QqyMU+SQM3U9MjtWbqcOo2/iex8WahqEmn6V5Qt7y0mkMiwzhtgEajgqxPX1w1ep0UL6f8DbT8GXy2V5K7MbxhKJfil4U/tDQwlj5dxPa6lZzupESR+Y6soAHIGCp6hjXcfDyXQdZ8N2OqeGIJ7fTJHd4kdTHvbcQzMP4uRwTWBp0nizUdVmt7rRLPTNGvrhpmmt7lftVrsIK+agyH8wqFbaT8rEGtC6gltbvSrrTLq1stI00mS6gghIADg52KB8wY8ADuc1M1KSUE7W/r7+nUpq6bR2c8VtKTb3MEcse1mbzAGByMEEHrkE59q4zRvC3h3wcZLy0njs9IsoZNolk3eSHZWO1ySdvYDqCcDtV/QryS4sXt2X7NdSy+dbROWlljhyPmlbnDkbuM9wPWsf4qXFrcaDHplrcy2NzdtEunXtqRJiUyqBlAcgZx82MD1zxWUKc4y5U99P6/ruFkiv4qvJvDvjPRby08Q6Bo2iygG4t72Q+dqTOQGc85JVVQKx6EkHijUfFkenf29pviqyXwxoELebZ6vbThUuY2bK+XtGTKTklRnjr70PGXgvwsnhbw3oviOW/nnWc2cOosxWWSRiWdXfrtY7iO2QOfXrNSTQItIs9N1LTbK50K2UCGK8j3tujVsFY3GWOBjPua1UU1GSu3/l1MrSbbK+qeLotI1XTdUudasJvDGoxR21nDBG0txNcO3EgK5yuMg8cYpvxAv8AxDbeG9XvdH8PyT65FI1ppjQlJnCOo/fjPKjJIK/7A7Vw3hzWX8QeOF8R3dppthoXh+1LRvFKJEWKUFlUAdJuPmXHy4A6nnt/hfqep65LrfiK9fyNF1CQPp9vKcOkaZQuw/hztH1xmieH9iufsvxfT1tq9xKXNoY2q+ME8P8AhLwpqHim41Z75gkN5aRQCOSZ2UAmRDj5FJ7cHPvUvxYsNRvtT0bS9M8THw/YNHteFbUtFNzgKWAwowMYOBiul1nwjpHiK106bVriW+s7G6OoW5ExIbncu5h99R2Hpj0rmPEnifVrH40aJ4Y0uxhksb+0ae88/gSjJy4PJ+UDGD9OmKcJRlJcvS77efb+tgStvsbmr+FJ9Q063sNIubaz054gZ2hTCzbvvAY42MM5A65rlfDt9d+LfFlrqHh97i08FeHd0MK2+cXzqMAIo4ZcY69OnBzXQ+FXfT7/AMd22uXoltLa6+0wqr4MNm0SuECDlVHzD3waqaD4zsNV02N/CumXVvpNg7i5s4IFik2kZV4wDjbnLHHXtnvpCdRpxtfz9Vr83su3zE9Wr/1Y7TSr27m0eG/1WxXT72QfvYEPmyIpJ2LkDlvu8e5q5DcLeRzpJbkIr+U8bbX3AgdQCfXkGsG3h1lbPQrZ74Ruk7C7cje0qYYqgJ4JxgkjoVrSVra3j1DUluzciIOuIiGEW3quB1bPUnmuSdON3brta/ey/rsUtjzXxZaeHPg14J1i90rRr28W9dILkLIw2o24L8+MKoyRgc5IzXZ6H4c0pvBGmaRALpdHkiSURXEm5sMyyBSx5znjHufatvWUuJY222ltf2hi/wCPaXGJJNwKkkjAAxn6/hWD4i8ZwaF4ostHks5ptQv7czwjzFRCEOGQEkDdyT+NVGVWolyPXffqjOVtyv4uS30mWbxJqeqLZaLplv5UUaxhxC2cGRRzljkLtI7VU0ltJ1S38RQaPBc6VqOowC4ub29j2yTIVAWXB6pjI4xt9Bmu1MO+ctPCktlKgKpsDeW2ecgZznPXtiuO1/QbiDX/ALVYXrq8/lyMHHmO7KXBWPPAQq2CvTFbUZqa5G9Vs+mnR/rclon8Y6F4d1zw1DJqk0ZisoEYXsO1n8vK/Kpwcq+zH4Vz3w88c6h4w1jXEh0aO2itEwo83czAEoYiDwpGzPHBz7UniDxrb6bpmu6zoF01xp2iWyWN1ocdsI1t5Gf/AFobjoOMDjin+C/FMeueCNY1nwtplhbeILqNykskKwC7lTPJPG/ZnOT6/Wqgp+xakr69Xte3Tt1+7zFpzHerpC3U8F5dGSLbD5U9lvDxMByoI6ZXPUVx3g3RtOh1u/8AH+sXMcd7qqBbRLwqv2O2XgBSeclQCfyqj4KuPFuuX3gTW9RS6bTP7PmS8xtRjOxwGljOPlIUEYzjPvXQeJdM0XU7Oz0a9iKxMfsChF5ZHXkKeoGACGHTFZxTbdOT+7sr/wDAKlok0UvEssHjvwwuoeGNfay0yaJ/N1SBQj2yIST97DAHBBHHHNecaL4r0e1tU8HfD3Tr6337B9unjUm5Z+Cdp6Oc53dq7PUPDswksfC2kfb5bWM+ZfyzsQl0jfKXduh27Rhe+38ar+CPD+nadpMOkwn+0LSyumvbrV4TtaS6JyvlN02gfKWBwMY45rp5YwhZa9vJdG+9/wDLqELqV30Ors7YWOqDT9Pmkgt4EWHLsGckDBkyfzNVLmJ7O8kvLTfBbQx+fd7FBmk2KSCq/d3seMds1Xi13QtL0KfU/ENvLby3RuDHAqNJIY0baxLAYLMedxOGyMGl0TWtK+I+j3a6Il7pl5ZTI0ZvLfDKR0Vhz8p5BGaSk022tFo3b+r6/cS5306k3gbUYdd0GbV7XEKrJ5FskkSr9jx99gOgGOT9KsaybjWg6Wul3M1vMRaw3DlQU2tkzqCeFxnDdScVvWVoum6RukEEk5YyTuqBELYzJx6YDYp0N5D9llntJWhtYowifLuKluFOOwHpWMqt6jnTXXT+v66ieu5nXerWOpzyrpU/nrpcwnupLYjcMKylc9C3r6jI61haqum2014LbSLcTx2p1EWsEIi/tBxyuNwGcAEkDnPNYmg6F4ntPH2zUrpE0yIi5uFEglNyMnEjIOhLAY9Np9K9I1JNLvb6Gx1WCOa/RTPDFtMjIpJXIbHy56duh9K0bVBqMXzK3T+v+G+4TV9zifg7PqmueEtRvvFkUMFvql04soHQRgQsoBCqfU7uOpxmtODR9O0aMWFpaCyis3D2OVUmFcneQx/hJ5warfEuGBtSspdVt/Os7Szkns7fAZTcjHylByTtwFPbLVh/BjxDP4osNdsteiWQaNPHLDNnGxXBbyi3Q7MYPseaaT5HiL6Pp+Gn5P5ktWfKjavvD2vWlvZyaBq9pp9xdam1/qUjAZnjICjr1G0Akep4rA8ZeC7fWPEkEw1yaCx01hG9v5QJBOHAjPRRzyTXpDTPqdxIbRYUhhjKxO4zuc/fXH93bsIPfJ9K53TrG2vdS8ya4M1pBFultkIeNkVRtRl67u+DyaVCtJXm3b5f16IqT5lYvXLa/feH2vdBj0uDW3lTy5LzJAt843E9csASPY+tJ4zs9Xu4NT07Q9Qm0u5uVhuFvBg/dOHijH97ag5/2qhvNft7fwtqes6XcRWt3qkzW2ntdIdqSovlIrDsNyMcHpmqHhGWLSbOw0PVNYTUPFmjRS3l6jsWkdpSzsV7HhuO4GKyinzXt8vuf3J2Q3pG5jyr4/Txd4e1W613T7HR8RxXOlzS5ZeAG3n+J2OTntmuwuLLSV1H7Hrf2S6sopBeWf2xRIsJ3YIG7phjwewqXStWs7/WUtbFbiERos8jSw7C7sPutnvg5NcZ8S7XxPdpFd+CrraltC2nXSSN5WGyAT83GOc7u2K1jFynyS92/wArdvT/AIJm2+iNn4mW9/qXhaW78HaZpus6tHMXhdpFbyhtILqf4nHYHtVm+kurDQYLi2je11V4vtNwsjZj8/CjypJOq8khayfCFlNolkIY5y12uneVPdW6EwGYDGS3QEHnJxntWbp+lazH8W9SuL0x3mgarpiMkclyoEsgIKbVJ+8COvbNX7NwfLzXS1/q/wDX4gjtLm4T7Dp8sVi+bjcYY5QALaTG9gWHTGxiD/eC06PVLO31eaztAGvJEE9xNJGFR+wGfU9j7VnabqmlxQy6XPcrf30Eyz3kFuTKkWTgIXHAwSCc+hpyW81hCZDG195uYo324EhZsgMDyApx+VL2ad4v5ef9f8H0Vipq13dWFvcoqss80ai4beFjtI2LZVSeS3TgeorkV8RWthqDWWmahZ6Xp9pbRo73SB/tEQf54UH8UhJ7Z+8axvFWhzNd6wjapf3kFpfxz3dzNKWWGLYchV7guUAH+z7VzOqRm2+xajCCktvcqYDKQQZFBZgR2GNnPuKMRVjQgut9X6f1tc66GH9pfstj1K+8Zx6n4Z1fVNNSSSz0Xeby0hfZIVI+RW9gM8e1UtGaxvPC+nahokES3UVoZrSTUFBuLWd+j88MucjPYYrk/hHZyavqfim0vBA1jrlpLbybGCsZ2zIM+pG5gD7CtnR/AF/p+oaHqmrajJaQ2Olsk8FwQ58tMkgEdeowD6GutKCvG9lo153X49Tjszprvw3q+qeI9F1GHUrTT9QtbVUv9L3MIN+MGWMjg44wDU9x4XsZ7RmttYe5uTayCO5VFmtoJASCcnJHzZ4Brk7nx/oeq6bY2txFqwkng+zXJ3iJ3SXlNzKfmXHbr6103g7T9L8GeG9dvZr37Rp1mi3ywAcx2+0kkRnoWwRk/exmspxnRj7zt0/T+v1BS59hI7azvfDWl2WoajfXuo6epki1k26SzW0+OVCsOOwB9hWpEthdXenzyxQTNYv58G5RvE2MM5z91m65FVfDGpDWyt3FplnpcU0UdwskcvmCSOU4CSjoD/KrV7OtiVa/jD28DbtrDlcep6lR79KFBX5bF8yZ6hRRRXz51nnfxDfXJNPgsvD+v22ma9qEu6FLyNSywAfOiYzz0OTyelalz4YkubnTL25vpLOTSS6LKrBjPAdpYSZGFJ28kZrz7xTd/EVpItL1jTLG40O6he3OpWiebOkm07JwinIwcNgA11fhG0v/AA5oth4cvtUhvb235Wd5N3mAKS+5SckA16STjH3Gr6/d/wAMapNsm8GeJNB8U3hHh+SS1e3uXmKrt/0hCCBIw67W6g+3asXR7a00CDxxf2FrL9jtrwfZ7YOXgjfA3SIO3LbmHbFdRpmmaJ4XtZtRtYrLSrOaQ3t3cRMPKkLKRwT0XnOMYFc18OfEeieIHS08MQL/AGREzwpA4Iktn+ZmklXncHPTn+dXFrWSvbT8NXr/AFp9zS5tLs3Ne8U6f4bisNT16/CQSER2wK/fRgoMh256llyPTnFUjbXd14vmttQ8Dacmg2yiQ6qbpcOcbsrFtyQMnr3FX2vNI1i7RNU0KRdQ025aG0t5rcSgEFQJkCbsJkr8xxiuU8CaXrdz401C78b6ReNeRSZg1CS9HkrJ0At7cE4Gw53HP3T3zUq0Y82z/razXzfcG23Y6L4gxWOvanpXh7V/DFzrWn3bi4juI3VFgI4JzkHgHJ5Gd2BmpI/7Gv8AxlcwWplM3haGKJ9PWJWBDx7omQ5yMAkdugzxgmxL4h0G+8VT+EFuLye9FqHnkST93EI2JwXz9/kZAB4xmrdktodVg1yw05BdapILa6uupMUYfYRjOQSBg+h59p5pRikk1p99+vldJ7evUVuqLerX+m6Topu9YtYII2O8xFFbdK3O0Y6txyenvXA+JvGMPgfwpYarq8MrXeuXAEls0g3R24U/IhBAAVSO/Vj+HcaLqEmp6zqsDtuexkEE0Jx+7LDeoHUE7GTOD/hUXir/AIRm91DRtN1+G0uru6uHbTormAyDzoly2MDAAHXOAaUZqk+SavfV6/NL9fkEtFoyp4F0TR9N+GyWeiT3Vxoc8Ms9uZwWdYpMttHGSBk49a2Bqk9zeQ29xZT21tNaJMZR8zCRjzEQBwQMEn3rnPAFl4i8LaXqUvjbVIL26v8AUf8ARorZXMNur4VEHGVXPboBjnrUeg6n4jsoItH8fva3mrahc7LX+x0cbYgAS8hIG1QR19+lQlzNvfX+mumhKN/VNCik1S21Kzs43uRanTjIpAeKFyMspPDBeuPrjnisrwT8PrPwlrV/faZiN70gSqn+rVB0QL65Oc9ulSad4mujo11c+IbUJD9se2intlLxzDeUAULlxlgRuYAe9dDbXkn9lNc39s1tHC75SQZbYrHa2BnsAcdabdWEXC+j09RtX3IPEurzaLFb/Y7C4v7m6doYLeLaq7wjyZdiRtBCEZ55I4Oa5z4eT2snhi3/ALT0a20K+vpJbiTTon+ScjOXAP8ACRziusm+1315YTWF5HHpoEhuFEeXnyuECk/dAJ3E+wHrXFxaP4o/4Se1slAbw5HbrBfS3coc3GASrQKvKEEYYNjOfxoouPs3B6P116/L9f0hqzOn8SaNFrnhf7DeWovF/dyG2ScwpKyEMFZh/DkDjviucsrZNT1pNf8AFvhg2urWMhgskE4uAsIy6zKOAHJDDaMtgDipPC3xF0TxJq76TozXcQtJfJW4ni2xTlAd6LzuBA/vAdqu+M9a0+w8QaNpn9ptYa7qYeOzItWuFcKVJDKOn3iQxwAN2TxQlOlLkmrN9ddv8n94aS2Oitr611bS4byzkM1nN0KqQWGcd8FSD/KqOp6NFfBrmdBdX8HmPZTKAkkOQPkVh05A5J5/Cse61PTvCXhq5ubeWbVxZhp7iG1IkuJ5S4G4KCBjOcjtj2roo76a70y01CxhcLKiyyW8qbZgpAO3BPDDPINRyypu8Nr6X/rqI808JRX1jrd+fElvovhuwvkDXNhJLE7XExGA5fOGJxnPsBW18Qbm/wBE8ERXWmaal/qtu4hhubvY32ZXPMxC59AAB7Z71u6poWiwS3mqDQLe9v3haVg0YklY9lAOcZyenvXC/BrS9X8OT+I5tUSytPDG77XBKrjBkP8ArF5YkJHt2jOPbPOOx1I1F7ZLRW02u/Ld/fe5nqnZG7p9vrGueCJdP8aILXULyCSOVoWWNgrHAlbBwrBQMAHnmltIU8H+DtOttBgGo3jZtdOL/JhSxxkt+fuT6VneDGudY8Papr3iZ/s1jqY8x/tB8kvACQhAJ/dj0z1znvmtSDT7q61db+S4aW9thMLUIAtsI2OFQrnBCrj5s8nOKqaSk46WT1tt6enfy+5OOq1KL6fo3hLSfFepau4uLLUFjXUII28yIEIIjEg6ln5LdMbvauNtdLvtR8bN4XsdDn0LRppLbULh7qVBI1pDjFukaEgRlh1znkgitjxZo/nPbadLrOlx6BLbvJHbHO+W5IwkpkPG3pgnA+tdL4J0+503TtQ1vVLpNX1acJDJNaxnb5MS4CIrcnPOcdSc0ThGEfap6v1+X6sbnK9ugnxJtLePQbXXtSfZbaNIZGhbAintpQEkiIHojEKeOVHrmtTwrosGnafLDYaRDp2lXKnybRcKIkYbmaQZ6sewzio7PwvL/wAJkfEEN00KX8DR6jp7N5kM2BiJwD0IHXHXJpuk+NdOvdXv0jYzW+m24FxfoAIpZC4XCDOTgjr0OeM1zpScXGnr+nl96/HsJtG/fQM0ItGwZJx/rSMKxGSEx24H5ZrirSHx2nh7WGW6sptemuD5KuqhLRcYyvZjjsTXR20kr/YrmS0itHmkD7C5DqXOCO6liOozkVoSrFOJIJCBbImUK/KEbJXBHXnP480KThFx0d/Lz/4YlPXmtsZF7qmieB/CdhqGr3EVraJJGrybcGSaQ7WbHU5JLHHZT2Fcp4s8O61q+ivE4ke5nme7umjcLHcAZEcaSA5j2rsYE4B+Yd6vfEE6J4vWTwtr+jX97bRTKRcQOkbecsbMTGC27pleRg7sDNQR3ek6PpaTx3mq+HtK00R21jK6tJBcxcDdJFy+Q7kHeFP3exrSk6lOSm1q9e//AAf1+4bipKyNrwp9us9B0qy8Vyo144P2hWHmBcKdiK49AAc89TzVfwQ+oXEmoW2saBa6LpsM7tpFvDIC1zGCS0jqDznKnnHLV0Ztrt7GVHgR765BEkjf6p1GFyRk7QQcgD0rM8X2s174bv7a21+z069t2h+03QkCeTGrBirnPyhhnrjOfeolNSe9rvp+a++wRjd2MtobO6v016bUJ7Ce2gSOYywniN5GOACOS5GAQDgAYrWvr3+zZTa6DZ2iXt1KrSGT5NjNz8/+0FxgViWMd/rGzWrrXYri1EoewFkwa3faxwxAyfuEDaf4s1salb3reLL1jcaZBZXFtHHEXQrOznIAyeGOQenbAq9OZKWv5dP8/wBBNW2dyGPw9pPiDTTpOsaaLjSHmOoQLMx3mTzCzlsHqWZm44+aobbwbYaf43vPEUMszX12GhtLdxiO2YRhWZMddwUdeAK3JdMhtNNsjH9sM+nyNLEI2JeRiSWQ+qHP4DHTFQwxyz67FI+ZhCzzJJuIWJmUAKD3UnIx1yKhSu5Si7J3v/Xnp+Ia2sznIl+0z3FtBCZNTMnlDa7MEZTxIzgYBA5x+FaC6lJfeKdRtDE9nqFjeBUC4/0u3aLOQRnuc89CKxJfH2n+DvE/h7whqWi3S6praxNPcxbBG00p2sfvZPzk5/TNdlrUdtdrBaaox+0MshX7P8kjhe4YHCqR1BI5NaSrc07W0t/Xy/q5LikUIH8+KezeRokvbQyQozDeF7l+xHI5BPBrk28VaboGttZQ+MJNVutSiEOnadDbq/kyrkM+R93PQZPfvXdy6dpYtJ7IQrFb3MH2TYZAHeNkI8uM7vl615fpvhG08CeAPE8/hG4h13xBuQGSdN81uuQEQxjLKy5JxwSR7U4TjN2tu1/T3/MFfoSeGfDtt4V0nVLdpJQzFPOumg2tbQhgXeT+9I2T0zkLxVv4eeLD4k8b6loqaft0y1LBbwTFWlAxtDoeMsMnjnA7Vo+HNR8TweEor/xYqf2rPOsdmCojbcUIMjIDzgZIU8gA8VqsNR024S4t1tpRGpnuk2Y+0x45Kj7wYdQ2CD0710SlKUZJ2u9N+tunp/XcnTc5TVdLa+tfGmkzXUaTXKJKXxxCyEkMPXAVeK8y17xBC1rHfCAwFYBAqIBsucf6yVsdHOBk+mK9svNEM3mS6ewWzUq+6ZWjeNG+ZnbcAccEd+mfWuW13wGusSG8t4vtdzcSbreVGHlxxgdQBw2cZ461lWo06yvezsddKvKkrIw/gxo82neL7iG6tzZpAkWoJLKSVuVkViu30wMjPtXV6fperR+LrjWdA1OOTwpqcxa/tZELjaOGVUPKkHPI4O6quqeFb64lih0m6ji2xRS3C3E2BiNsjawzgcn5e2ea6vWob13ig0+KYi7cLMhki3QREDzJg27HyZUepyMA1rJqKV5X0t8kcstZe6tDjfDPhnxL4S1DxYdEt4tH0bzkurJpIluJJlIxsC5yqr1OcEZrQ8XfbLnwNqt/rWjNrLwW4W7t4JCnmgdsD5tv8fTjJqTTNa03xLHIvhrUrqXR9Am2XElwpb7Uxz8yyE5Zc5B4H5YqXTbKxv1tNR0/UtSs9UleRbZlvY+GViTC0Rb5iBxjHTHSp5nZyaV/6+e2vUFFO3Y5j4Ha1ZahoNxpsPh1bLw/bRNJd3aSMcsOQ5zyenA7YzXZR3Fn4isp7Xyvtd2pJNmxAklg6MjkcdPQ1Ml/DeaF4k+12Xn3EQUXNvbOIxdt2UH9CB1qbw6IU02O6m0Sfw+QyR+UbhGcZOcEA7h9DyapyScpW7fp5318ltYjXY9JooorwDtPEfGEPjKD4bwxaJNPZ679pCR22nOkv+ju/wAqqxPIAIO/jpziu3uf7N1dtS0jTNS06KKHMeoJEwMiPIOhbP8AExGeh7ViL4psNA17TPD62sf2mKZLSS7kbcVaUjhOh5z7AVtaPZaPpkt3c2FhYRapNu+1qsBR5CD8uQ3vyTznHFenO6963p9/9W9TdX6HnPgg6h4l8TP4c0mGC18EaLJLbahCq+bFdsQQVDOd2054x0rt9Y+H9vZ+C7rQ/BskWjvcXKSTyqpVpEDgld4OV44BGfTuaLW51Wy1SPTF0GGOxJE2sas9wtqrS4BZ4V+8yjHUgDAxXT3Ml+ba+ngktYrpwIdPmkzLCxbG0soIPXGRnt1pVqs1JST/AOD/AMH9CFHdM8rbSvGviDRPF2hafqM9gI72KGK+uUKGWIgiUIwycfdP4Y/iNehW0A0ew8i81Wa+uNN06OCa7KATFs/q0nAx1GBzk1rXWpnCWyTxPMoZLl4x9wgDO0c4bLDAPXNJfX2l+H9OSbUrq2061ldfmu2AJmYgKSScE5x/9bFRUqyk7tWuHLyvmZ5Z4st4Ph7a6l4rN1ENa1O5H2cTJtSy3RjKnAO84QA5xnNdTZeKtTsvAvhjUNf0Wa71e8YFrexGEizuIc+g2Y4965WXwZrPizxxe6Z4k1mzk0SzcSi2gkUzzJlWXev8OSclvQgd69SutPkN9Jc6Y6lnjW2YBwFjRDkgDHU5I/Gt6sqfuqb5nu+nor9hJXk3sQ+QdP09n0W3aO51O7Fy/G4xtJjc7juAAM8496LGxTV9Yj1HUbe1nOmsyafeQsQW3qBKdoJA+Zcde1WwmNLitkQW3nsYfLiOWROQcEZ5HUnkDmrOg2C6TplvpsMarDbRhEZFwpGTjvndgAk9yc1xzkuV9/6/4YcnbYjjtpbe6vLhAJJ55MZU/cUKMBhkAn/GsUX7ate6jNYot2tvCfsN7bBSFyvzKG5BJYdAD2qTwvN4isJNXXxnd6abX7YRp1zGRGzxMSQrr03DgDHJ/WobbQ9O0zWtZ1Vby5so3hEH2eKYJBFwBuVMYEhI/UetXB2bvq7afh/wwRe9zz3T9d8U+I/+EZ8Y+EH8yxtbZrPVdFlmEckkqscjGCqseoPB5Fdf418baponjTRPDtjYwStrCMYri5LKkTDOU+UEOfbj61r6VfpoOiGbXdQtmWBWe7v5LX7K075+VvLGeccHuSAQO1ZFl4ok8T3sF/o5WLTbJ/38k4jxEM5Lk89Y8gAHIzzitYwc5OXLou/5EtWdupm/C3WPEdk9x4d8UWbxy6fmRLliD5sRJPzEZGec5B6DFdub69h8RiArZrpLIYk2OTJ9o+8PMGMICoOOucjpkCuT1d/E1r4xF5azR3Vpdsq2UMcZeMKVxuZh0HOSScelWvC/gNtE8V6h4hudUl36miG6tC5aMzBgQwY9RxgcAiqrxpv95KybW3mSlZWOY8Aa74Z8W6nFFrWmW1r45fzEvRCjRPE0T7lLbsHJChuM9ME9q9Hg0/T9U1E6umnFbi5tTb/bS22RYwTgKM5XO9yCOfXtWRptxM/jPXNP1SWOe7XZNYyrY+V5ELDG3zSfnOQM46ZH4WLzxz4a8P6zpXh6+1SIajesYo1U78SZA2uR90lmAGcfhXPNyfw3/wCB1BpWKfhOaC98WaxZLPuuNDdYzbqo2IHQ+U2cZBK78jnqD14rsYFaOZdibFdWkkGOC5K45/PiuQ1LQ9VufibpN5b3FjaaHaK9zLDDIUnuZmR0LSKBhgMpjP8Ate1Z/gGXxwPFmqw+I8vpjF5I3ZU2RuHx5aEENgoVIyCOGycmqmvapz5krLZ/p+YpJpo6u5vtSj8T26LEDpLQFXIxmObII3EZPKngCuNHg2+HxH17Xbu4fV9D1FIo00zzNsUMiBcmRDw2MZGM8k5Ga9Hm+a9hVJId6KWZWPz7TgZAz04PJrL8Q2moanYXNppF01hIoDJcIQA75OVPBwPXjnP1qadSzTWmglG7scsILnXLXU9Q1NBqGmA7Y7O3jw18qnKABm+QBiRjJyQx44qzr11LL4WthqEFto91cRhZoXnMkMJ7R78Llug4AGcjPeua8deM/EPhq6WKRbNNPuoUs7S9hUbppyMkoNxxjJGDxxXRadZt4sgji8T27zRRAXBs3i+XcDhfnB2scc8HrXZytJVZfCv67W+YONm4mH4W8M63fWXiNNYgbSob2ZId166Tu1vHGqnCL8qocHHzDHXmu3+1Opd47q2uYreAN5Rh8tCWH7tQ2Ttycc8/QcVTk1mz0rRfEdvZXFreSaNalzp6kvJD+63CNySS2T06cHHasf4LeI73xPoF1Jrlgba8idFk3QmOObjh0VuccY/Csqk5zjKo1ovLvb9LdSFbZErarN4z8PanZ6Rqw025EIW8mRS32NyuTGGOORyCR168Va8IeC7fwd4XGlaTMsdysgllnMfyTSNwFKnPy84HPBANaujWumaDdSW1jazrPqMsl3du2DsY5JaQ5wAegxW1LCZpFkDq0LDB25zjHGDn1Oc1nOty+7HSO/8AX9dg5TmopN2u2qsm37LbS3n9nldzRyj5Nyv/ABZDsO/XtWxqKR20s8scKvLLbM7K5ADmMjaCex+brUl9pqtdabNbRBZbZyok7JGR84POTnGB6HBrl7vxBeazqGqaZ4YjuU1JYHFvqVzAfsUboRhc9WLHrjPAz2ov7S0o7Ja/f/T7j5TS1C2vtN1C91CG+0yCzuURjHeDZ5Eo4Lb/AOIHjjjB6da53xBBfzaDew6Npmm+Jrm2C3cM0kwAe9L9SnQBRhsbu2Kl8Z6ZqWpXfgbUvstrDrdreqbyNnMkEUBifzi3TK/L8pI+8V6VsQGzttTmvoQ9utqha6EZzG6HcUC4wC2SDj04rSDfJfd/5adPuXTXUNnc0PD9zcxwyjWdUguLm1hT7VsjEaRPty/OcED9B1rxvXvFeiNqXjXU5fD02r+EdXtraO+vrKTJBQNGrurbSo7DGfuhv4sV6Vd39u72Oj6k1tc3OsySJ9jhQgtERuaR/Qqu4HsSw9KzfBvgFPD+myaffIbu1ub+VQvUG0Kny45R0bGB+dHLGHNKfXZbddX07Be+hw2m6vqvh/wn4dvfhToEdx4QlucTpK2ZWcNseRmJ5DcDgDBjJ6EV6T8QrVTPpmp2vhn/AISXV4LwR2aLKYVtePmd35GAQeo74rL0m1t/HdhfRyTLpuiaRdyWdoumSNEu+IsHLEja6Y2YwMZDUmsXl6h1AzaxDb+D7O28z/QCDcTQGMbpGkzkMJN33cZBGTTUVNpx3XTpbor7t/8ADCkmnqanjvTrm9+HeoweI9eg0bZtml1CzRgIUDAlQMgngFc55z07U3WbiCTwoL7QtKk1+1v5YFaHzvKSOFTnzcnBUBeeOc4rnPhneT+KvhVDB4g0+81OGS5ljWKSQGW7ty5IdyxXIBYqTwCV47V0fhfQLTSLM2OmubjSpZrkPD5pkTYV2iBG4AUEEfNznvUuDgpJvVPbp/wNhqzS7D7a9t9Ums9dt2gu9BW3Mmmzx24LxbV+d8v83IBA4rlLLxBrXirwrqEsSPJ4ptW+yrbQhVhWVm8yN1Yn+4FzuIxzmu9sYY7WGG20y1azdYvscMGzdHbohO3cgPCkDhu9U5re8giOmaQv2NbsEr5FvtaNcgM8jE8Sbeh6ccZ4Fa05xjuldWs/Te/69yZK70eh5/4g0Pxu3gjTtPtboT+IsST3lrbzpE4kIJjAkbghTg4BGMdcV3sv2Wya712aK3t5liSKbUYbYCRW4DFxu+demMAkc1z/AIR0DUNIS5gv5RHbSXMks0k12WlghUHLh8fKd+DyemaNK8V6B4q0BbzSTNBLod2qqt6xABY7VkZVJDggnHoTWtRaqEdUuq8/v9OvnchX18y3q02rTStY2MllqV2LhY7+2nxGbGBwzfauTk42qQAOc47VhWvhoweLIfFK6lfu+zdHbBC88kRBVnL5wsePmChT2rWtPBtrF4+n8TWuqzm6meR7PO4LudMOkhP30AyVXjGODSap4u0Xwzqsena001k80XlFHyz7ck5jC5+Qnk88bacXJrlh27fehStbUu63q/8AZGgajNq13JDbQRhvOnQZaEkZBGfl3ZC9/wAM1yWq+MYDa+F7nw/ax6dpmpW0j28162yFWjcEoAudv3TyePmrudUsrXU7V7i9RNQS8CscMptbmPgbQM5zgfnTBZwTwRwW9pYw6PaoUtLRYt4PruB+6B3A9amEopptf1bb7/1HJX0K9pt8SfZLiygEtrdOtyeQUiQ5Dk4POWU4/lUWmXOl3ieIX0iVC9uz6RtdiBCV3YHrgl2bPOenar1o9ta2kVvpkNrZfL5ckcJKpyf7nUckYz2Y1mXX2TQ9WazsdDZJLkie6vopFUTXK9I0DdSNxOTgAHrmqu37v3L87gkYs3ha+0H4T6f4b8H3aSagsEjreogUXDsxLhc9x0yewFcxY6Ek+v8AhI3+mrY3OnXQur24glEvnCUAlpXBG3LZ6A/hXZeMZdU0zRNetrOyu/tlxp8k1pfRndDE4PMaj+EkHr3NeXag1w2n6PZ6E1xDZrZyW15qEgx9qYOWARhwWTJB7j3pOqoU736/mbUqfPOz2PQLXxncaL4t8V3OsWJOn2MU89tJkBFZGIQdOhAAB5PtW3YeJZtZTRb+ZdLvFnYNL9mVhJal/lUkHqyng/SqukaSuuxSXGIH0nUoktbu1uJAZZIHG3ew7HPKkd6ueFPC8vhK3uWaOW5s9GtJXtTne0shyc9BlscYPerk6UfVK36W8tTBxs7NnqtFFFeAdR4xZWXjoarNqnj6z8LfYLZXddQWYwyWad2Q7GDcf3uR6iuu0PxFF4vtG1DRdTtP7KiuBbm5jUtMzKRwMrg7mwBx39a5lrOKXxdqCa14iuNV028d9Lg8O24Dwqu3DLJn+IDLZ4Ix1rZ0LSbXwzoM+jWMEmkWs3mrZZYSNAqKS8zPghSeoySc4/Dvd3q1Z9PTyRtGLOV1TRPFeseK9U0rx1d6dL4DuHkmRriWOK4jiHKCNkAIOQNwYY2555rqvCq2elXEOjaVMdRXTo/KtUcMZICVJMlzIePm6DC8D9POfEfhrTvC+gadrGra5d6xqF1OshnmVpo5IsH5VLbiDjpzgntXoulG+Phhpo1u4/7Sije3+RftKEc+WQR8wwDyexNdEoJxVno9Oy/rv/wRQ310Zfhj1TTrp7q5tLa51K9ut0VrANgjhyoZmbOHdevUdfywfjTYeGdYm0DQvFdnqkUF3c+TZ6haBSsUz8bGznqO5XjitnRdd106qLrX7G307QHj/wBHjuBi6hkBVQGwxDA5Yk8Y+XrVb4ueJtX8L2GmNo2lNey3N2qLKbcziFiecqCNvykkH2INYtT9ok9/J/1sDempSmj8A+D/AIhHWdQ1FdL8S3lgltsu5cK8YYRrIQOMnylGcgYXoDmui8f6bq+reGGtdBvfs93IF2vBlBI2Qfvgkoh5B6nGMH1r+MfDmgXDWWueImtfJ00lpZL1QdyHDBWP8WG5C9OcYq/4U1Wx1jTLqbT7ucWwuCZ47pDG0ClAQijjaMbW+jH8ISUUqsOm+mhOidmUPBmjzeEPBkkl9Ekt7aRzSeTbSPJFGCS5SIvgkZ7nnPfgVg+BPiZNrMcSXk2mEJOBc3U0v2dFR87FQfNufPGCRwOpNeoW81vcIwglimRflYIwYD2OPY1xvjb4deGPFemGyv7f7JFDKLiT7BsickA43YBz396IVoSclWjq+vYlkHjvRdF8V65pem6tqsCXVlcC4jsymd6kYxjP3+Dhu393vW1eWupSxatFd2Nrd25uYWtghG+VMJuLA4AZSCQc846DpXn6fEDRtc+Heqw+D7yS31izsQmn/aMG5lwu1CpYHc5IK9zk5710/hu1uYtO8N3XiGTVZfEtvprB7cS/6zIGd+MIzjgZJ65PNW1OKUX06fjdbWXfXQpPZxKupabqd/H4pW8jNtbTW4CXEpWZTKv3HjXAJbGOoHzetZ9n9k8KQ+HvAkehzXkutCa4u2jkCFEByXc4+Zj8oKjHf8e5jk1iTxRdQajbWKaBHFGbO4D5mkn/AIsr0AHbjqM/TgvH3j/WI9E0bVfAXh+TVDczvC1zcWjnyNr7WRkBV13EHnpxTjXlUtFLT1tqlp+QNX1semWZCTSWNtC9vBaJGifJhWXAwFPoACKwtevY4tXuI9SmhSGNI5beKXlZEzh2AHJcHAA9x61s22mxW+pXVzHc3kjs3meQ0paOMkc7QfXrjPHbFcz8NvGKeM59din0iWwm0e9NqiXMeJNmMqSDnDccgHsKwptRbna6S+f9f5hdI3BEZ7nS98Jgni/eQlo/uAgh1PzYyRxjtx1rj9c8DWFr420zxE9joyWcV01xd3d4pE6SswWPZswrLk8F+VOGycYrrPGFxqOmaBqWqaJpratq8C5tbTzMBjwDjp2JJHU4x6Vy9xo7eMfBV1Za3LNoviLxBZo89kblmETR/wB1Cx2jldwHXvyKqD5mney6/r9y/EXO1dI1L3xHJN4tv9P0u0h8+whCTS3sJiTzHKtGRL3XG4YAOWxyOtdFo8epmzs5tWkhGoBCs8duCsLEkcgEk5AA7nv65Hm9/wCJLuxbQtE8I3GnX+kWsElnqGr3befFZTxgCIyNuyDkN167hzXp2lXkVxpkMovra9KKEluLcgozgDcQATjnnGeKmsnGKshPaxyNp4MmsfixqHi9dZlltbux8hrBxuKupUfIeygDO3+8xNYOt3lzYX32FtQudBtJ5JGtLm32ySXlwx8woMhgqDeF6ZJyMjFeo3qSl4JIljYI37zIO/bj+E+uccelYs/9lw6hY3EUUcr3JcWpJ+RZOCSAeFJxyR1x61rhq2t5K+n5XIa0scLHcazf6zoOm6voVlfaYNL+0agvlYktb3qVHzHaMEcDP1rudMmWz/s2OGZPsEkssUeBgZycL1znINed/E661vQPDl3JowNz4lkUorQcm1Rsb5WPdj/Dn7ua7jwro1/aeGvD1m80TpBCj3ZuMtP5x+ZyGHAO4nt+Nb1lFRTb0f3bPb9P+GYk+hLL4Z0u013UtR0a2trPWdYgeGe8V/m3KPlPl8hjnGenT3qTwzY6haxXOpaxuS+uyi+QH81YEHGARxgklj6dM1l6N4als73xda380osdaupJbeeFyJId8CiUhudnzA49DTfhX4b1Pwd4evNNvb+5v4hfM1q1y+4xwFgAvXIwvOM9TXPL3YOMWne3z/rr6Dszblt5ZtJ1BbOy8t5biRSsj7vO+bG857HsMjA/KrllEItP00eYVCKMMh2qxYY27ec9c+2KyviB4jHgrwfd64ba4u1ttuYkGTl3A3N7Atnj/wDVpJqUTWGjTWsDn7cY/JQgKUUrvOQemEDZ71neUo6bX/QOpzHivw74i1PW9F1CxvLiHFzbtdWy3xSG3iRw0oUKoMhdcjn26Vd0/TvE1v471fUp9Zt7nwzNbLFZaei7WimyMknacd+cnO7pwK0LCWaC+tLe3vmvbKSKZnaZ90rSKR8qsMDuePar9rPLNbG4SNQZWD7Su0iPOBn/AGsZP4YqqjlZJ2sv6/r/ADFa7MLxDFJ5/wBqgvreyS4KW13KzqpQryV3FSMkEjoBwPWrO+2imtdNsmgZ58lrdwASiAndgHrnHPHUVqa3e6Xpmj3F9rUtvFpkaq8sky5TkgAkY9SK5y+8XeEdMutfuEmjn1TT4Ee+itULThCBjavfgjOOnGaqNRyjaz0/pX9P8hvsyfRJ9I8T6jJrOhXdnPd2e6wmuQheRW6tHn5cAHacgcke1S21uuo6vZXX22+S20kyFSso8q+YrsZ3AGTsOQOay/h7o/hfwtpj6zpl7JDba+0UgN64jBYhiiqpAw2GOe5xWisV1E97pqW9xbrMzxW93HhkUk7wAo+6uDyT15q5JOUoxei0V+3X7iYuyK08Nw2iz2cemRWGlmTzofssgO4M5ciSPHCsWOcHqTwKqPpkdtcz6l4iNnaaQkQX7AkO4lCSB5gHAXpgc+57Vd8RalqNhpkE+maDeanqvmxxNbQsIkAQ5ZsscBCCSD34rm3sPED/ABbtvElhJPfeF9Us/sU1spB+zSKCMSI38O7dkjuTn1OsG1FrZa/8N1tfv5aC1O8v0mtppG023gJSzMcCEiNM59QPujjpXmd5oWs+Gfhn4lg8N6pc311Ldo7QpGEkto2CLKiFiQzFcsGwOTnFeiR2cUWnabp12lxdRvDJbyymUrsAHzZI57YGPSub8H63JrmjzapqUM9j5U8kYtNpjkVFkJgEit1fZtJPvU0k7XWqTXz10/UNbalDTT4nj+Fmk2FzNFYeNb5JIYJb6XY6kM3ls5QHLCPb8uOp55FZ2j+FvFtzomu6PceLL2S51WVTFrcOHEGzkxYBVlJAxuzj0r0HV7xW0q01ee281IY5H+6N8TlTggEduQcYrnfhVr83ifTb55bWPTDZzGCSG1bdE6lODls8gdf1prm9lKpb18nf/hhO10mY/hzwxLZeEG8PrfX97Y6q72+o3l2w+dJAUIgbrn5upyODxzxe8CeFdO8Gxm3sidSk814bp4XSV5XKkhJF42BQMYGetZvw60zxR4d1UXeveIrbV9Cl80xwKuTEqk+XKiADG4cHGRz+NTaB4L0DwIniHUNRnu7WW4vjOs8t0xZIiwAIYcHOTkEEnoc1tUleTV9H269Pw/K3kLaz7G5aSyTalqPh68s7m10zTJAYrw5eO4jcAhFPBDjJGBnjJyOlTeMdDsvFVsbJrE2uo3Kb0mkASdFjYYEb4baTk8EdMg9cjItLSw8cXuh6vpWtX8mnWM03kxbWiEbqMFpFOCx3FcZxgE1Q+CY1KGXxHBrviGy1me3vZHiRbjzJdpyGZi3IGOABx61k7xXOparX7/8AN6sq6ZsaHpkFnpFl4c0yGW2jsvkjn1C4Rp4Azhm3IvGScBe3OcjoZobpfE8uoXGnzz6ZNbagkFxHfQeVLCFC+YiYJBMgIIYZ4qS1udNt9Qu9S1KO0nkurUrcX9upzIBIAkZX1UY5Hp7VaM9k7RaZ9rS51R083y55VE+08Iw9R15PPA9KqXPzX/ru9/8AgemrJ0scroPhvVLD4sXVyYFOj72kjuVcsbncowGzx8hGD9BXTWbQRXd7a3aD7fPMbiKG6Axx18rnoeeRWZ4z0u+vtGstO0EzDUkDN9nllMa7AcHc44zk59xVzQrC30rwxptne6jHq94YpDHfOwl46FYX64XdgVU586Tbu9vPS+orW06FK81prnwvqB0i6ttRktree3kW1lLpFKMEB/UgH9K8z8M+E7jUYrfSp5NRlsogbiQNKsC2Mj8mVRg7lbqPUHPFdP4MjtvA3xCtvAHhuzvJ9F8l9S1W6u1DOHdAF3PgLsAA7dT7V6B4W02xga4XT1cxtO0ZR2LKoUkKDnngDhfTGKmTh7N80d9fvNKcnB3RHa6XZaZGt/uihlntorD7WCD5apxGEXHOWOeSeawpNb8RN46j8ODRZZfCaWbfbNUY7I5WZcvIH575GwYOe+Krat48sPEEFxpHg6W3urvTriJAgj5llDDAjQ/wAj5mOMDP1qXXfEU13rd54Jhimj1G40lp7y6gY+TYTMuQAuDwSck5peyk0nLr+C7/AC/rUz5ru563RRRXjnQfP1nc6PpfxdupbKe6uL26e4u4JrtjHDDK+QUhjAwxYHBds8dK9Ft7ONLa9s7GS4kszZyyKpYbJdwOSQwOCGPbHvmr2qXaNouiX+pWyWOs3jW8KJ5KySQTSlQwGR/DlifZa4m68UR6n44j8M6Jpv2kTTM2oS3LOB5PG0wuD8oCgsfpjqa9NSdRXS2/T7vl/TNouMY+pLdeLlFpZ+FvDFra3uqR28Sx2+oSeWNi4yjHpv44xirWo+OLnR/Cc2rXdpcPrEKcaPdRiNo5AQHZXwTtClsEdfbNR6t4Ps/EVyj6xZJPrFszLbz6VcNEHjxlHlYHhgRgHqO1Laa3aWHiPw/4VurSXWWs/wB1NqU58wrMEZsITy5THzdwCCeRWj9m9Er9X/Xn8mDutHsdH4eivrxIdU1izbTtVvUKRRTTCZrZSu7pjqGVePfmsfwa3jyzvNXHjHVNPvQ0JGm2luqRSzFScv0G3I2jGW69sc2fBE+u6jruvXesxFbY3bRae4Vdy2zA8Bh2yobJ9cVjnwJPJ4l8O6rqOszXOpaXuknbfgX+C3k7f7p5wwHB4rNxjzNTt91/kvLv/TBpvXci8dW9946hks9DktpL/TAkdzoGqlkhLsMiTzEOXZQCF5xwTwayLLw1418X38mj+N9LXSPDKJ5Uy6dekCdlCkO5bcZARhc8fd56V3viSPwijRTa5cw6W0N0lyzpOYCJDyBI6kdTnjP86qfDKPxfL4g8VXfizzI7aW4AsovOEkDJjhoh1Vdu3PqWJPNL2soQutLbJr8u/wDwxE0r6D/h74KfwxfXjW17c3Nnc7JI5ZFRDGi8LFt288EgtwcAV0VvYaH4buNS1hkhsZr5t93cTSfeIJIBJP8AtNj6/QVH4vuNSt7axksZoUjEm263AbdpH3ieoUH+dYV1baP470Xy9Skju10y4HmtZBtsUygMMIc712MvXP8AhLUq1qlR6Pe36lWajp1MfxXpfhrRvDj+LvBnhvT9Y1G3uUltzalpEVy4VnAU4yASTjvXomgaO2jpco2qalqPnS+buvpVcx5GNq4UYXjp/jWF4K0bTNCmmt/Da4s2d7i8kaML5kj9BkADIx6cAj1rL8YWUHiDwjc+HNM1G70a+v8AdLG9xM6zK/m/xgncFcg4GenQdqmcXOXJzNru97f8AST5WkPsdV163+Jt9pl/p1j/AGfIj3kUsLsW8lQFViOm8twRj6HFTaF42P8AwmzeHtXZvN1BPtmlsItv7rbl43PTKsCAe4ra8KaK3h/w3Z2ssz6jqtrapbS3cgJeZgOMk8lcn8qt6hYBtU0m7ltLK5e3Zw95cACSBSp/1fHdgARkfjSlUhK6a6W+7qGkkcjqsfjZfiBp97b6zpreHRe+RNp6oP3URQ4d3xu8wsQAvTJHavQEgjheWSGCJJZWBdlUAueBlj3IH8qp2unW1vrN/qEa4urlY0lw55VchSVzjuecZxXF3OjeKz4pudSuvFr2Wni5LJYwW6sGtk+YKd2eTyCw55qUlV0TSsvv+4lrsW/DXiXWb74ga7o02ifY9Bs4wYNQbIa4kJAJH8JByfy75qj40g8LeDvFA8fateXiXh2WAtY3DRO78bxHjO/ZnnI4FdpJdraLPc3kV1h5IU2gGRRvYIoUD0LDJx79qbr1hBrFsIJ7VZUSZQzPGCygYbKZHXOBntz6URaU1fRbMJJXOB8XQeE/s/jC11XTxYRxWKNdnS2Hm3FvK2RI0QXG9WU/eBIBJzhqg+FOpRW0sWj+EvDMtj4SZCyahJLmaaQqv74of4eMH3xwBxWla6VaRfFPV5xpQuX1iz8rUbyJyq2aooCRsc8s4x0xjaD71d8E6P4c8C2Evh+HXnna6d7+Jby6UusZIHyHj5QR27k1rzR9n7NJt/1dhLR+8TaH4w0qfxS/h1NckvtQ2urxyxqkkUiYJHyqAQQfTjb71D8QdM1VpLY6HY2N1aCErOkww1uVO6ORADyQd3H880a7oWk6Hcax4rW1tLTXBatHHqbZZpHKAA+X93OQAeOcVH4f8Q31p4EbWNctNSeO105Lp0PMskql9+3GCQ2FIB6A+laR9xqvS20Vn1fyt/W5nrszdi0+TVLHTdQiusXjWwDTS242uHC7t0fHXA4PTH51PEmvWHhnwfq+p2Ai1KbS8yTJEwd/NzhiwHQ8nPpg1X8Da/qHiSGDW0sri30jVbZpFW5cK9m8bFNpXgsHA3bv/rVyXwl8OaNpHjHxHH4Y0O6/syXHm6veztItwrAN5Man7wDFsscnHXORWTUtb7R+70/S3zQO+lup2Freo+qWehS6Xcrb6lZm+nKt+4tznLJnHO4nkfU960dE1+z1GK8vkjktLGKTa13OBGlwwG0lc9VGMZ9RxWy8iW1iZp528q3QtJI4C5Cg5JwBjpnjj8K86u7bRPHviXQPEdtrceoeHtLkMZsFJCC6JxFKwH1AAYY5B6E0Jqqm3F276/1d6L5dxt20O48RX0OmeHr2+vYPtkEKGRogA29c8cHjpivNdNsdZvviDY+Jb+7N5pRuXk02Yz4SOCSJkWFYQv8Ardx+Zjn5QxzxXoNnZ29/4em0bVbcyRRJ9jnjb5ROmNoYYPAYYPXjkdqxNV8Q+H/BN/4T8Ni1lkvL2YQ2kEZ8xoAchpWJOcfMQT6E+9OlNUlKCV5O/pZr+vkJq712Oh06yV7yOX7O1tFZB4YlTASXdgs230zjHfrVSw1KK4u7nTrQzG4tj5nlKfkVQ3Chvr2PatqO1SBgEeVV27UAc7V7AAHjP51T0TTLC1guW02BrQXTmS4jB+bzTjJPJw1Ze0i029drf195VhfEWj2+s6Bc6fdQC5gk2uYZGK+YVcOFJHIyQOa56/0LS5Nf/t2bSbWLXIZPMhugx8x1CBZA+3GcKcYPXArVe5/4nM91YrqV15X7qZY3HkEDOVCscFlPPy4J6Z7VJHfaBqGpmNLmCS7bbujDld5GcKR0YjB4OSMc9qunzUu9vLz6MSV9EeU/tCaXpK2qXvjHWNcuNAmdPI0+z8pfIkHBkHyZKhT/ABEnJPIBr0mxdbfwdYxaPqEj3t5YBdPu71EDyN5e6LzMKBkAjt69T1xvilqfiVJrHT/CPhmz1mSUstzNfDMEKnHyEZB+bHXpgD1rf0bTra6sLO51K0iivEgMZtYm3Q27bQHWJehHHXB/Dmm3+6jzbL/g207AkmY3w/sPFs3gtrbxtNbp4j3Ov2mIJIWiDZTfgY5O7gdvQ10Ph2KWODVJbqSFFmuWcJA+REAiqwzgYO5WP4iuc1mSc+DbsXkc+jxFlhd7O4LXCWeWEbbuqsSTx1AJ9Kj+HdvPpKWtvfrKLy7UpLDLIZZEVR8hJ6Y28Z65NaOjJ0pNv+lq/wCv8xdfIh0/xroV9pWq3K6ZqE+l6LIt0Z9m9y7YdCig7jw35da3LnU9Fk0u31vWvJtdJvYre4je7OwrK4+Vcdmxt/Gq3hzwbpOjosunSSxWJ8q5ktopGZPOjULu39SoAHyZx1OOaoaN4v8ACXxI8PanMwe40q3uUs3F5HtVmJXZIo7EluDwaJuDqXp35evfp+NxK9tdzpPFV7bWOnXkt7dosVxbMkAlxt37TwvqSPU1S1bULHw9pOqahBa2q2lnavdSW8cZSQDncSo4bdg81l+PltfFMNh4fjeWE3Nwr280YBDog+ZwP7oB6ng1wGs3HijxJ8ZJJfDF6y6VHBClvP8AetLiIjc6nswPIPv0rSjQTjHm03b7W0/yf3MUpNaI67wxZ6frM1r4x0+dp7zULQW0UiAiK0dVIB2jnG7AOSR7CqHh+71OfwRqLfE+K9jbTL2LNwjK/wBokSRWWWNQoAUNtxgYxnNdBdeI7Dw1r1l4f0XRiE+aS6jt8JHbtJztUD7zMTn0GPetHXrrV7QalNaRWuqhJIRaWBIiAiOBLyfvsQSBnjOKc5z5lJqy6d7X/D+nqVGKe25x3gK7k8XeB9fmvZbzSrjUtReI3Nt8nz7gFMXUt0UN2PPvVrTfA+m6DqevXWgM/wDaWo2iK0M8YSKQowLuGIJGccqTj+nUa3YT2+iC40VQ93bqpsYnjVViG9S/ygBR8oIzjjn1qSxS5EEzJcRXl75ctxFHI2Ck7rxH6betDqXvUi7K+3pb8Pu6iSaVjBnu57bW9Gt5dG2LettZAn+oZvlBByRgck1wfjSyurDU9V8fabZPdan4fvRp1taGLIMSr+9lOBuJO/jJIXB6541/CmqeN9K0xLXx9KstzqEiLaQwuBNb7XLOXdQMAqQAM9vrXR6h4fm8Sanaa9L4i1axgVt0dnbOFDQRk7lOBzuJGSecd625uW03t99/l+Hy6k2T0N3wxdy674Z07Vp1CtqMRmktpDt2xsMMMdScY5rM8KeHdP8ADllpmj2Fw7wWkM6QtdkNJGpfcGXAGfvY/DvWf4i0i6vtf0rXtG1FbS/srlhJNK58k2brxF5ecc8AcdcmujsZYDLNFFtngSRWtY2bcVkCgyRAn0z9Ocdq55Q5byX/AA39X+69/O23sT2n2DU73UIbZraS5jhRZYvNy0mAdokA/hGeg75zXn/gf4gWT6uNI1243apPfAQNZQnAdnZfLk7fKRjJHTFdH4b8H+HNE8T6rr+kJcR65qOWWCZ8CPPzOkacDkjJJzjPpW+mhaXo19datp2jQJql+6yXE744YADLHOF4z90YJ5NS6kYpws9bWv3/AMv+GIS1uzjfCPibwfJrnjSbSdFNjq2lXrW+ozW9sGkmXzSm9SOxKksOwGfetvw54Xg0XVNY1ma4kfWbwG2nLSF0fuhx2J447ZxUHh+TUr3xNrEE+hR6Zo893MouIIFRr1VHEkjjsSTg9Tn0rcu7fVrjVNCmsLryLKOZ5dRjWMFpvlKqDntu545GKUm4Llvvv/lr6P8AAaV7HVUUUV5hoeTapa20PhrRotf1k3FzoBWK71SAHapwFAY9WbGM4ORyTWvo3hPT7PStTk0K8tpL/WdlzJM+ZI5YlYZQEkt5bLlc7jjdkelU7PxVoNzqOpeENNgtrkaJtjltJ4wAdoyZOeDhup/Guy0q+gvLKOa2jRW8sBLdxsYMvVTnsDgDtXfOc1FJf11/M25dFbocD8Lfh9qPg2z8TNcy2kcmo3UctuLSNnVI1OdhB5I5xz2zWnZ+Eray1tdTjRJ9QtcvFb20vlxRSupVysY6Eq3JGPem+J9J1nSrKW8sNW1vVIDqqXctvA4ae3i6NHEP4wMj5Dxg8DIrV8dwRz+HRZ2N9JYySShDfwMVlgVTvkAk6qxVSv40oVpSlr1/r1KUVCK5dTS0LT49IEkUIkeaba7MFZowobG0Hpn5j79+1Yninw9a61e29zY3cVtdafLFLFJbqC7BH3PFjoQw4GOhz9Kl+HOuJfeHdJhnvf7QmkjP+lLlt4GQBKf+emOo/Gr2v3UmkXNsLFY44wGwrjiSQg7EH1PH401zxqNdQjrv1OIvJNG8U6Y7+JI18Ow6zclG0zXcQSvOgVBLD8wy2Ng9jXp2jafDpGlQadHJPLHbQhPNnbezAd2Pc9a8x8b6TeeOviDolrpt1bxw6NBJJfuUS4S3ncxlYyrZBYhT+FS+I/GmqP4/1PwvpdqbezsrRZ7u+RC0xYKr4RemwqwXOOu6hwnUSpt+fp2f3Gbs2jtr7Rbe+FsJLXZC0bxOUwrJERxGMD7px06gmuO+HlxrMGp6jBbaGmhaBZyPJIlxvlnnbCgF3Ykltqggg4CkA5wK7LwlNf3Nna3OovarNewm5aGFChVScqcHkHaVBz3zUXjW51HTfCl/eaJYS63fhVEFoTkM27nPtyc/QCn7S16UtfvG0nqdF9oVbP7RISsYTec44GM815ZBqKa/48urfQbhDFLNBcXFwsBZvKRFJy5+4CchQe+e1bfh+PxBd+HtOXW7M/a3laS4t5HyoRiSFZ/9kEY+mK3vCMOgWVq9poLWpyd0rxcmZxwWLfxenU4GB0xThbDKTjq/LZef+QnGyujat0bfJJKm2QscHdu+Xjp6dBx615h8P9K17wv4q8YXeqyzahpVzI14JTbuJVcnhI15Djb129wK1vDHjHXZ/F/ijT/E+iDStH03MttqTttiaMHHzOflyR82R05zXUavc6hbaDdGyksG1gQu9uszFYmYZ25746ZNYQlKPNDvZCSu9UefaT4g0vWtck1/QIdQ1fy5WYzC1aJ4UHytGvA8wE9FIz37V0t/rd/cX2vWVlb2d1qViiSW9mGIeSKRRw5bgHdz9BUfgG11Wz0uay8S32kDxPcp9olawgWN1yMAyAcOVJwD0IH41mto/i9bv7PJ4i8PPc3EZja8ksCl7IpBPlr5ciYAAJBBByM5HWuipJSat9lde35W32Kg0tGjoL3R9QbUfDA0+5+zWulsftg3uBKhiICrzhxuAzuzjORzTtcnh1/w5rdraapcaaYBubULGUDyyp35V8Y6Lhh6Eg9axT4R8Wt/ZHmeMrN306czxM2mS7pQVZdkn+k/OuG7/NwOeueF1KPXZ/Busp4ROn3Ojak93aTxWOiTW4WQRtmWIeefldwELdATnacGuZPn13f/AAbg3f5GodX07xhp9xJb6C+p2EF+supxxyG58yQIvlyLECVkQ4IZAByQ2OCa2PEng621qbQL+SK90+5tpBawQ2kHCQnDlGU5Cj5cFuMAkV4J4C+G/wAQbK5iv7a5n8Lwuyhp55jE2DnGYx8zdDwRXvfh7xHfaLrEOka9qdzqFyNpnuriFYEdXysTIgPQsrDI46ZrpozqSblSjYmUrxSkbniDxXbaf420vwtJo11NJqcLPHdCEPAnl5PI77flJx0yK2X1SwtNZi05r21TVrqAPEksmDOFLZKjPOD1A7EelUdfbTLK60z7bCftM8zxWM3k75YJXyXw5zsUgYJHb8Ko+P8ATvCE0Frqfiy1hnk0ufzLRHdlPnMFIVACN5Y44ORnPvWSimoqz17dSNk9TptSjnudKlhlijcyKI5EyQME4cg/TpT7eC00vTiPNWC0h3MzMwRVGSTk9sVnw6ne3NnP9storG7i2ymEzLKAowWVmHAPP5EGub8baTrviaXVNEnbT4dGLRSwQiUh9Qi2/vYpMfMmGGQy9cjPepjBu0JNJX/yHqdzJFHcRywTgTW9whBDEEMpGCv0x/OuQTw34P8ABPhW4s0VNF0ZZ0kkuDdPGRKWGxjITng7cZOPwFaHgvQbrRfC2j2c0ji4skkHltKZB8xbapY8kKCAPpU3irRLDxTpWqaHeXaGO4WNbmNSrOkec4wfu55w2OM57UK0J8sZe7fp5PfqL8yxoWj2WkxTXdrNLdzXOHe7uJvMZ17fN0CgenFZvinwxp3iPTpL+wt7X+2lhdbK/aIF0bnCkkcrnjB4wTWLf614i0jxjoXhbw74PZvDCpFFJqDsfKigCgFV9CoGMNyce9aDeMNF8Narpuh6g0lrc6hdm0tV2jEj9jtH3VJwAe+R9adpv94nd/p5gnbXsM8Nf8JGq2N8JNNXw8LNEg02CNllU8YZpWOOB1GP1rqdPge285HdDdONwY9Hx3A64BIBpNdlFrps06xvM0ETzLbxjc0xVSdgXuTisnw3cR65Y6Tr9zZta6pd6cfkVsmNGKsU54zkD8qly503ayf/AA6KeupieJNU1bT/AAjbjw7pBvtfkmWCO0kXKQSl8tK/oo6g5x0Na0Vhfaf4b059cvNNutZt4z5t9JbgZlbHMY4weAPfA4qbQjrEMFvZa80ck6KDPdxnasxZiFUY5DDjPY0arp73XiUXZ2TvawqtsDCGNmZA4aZc/eY7VGB2z6mt2/ftpbV33v8A1/WuhKT3KXhbWtK8R21w+mTPFc2suZo7qHZNHKODvz6hRnuOPatiBDKFkksgJiwkkctgRnPJVj2IHb19643wZf2OvXN3ex2nlXLXJ0y41BE2LqShTmQquBn5AoY8jpwOKbbPF4x8QeI/C6XVtqPhGCJLO7tGVoZrSRQRtRxgujFQdxJwVYZxiqrwcZOytb8Pn+Qou/U6jwrBqtnPqX9p6k16lzqU80PnxlGihOFSJB6Aqee4Oe9YPhnW/FMXinxinii12eHLHbJZTfZ9pYEcohH+sAA69ckVD4V8RpLOiazpZ8M3NnKNOsl1CYBbzHyt5a8HoqjdznIHOK7u+TzLTyZ7eWVS33IjjPzcDII46flWMoqEuVq9/wCtGNorxXTwtJKsCCEIkjRoNrjKjkj2GPwFZ+leH9M0i0+zaFp0FppasbyFbXYY55XyckEHkHBU5wOAMAAVLNLMswESR6hfRrtlk8zyUg+XnfzypOTjB71NHHLp/hcW7RHz4I/9TafM5UN/D6sVHX1ocbWt1t/X/DrqG+xR1q20qaEaeNRtbDVWtGsoR5i7grrgIVPXnGB144rk5dH1Dwl4L8PaR4ajN1b2ziJJTGZCrMxLMw9MscY6A5rK8TaVZajdWPiPV9f1XwveX8iMLJ1bM3kAEHyuqkY3Z6/nXp9y7aPZQJbiW4uJDHEkIbgqn3mHp8uSa6Iy9lyrd32e3nr21C3UzRp9jZQLdXVrAk0tqbaW4X/Wl+6g9gME57YrntP1nxc/xLudN1/RbZfCQt/kvVCmA4GVcsf4icLt6c5rR8YaRqXiXREg03VF0yZ3kkRrdQzeWykfN75OSfWotb0G+tfh/LpVjfo97F9nI8ngyFJFYkgk4LY+Y/WmrNJSerdvT09Ad2b0M0EskLaXOk0YZmRU+aPZ32kcAfw/jUly0YjdI5TIygeWq5BGTgj3UDOT6VieD0+y6IkN35llczzTPFY3Tj9yT0RR1ZTgsAc+vaqnjPxZL4cXTdN0axivvEOoIVtdLXkqf+erMOkfrnGcEepGVW0JNX2/r+vzKWqNa6tLbUkuLRGZbFZwTGgCEuqgloyeNnQZHq1X7gonk3RBhPlskKQrlAmCSGA7dDnpwKxPDVheaLoFkniK8iudRkZhLcMFWNlZs7EAA2qCcAfy6C2dd0640W71fTJ4Lyws0ljdIJN6s4IyqkdQQDkewNO7lZL+uhLWmpxlx4g0x/iu3hHVdKklKWyPazWU0pKJs3ESAHB3Hpgcd85zXb6Bc+GbxprHRZ7WNNHV45rbJV7Uv8zblbocjqemGp1nZ2P26a8SCC0lkgjktb1lUSMhGSjP1KjdjBPGeK4nRPhppGk3fiWTWNSeafxNG0BiSUGVInYl2DHmTnHJzgDHOTWjtJWcmrW/q3p59/nEr30Nuz8QaP450/Vbzw/qtzZtaN5P20Qn5wrY8yPByYyQQWGOntXMaJ4J1aL4mtqM0GjLaiEFJkchWQj76ID1z1575zzW3ongW70+28T6daJHYpNYrZ2d3Z4iDbt3zgDhCON2Op5FZ/wz0PXNPtNb0jUvLWx8j7NptzDLvaF2Vg5DE7lLEq2PpW8ZqnCSpz0svxS/qzJabauju11zS7WSx04XQuNQZVEYgjaRN5GN2RwAfc1weoLql34X0vUrXxBDLdWmtzXMYmuDAtwhZisT5++0eQNo67MUz4e+EfGVgptPGN1HNb2F1HcW+pSzGaYxp1RO6g45B6Z4Ga3rfwjZ3lnd2+v6dDd6bHfz6nbYkKFJndjtXBBxhic+9YyhSirxd3p1/r7hw0d2j0uiiivIND598Ex6X4m+IWq3eoeHzD4jRsXjW3mJZtHnpLnguR2PU9a9b1XV004KI7dxGmFiupY8Qw5wMbjzn6Vw3w/e70W/8SQS28iWcusNcRXl0wjWa2K8bAeXXPTHrSjQ9R1H4j/2je63dLosViYp9JlHyQEphlPbgfOG7lRXoz5ZTu9l/X9f8E3hFpXaO8tb2eS+kcTOIYwE5Q+WZD1I7nnGOxrO07SdJ0TStQ068WKTSS0kl7cX0qsjZ5ZpHbgHkcHoKybLXn1Hw3qK+H9Y8yOCaL7HPY2vnywQllBR4yOSoznPUVGNG0f+z/EXhZdO1Ce2lkWW/ubmcPJIz4YSDJ+YAgccdOlZ8sr8uy/y69O/3l7+pRS88M6H4a04eHtR8nQbe5MyOodna43gohBGdpG7HHIXjIrs9V0Ow8Sv4e1e9muraazmW4hWOUxiQnnY6nqCQDjGeKxLjw2un+HdZka+tLue+iR45L2FY7aBUGFYDB5QEsM9SPyr/CDz5/hjpV94gvm1mTzXuLec7mZgGYIcHnOAT7VVSSa5ot3vv6/cZtaJI09P8FaRpnjbU9V867mvNUJlkR5GKr0GCf7oIG0e5/DROn30uuiO7ObUIWFxbSeW7ndwsg44wAOOuBWF4qju/Fvw9vJvDk0lpfamF2o0widwrEbFb+EnaeayrnSdbs/hJZ2M6TR69FC8ccpk8yRJGb5VAXO4njn2zVxjKVlKWu3mvP8AQE7OyPTPLkiW7mtUt5JDgRqBsztGNrN9c/SoL+6uYdMaS0hLXqhXa3zvYZxkcdcZ+lcHrfjLVvA/hDR7XU4I9b8Qm2BumaUQKCBzk4OTzjjk9e9c/p/xE8WT2RvZrDTra0knWFI4slovlBZATjc3PpjOa5px9naU7We3mlp933F0KE6z91bHe+L/ABjH4Zm0yzjsHupb8lVdWCQJt+9ye/XgUXdppeqalpsi3Fslw8KyQfZH8m6dCAcqCQQu3k+3FP0a60PxnpEOotCbr7Gzho548SRSdSpX1xjpVbQPA8Nv8RdY8ZXp8y7vYYYrSJhzaoIgHA9yRj6D3rSNSEYXjo9fn2/AzknBu47WfBMVz4Pv/DZ1HUUsLy4Z0eHBa3RpA3kgY5i6jBzweeKnudO+2+Pbe6uNFdW0e0JsNS88qkjSgo8ZQccDHXp7VZ8TeMdL8OyWUF7NvlupNojiO+RVz80m0DJVe5FMjuNXm1LWLpZ7J9IVIU0twykGQgrIzNknIY4A79O9ZqE7Xkt/8xqTejMv4kW3iW2tNPn8FQiW5bUoZr+LhXmh3D5Q54ABxn/Zz71b1OCx8H3WseI3F3c3GozW6JbAl8SHEYCDoCd3NWLnX08JeD9NvfG+oxx3MSwx3k8afK0rYQnao+7uYdPrXO6TYeHfFmveMJMXkke9bO/sWmJgnddrxToR0baAPlP1Fa05St7y93rbqrrT8DPfc2TFL4q8B3EPh68udIkuoHSG5yfMt5NwPyt/EuQRuB+h9Obh8G+IovF/hzVdT8dH7dbwY1K3iAjS5jQ5ULH02nJ3MR6EY7dVBq+gaU8+geH5bGTVLFEVNNE4BjBwdoHOOOcDmofGWo29hoEmp63qP9mR2ckVzcGBNzmIOAFYfe2kkjp3PvTSk53Wif36/exWuQ/E7Ub3RfCNzdWuiN4mSe5QS2bfMqxE9VUAk4wMADrz2qG413w34e1CxGo2t3JrQtw1uGgeedLdmALFsYiQM20liuMc1oauB4j8GrD4W1ZbG4voluNPvYlJjTBDcdugII96be6ZY39y8Gu2ceoh4xBNeGH95A+EOwYXKxty+QcAgg9RRTtbllfzt/Xy/wCCNq50N863KusEcF4EG1oS3IY4xz/D8pJ59sVi6hpQl05rMXSaba2DwPa3MjpIySKeSwbjBBA57k+1WJpreV7ySzkZobO2+zERzbd27H8R7qBwc/xGvKPBnw+0zRfHmuaDPPqF+100N4k8jZ8oxYcNIvQhjKVGR/B6mqpU2k7O1tf6/rZvfYFbS+x6J4ua90m80mDT9Al1zT9UujaaizSF2tYnOchT/BknPQDAHpiTW/DkieKBrlnG08sibWy6r5O1cL16r3I9az28PeJk+Jmranb62mm+G7hLZ3h8tZGuJFG0gFv9XwACRyeKn8S3+sapPpi+Fp2+xTSm1vZ0YB7FuCH2n75/hIPSlSc4yTjLda380tH/AF/kSn1Zk63daebyCzWbUoNXuERZdbiwv2aR1AQYYgsp4O0Agd8Vo+A/Dl7o2p3lw+t3OsveLtlu5lVEiCjEaIo5LYOSTxU+oeANH1KK3n1syNBZofIRiEa3iPLRM4OWUdOvAHXvV3Utf0s3+nxWV2ge3t/7STapMclsAVfZgfMwXJCrnHGeorSdVSjyU23fft5f8NsvMEtdTk/Eh1zwn4P0DQtA16P+3r678p767tJJjPMXLSEAAquWJJ3ds49a19esPCljqqeKPFOkQSatp8UZN/FbPMN/HKooYghvulhnpg1cttWudJvrDTNV1JdQvb6ee4gnWMRxiBmPlxjH3mwVHGfy67d7YRx6cYZFW5mGyRmaMAzCM7lDEDgjjBrK+q5uvbd6/wBb/wDDXKLe/UydR182+sQact5p8WrBWmWzmZlAjbgb3GQDkcDv+tN1XxBDomlyanqd0kfaBrhDBJPhvmQqQPXC9zWR4s8BWGr6g/iXUbrULW5hjjlu7a3fdFMsJ3qNp6HAxxzzVzTk0TxW2pXV1ZSavapJbmG5uox5UjqxKpEp+7tbAY4GSec4rW1PkUkr239e1+39ekXd9TpZLqzEEOrKFigMH2iZpUIZYQjNnb2OSPfrXneneI7XT/Cura1enxZFDBP9ps21XERkEjHaiN02MSB8/IBHpVu91nXbj466fotjb3iaFa2zvfMSWim8yJyrnPo6qo+prRSzudfudesPGNnbvYpfD7EwIaNYQo2lh0LBgOo4L0oQ5LOW1k/O19v8/IcZXTSNLwxqS69psctvaPpkxiZ4VVVaLLD5nRgNrEMcH8+9cnoZ1WCaSSJY7S9S6WOe2jtts0ke5Q84BGXPuMjBqx8WbGeOz8P3Ph22mm1XQ7+K5t9Ot2KGWE/I4Kr1XkfN25HrV/4o+N7jws3h61Ph+51JNXmNvceRIw8gfKCNyjkkt7Z2mrpzs/djpLv5eu9/zJbsX7jTdW1DxsX1ey06bRLaNpLV2QmUy5G1d3QLgZOe/titKxju7y3trnWCItT8swSR2rHyrd26lWPJOMDNWrOODTIXtEkGxCUg86Qnr820/wCyMgD24+tiwQR2KwlxJEH2o4J5AxnJ+u79K5ZT0uvl/X5mjbsZun6nbnW5dDtwu3T4VeUFsuucbScdjyPXINZPxDuvEljpdvceEbe1eWaZFurq6ZnS2gU5Emzq3XnHufery6TZ6LqWu6nY7Pt2oXEdxcfuwDtWNE2bv7vylvqxrBg8aeHPE+rXfh2Fwt5F5Z+zzpsju1RydiZ4I45HoelaRg5NTitNL/qS0tFfco3XjrUtF8caHpWt+TeWl5axrdPbQmIWVwxwHO/nYQec9O9c/qGv6/B4p8exwvc3DaPaJNZwLFt+zgvgtGh5YCPPI4bHvXovirw9pHiFY1vrf7UtkfkRUJkgcjIOO+eBg8CpLhNMupLjWorhrWUKLW7aNNzt0wjKAfmBYevWtqc6aSajvvp5q23fYlxb62K/w/1S71Lwdp+qaxstb6eN3Y7PJEq7jtkKn7pPykj3ra8+WGA5h8yUbQPKXe2T1z7e9Q+I96afc3QL7YoGkBZcBAqk5b1GcHHXiqFteyazo811pM0f2q4ti/7xsRo6DgOwyQM+g6ZrHlUk6ltL/d5GsdFZs+bf2lfF8mqeMYtHs3MVtpPzMEcE/aGAJJYHkqMDrwc1N8IfidpHheO6vfE9lfXmqX84hl1A/vHaALjAYnjaQuVHXcD/AAgV3nhX4N+HIJ5r3xJdzazqUpkad5EMcUUhychf42JPQnkdq8a8by3nxE+IFxF4U0ySa0g22tpBbR4RY143HGAoY5POOoFc04yjq9BWPZNX1e++I96lh4UF5/wjUSLDe30eVebJy8EJbGPlI3MR9eMBut+IkZ8LfD7V9O8ERR291aQwvBFbSgS2wbKs4XO4nAJ9WJPU5rM+BngXxL4F066i126t3ju2Dw6bG24o+Pmbf0UkAZAyDtHNbknhS+j+Llv4u06/ij0+e0Md9HLy0i4+QIvYg8k10Upcz5pf15f157kzV0R6/ql3pGo/DaKK4hkOoTLa3ivHh5laH72D0AIJI9TWt408MWV3dQa5bQSPqGmqqQRwnCths4JHpz/WrniTSLbU20a7uRFHe6fdebbu65ZTkAlc9cjBNUtX1/7D4nbSrK6itCbeSdISgLXMrMDgZ5DHLYHfB7VvScpOLp7q9/v/AOCRt8Rta1F/oGoGATJPe2/IDDaG244PrjH5U3wxLH9jW0hR2uLQpHIZF2ttPcZ6gcjPcD6Us0r3lqqy28n2uNQ6gnazj6evUEe1c851ZvEVtJYxq+hzWXmO1w21plIxsZfvBgOmBzWcIc8HBv8Apf8AA2GzQi8VXtzJO2naPcXWmpLJF9v8yOEDbxlVcguOOGHBHTNXbSe2TTYJILn/AEeUnDT/AC5X+62fu7ehHfFeZ/Efwbq2u6JpNlBDKn2HfAlpu3RXibRtmGOFcDoGwRXb6/cW/gXwt/aE4a9tdLsDEsCn55HA7n0Pcn1q506cUlDr28v68luSr3dzu6KKK8os8F1vR/EWseOWGswWGq+BAomFx9pURW2xeWVwdy4PJXGDzXq40mHVdAmtAJYrC6gNuI3BDxxFSCBnkEg9+leS6HearJrmjeHpXt4wbQ3/AIgBQEQQIfkikXP3jjBPU9xXbaxZ2HxX0jw/qnh/xFd2tjZaity32cFfOMbcow4KkYOCfXpzXbWlJWSei/r72bOVrtb/APAMXxHoN18Pfhvq2peB0vDqhW3RBdDzXghDqG+UA5wCxJ7DJ7VY0DX9BvvDel6j4yltrzXIlRL+VVANoWJCtIoOUTkDOP4gT7aN1Avibx9BcT3OoaJf+HropDHHMGS/hbaSWXHCnBHqK5nx54N0XxN4oksV8NwzBmQanqGnaokVzAOqiSE/fDcfoe1NPm0nvvcXKejeKIILzQNRt763ubixmRrWW0s4i8jq4ABT0IBzkcflUHg/S7PSPCdp4asr8XNrZW5g+0l0LsoJBwAeMZwSenFaHiuO4Xw/JbadLcQzylIYfs7BZFBwCFJ6YGTn2rnpIbPRNB1Cz8O2tvcvBbfZo7W3cGQStnJdRzyxXJ75rKMeaK9f6/r/ACKj71myv4y8Fw6lDolnpcrwWVhHudIiHfy8gjaCeScNyM9K7TT7gXUCSEFJ1jDIj5LhGztdlOCCcHr6H3ryHW7n4hWd/wCFZbe2We7jKT63BaMvlxv8qlSM8KIxnCk8knuK6v4feGdU0jXfF+oanJiHUL+S4tLcyh1MRAIJOcgZzwcVvUblSXNK9v13FdXs18y/4n0WWebTILd5YnLySJcyIsiwOQSzvk8nngdK5ew8KXep311o2o+LILgxxRXEjWcWLl03NhieiZIYArkkCs3xB4t8Wad8PrLy9Jn/AOEi1C6c/YihnMcQbGAB0U9ieAK7v4XvfTWN5Nf+HhozmQKXaZZGuSOCw2k7VBGAM89R15VWkowcpO72/E2WKqQXKnb+vzOX0PUItH+Jn/CF+BtJjitYYhca3eyKzOjsm5MseCxDZ75JPAwa6p7W90Ky8PaJ4f1OMyPPIZp9QPnPcbdzy55B3MxY8dPYVqtLbWMd3dRQQWq3NyUcn5XuX+5uLfwnIIGc8AdOlMawtWumF1O7SmZZIgxyLV1RVxGccKwXOM9WPrUSblv/AF6mcb3vLX/hjNvvD+jX17Z31xbzHyw8drcW752KzBirEE/ebJBPGOuDXOePfFFj4Z/sq1ttGs79tSeWcuLny4/vctHkHc5JBwMD0Nafgd9el1TxFFros49Ot5wq2qWrRxxnywcI5wGTbgk46k9KmvdP0bRfCcbWul/2rb6RKZYYbhDI0Ic7sqcEkDcCMA8Y9K6IO01GWtuz7+fqZvVXjoXvFmljX5bewj0+G4tZbhJb2a4T/UGNQ8bBWwHyRj5c8nnjOOf+Idx4j0bSfD2i+A4Wj1LUbo+bdC1DRRxhSzs5xtVjkHHfBArovAeuXfiHwtp2s6hbS6Y7rKkkExIPDEBvmAOPlJ5A4rJ8S+LH0TxJp9zPfxJ4OWyZLuWBDO0MxI8suUyyqVyA2MZ71lTUlPletunpf+kEpXj5GHdWb3/xTa+8K+GdBvJrcINR12S4G9JQOUCDo+FC59+am8S3l/qvxBg8KR6bNJp18C2s38tqxTyNjbbeM4A2kjBf1Y+hrc0mPwf4ZttRutDmikN8V1CSGGcO8/BKbFzyDzVbwt44vr/xHFpGo6X9huWi86SAgmS0jP3d5HHJ2jHH3uvGK2Sk03FaJddH0/XpsS1bYvaBqlvqbTab4OFtHpWhzrZTR7A0Ey7eVjdckMn069eua6AxeTcrIzLBPtCxoGBJiRgPmPp8/PpkVR1bxB4a8O61o+k6jdQWF/fyM9pGsTIk0n3W5A25O7uepFa17bpcSQXL74p4GZdyN0Q4JDDuDtTI+lcrqJvRWX9ff/wbBFnnfxV8ReH/AAzpS2WtaPfSWF3dbhDaKqrJIhV9zSbgFBOPlJycdK6zxLqur2ngyTUvDunQXOszpG8VvPJ5as7BfU9QOMZHSpte0m2vIVuTp7ar86M9kkqCJ2HRyrkKSDj8h1qlayR+MfDkV7BJPpl5NKZI/MAZomt5SuCOjLuBPuGrTnhJQv31/wCG3+YOLeqK+maxfa98ODPrmjx2urTGS2k015AgMquVCKzEAk7QRz19cVW0Xw/Z+GJtXubfWbn+xFb+1Li2nG5omALHDH5gPkyVIz29ayPiD4OtfG0PhnyvE8Fpb2d+7ySQLuM87ncAmGwDkHHXAPet/WfAlj4our+fX4buGe8svskptbsiIoXYgbc8uoxliMHNNTjTi4ttLXp/n6eqJ5e5d8Oa5Y/EfwM13p8l5Z216JLeTjy5osEq657NjPIzjNUtE0N9IsbHSdKgstM0uyQS2pmcz3Y3NmTepGAGJbJDHg9u2louk3Nh/YUVr51pp9pBIJbcuDvZlH3/AFO7JyO+fWrcyQXFzerNbI1q6pKZ5ZAySrjoAP4Rjnsc1CfI3GO2/wCn9blRWo+XUM2TT2ls1yIkcRSCMDLqCCVBxlT2x17ZHNVtRngjg1S/ub5Gt7BXE/DBFiCbnRiOpHXIyRTwFublXtJcX1nGWMJYMAJFyBjjgdjjt3rOuNYltReX99FDbaYqBIbppvN/cMvyytHwSS5Ax1xThD+X/g/012KtbRDfCurz+JdTOueH9UsL3wnd2gjQbXWaO4ViCSCBxjgg4PT8anivxhJdaTrsPhUC5u9OVftMoYEIhJ37VB37goODtxk9Tg1D8L9F1rwtb6jos1jY/wBlK0lza6nHIF+0O5yQ0I+7j69ABVfw74RSHxZP4mmMdrBe2jW0ttCch3LEF2ZSQUIGR6cU6KpqTlPW1ref9f8ADkTTvZDYde8R22k+GsSvLNfaj5S/aLb5pbUxsVaUg4jO7HPU8dzXX28MOpSSQag8k8tkxzJ5bRo4bnGcANjGDjpxVCS9toLOA3UDC6S4gtrryHGbcK25Cc/8s87c47MfQ4ydX8M66fiFoepQa5HHpccjkWjcEMUcsgGfnUgn0I2g9q0lZ3+y9bP/AIb+uvYPhNeDUTbfZ4tQvE0/Y5jDybVRySRHHGz43lhzxnlMembGu2J1L7K93PdWMNvJ5xjhdS0p6DfgYHYjB79q5fxv4DTxZf8Ah5bjUb6y/smaWdJI9pDksjZXnIIwAOOAT6V2z3kNu9ske955yyRxk5ZwucnJ4Hqc1nO11KO+v9f1sXFuLujK1rUtN8O6fd6rrMkdjGpEcW5iXlJUfLgAlmJ4wM9M+9ZngvxJfa1cxxPoq22YQTcwOTFGMfdYEDnj6/TFUtW0628a+I7bUdO8QiFfD8jxeQtt5jQXH8ZLNwTtIHtjjqak/tTw5Y3eleHbrVhZanbzLdRxyktMwf5tshHCMxYjaTk44BzW6jH2bi03J+uny6/j/nm273exD401nXxreh2Gh28m+4DySIFCq5XgeYxPyxL325JzwK0/F2s2+heG59f1a3gE0UKxPJCyhlc8KsTE9Cx3ZODtI4zxXROiXQZJomhuJx5QfocYBbb1wM5474rO1TQtI1DTDpOowLPpbxoioA2fNQk5wOhGFINZqpH3Vy7duv8AX6FNb2KHgjWrzxD4cXWruz+x6g+6H7OoYo7Kfkc5UMoYY69jW3bBoppLjTkEwLhZ7dG27TjqN2OenXFcp4n8W6b8OrKxtLi3vbi2uZXK3RnBYkZLsSeDtHY9gABVb4iap4k0WbwrrOgTRy+FrTdcazMgVt8O0fMRnJG3cQVBwcE8CiUG3dKylt29P61Julp1O5EgvWv7eeSPy7geXHH5mSV24J9s89K5Lw3axaZ4Xn0lv+PO2SQFFGHXnkA9CM88nNbdje22t6Lpus2Ns8VpNbM8YwFkXOAMEHA4yQelNuYlstWsLm9lZUeMxSrMMo5HCk/7RBOfpTpvkTj+HmjWKW5T1fRrXVbu4s9RNxcCaKH7UkcjIrShSVdCvzAYVgceo7itXQtAsvDtsiWFnb21vCSyx2y7QC2AeO/Hfqar/antA0kEcjTwt5ByhJRQw2q2PvDazH8q19Uit7PS2iEWIXkGVBOMls/lms6jk3GPfQbVtDC1PU44dW0O0vIryVdXlkt4pvuJBIiNJtkGf4wpwOvFXLu4hS0llu2iiS02NIpOfJjLfMMjr9yrsKZ+0y3THy5EDebn5OM4YDsRj+VZd9pkraeunNM19A8bNebhtaRGYYK47gBsc04tX1f9dfLy/pkvyMVPHGn6n4lvvDrJ9hvIHEtn5zDbfR7R8yehBz8v4/TTuNJ0rUPFNvqF3pjvqflBBdIf3ZVASAxH3SC3cZ5715fp2m3dx460fw/4gt5ZLPT7p5tI1eGLYShXcqSHnd12kHByPevVNS1G20JJNW1a6W0tEYRTvHGzrM2SMbACQfU+wroqU1TaVPdrTf8ArW23/Dkxd173QvX0oTTzdPHHuEY2ruJXyiACueuPfGfapLK13XsIQW/2EW6BY2YmRNpyvX3P5CsLTtagOk3V3YX9te6QhBa6MyqtsgAID7sEDaR2rU0y+iuIbS6tLoXFpIqyw3EYB+0o2cAemCcYrCUHFNL+v+D+PyKdujM238SnX4/EemrbYuLPcImh3HJ3MqjJAy4K5445HNa18n2+3to55tsHnMrKq7hOvP7sj0I6k1z3h7SpbLXdc1GbeGu7iRIsn5YASSensRxXTOZYUjjZkcfafJdSuAVI6n1OOaurGEJWp/1pqZxi7a7m9RRRXlgePabYQ2Wq6tpn2P7Pc67ZtqWpXVy5BSTOFQN08snjrxk8VH4Z8Op4U0DxUNc1Ix2WrXKbRaoSYP3fOQvTeQBjvn3r0V1a/t7lJ7NPsqNtjjuEzuAPzAjJJ6ZHbpWdq89raXEL2zokUZAbbKsccQBHLgg7iP6cV1xquXu9/wBDrUUyLwTPdQ6Fvab/AEZmDWsM53TWiEDEEmcEnPA7jPU8VQ0LwDYaF8SNe8VS3ryTanhhE3yrECAp3HPOTwBjitMavc2O5IbB7qAOsnmrD+8kXI3OwyMtjJ49OlWby4hijgdGaaSRTPb+ZGz7zwSfbA4Ge570pJ3b7i9mm7DtQuvtETW6XyRXcmU8zym8pM8bA3TfgnjOeCeBXBeF/hzpuifE6LW7TUZgio4a23Eq0jDALMT36hSO3WprdfEdr8VdW+2PdaloT6Qb6ys4IQkcExkQbecZkADHnnDHjtVTXviT4btdZ0p7qy11W1J/IMscTJEJsqMHIyT345GOlaQco+7HqvILRlFuS0X4E23Vm+NizaZBfL4eMG6/nkYeQ8qFgzN/db5UAHcLXoOo3KXdqfslwysw+1tEhzM0YGAQh52kj8aihtL2zhFsk8cSR3JmMrrvaSLHJYZHOeC304rzGbw9o1z4tm+I2g6vd3Men3BW4t45SzTEcHy3PRPm/wBXjBwcEVS/etPtov0+8h+67xO41463e+E9mhalb6N4huI0ulurmDMQXcBsYnO3PHYkVHrVvrGkWM2sXTXepapDZKBaWUhSG6uWAUqiE54259wfY1B4tvofEHw8upr2zfVdMuVY/YYYjHdSqrAAp8/UMpbOOn673h+5nutK02+mtLqxhuYY821yQ0lmQCBzk8MO/Ud+pxnzShr/AF6Dtre+555r/i6eDSn1vxOYT4O8kWNzp0EJe7uLjADt1AjVWzg7s8c4yK7a+sNK1zw9psFzLqRgs3hQXYnWKTdtVQzsSN2cjOM5PSsxtLsfD2nas9posuuPd38cDWhkEo5PyscrhVClSeD7+tY/jrTbj4kPNY6FcR28Gj3zR3ls4/18o+VWOCOEKkgZzW94ufuO0V1/D/gEtNLme50ksk+l+BJLXxNJNrcVs32WaVU8p7sM4VMjOAMMoJyc4zU0N/cHX9Gtb6TS7O+NlLJ5DzH7RvztDR4+V4yM5U4IyKg8dgWcvhOO6m1Ex2t9G3nRYKykKVCzcYAJI7flUusi0uPiR4e3XVkbxbKWRbWaAlmTOC6P/CR6VmmuXXRO7v8A136/JFXe6KWtXtpfWwtdXvIIZtTElrbLHL5bahJtO0Qgt8qjpuPDEjpkZ47S4tF1aeXwd9vntNX1exh+0wwWo/0aeKNifN+Y9NuNvQnHPNbEv9n+M4NJsNS8OzQXtiYJNPupJ1gLwF1R5ImIyGUfN5ZAzgYPSr+neKLTVPiHfWvhW5s4Li38z7ZbPbKp1J48Kdsuc5X15xzkEdJvUcml0NnLki4vT+tDG8Lx29hp5a68N3Oj2Fs502CbUCiTXNucgxr827fn94GxjCkA961pWutP8a6JbQ3BvZNZkeObU0hAIihjd442HTI5+Y/e9O1cLeaff6t/aOl6t/adp401a/BszqEyyi0tkyylAv7s/KHX5cdeTng+sWkJuNf0bVVneeC206aOeZYTGkjoyAfIfukksR7KR0rfmtG17vX/ADX3/iZO6ak100J7vwsms+LdA8T6ifLn0qGeNLRgHTc5AEoPYgA9v4h0IrS1LVbHTbjULtpkP2a1M12gcZCqCV4zwefxBGT0rmPDnxF0nxR4wXTLW31SMpE7RPIm2GUg4cEe3ABPHNdJNa2+n22p3zpDPeXLFXLqvO7CrEcdQBtGO9c8qcoS5ai17erMFZnK/Dfx4fHF+Vk06a3e13SiWJsxbWACox7tg5IxjoQa6rVCLuxlR5BBdLl2gE4GU6N052kHP1rldT8P6xoD6bP4BtIYZPMSG8tZQBBIhYFpCMg5Az0PpVjxlPceGDq2pWWkfb7nUbm2WLYcs4IVGj9gPLB9Dv8AUGtnGEqidPTsvn/wb/0xxutyx4Y8OWHh2xs7Dw7a3T2NwzyrJOwlFuwxtfnsOcDrz9a6vUmgiMV5KqE25IDnJZd3BAHcngVyepWFh4f8U3HjzX9cu7K2NlHZGylk/cxEt6LncSSMADrk8541NSnS8s4JYnjmFtex3EwgywWPJIJ9cAgnHp7Vi+arJSf3/wDB/AFvZEniL7LLo93DfER6dewypd+ZN5bAFNu1XJAVu3UDOea5/wCFuq2N74Ihg0uyu/7Jt3ksbdJ3EsuxBzvbOOegA9hWtcXEF14ktNLRUvLKdZpLuGUCRUZQu3KkcAnPXqapPrenJbaTD9oW1u9UtfLtLa3U+XH5v3XKjGOo7g9cVpGF48ltd/zG1ZplDT/A0emfEC58WvqF0+0ysbRzvYGUkHnP3B1UY4HHauqRBd2csMxWdLWDypBLHshncJyc8/L6jHH4UyGVLud4fOtPt2nSbZUOWZouxPIwSO5zg1FBcG+0WyUyw2UF38iWzqWkePgAdQc+vXgn60SlKdubpZfL+rgoxS0MX4mahc+DfAFreaa6SXtnPbwxPOpKEuwjZmUEZ4cnrwcVu6N5kNxIsSW8VvDEJ5LWE75EdwSVXBwUY8jpyMdDxJ4hltb/AMITS31gl1aSIjTW0oyCu4Z/EdfqKvWMNvaSXc0cEcCsy75CcFsKOT6AZwBWfO/ZtSWt3+n+f4+pKT1bOb0SeC4tpo59LurSWOLyfJnHzOhY/MCcErgnORxg+ldBbF4IyZJRJFaxlWV1+c8cNuJ6Y4z3rkvCNvfQeMPEqahc2s2oyugjeBWZoIiGZC+445HYdDj1rpZlZ7VjpL20tyoNv5lzuZCf9rHUZ7VrXS5rdNH96KWq1MefxBaaJpBvdQnSKIEtJDG2+R5eCiRc4xgNkdeKt63aLrttb3en3T2WpRosluSRmN3GQJF9D/jVDWUtLnRLmKeyhu2hceZG0ZG2dR95O54zj0AOc5rZgjW406F7WQ2jXCRk3TAFmxjCkf3sZHtVStG01o7/ANfqFr6szNC1aa4stSF5bWi3drJtvGjAUSgAglvQ5Dc8/drgPifqvh3wt4otb7TfD1vf+Obx4hZTTsz749oQTEA/MRgqB1+XORXeRtqR+Iv2drBYdNNtNPJMv3GbcqruPRiRlsdRz61ovYWgluL9YXvZi+bdJwjNG4A2rDnBVepwSPXpT54QmpW3Wyffp/XQmS5lYmgudQQDzIoZLlIl8/YxAkk5wisQB0P5+tWob3zHm3QTQygKDCQoZzgElSD82AcH6UWxa/WaJmVRG6ksi8FhhiU9s9znnNSXqymKYWvlrPn90xTcVY9eOPrnPeuWUot2a1/r+vIrrqc695YajJfWNvaC/H2vyXgmt/NitZQcM0nXAPUYPfnGazvHHiU+CfD3iXULTT3vorCGBVsTwjbsKXzg4UA88c7e2a3vEerXGjWFp5FpiW6ZjPNGgZYCELMxUEbjwQPfrWX4L8TR+L47i5bTZoo9q200U+1kdWG7cfUYOCPWt1eUHO3u+vmv8idb6mnpd6mqaXpF9ppFklzZJdQIeFwwDbGXso4Bx61j6d4YuNMu9RhjmubnSZ1Zms7qRpmWYncHiY9F9jVnSvEdr4mude0qLTry3fTLg2j+dHsUp90yRHHPGePpW87zD7M2+aeVY2z5GF8xcfew3GQccZ4zQpzp6LT+rr+vuLSTSZFY3F3dahtyI4Xi3iRUGWIypB9Dlgfwo1Z4LzT0WC4F01vN5b+TIC+8KQVwP4hnJU84ye1ZPhvxToOr+Jbqx0fVoZ9StgRd2XkvG8QB2nhuhDEbutWtAsoNLfVGSMW0k+oy3lx5hBG58DcD2BUfnWb0lzJbCvd3XQj+y6snjq4v3vIn0A6aI7eyjBMjSBiXOOnQr+g7Usk6R2kUmpTpDOq7o3BYbhydrccHj8MVd1q/g06KJ5rlbeBsqZmOwEkZGw+vcj0BqrJdaduhCXFvJfXUReBmIIueBkr256Y96uF2k2v6X9ajjaJUsjP/AG/cWt2yC3utsltKFOHwoOVPTcCT0POKvFRJC/25mlgljZZmddqBfVh6gAYPvXP3vi7w7o008XiPxHp9mtuUjbTocu8DEZCsRkn/AICABU/h/W0ura5u4/OuxGePs6/LPbsTh9r9DxyPQCtnCUlzJdv6v/SDni9OpxWseDNM8I2+rzW0Gp3XhjWbX7JqFjDzNFnlJFJOMjJ69j7V3ml2cHh7wvYw6TMj6fp2nJHEW+8AfvSH/aOOnrn6Vq2bfb4k+zTyW05jwweLdGv+zgn731/Co57KcxzWNxawiK5iC/as/eck/IUA7epwKU6nPJc/xdfNf8NfzJUVHSJJdRzeRiYHZFAVLg5ORyu761aN0ziJHgdTJumcEZG3BHXsTVTTbuyuknNmZ5HtpWhmKBmDuOo5HzexAxUGuX1xY6fcTTFrNIo2EZYhzI/YYHTNZcrk1G2pTa3OsooorzzI+fdd1ix8IfFP+0b3UNe33UIKRE7oHRsBUgzxJgkE9CPWuhnTULnWjbWsGy100iNW1NVCXTPwWTB5Cgnr3rIja70y3/tLx5dw6k04IsLJ4UbynHA8o4xGQcZ47VDF4v0i80q1S8j1c3FwHZTPGoVyvYDHH4Y5r0G27NdPuO6mt79TetI/Gl38Q9PumWO18NadBLaPa+a3nXChCVkYYIGWVec5xn1q98VPENx4W8B31zYNJHdznyLb7OnmJbyZGWYk+nI4xmmnX20vQdHUTSOzmJIds4knnBIH7w8c85PpirV5errljqcK2kcqw+UsySNnBLYIAHoMk9+lZpNyTktBuDje2hi6te+JPE/hPwta+DNeOn3eqWn2iS9ntjulaMKH3SLkRtz93ac4xkYrt7ETusNvqQXU5rG2imV540DvMpIaTAGEY8bfx6cmsXwppF/pupT20EkcGgwj/RYYeEYDDAgHJ5I5ySfesfwi+o+EBe3/AIynga913V1KQ2bM6xoxCgsTnjkfLxgfjgny2dmvLv8A1Yy5HdaalfxQPENj470nxPpxt7+0u5Ba7d7q0MDgBkKAHeFI3FsdTjGBmuo8MeENP8P6C/hmJ7e5hmaWSch9s0rOxYNgH5cDIGM/d7VS0/xPPdeO9T0uxtraPTtPt5y13Lj7RLKNmFTHyquWx0Odlcx4L8Z23ilILVtLu9J8V2rAmCaBgkoD/PibG7JBJOT1rVudknpt/wAD7iEoqRp6p4xPh3VNHsfDWgPqulmUadeOkxN1bszEJ8nVRwzZ6HPau+nvINCsvP1ad57df3EW23ZmHJG0gZLZGBnHavKtEkXwh8SPEGgeENLOs6tdx/apZXkMbRqxLYknYt93dgDHp3zXoWn67Bb2kTajNNDLFcJaXeZGkC3LbSq5xjadw+ZcAnrWc1fXp+L/AMhtX0TNYySWe6wsVjTcSqMi4MQK/KzDnp0HHOOcVT0y+F1pMdzZ6Q9vfXUoM8bosL+YMfO2Cc8DcOuQRyKx7LVNWvfEviPTmhQPYxJc20pVkKycgrkk7kbGR6ZOR0rK1Lxtpo8G3fibS9Uu7LQrXUolN0lp5xuEXYrLGhxtXOVJ/wBk/Sk48uj30GrPVmr8R9Y8Q2P9nSeHrV7i1eUPcnyvNIjPAJTqFB5wCM+1c5beLtXutJ1y8gsI3NosNwoMDBlDuplhUnB6A/jXS674l0y2j0y9l8QNZWGo3Uaac1uVZbnI/iBXITPfOPpxWtEJtQujcI42ENaT2jKVCsM5GRnjPetYtRhZx+f9df8AhghZO/QpeJbXTfEZ0CbU3aG50yUar9iCqzyFY2wmc4754PO0V5Cb/QfFXhrxZq/hnw5f6L4509jJMts7PKrM3zFccDcA2cKOa9KmFnZ/adOuJLiGKK3ksY5HTzNgkXlm2gFivQYYDbnvzU2k28+l6rpdr4Zm0uPSvsJk1C5a3w8kgwFkc5BPfgnPqTUwfsnzRT/QqVO+ly62pLe3ljc6l4fuluLaxEsGpvGAqySlE8tBksGOckEcYq5HbT31nNCb1be+S4EW4kOMKpwoPc4Yn2PauS0PXX1XUk0BtYuLnXLbfJLLcw+WJAwPzwBQFYAcA44zWrPf6rBZaTFoOiwTMSYhc3KlVhfcFMj+5z6Ek96pQcNNn/XcUtI6C+HfBlrpdnqg065ns9TvYVAnluRJLGqsTkDA2Ak9Bn9Kn0rTLbQ/DVzYzNLdQyF7q8lupCE6kths5U5AOee3TPGZ471w+AfD41e8tX1fVLi4FrJIIMKwIzg7RwMA4966C8sU8ReHYpII3jgv7REijmJX7OcFhkYOQehB9B+Dk5WTk/db/L8fQyXLeyMLxDrv9k+B7fVvC+i3viJb8jdDLMzSeUTz1yfy+tbFxrdrpeiXl7rkclvaWNvBeJbMBJPbMwZdnBO45HHfn6Yq+F51027TwwkF4sNii7NSmAjV53y3lxLjlQu7ntkD3qW5fxDPZeLLm00LT4tQH7vTlZwXnZNwV5CRj+6w+uO2aiX8v4389PwBKyuwfQ7Pxp4H0y31pdRhiMqXsbyL5U0bIxZC4bOOD0P6cVsWl1c/2QbuUwWtoLbcvkjc3PKtzxkf3eeTXM+EtH11oNE1XxPczf2+NLk0++svM3W8vzkpJJt+VWxnJA53Y7Vozy5u3mjnmbTUJEU0wxFHcE4AC4BMfbJyB+tSlzNp9/6+8cUnr3KfibT5tA0rxN4u0ErceIpoAyKylkfaFCoUB68Y69eTT9E0NNWGi+INY0iODWkjVriK3mJRZhgJkYwdvXj7vvUHh465e6leSa9Ym2mtrowxeXOyidQgLTbBhWAzgZHasvXPiTZaDqup3jRXv2O0njsZbZDz5xb5n2HjGMcgjn61slUd4xd3+m1hcqSuV9G8MR6V8RdV8UahqdvLaX7PFpyRzZe589h8oUnBClsA88c8Cuv1201CHXtImtkLNbylYHC5idHIEiynGUbH3SMgkY4rG1DwLp978StJvZmkRdNsIxYJGuVUxvxkkELgY4GM11mqfbbm0sfsKs9xbTxyyQu+BMgOCGb1wdw91HFKdW8otPp/X/B9ehMY2VlsUdH0238PXF3pFzNc3Vjqk8s6NONyRs55iLZ78lc47jr1u6jY2l1fXdlq8fnWt5aMjKThJYwQGD9MMN4wc9CfSuP8M3OleItUudX0iXUpf7SvIwtxPJhH8ltzRCI8KE2cHbnJ+9XT+K7ixg1uxl1dX+xQW8sgLRl4mfKcEDqwUNj61ElLns92tf6/rYcVrZGj/ZMUd9DdWGyK4UKkxRcedGqsERjnopYH8PwqlplqkN7fXJnnCahIifZOClpKoOSO+WOD+XrWVqGuyeFbqyv/ABB5nlapeCzjityXjtgxxGSO5OBnHTJ64roNQWG1vzLM0qRzOsu6JCSGXAw2AeCBSfMtG73X5f5f1oNWbsZOu6vY6Zqgllnd9RtomlMAIxL8oBUL1LHb2yRj0NdFEbaTSUMqlYJE3lCCCufmx65GfrVa40jT7ho7yS2je8DBobiRAzxsScMpPIxuP4Csae+07w8Gjm/tG6Nhvuby5jXcAWXlpAOpweABkYqXaokoJ3X9fn+ZJpm+txphuf3r2sbfKAN7sScBjn/aBrL1a50yFFsNS1Sy0u6vSHKXEgWWTn74ww2E4IHJHGPat/TJLSHQraRZzLZrAJEkdfvpjKk8cnHtmvMtM1Lwn8UfFUB1Pw3I720bPa3E8e5Zo89JOMAg5IUk4OadOMpc0knZf11BztseuW8sU0SyW7I8RHyshBBHtioUSdJpisgkDShgrHGxdoBHA/H8a4Tw38RNPv8A4g3XhD+x77Tp7bzGt2ZQqTKv3mZB9wZyVznPXjNdmYJV1GWSadjGzARQqdoKkAEk/wB4HPTtisJU3CVmKKuVdRlgmikm1Bokt4n8liWIEe7CkZ75JAH1rldV1rSPh5ou6GGO4muH8rTbC0ctLdsT90jHqeTzj6kCvI/2o/ET2n2Lwna3bmMsb26iVgVXJPlrnGSfvMQT/dOKxv2d9duL7x5Y29/Et/esvkW93e75fs8CJI7xxc4VjgEE54DDvVub/hxeg20e36Nca54btIL7xXb3Wp63rN6jPb6dGpSyUjaEB6sFGMknv1PU9XqbPaxLHcY8og+VOinKtnIHHOT65rJ+GHjVvHum3t8NMudNS0vHt1MuP3yr9RkHpkdj3qGLx1NJ8WrrwcmkyfZYbH7U12FP3+uMdMHoPerV4vltqt9fuCMjTt7LTbbUJ9Ze0tTqZQA3MESpcSqRjB5+b9OnSt1o4JfK8zatxIhVRJjLjrgr3xwcdqoW99bX8JNhAi3SMrtDcRbWUZ5JHr3qlr99Y2ejtd3t5G32QmWa7hKmW2jOfnXOcdAPfninyOcktU9v6/rXoOTtrsT+K/C1v4m0SfT9Sk8zzCHDMuVRwCMhcjsT3rM0PRf7Ns7XRksY7eDTIFWC4B87YwyVkGQD1zkfrXF3Pw31O7vo9S0n4meIHa4cXFoJrgtG6cHA2kL3/u/hXa6JqF5LqSaTrjz2+rQDzEkUfJdRg+oADHr27nitYqSp2Urpa2tZrz/QmLd7s4KD4UaddTX914iiu5rnUrw3LS2OBJGSc8gqSityepxwK73RI00/dZgILOzhViW+QJGc7if7/wB0+lUPFGnavHI2q2zg2sj75xbuyPsHQOBy4HpkY+lSX807zqFe3FykInijyQs4wT5LDpj2/wD111NurHe6f4f1/wAEqCSvY2/PZ7Ugq08E+5fJc7TCrcgEjqcYI7jNczrPji00Txjpuha2Z2iuUSM3STBY4mbhRKvXJIIJ6dKb4pu4rW70TxHcyy2406xuNYu7GJCPtJMSJjr95eOua57RvDsPxK8GXd7qtnZRXEkrfYLyL55DuO4+YD1G44I7YNY04RScqistvm/8vxInJNe7udbrsd/bQ6fZaZJcWIM7Rz3wVdyheQiBvlIJ457e9btpeG90q3uLq0zLequ5duQJFOOeeBkccmqOsX8k2i6xA0Yb7HaiN9sZc+dj7ypjnHUVb8PPClhBoKXYi1O0t0mlhU7miVidob3/AMKio/cTktU/+Df8UNuzudPRRRXmEnz94o8Pr4nie00/U4/7WG6MwTgolxIvO8DqjcfQ1JpWg6je3DSa3dtJLaqkK21ugY3DY24Q/wAPue1Oj0A+JNU0Hxjdajb2j2UYj12z2kPcyxngrgj7xAH+NdzYxj7NfSW8kqTOqxQ74xFNHsOZV2rjDEAnI611SqKOi+Z3xqOTvYwNb07Q7m1Wx/sy31G50yHFwlnd7JLckjCKRy0gPOT1xjvVyMWOk65qt1HJHpmg26RXE90WIG+RCFcA5y2cAiuP+HmnWq+J9S/sbwrrXh2aZZf9PnJmtRjLb1zg5yAQCSK6Txv4Wt/Fb2qtc3FnJZ2zPaRLGspnVhsmLIwKsyhuO4z+VLlUrX/r+vwJVSUlf+v6/pnRSSvG1zJOJ0sILQ3d0FJE25eVjT/ZYBjlecjHeuW8BayPiFoJi1vR5tNW9na2EtsWjWSNP3qON2SGGwKT6k+2OokNvpwscG7nggg8qNUl5QAocsx6Yx0OfatL+yVuIl1XSNSnvnSOR7eKefdbSTEEKTgZHJI4OPbNRzrl16hJtSTbsclq2t2fhfWbeJNMsluNRk3LdorSDCsFRSOcN0OSfU1NJrniDU/HUuh6NefZdO09vOv7uWIOCSA22PI+YEsR6gqfpV/SLrVDplnPqsMNlrCSGK9gtFBTJJAIznI//XUtnaNLJaW1vdMFsZ2aF87CMA/LJ/eXLNgdOlWpxtqtfv8AmOVNvbYqa/8AbNW0FpPDRtLTW9Xdg8k0RO+KNiuwMMbSQOpz1PHTC6dft4b8JXg8U3jIlrLEvkxxq5tmb5hGGxhxyCG7Zx2piS+K7XxPHaW8tu2nzOs5iYRny4mJMkjKFDKdxPOcZzxVvU9PGs2us2eppHqPhny0jSKCcGSeTdl3JHKFMLgKRnJ9qttKye34/wBf1sRZ9Cbwt4rufFL503TJ7O3uAx/tGVlZfl4Cxj+I8c9hz1qS4Sxu/D7aZq1pbwaFcSsFMKjy5FLElGC8hmOckdTmud1S40C4sZfBXhHUoLTU3tCLGDy3VYSR837wdCw9Ohyec1Z8F6ZN4WSxsda1eGRtQlBghijZokCxhQofPEhOSZBgMSeM1DUVrt2XUXk0VJ/h9pWu6ppl7rs0H2i2j22Vuj7USFD+7RUGOFOCR3rvLW0vbSzFrDdL5UvJvTh2Llsk7eOvPriqVoumWPhya/8AEkdtAs8rvMJAG2FnIVBxnOMcDvk1T0K61K3uJbXX7mzlNzcNJaeRHmCa0P3UVR0ZQe+c+9EpSn12/rQN20kV/GN1qC6bjSlFvNEPOsi64U7cKyy5zyDz9PWqtra3euaRPFDPFFe3MIlumUfuW6ZRe4VhnnNRaBZanZ3vi3RNevrnWbRZI7qB7jOFR2zsDHgEY6dKm8S6zd6LceFYtNjlurDU75opS6qgERG1YdoAxy2c9th9a2T+xDfv8rjVTlVy/p2iNHeaRq2pXETX2nW/9neZH8sTo4BkZV7fdXBz/CfWukmmuUE8NtayymNSyyS4IZwMgYyOvY+tU5re3tdWzFHuM7KJv3hKqRxGoB+716ivMtV1ybx54hvPCuh3j6Nc6VPKZXuXcfbcAAouxlO0ZPUnjB5xWUY8+r2RE317naeDj4gh0y5vPGdwsl5PmdtOjVGFooPykMOvAHFYXj+XxbJr9tJpMEsumoibFtpihim5O8r0dcHocjIrsdOMM0tvbTIzhbZLgORlJFHGDI3JIbk89DVXTLHUbW1MTXC6jf3MzXMkzMUgUN93yxknaFAGM9iaqNVRnzNK/wCA1BWs2JpV1qE2kQXPiKBE1O1JM5j+VUTsxBzgsOeO47Vq2l1IFFvbh2VAZZZWGCockqvPcjk+nFLbyxyS2kZkSWIKyKyMcNKASQQSc9DjOehrkdT8Watp0WpGDw5e3N3beU1tsb/j6EpIwDjjBGCDngAjFSk6jskNqyt2NVhDpNheQXFxD9iiV7nUDJKJTbLw21wTuJcZwT2HQ1BY+IrTX/D0+oxveT6Zdy/Z9pj2SW7BiefbBXke1Y+leFr5fFQ8VeILa0tJ73T5Ita0+2ledblgQsZKklSFjVRwOpPWtKwgtfB9hpOk6ZZ/ZkuJ5EtbRZHfcuSQ7lieSCCRV+6/N/hpv/XYmLk5Xex0cGmN9mgDReaLd5I0hZv4NxAUt3wMY/KuZ8c+FtK8XWgS6n+yJuP2po1/eF9uO3BOPy612FjFMlvbw/aibiABXiyCr44yWxuPr15PWs+Ga3t5tQ8uAOEjQyJjYHnLEBB6ZOB+NZxqSjK6ewWundEguI9O0qx0nSC1xKixW8YD7mSLgeY57YXmprjy7O0t5C9wmw+a8SMGaUjAG7jklto4xycViaZ4plPiO/0KPT997DH50ksa7YIyRkKXxyT1/SnT3tpFHpzTeZNawzFopxwzPGG8wspGT0Y++PpR7OV7Nf8ABv8A1oCS2Re0my8Paf4gJtraztNSvUa4hTzP3kqnl2EZ+7z1xXD/ABV/trX7gxeGLe8uPKiKwyxyhYWlBOTnqCpABzkHpiu3uVW28SrK0UTw28Mly1zIoaSGNuqRnGdpIyQPT6Vxngu9ttJ8Baj4m8TXVydKilnuLXzCVka3dwYy6DGJCeB0zkZrWk+V+13ei76u5k421Z2ujwXZ0/TIL0m7lsrdHnMsA/ezheNpP3WB7j1rZsTGkKO10ztMdoLsOWGeAPXqMe1eRaH4i8Y+M4bPXNEvLa008SbhYbh5kKqfmE24fOGTOMYwxBrc8beJr7SvCdprGlaM82o29yTHZmESBi2QQxAynBJBHcc5onh5SfLdXf8Awf6/pDunG62JdJ8aDxR4zg06OCWyTTLmZpQz/NMVRlU8ceXhmJ99v4z+K4dXh8Pa5rHgyOS8v71BsgkAVkZcgyIOjHbjCn0Bz2q14e8NaPoOuXd/pNtINTvLFpvsbys+3LBmCuxO0F9vHQEZ4rQtNPvUsNPimNxa7h88cEhcxElmVGPTaAdpYDk/hUylC65FZaaP5t+YR2s3YoeEtDv7j4caLZ+IrgnVows5nMYDxybyynHTcAQp98112nWqWtmsSwww5LSOkS4XezFmIHuxJ/GsTTLO7PjbULuXVZWto7OKBdNWN1ijJYt5mSdrH+HIAPBz2A4j4v8AxAlsEuvD+huRrKxCS4Cs0bLGRkiOTjD4IP0PrWSjOvPkXr95Mml1PR7y40bTtRa5ums4L+WMBpCFErIDxk9doOfaqlomqHw2ou7uzu9W3yPbyhfLjkxIxiBHY7NobGec9a8u+FPie21mAXeoRgTSYg343K8mTjGefu7c5J5zXU+JNEg8QxwzWtw2n6rZeY9hfFfMS2kcbS3lnjJHpyDzW08NyNJMuEVKPMmcifg3b3XiafxN46nbVLm8laaW0tywgiP8MZbIZgAAAeBxgivWNKsbO2gWx0qygs47QYHkxBFiJHRBjG7HX9SaoeBV19fCItvFrQnU4Q0YniIczRjhJSD3I5wfxrE+Jnha48TXHh2yg8QSaNPBdm4h8oOXuSgywJUjBCg85PNYxiublvt1F8tQ8a+PW0K+udJ0nTTPPFFvurqKRUS2lk+78pHzkk7v5111jfNdaVZXcEcP9oXdujneMcDG7JHYbjgetR3Wh6cmstqn2OGXUZ4Rbu0gBMqrkjOePxxUFhbPYWoi08W6ozNOqOGIJzkqpzwvpnvitP3coLlWv5/8AUYN6jtauv7Fsv7XuEjkjto3klmGFYoFJwT3ycfiBXkehweFvDuj+JviFbWWoy2txAlrc6bcuGVVkmXeyseo5U47YPrXd6zodpZabr0ML3iyaxKsjz3T+dtI5AVeyKARt680mieGrK48KHR9es42tNRIWWNWbEqg7kctn5SSB8tbwSjSbvu181v/AJ/8AJxbZS+G3hbUPCej3GlXd5bX2lpfL/ZpfPywv87DJ6dRgdMr711urNHcW3nyWXmWNuxdZUl2yRFf417jGDx7CnG1iiWS3ZYJLSKPZLBz8o42gnv0GM8jmqk4a4SF4ZAigblYg4AH3ozng5AHJB6fSob55cz/AK+7+vU0ULKyDwvq0d8l3JYW9zFp4AnS6mAxdMSdxA6KcryMc5zxVLX/AA/LdkXGmukLlle5hHVechlP9PrVmG/gS8ktoovs2mypuD2yjygGA+8MYBznkVfexTUNLltku2tJpIfs6yx9cDjdg8MD7+9PmdKXOtNvP7xWsrsz9fsrLXdHm+13KSQy2MlpNeWpDDbIQCQR6EZx71i6n4RvdI0Xw9pfhdmeHTbhp5Y2l2vOxJKuW6Dkknt2xVvwn4ItvBWlXWj2U9xc2eoXDTiE7QI2IGVTj5V4zznGK6OykM1sE88y3FlObeYx8MxyMDj2Kk0Ko4JODur/AC/rdfcRyrRszvCNtrsOpXh1ya0ZnA+RHDTEc/MSAAq9cD61n+ALrQNb17UdU0eF5b2JRBPqG9j5q5OI2OfmK4HPtXJ6qmpaV428Za7pwvZL6S1TT7FZDxPO5wnA4EcZ5z165Ndz8O/DMPgvw5baOozb2kCtNMVwJJjyzAd/rTraRk3u0ttPX1I3OzooorywPCrPxHBdeLtc8LGzniigR3W/YYw8Izlz2GRxXS3SXMWkuXmuRHJIq2s+0rLFKpwOOuGPrXJaLo15pnjTUPEGr+Xew/Y9urCBCzzApjei+nsOcdal8P6Je23jnW/Ed/rrX1u4YWBt52kgulKn5nVScFB8iqOrkYrplyrWPRL5s7Yyne0tdTT8Ra3m4uotW1TUbmRXWK2trUmBWT+PeRwHwT1rpontbrRZoXVLi+t51JkhfZsLcEo3XO3gkdc0yV31XzpZtPt9NuPLUpbX0oWR8/x4HRj0yeRSfaIptEktoxawNHKELyLsHmKQxSMdW6E5PvUtqyRSV9jkPic9qdP027vJ50tY7lrb+z7GPLSuMEP/AMBwRk92rq7CTStPs9PluZpNHEoJtrbcSGUqS2UHGcZPTtVWa6wZZLaJDefZwEWZyDIzOFUgjqTkgnqBWNqy6tbvq7vBNO6Wqw2MRxJGJmPzpk8Pgc+wzmtE+aKj/X9eo3Hluzp4I7PWLW0v9C1U3mg3URiadX3GCRCSsgJ+6B8wI+lXbWc3NvNdLDK9m8wXzzGC8zLtG9R2QlBj8TXE/DpPFWivDZXEGlHTp02ww28CQBlB/eEgADK7iffFb2ra/ZaFpU2r6jqF5dWBmMNvJbqAsiFfuqo+XcCpGfY1Lg0+Va/1+ZEW4+9Loctpugrf+I9f8TP4je/gvJ2sI0sfklecqB5LOOkaAD5enBJ99H4ceA9O8JXIlsZ7fW77UPuao8ahLcxjbtjAzycEHB6jnNaHgvQ9D23es+EhPaf2zZlpbKSTMTyNx5gUnAYYIJHX865zT/DGueGvh9qmk6XrUUet3ELtAsR2LBtcmQDJ4Z1I+YdCK1c3NODdtlb+uxmo2d0u53utaXb65dJLOp36U/mQGBvL/eY5hY916Vyei+LYrzwnqk/izwzdwX+n6n/Z0ltp26VkL7T5inPA+Y89OKm+HOtyz6ALXVUu7jULFWzPfRCOK0gwSrvMRz8vU5JOKtarbT+JfBOm6Z4b1K2fUonguDKrNFb3igAkuFO47lIbB68GpaafI+jKT05kY/iiHxN4Z8YeHrPwxby6haG4jS6vL3987PK/zs5I+RSMjcMY6V6f4Xjhi068xALaMXk7A8dQxBb9DXlev6pcaFo2l2vhDxNoL6Nocy/bRfXRNxM27f5O9icKwOB+VbXhXwzqWheM9a8Q3Ws2z6Fq1t5v9mAs0hzgqTg7cjJG4daUlzQt/TJlzbPfQ6l5Y726m/tASfZ7aOOdYLvASRt3yvj644PfFX4rz7QIrp7XdYK7TSyPIQ0DqP7vp61y+uyX1v4W1DxCkYdLWNRHA2OERwHkcDhtgBcL/EU96T4f67eap4a0/Udbgkt2kilR5RHs+2RggrMi/wAO4c49+KTheN0VJpy5VudPZFFvxGnmtc2qfM7LtV9/TB6E9KyrpNFu9ZngtLeA6ra3Ed4jCMb4piGVzk9flJHfG76VcgvBHJapbxP9qiUokMRDZB+6MnouOSfaqFxpNxZeIo74yQmNCfLaOEpgOQJPMP8AFjjH40KzbbKa97U5nxT4ki1fXNe8E63pN3Nb3JSKDyJfLYxnYT8/QAnn6Aiu1iMGn6lb6ZYxRW0iQ4sEMuQyRqFJKf3fm6jutVLu6ht9Tt9NvrpI7G6nKxRBGaS6YDcfZVXA5FYPiDwFq+t+N7DxDY6tFarEVibYCSLdHLBE/ultxB+laPkdr6aGbTgu53DIWsWaL7KsXJWTzNysedzAjv1/Kq1lfrJZW93pU/2y0klVEnXBLKcoVGf7pXJzWdZWGh6ENWs7LTjClzN9plikuSIncgBgCzbUPfAxmqmi30uma1Y6ZY6JdLpMkbv9p83eF3NwQO5BBB7gEVnGLaehUrr0N+10QWmnJDPKHkVmY7ySJGzkMBnIPb8KqaPpl1d+NLzVbp45NPto1hscNlg+MSE/TGPxNWPE2mPqWkXdikr2LyRM0dxEod4z0Oc5ySOmOePao/AcNpp+jQaBbzz3kdlCoW5uCCbkHO5uOoz/ADpOb5XK+r/ImbbiUtEvDqOtz3tvILWO+4syvziaJQB5hU/TI9iKv3VmNSu5dMnVra0WXO9ZcTXDhQQ+R0wcdfQV4X8LNT8S6Vr41Hx5cLY6FpkBhmMqhE3OAIljx2PcDg969R1ZNX1Lxh4S0mKG+i0y2RNTlvI5lAkZT9x8dQc4I75repDlnZPZfkSpaXsWb6CSyiOg215Z3yyTST6rI9wqXFlbEExusY54wozjtnFa+ntIJra81O0lleZA0fyg/ZFxhgc+oyfXANZ0fhbSU1jUda0HToZL3WgGk1IyecChGCEJyUUjrjA9Ogxprc3ESXZluGE1qxRNikqUxlW9yOnPFQm5J3/r+v8AgGkbuNu5U0S/03xTpaNbJFCbd/JWNyQ6KG+Xv8ynAIB4yBWZ8T9KtfEtsdDlWU28Dx3kzI+N0uSED+oABYj2X0qrr9vJpGr6VqVrpKWdrCJJJZYG2CV2XlJFHTkgr3BFdy2gWs32642vb3d/5bTPFIThkHykA8dODxg981cpKm1NbdDJ22kebWmgaBomkXot55bdr1ljkvypL3ZB4TH8K5wAB3ruPDtnd28n26//ANFtIYgkayEtM4x96Q/j069PpVHVdQ0fwbpcmuatcyalcxN5AeJRuzuwFWNTtU5IBIA681wT+PNV1fQ4/E194fvhobMyyr9qKxqobCOgUjIDcsx+g4q/erK0du/+W39dhOaXu2sej67BdSaTfQR3B06a5l+yRXdmo81EYbt4J6tzj25IrmPgx4UuPDF94iuNR1W71S9uFgSaaV3kB8vzMYZicnDDI7fjW/4f8RDXvD9pq1zZyfZ7u1kaaFQMK0bAZB75BJBHp61NqehXF5rHhTVdAv8AytO05ppJrQM2LtJUABznll6jd6msJScYuElv+gOz17mH8GdWjv5tet4dUS+CSLcyRLKZBbySvKzKCSSBwDjoOfevMpPB03jHxFrV7a6paXkVxqssc5VuLAoxBZwfvFkCgAf0r2L4eeCdH8Nar4g1jRI7u2XWZg0ttMwKIY2k+ZO4DFycEnqMYFcJ8NtIGj2mtXlncRgag82xdpO1vNcq7npnnAx2ArppTvOco6bEKHO7SRT8G6XY/wDCRT3VvfTW6RyNBa2TLuOAoBy3YKQcDtXZ6dqSXDXkEhdZLRhHJJnB3HgOfUMenpWTp1jHpLXmpXhkjmVFJhSXzvJcKN7AnOC5yePWn63rdnbaRZ6hOLpZJ1Z1tbaMPPKi8uceiDnJ7VtKXO9fI2ilCOunU7s3cM2h2s+q3TRRxBlunjmKAFVyckHPbOPeq3hvVH1nQprm6eaJrgMjIhKuuVyqoOzgGuHuvGED+KPDvhKPR7jVY9aiS8a7UBY4ImU4kUEckDlifU9c4ruI2tNEt7DTdMt4mmvpS8UUf3VXgyMSegxngeuBXG4JJxtr+n9fkTpsmaDo++2tIBE0MSiNzOSWDbc8MP4vemzymdpZlSWZIzhmLFPLI7bR196oajpN3N4cvLPRrkJrEsEsdreurIluWyuVxyNgPy/TrWo9kLi2gkaSdJETa2G+ZiOMtzg985rPmSZSaRjz6fDeukN3M8kW0rCR8xXd0BPXIGcZ5rQ8PsjWS2Mv/HzbOcccnHG726/nQyGz1JmQRrbeWJUKnGSOGGPYHIAqxFtkZZowSGlCMVYhmx7+mSCfpWk5c0bdP1KlG6uiJ7hnuLRJIdto+WYlgV4DZWQ/Xb+OKLed3MzTMXtbgjdFx5ltnCjOOxIz7VieHfGnh/XtY1bQ9Lumu59MwtzKkYETZOCUI4YqxAPvW1cyWySELOgdW2sJlz5jrgrk/wB4HHHvULXSxKSkynpFpcWWnNazx+eYWYMFbb3yAfXOaxZvDjnU5vt0089g6FvLc5SCJuwHUsGydw7GtCLUbS4u9UsYrmGXUbQRz3kBVsxPJnYA/fOCOOmK17R0DidYpI5jG0U7u+7ytrY47Yznp7Vv7SUW5dweq01F0XS1stMstLe8uLlrKPAuGYhmGSACck5A4z7V5fqEF7pHxJu9N0GWPSrXxLYsFuXyz284dgzoCeSevXuDXqo1Swm1O90eG7H9q20CySRAMHVHyFbPfoenSs/xHoNvqt9BczyLDdW6AwSABnhyfnIB45GPmHIrOjV958+z/wCH29TLqrDLiC5sdWa88ie+aG0UQj/VqXGd7ux4yeKs6TLLdwxPLK6zTRFGBBIbPJZSeOPSneVO8cUqNHcq5b7SxwWZMcDb93+lLujiRBcyrErMVGHIU7TyRjuR2FEndW6mnKdBRRRXAYHjHg3WT4s8OaX420fSo7HU7O5ktp7GJsRXK9H2njnBypPcc0+eKPQ1a50q0LLfXCTWulzPtXerh3+ZuI2ABYdOlZfjXVNdmufBFnouoQ+ErGXY9/bo0amPcRhVAPK8kY/OrdrFqfh661O21GW6QQXyrZ6nfyBvtxl+/wDu+gCqSARWiureZ20rpWluXvFVjd6zpt4NFgWS8udPEc1zLLh5HLKQsbn+HAYZHFVfBx1GPw8uneMryKfXNT3RJcDDi1lRCFRiP4tufmFUfFlrrPiKysbfRr77NPbz+YyLIQHhXkOCOhXqAKmRZrDxVqN3Ne+da6iFYJAQIym355EB6M2Mcd/rWi+Dlb/z/rqW4+8b13p0Ky6beanLJZsIvLLhdwjmYHy3C9wNrA5/vCucsvGcJ8ex+EWaS50Owt5GuntwwYyYJLuw428jgHqfaqGv+MvEvhrTr671m2t0tFu1ttLnTASSAKxYSsOp4THqc+9dl4O1YaXpBlfS7HSrWZftLW1vFmSV3BzvPr33HtxTu4xu9SJXlot0UdRkvrPS5P7Gs2vbwob62eRvnCA/d9xt25XviqzaYnij4biz8Y2UVoZ92oRwQS+Qttg/eOSMZy3H+1XG+LofFNp4i0yLS5tV0+OUoYUVyIXYyElGxxs2n+dek+MdM/t6fUNPke8ittRt4hceTGGKiNhs8sngDJfnqc1Tajyq/wDn/X9dxSfNJ6bGV8QvEmpeGdB0TU/DOnWV1plxJBAs0aebHFCBtEb45wOcEdDml1qTWrzVtPs/BSafHawXPm3t9KQxttqgtHN3Ynd8vtirHhXRZPCcV5Do+p3M0cN0bnEimGKKJgPNEkXYrgkcd896NI1/wz4gi1u58P6RO0cvl/aL2ECOa8jGQsjKPncAhuSN2Og5qb2+FXS/rUSvs9Lmx4s8PSeJPBF5o+q6jcR6fcMsqTR53lN24xv/ALPIx7AVknWfC+hPcwarrtgs1rDFpcgijeMxuPljcn+90G4dABzitCK31eSUSXF9DNapIkulGNMRyQlAArd9w/vGm65pOh61p9vY+OI4xdQDJtlAclScKxCggHPTvipi7aX+4rRe91ZneL/h74R1zUY9S1a2uNPvbqQWk0unPsS4kwOSPTtuI+vrXS6ba2Ol6ekLWcdu1tCtpEwbeyrjAIYc89D6VTv7O21OyW3u2a4s7fcrSW6BVCj7rbh06YKjjrVwxIWjZnWxW5VA0cQ8zO4Z+Zj0Ge3eq53yqLbsOMIxd7Gf4Z0S5tdPe31m4mYfahcFYpPN83PQZ78cGtSIkGK1mPkxtMRa7TkKpHyx89Djg1PEI7K2bT9BjthDCokAIwrfNyoP6k+tU9RkmiMbxh/OnkENqVfZkE4bbno3bP4ilzuT1KWiubWlxBNavJJLYRxQINknRRnrgd+AefqKzPD2sWfiFrieBd8F1I5tZNxxIE/2T93pz9K5/wAHeKbFvGM+j6XPqLw29xJY3Md9L5iq4XcDE3J6gghsZBJ/hqv42mn8N3V/faKoSWVgJeF8uHCsQgUcbnIHJ45weoqlTvLl6vYx5tWzuL5hIFaRHiuyAUkK4KcHdtPbIGPxrz3xrYa4fFvh/TtG0O3vLadozNeMMfZFDlmGegwBkdyTXT+HZL5vh9pl3rMy3NxcKDLcsADCjNlQ2OoXOOKb4p8WWPhHwpr2p6jNOI4rgWqJGoJMpRcbPY7s5OOlOnJwlaKv0/4I5O8LrQj8YzP4j0m9i0q6s44o7p4XlLFAJEC8O3buMj2qh8JNA1fQdP1dNQ1WK5tppY5LQRsXiik+bzFRj1U/IPzrT1nXbHw54Wg169TzbKKKMR2tuE/0uSUgKQSQCSSSRntntVLw94Y8YWPxXu9Wn1lH8LzQMBZluVLHKptHGUbPz+nFHtLU3BGc0lqdA15AyyWuny+dcqGa3iztAOAxUA9doPHpVi1EWmXVo7JJOy2zb59mXKs2cE9wvHHXFeXfE/wP4l1DVrnWNCjaC8gnWezl80buAoYnHKnOeRxjGa9RhstVs9Csp9TvPtmp2i+ZN5WFjkYjBC5wcD35NE+VRVnuVz3fL0OV8O6TbSWOqaT4gNvrNpFPGZlkA8pVUB4zg9dzHOOmDWjqum/2po95oksUGmLqtt9mWWxGJIEYHAIA+6emRxzzWjcfPF9nhs0EDhWuI2XHGcpF7DB4HQdK57xZBrsXgrWIfBzsdaYLbwGSUbraIkeYysTxxnA6gjinz8zuzRq0WxvgIT+CdOTQNQuBrWqyNzb6ZAEgtI1UKq9sZAySeSSfx6fUtTtNG0W9v7kRizs1E1wqDO4jsvrz2/CuY8HeHJfCPgu30VXtlv5ofNurq2J/eFQOc9TkDk+59atajb6heaNBb6VqQ0wtcqZrlVXL2/JAiDHjLbcg4yM0mk3da/1+AU4aHTzNLb2t5OQ1yrxh4lJ3DA5wF9v1rUs7kG7ntC25owHU46qf8D/SsZ5XGmW1va6nJJJE6pLdMq7yx+7uB4JJwCPeuE+I2seJdA0zwd/wg2luYJblvtZgh8xFyMCNh2DMx5OACBzUcvPp/X9aGNRpRuztPFNhZQSQyS2dq1vPIwnEsO9ZGdcASDHKZCk56YFeeaA3iGTSNX0e5huoZZvMtLa7cgiF8H5I1/iiI2jjgCvSrC/v301rbxHZxRzi182Zt6+W3X5CMnsDnqMZqnpNvbjQZdU1S6msrMxZRjO0QgiGTuzxtzkfgBW1Or7OLT1/ELaXf/Dmf4O02+8I+E9F0WUpf61BbzOoR9sbSZHyZ7KA+T/u10KTSaV4eN5q81jp3lI7TOSFht2OfmBOMjPqec1Q0CbRToNprllrEB02AySm93BUeE5yrk8DB2knrlc964NIvC/iCF/AWqXUep6Reo2r6ddQXRM1wz3EjugAGBtJIGCRtznBqJXm3+P9fMT0Voq56DqGr6ZodvanWdYCHU4lgiKqSsr45kUAHGdw9sba8v8AFtz4g8KtoC6ZamS1RlhvLYjdHKwwCh9QQQQR0IOa9G16GRNNt49Lg0ONrKSGKzOpRMwtjjaQuOd2NoBB9cnpRcWeoNreoQ6dDJa3MSLPDdXU3mQzl8l1SPJ2gHOc4wTwMYrSjUUHr/X9XG1p2bOA8feK10O8uNP05IJryHY08jSKyxRnqrJ1b0OK5nw3qGnXeqT79Oa5lulD3MZm2R6eS5x5XcoUIyPwrotV+E+p6pqgtWAXR4pftNsbh1eSOTGSm8Et5ZbJwfWu18I+Am8N2s5gngivpNrhrSEA7g2WyzcsrZxg9BXT7elCO936mbcpSu3oXNAv7iw1HWbS/wBOhtPDthaRz2epopCvDtJYMT3XGeO1cX8PvEF34ybVPGsWnSSCMPZ6bBKDhSX2ooHTuC5qb4heKLHUtX1L4WadHfRatqcRaS6bDRosv7xwpJyflJ4wAM11N6qaT4cs721gFpDpE5S1sIG2wybgYkWQAE5UuCfRga5oaK9tZf1+I/idzXivLi3tYkur2GfVElBuVtxlVHXaR247mkvL6yTVElEk0k0sJUBXI2L6EDqee/pXL2VjBpWnS2ujW6W0LStI+1yzvI5+YMx+9149KqWjJb3qTLH5bAuhhlkwn19ST1x7VcaKldm/Io2O2tz9pIiHGQF5j5YgHKE+3rVHWJRo+lvqlzqi2t0h+VZQAr84SLB5wTgZ/HtUVpFqttp0+o2sEEcwhMdtbXRLGSQsMO8i5IyMjAz1q54x0h/EXhs211aIkzorlJR5yJIpBCkDqM/xD05xWfMlNLoZynd2QeGNI0a0j1C98N6TbafcXyiZpo4wEldgfT0I5wB2rGtNTNump3F1KrQ6au2TfFujikALPIcDgrgfgTVjQZbnQtNga5SJ/LhBMcS+WgXJ8zYOgOdh5x096zvHvhr/AITbTJNPsbm6sbLUtrXRt8Bkf+FnXPzKw69vkFUkoyae3caUo9Dbi1K2eyE+pJArSRIJL14eGDHKEH+783Hoa5DxFqF241vQ71HsdPE0YtJbcZSdCDv3OOpbcDjsRWl4F8YaJPfT+CoF1KafRLQwTXN9B+7kSP5S7HptJHGfet+403SvEAtrzel1p8ATyra3x5UjjJ46BhyPpt+tVGpGnL3l/XQm91sO8C6ddWfgfTrO5vJJ57ZdsM8xy+0H5d5+mB9Kn0rw3pulxXX9mW5tjdM08YeUtHFLIPm8sE/Jk8kDGSao6nqUlvpl3qEM6y2sKSBzasPLh2D5U9/c9q8+8ex+LjHpuv2FpdxaVcRx3l5ZIxZ4plQfLKozmM45K5I74qVSc5tt2u/6RMnyK5s/ELxJaeH9Et/EmsDWvsul3rwRadZsUS4l3fK0zD+EY4BOOnBzit7XbePxN4Qs7nSLme3S9xeW7sPLcBhuMTemcn6fhXOaDfav498C3tgkkWjaja3cTfv4/tETwoVOGB6gkMMHngZrSN54gn8eWOpaNcw3/gN7NnH2RovJUqOTnOS24cY6fgaVSMk5Rg7NXt28ir3dz0+iiiuAxPn7T72GC91HRRZJb2ywxvKHHmiRT0yx6Dtgc4rQ3xW3h7R7HXdNjnv7YNcvLksIlJ3JGjd9wAU/WrV1pjWs+y81EWmhujKkj8MpJ4BPXcfU029uG1TxBqUto4SGR7cJIuSseEwNy46Z49c9qtTT1/rsekk2N066W0htNX1m+uZdO1S8SRYrgeXFaIAfKh29SC+0Z6etYXhyDxnpU1zZeNrCBrG8upLq1uI7pC6nIwqgE4QZU4rekEl1LYvDF5kWmETLLK+Ayq43DH8WRkAHHJqje3en6TqkOm6e0wnvT5iHbvJgOWxknA54xxj3qo9l/X3A4tyTb/rsXJ5Dai3a2tAL928yaWQ7oS+cbgvqePyq9JZaivh7U7m1xLqkynbcO4CIFIYDJOOvf8K43ww8he/XVLe7sGtoY4LeyeTzBIGk++jjqW4Azjv6VZ8bSaNrOiQ+D7ma+sZy+9rq3YNFE5PCOAdxPQEYxkg5q+W7t23Km7Rua3hs+I7FbQeJ7xX1C5vopoIjlzBG/BXb0KjaW9s1c1LxFoeraB4ou7+e6k0fTbhra6mQMhADLxtAz97BBHrUHgya50O1ggXU016bTiLQXIh3S4bgKMkYAI2nr2pNL0DR/BXiDUdVS+u47Yo6apDdfNZPLJhjukI6AYUKATk/WlNrmb6+RjaSRq6bd2uraGstjdzNGUEiy3smxrhARuWUnqSCMeoqbRfD9nput67feHtNjgi1CJJjDNKEjnyuF2D/AJZ4IbI968x8eSnwn428K6XpTWN54a1Z47saNMS2SW+WRmxwDwFwT9zkV6vqqWcd9cRx3qO8zBxZZziUkq2COigDp2OaUnb4dn/X9f1YTU3bqin4Q1b+3dUuLC3ieC/0uZI55Wz5PlA4GztvxxxwetYsXi/U/FHxE1ixfSIodD0WeSFbyaN+qD5iRjnPYfSu1MsyJ5UaFojE0UaRJuaJQAMB++cZyRVOXVby5sdUea6Men2aItzEIP3uCoPmg/7Q+bB5wRnFCnd3S/4H9P8AyBxd07mdq/nm90u0bR5RbsWa5ulnXciDOxdoPylhhifw68Vr3shsBJcsgtYvs4uJzHIAIolHU5/vfzrntP1LS9T8LRtYYupbu4Cm6ztATzMbjzng9PU1Dr0+i/EA6/4Y0G+ie9nhiZ8vJHnyiCjZ2/MvAyBVJNvXZf8AALlPlRvRSXl1qFhqE960dtbWz3AsOGilgkGFcsMgsGxt9s96oWGmatd+J7s3U1wpluPtNvcbhm1jxjao/u4PIPOa0/Duh3fh7w8mn3DRrczIEt41kLohVdzKCQCA2OnQVe0y5fWIc6XeWN4rgg3UTBo2wcYIGfmU1LqKPwkRSaueW6Ffazd/EZrHwRpVvY2sdyq3upXMe+W4hj+87k8LnJCgcnPOKs/Ef4m2vhrx1caWtih0qNlM9zEDv85wSyc/RWPriunk8caXeeKbjw3pa3LG2ZP7T1ONAInwudgZcnnpnHtzWVrttpI8SXOrXulRNcyoyPcOvHl4wNynpxnnr7V0XvK8o20M4wk9YsteAvFVnr/w+1lrGR7o2V6FJK7EQMykbAf4evH1rW8aeFYNf8uDUrZrm0+1xXFo4lAijcKSXZc/NnBXBBqL4c6JpHh/RtZvdO09LPTNUeMwxZL+aQCNwHZSWGB7Gr93drMbex84MIZNmEP3AATvOOgBIGDzxWUpe+3EunByTUiWxiuLa8M8d5FeaeXDXGntECseRhfK9wQue3JNVrvx3s8Z2ngeGzvG1a6WRp7mMqqWiGPcJEJ+/gsB259elaWlieS0lktLORpRiLeAES5fnc4zyEH05xTri4XQtKu7DSp/N1po2ZZpYy+ZW6Mw/ug44HYd6htNtPf+tf6/QmpFPSO9yjolrq+habpVvqHiB9ZtXLq11cR7ZC+4lHBzyB0INbk0z3d5Yg3E2LbdLdIq4UMP4iT2yDgD61y+iXEsNrZp4muIpNS8vyL6SDIgmyxbKg9CuRn61pag94S8CX0DThgojaLa8g4wQc8nHY0S3NFC5Hq1nqFxa20mlQ7rfUis1y7yfMFOCoA6k89ccCoNHvoP7UurW0lF7eWSuJPLO02pBw249Cx6DrWN8QrLXdQsbiDw/qElg8/z3U0oKSGJuPkPY9u3tWt4H8EaXoWjvpsNuBJOqTzW0sxLTHpvdvTHb1rVuKhdv+vMluS9P6/plu2DRrLDawyCSX97vVDmKPoMN0ORyeeta0dp/osa21nAIrU5RUJDr3Y5PBBz0rzzX/HMj+KtD0bTru8tdQ1GWJLS1g2mKC3yMtMp53FckY7V6lcXzi+u7aKCQSxxqY2Kja4xkhOeT9azmpRtf+v6/wAyXNt2tqZ+pOlnpUN3PdRWMTkCNyvyruPy5HUsePpS2Useta3HPeafLDPYlpLOXcVypG1g2OM89D2Nc540+INvout2llJZw3FuHRWVhvkDMdobHRQM455OeK7fR3kZZYZCFkjJyhAOCeeSDzilNSjFSa3JbfK77mfa2Bntwl5AizzXbzyIsm9ABwQx+h+7649DU/inRrbV9HvbG8kmWC7AUmInerjG0p+X+ea5i08SC119NHjm23s87CZiu7yy2cYTrgkAZNbbXVzIrQ3MrvIJThNyxtEQB1IPzA5z9DTlGakpXDlcnuZOj+GdO0HQH0DREUrLL5V0+oIXW73qd+R0boR6davXtvpenX2kznTbCSTSk8gXaxfNZKVACIAM4IOMZrMl1DVF8YTzJKDpenWv/Hsq/vp5X4jUZ4HKtyex9OavWbFjKzyybo/3srM64tywBZZRnLHIO0gEVbTb5pO4+VLR7GzZfZrbU7uBAcMd6qELFGJLE599wOO1R3uqSzyTWekSwpfPDIkMs0bHbKM43DrtB796x4rjxEPFtmieVb+HJrOQ+UV/fNchzyW54III9ec1SHizTovFcmjWmqR3GsWNsWn08xs1xkYy28Da3ykHaDmp5Nb7i5bvU5XVPipq/wAPvDMdl43NnqfjOaVjHa2v7tFgzhXkYDaOhOBzgjjrV3SPFC/GH4d63o9vcvoXiJ4xBMIsttB+ZCCOfLYHBPUZNcb8WtNPhn4vQ+JbnTjfWd/sEPnfOnmKgG3b6kg4FZ37PmkC8+J1xq+nSInkxySXURlIePeSoQoBg4IP0xXU6MPZc69f+Acl2ny/16/8A9j8J+Fb/wAO+E9Os/tVndeJktDaf2vLGGdgCWEQP3iijjn+70z0q3HxK+H1/o+oxwamLq0tjHa3kkML/uFLbVcsVGVBx8wzXW3CzWlttdo2VH3O4Q/NGMgKvP3+Bn2zXklj4N1ptRijufB+hX+havqH2jUp7K5COpEu5JAGxhFAwUGcnPrWEbTfNJ9TotZJnptnpi3LwzrcJeae8SzLcA4V4zyMEdcjvVWaz0bS/EGladf3DHUdRMgtIQuRhF3tu9AAMA+tefeKjfz6u3hLQI7nT9K0go8ef9U2W+Z3cHIRQx4xx+QqsPFHiTxOdKt/A+p2ukXOnXE1tcxaqPNkmPUSKAGYx8EdB1FbShPlunuXeTPWvFFj9rvtNt3Z1sbcNdPGjAeYykBR9Bkmprw27pDql3dyw24BEirnD/3V/A5P1rJM5ecvIbP7RtUyTx7jHG4IDFVPPr8vqQe1OaSG+LiKEyx25aOOMPtOOpkx2yfXmsknZJvb+v6+8tU9EXmsc2qG+E9rO4ZGlVgcMc/McZA44/GuL8Up4e8EuNU0/RbabUrez823SaYh3DMQzHOQApA/777V2GpXUqeGRdGVbm8sl82RE/jAPPB6jHP4Vzeua9q0UWkjSNLtvEFhqn7661C5kSOK3tmK7/kJztUdecDIz6VdOUuu3a9v6/qxnPYpeAfiF/wlVw+mW91ZSyGLfcTwRmI2x7AhuGGcjIrsTcj7e0d1pcglkiWJ5YJBjqTtIzwOnPvXn3jzW/DfgCytd/heyNjfNiCa0ZQl1HgEKGHIOCOvB7V0Xw98TaH4s0O4Xw/DeqICPNtLjCSwDnCEkncuSxHOOuSOlVU5WuaK0/rs/wDgChKOzepa8c+HH8ZeC7nRtQkWwN1+8R1I/czKcqGA++pHWuVuZPEHhzw3oel+Fdchv10G9WDWvtZEErK7ZULvwNg3EKB1AGM13lvYPI1lPdK7S2z7hI7582PpnHqBjOcVk+MtGm1LW9Ln06JNStlMUWo2V2FMEsIbImLHBEiHJGM59KzU+Vpbr+v0HKCbuTa/ZTLrEuneGvI0+81BEl1GUOVeKAMwE0YA2mQnI5Poai8D6DeaPo9466fNpVrdTK8OmGVZGtOzuWUlSWxuwDxmujgt7Wz1u/1Apm8u/LiMjsQrxrnbtB9M8kZyea8t/wCEe8atq99o/hLUbix0C3u2uY764cCR5mO5xIclpIzk4AA7Z6ZoinP3W0l3f9XFKTgro90oooriMDwXz49WhsVu9P1DTrfTtzGC+TbJcRLyWCknPTNXRJb6tcHyr2N5Jwpba6rLH/e3KP4sdKytP/tf7FPdeILwXt/drLNE0jAtBGQQYgRgEH07e9cv4e8F2Fh49gltdaa/uJriNU2Eh4WPLh+PmAGfTFEUmnd7HpybjZpHfTTQJcR3AmREhLQKJSAyRnvjOGckVwPiaa8vPHklvpaz3WpyQyQta2wADRbDlYyTgHHcE4p3iOG81zVdcW21TTdHstKkWOM6hNsEquwUvwCcknAJxgkfWtfwJax2HgTV77xXOtjZW8sjaNeSMI7ry15k2N1ZWIAHrmm3yq1y1JbtFrw3oT+HrHS9EW9S8mgjkv8AVZXlD/Ywu3ZDvz0Xc5x6irXg/wAK6M9xc+Ita1KO8FvHJOkGcKsQ+be4/iJ7fQVxfjZNSufD9pYabF9kguXhubt/uMyyOAkbn+MnJYnp8or0I2tro2hXyXVxBDaJZm2vNse6VowDwMkAdcnrxWkm4x0e/wDX9fIyav7vYr+EvG2k+JLW91TSNOj0+DzYrSWPaEkRjuMch7YbI/IU/wARaDc+J9Nt9Fl1Iw6Tay+bdNOmWEjFwyvz8xH3l6feqj4K0TTYdHlk0j+zLK1uFjLyDfILwHiORFPTncMHkEHjpXVeI5rKO5todPu7ObV5JkjuYVm++Au3Lgdxg8+1Q5KM7QIteNpGVp3hTw9DFpGu3ttPc3+iodKtJGkL7sEiGQr3IyT7ZqnpfjWefx9FpkdnajT9ODRzXMq/v5LkKqneOwY5I9etb8cUghlVlV7a2l3xCFtqFlH3xn7y+9U7Gfw3N40dpXjtGgsv7ZuVuIsJMi8GQSAnIRs5BHpVKS15lcpw5VoVrLSY9H8a6nfxavKryzLDaRPOdkM5HzmUdNnTaK1Nf1W50LVk3WluLK1Typ7l7jarZ6GQHv6ZzVXTNO0jxC8utWFzb3FpqFwTGWJCyENhn/MEgduKX4naBfawgn0yylv4TKrTR8MfNjbbhkOAVYD14OaaqRlNKXbr/XqL4dRZPEHhHS/FAntprg6rNbJcRKUH2cQEgPsA4yq5Y/pTfB8Oh3Gs+INa8Gi6lmuoHSWKa3eEZXJ2REgcFucDNc9dzDwdr1lonjMWsvhnVLOWdoIbdpGST+6XHzIBnAxx9KXShq+j6n4i0Xw3rF3qmtXMT3ejXUsWLVMHLwYIC+YVz82cHI6Yoe2jev4oV49rnZeDNYg1xf3to1pq8DCO685naFEIwXjLAcsOCv3lJ5ApPCtjZaNFaN4e0qTRbaa7mliSUljdA8F3H8C88D05qTQtS1KXwZDNr2lNpuoxSbLpZokYXdw3DvCqOTgsepxwTgVBfazBo2nTa74l1B7XS0xERzu80/dWIdlPfPpWabKutZPYzbvwdLHrN7JoUMdtPq8/n3T7iFG3k5XGQg7cckiuh1PRku7rTbe4ujLFcFPOKL8ssancSSfughSp/wB6p/C0llNe3XicX/mf2lBE8UpbbCLde65wfTIPc1Uknby7g6dCJbCadpGlbLDY2BsXp1PQdASDntTlUlJ2vsOOraWiNS61JZL+Egt5Vu27ZGAI2j6LsPTjv2rzfx+uq25lt9Lt7mVbuaWOX7PGzOEZV2nOMZLt1zjg1o+OJDceG9T06CQNrN/Zi2tbSI7GjDNwpPQEEc881q6n4m1TwvpOg6CunX1/dHT4hPqEJBSBlwHB45I2/kc1pTvGScVf+t/6+RE24rliamkH/hHvB2kaasr5soFglufMzsnIyynPUg/lkVgyT24hnl1KZoZXA8t2lEYEoJ2liTyD0/OtDxpqFjp4019QSew0m8Bkebyg0EcpxtaRs5AYnHTOcVwfjrT7y901Hs/KNzaSmSHzwXABG12YfxAAAgds1VH3nr1GvdhojojLHNPGsFyj3lvmS+hjcSRW8h5XB6NkHBI7itnxfrj6H4JOpWCO+pTIbW0nnXzHjlJO5yPQAcH6ZrzD4U6bqwmvLezjguLe2QW8UmwgTKeSTk5JJzgmvULhFuLb7LJbySY3F7eYZdlPfA6bTn61VblUknqKF6kL7GZ8L9Oul8LfaNe1S5vF1KcSQPcNumSANgiTsCSDjGevrXYSzeXFdvMsUiyqzMgYkKq9V3Dn7vYVUitkGCITHpkSRwo28Bo8kMN47hiwxjoTUsljcg3FvKwimVmlQxkFUjBzkjsxFYSnzO5UdFZszrbw9pcniPTdWtYrebxFY2n2ewLs22NCmCJiBzgEgHrUWqa2lv4h8RH7NqdsdNVDLczsBHL5nA8jnGckcVq3klzE1vd2d9bxQHKSsiAh0HGS4/j9sVh6umn3MF5ZXV1NeRsn2iGMLkoUGcuTjcR1AwMY71UXd6iUbNyRo2OmQa/a2uuXmkxXEkUDiG6PyzOu07Rt6Nzg7iRjH41qLqkdtcTvpc8E/wBkaNb5UkBypB2knoCOcms/xl58Wj6Fo8MjW9vcbY5JYeEO1flT1AJxn1GRXjWg6xZ3HinVtas79rWO3DxSaSFCrcRgHOf7ygjOOo9a1pwdVOT+Rk3tfqz2fSfAWnyeJbfxNNc3NxdgvIiucDJOQD6qO1bU1zH/AG9fLtaVgF2bAGCuFAJb0HzD/vmjULkWmgx3Rv5LKNIklM21dqIRyMEHgAE45PFcZ4O8X6R4wh1Sz0KW/wBPTTZVe9muowJbpHJxIrA8ElT1HQisU51Pel6CjZS9TXvJL4s/9najaaaIr6Hz7udd5uIFUmTyxjrkhQTxw1YfhC30Lw74o14WeoalqGr3dx9plnurd8PG/IRHPysF59OtdRblZbdoRHEZLRSY5QmcRA9B2J59s/hWZruvCz02z0DTIJ7jV74kK0UO5YjnPO4rg46jPHNaRlfRGklZ3ZsuLi6urO3kRntTM8smCRIEjUFNpB67jg46g1wvw61qXXYNc8WeJfD+maBqiSPa22qzQNbyNEQMEh+TtGBnPOMV2pZi9vMCEMT7EljJ8tZioV0Xj1U9eOawvH27UvBOujULZ5RHZs588hnTHB2YAUFsDHvmqg1JpPr/AJkzhf3ux1WujTIbLSZdZvrKGNJFWKadgUc87SpPAfAzn69aZ4X/AOEdaUXPhaOykW9ml+1T25VWZlyrFhwx+Ydvr3zXJeDtB1C6+GWmaB478PtqhbfMYpZFzEN7NGrkHhgD26Dj1qza+H4tP1izj8M6HDpVxa2zPBcyMzQRsWPmo2Dknk4GfyqbfZv39CFeUdTUmu9Qh8VNY6vcWM9zJM0umtAHUJbZBK3C8jcOQGHX25rg/E134W8TePbfRNUtdUi1C1sZp7eJbo21rKeXIkYH5fmHDDI5rprOyNx8VfEDvI8ktvYW1tJIF4Riu4MFz0P1/wAaoapfeD/G2h+JPDdnf2qz2yRwQ3DrhY8kbVEgyWQP8renI561pGNrJ32Xyv8A8OJv3LHUDUp7bwRBrurWkSNa28j3Gn2Ei3XmwqpHlh/48cHI9DWH4Q1a71KLVJTb2E7rIAJrJRmSMnIjSTjO3uMcYrK8OlfBvgLzrWS0vhpen3d5dPlvKabB2rFxjazcfSmeEfFlvrHhrw+NXgvLG71m9uobaW3hWBoXj+YlwCeoUjIXn2pvljdb6/r2/rcuGjSZ0HjuXUV8PvJpz3drPPOqSSKqlwmD82Pdtoz6VuPI6pDIyh9kCwyPGuQJBjPPf1IHpWHqk73ulC/Sd5A24K6jHypkEAdCc8jnsauRPILazwztIY1fy3O0MrcFgOzEZH40rvlSsbpa3NHQ75ItPmF7DLNJHE5nEEe/dz0XHUYPSvK7zwveeJfCX/CM6bqbWs9tfPPYs7MIjCwJMMmBuB+blSMZr0zSb9rGVwzwpLNujjjhQ4KD7jbDyCPmznGaoXFx5l9YyI5uriQSq7RIIxcDA+YjHC9u/Iq6c2m7eplOHM9TC8O6TojeEdO+GvjG2nMh3x2zyqcSupLkxSDOCuSR7ce1dboPhbSvBmgXOm6FbMsLsftDyyb5JgRjBYc55OB/jVLWFvLfQ0vNJtGufEwAk0/T72ZA0eDtcRk4AJXPU9Kb4c1TV4bq8/4S3UtPuNQnlke203TeVjQKpVGYjlxhsnJqZOUrtfNfqZKEVLYwWttP8BeBLmzu/EmpotjcNq3kW0ivfJbbvljCsThf7xPHX1ruNG1mHX9Ns9X06CYadcwJcxeamx3BJBDqecYGR2PYmubtdK0DxNDqfirSrGf7dr9ibGYynbhBwysOdp+UA46gCodUjutEurn/AIRvQ71vEepiC2ivHVvsEBWMeXwCdsajg/Ly2aGnJty36ij7urOyhihguLWFF2RNK3k7ssCoGXBz90dcVnT6pBb2Ntd6hdxWltLMY1SR9hn67UC/xNgc/jXNeA9L8UG7uE8RXV8Z7lpFmS4iCwqhHPlYJ53Zwc8DHWsn4gWusa34l8HW8Gk3N94aSYTXIG392y8ebnquMk/0rTlSdm/61LbbWm57lRRRXnHMfO0lvH4T0W5S2330djE32QFvNczOfk3ewyDijwTbweFdBgkEqX/iO5ieW5O4MI2bIX5ux5Gc1JqV2lozW/mDzHRlMYTDB1HylsenrXJeCNJm028vJ7yRoNOmtmWVpF5lbaSz46jjNUlzQd3/AME9Fq0opEEFv9mu49b1mCzvbHULqSEvAwYXLopZIHB6AyBcgds1Y1LX73xpquiW09nYQzKzPa2boWWEsCsqY3YI29AMYqz4YTwlb6Zpvg3xhZXT31vNJqKyWTF4lLA7SWGPmI9OlRNYg6++q/2bbaRBYIIrNI3LG0thnDTMSf3jZwOeppQXM3cuc2notSzqurWuleKILxopbmLTx5EUed0Zk2kqjE8AgBiFPpXSeIbSPxh4TsmuDOQIzNLFZDZK0Ln5XVW5ZlcDKntms27i8Nab4W0/QfFSsg8RF76RmRtySdEkYjoRkY9ScV0lpZfJAbC482a1jTybsHDAKwHzA9CRmnKezXTqZpXvf+v6RV8FaDZ2WkSNpK6rYWdvbzQ2husCSW5cDdLgghQcYA7dRiq+ieBZJfE2meJbhH0aOwKvPBJj98EQZJ6nLHcfx9663Xby1srQfb9ReRTKJIcDfJ83YqO2c8+9Vr24vXvLxHuli01USS3WVRIJOR8o6EnOTz0FZxqzeq0uJ001YSSTw1BZu2uX/wBiNw7XMO9yot43YsiY6AnJ+X0qhc+MtC1OQ2mgi1mmW3e3MzwKwlVjzHj+7xyK5bxloE2v63DYQqusPb3nnC3jkUfKwXM0hHQL93B7DpW7Z6Xo+iazeP8AYrawlkzGI4FJBcgYYHsCMfnWiUUr3bf9dCrS5rdC9DFHptjpkdy4guXUvDZW8WYYlzlTwOM9T7mt7TL3Ub5b2Jrw2l+6GKAgjbFPtzlhz1PJ/GubvdY8P3uuto82vyQ6rb2qrJbqSEnO3IVWA/gGMj1q14VutIfS9RvPt7GzKJcT3Q4kEgjAKZ6Z4yT05qJJtXa1G5XRS0QeMdM8HrJ430Gy8Qaja3nlpFBMDctbyNyynoQCeAewrqRew3k9qultMssTtHJEDtMQx+82nGMdsiufttX1EW9ldaiYGiu7cbGsSCA7fdi3A5J754xVDxXqt1pmqWNjZST20TKrF7aPfMrNyEbsF7kdcU1ByduoorlV7i+OdT034f6bo9vpenajqFvZ3TedI8zzGBHUnIyc8Hp2FX/EegaF4rsdEstck1FdNndL+zhPWcMuXVz0GM/kavak1xr2n3d9oUcQ1oj7Ff26jOCDgMuccf0qfTta8PtBJ4cudXS6v9DVEuiVOFm/2SB0XkEUKXLFW3RF9kxdTlmu2isxp+n2ei2MBaJpjthEaEbmYdkGAAO5I7VWtL6O5s7LUSjmKYfaNiAqpCHCbk7DnIPcgZqTxDbWV/psti0y3WmXcaoyN90qGDNz1AJUflWdqupiHTr2ONrRIUiWOKC2LbmjyBsyeoyB7+lEfeSt/X/BNYq2i2Oe0CS51XWtU1XWVS5hjJlgjDEIAThRIR/EDyMV3BD6jDGt9dvYXYTbhTmNx2PHVua5/QEXTtGlSCz8q6mdJLW3V8DJJBLFs5GCeDXSXcYgs7WG7n26o0pQq0WwPlSSy9c9FGfbtV1XeWnyElZWe7HNYpdWjaPOI2hlx5Ftdtvecrhmdc8FlxnaDwKz7O0/tDxLez3uvafNpE2UGn2B8zYyKFyXwCmSG3A9Tx2rmNbh1Txr4K0jW/CetSx6loGoyAeZEojLjALKSu4qA2O+dxz0rV8M2T2unyTXsNlpfiPVLgz6w1sh8tdpbZEBnqwy/wBWJ7ios1pczjJyvY2tFh0rRbG7sNDiuIJrlSRcNIGcZ/ib+6Ow4otzc3WqLc27FJCyrEXbDtnjaR6DHPNFrPZyRpcWVlEt3JG+68weY1OM+mc5FY8Gshfi5beGg6eTaxPdTMuSVygbDN0yM1STk2/nqW3GCOnt7o3l7rQubd4G0q4igYxjdFdIyq8bjseGAPXGKS4lks4Xe9/ctcTLungUu7ZOBnnAA9+lRz+IoLK00m3guN0QlYyFUORySnBHfOcV5drlrqvgD4eXukQ6tqGq32o6q1yPJQszQA5wOuCxA3D3P4lODbS2uQ5OKu0ev+Ra27XcEUJjZQksNs3KF35OQOCM8k8YrjfGnjHU7DwTp2o+DdH03XNRvr5rK/jiR540cA7lUgqeoAz0o8Da4uo2VzPcFYozAZGgnfMyWzJ8xHQ8HgDityxt/wCxrGw03TEhs7KKVYIYIc8MwyvzDuzYyzZxmnJOLtIbjzLRknjO7nsE0C71CRbazjULcwqC4g3AAyFv9g9hXIeG/Amgaj4nvvEM/iaHVrKK4V9tsqqrMwICPgYHuO/euxu3NxDqIuIojp0L74Re8WxA+82Qc9fXIrm/hlpeoReLvElvNoSaN4eubSMrZug23Uu7iYMDwcZyM+lXGfLB2dmZ1YbXO58QoVs7CwA86IzpuSX5i6ZwUK9xtLflWZF4V0rwxp+rQ6Bbu8mpuJ7pp2LEqrYUDpwMnA9M1WstVim1K9g0q9l1O501WMa3GB5czfLHCzAAkliPoOtX/wC1XYWs92xFzCn74SY2I7Da546c5AHPrWS5o2RXLdoy7fxs0/jHxV4ctrWxtrm0tI2tJ5N3ly8KAWPTAL8Y64NT2l/qlhpF/fWMI1TV5J0toADmPeB87dio4PP0qcwWhmaxhtbJ4Ni283lMDcQR8vG7n6hyPTiuV8Y+PdL8J30NlpFtHd65eYknlLMI4kBAy/qzgHpjmtYpSdooTjyq8jrPDl9PeagLS5iA+0oweKJyEikUksVBHHBXJ79qg1VvtXw31I3Il2GVD852+YokHUehwfrWlretRQXlrZ2A2X0kS3QcoC3ltxjJ4z2+gqnqMi6ZfSwTxLJAVVpTNllaU/dVR6Dnp3qU3zJ2sV8aK/xX1HxjLp+iL8M3guJ7u5V7mVdhZYuNp+bgIeQTjPSqnw48ReL9Z1HWbrX0sUtbKR4PsEcbRvDcDjGTndG3UNk9afpelGK+u5tDWU6tqSC1mBcL9ihQnLenzdcAdTUPjTUbIXenaPaeK5NMOk3EMurXPk7g6gjy4pJOgZjjC8+9XGMV7qW5i4qL1Z0MOmTafqmrXRkmkN7KtzcFG43r/q4icZCYwD/hXBXXwx+3aFKkvk6P4svHN1etaSZtpHYk+Sq/3T1x2Pc1JceOdai8bTaPPojxwRyM32aDK7Ix0klJ4KsOmD3rqvGPiEeFJo5YtPOo3N9cpbafbIQu+5HDLn+HCg4rX34SVt2N8klZnFPa+KfCHw88KRaRLbpo2lSSP4givVDyhPM3EFT1UKWwAQT8tdb4UuPD7eGxfeFr2e60+a8lvpZJ182XfL8rRrx8gIPbkCtPxFb6VZ+ENQgv7a4vrAwT3F3bTOzz3DKjP5TP1zkADHpWL4BistF0tb/Q4ng0zVoIZrXT44sJYlQN0TMSS0jEnLH0rOUua+nUIR1XY0ZIpRJqNte6ld3Njdqq21s1qkAsAoIIGBksc9fTNQBrayS2ivr4W1hBAIzd3smHOGG1Mn+HJGB196twKLm4RXM9xdpKZQsx3eUx7nGOMZAzVK70fTtetbqw1fT576L7Qk9v9sUqSwP3AAeg6/jVLRWR0JKPqbNvBPp1msOhTQS3cV6o1CSRvMleNhnAY9DgjA7CoLFDHearPqUzQx2CyTBIFz5cIG4LnuRgkgcZIqeDWBdX2o2sNrYCa1Mf2kW8u5o5PRwBnoAOvQ1X1ywlv720kkurm2s1ldbhInXy5AwG6N+M7WwB1zx1qU9bMySav3YtnPB4h0nTtQLQR6XexiZJrjiVlPKkH+8R1A6U7RbmwuJ7yfSbCySG0m8tJ7omN5ZgM5QddmGHPck+lZenaXcXkyyTBYNPsHIsYnCxi0PTy1J4zt7kHg1XutV8NabfltX1LSYLmQ7ZYpHNwYSpOxlZcckdV+mMc1qldcq1HK3V6HY/vTbsIGh8xGDsUyiynuFA7+3U1xup+HfF+ofEo63d65Z6docMS29vZR3TxmaM8t5i4IzkkZ68dq2xd2+o6NIun6jd3Mo/fQTRWvl4lIwrKHHb0OaxtB0TxBJoU2mePfsupXvmhLR4HCidV+fzieD5mWII6cUR913en9eZLV2mg0v4heHtS1y50ez1vU7XU7aRo/suoDaJSvB2MeoODjnn2roESRNLN3amYW86CVsjAZTyIwOoHOCMVzniTwv4AsYoL3xFDHaXbYaCWS4Y3O7G4YXJ+YdaxvDesaz4p8cnxCsV4vh1CIrO3W52xGTGANvc55NW4pwco7ef5f1sZxm0+Xc93ooorzzA+bL2e+tplbRXtoWuI9l5NfSbVEn9wMeiH2qvYz2mqaddMtxHc20rD54ZMls8lM/p7jirL+FtE1WFZ/EE0mo2jL5iur7bWPPdcdfTJqfQbjRdT0D+x/AWpafaJpz+ZcGa0MqyRZ5yeCefek5aaI9FN38vUms7cCe1txpvnGSIiwghOweX6M4/UGsjSfs/iHXtT0u2lMEduwa8hKbU80ckY/iC4zk10Z1DUU8RWi2kMVpoFu7yX4kI+fahIeLuFPp71zXgMXDan4h1QW+281JZJEMh+W2B/wBZIB3XaOCe5oTsmxtvQ3fEVlpOtz2WoazHdyrYgR2SQMytc8gorr/d3qD7AZrSaSS8uDJfhi1yA0iRnZtcD7pPUjp14rg4/El34f1C2Fzf3WqWt9EJp7+7XdLbSN8nyYxiPaTxWpJq93JPHJpottWtJD5ErQgln9ic5HakovYvl5fesZ+ra1qEGuXkWlWMYwRDnLAkYyx3Z57cdOtWr5rm+Hh2e0NzCLW7EsvB+VufmyeTkDGOnFc2LbxxqU8q6ZaXVpZQI0ct1eOqRIS3ylW/u4GMe1ekzhdFgGv6vfXAtksIzqUVtIGtmKhgrQdw7NtyfetpSUbKO5inzJ3uZa3lrZ6h4istDsotIsfPjmnvYM7r2aQbzG7vkgAEcKQMk+tGteKdS8NWsLrAZjO3nq7Ksisg53txkYzgdqprejx34JOkXkLWl558N3tt3yERxktk9QOjDrmr0NrHbJaxOEjEEUkcc+C0c8eeY2X+L5s8+lSuVaSRT1Xu6Iq+H9O06+1bTfEK6VLYvqkkzTTbiZCpJDsIySBuPoK3fDnhvT9N8JeIvCmjz3l5BPAwiW5K+ZuycxhgMYAqpoYaFZL+6e3Wd1Edpbo56Hr5fsOuO1X7WaVYXstNKhVicxiMcsAT+IOPxxUTk29yowRkeA/DEdjpVnHpTQm5di8lxcDy41AHICdB9cV297bw3N6bS7ec20Np9rubi3O2RmTkFSO5AwfWufe7iksLZoEje4u0WMsW3cM+SB6Ej8jTtEazLlDcrFprLIxkcE5wCDF/u5/WplJyd2CikrIy/AXjMXmuW0I0R9L00xyvaNI0vnPLtLh52Yn90yg/jirfhyG48N6BqSXcOmx315qLX4FuxwiNn7xJyw5+VTV648SyXdlcW4jM11MypCSMmGLqTt/QGsW6n07SIH1LXv8ASCiebHbt9+WQnr+HrV25nsTCPKryNiKe0t7+6W5nZ5CFlxsDNLkYGUH1+7WBLdaleeLb6wubL7Jp8cafZ71MMmcFsE/wvgHAGMVkeBbS7vtLk8QTtLZ3Ooy/6NPIcsVB+d/YFcqB7109gtpPeJbpdxWdr+8a3t2l2vczbGO8A8HOMevNW2oN21KT5lf+rGxEUM8scVulzPdrHbwwychepLu/8Ocdu9WXaTVLuDTlF0upxfu5ZpRxaw5wxSTHzHO0DGCd3tWN4buodWmW3uD5USKlxJFGCcuNwMYHqOCa3dR1+6t9QtrW2hnWeRuLiZwILc4PDjq2Bg4B64rGbfNZbibfQzPHXiTTrOM+EtF12TTPFERR4PsduGWMrliJDjHzA5I7kVosG1aQQsrReIbqGO5uFbhXRQo8xF6AlduR17dq5DSvC+laDrd7evcTand3E/2m4eRCvyt0JA6854HoK6PTbW7uPE83iK1hu72WWRIw3mBESJBtLAHrnnj1Bqm4xXu/f3f+REYuOrNkxW2kpdTyRym1BV2ERLGRc5C7Oxya5nw3oqeGbvXNYuopJrq8upQrGXzN8buSUXHC9evXtUlpaavpOveJ11q8aSz1G6SW0fYYjEigZkGeS3QEeoJ71T06yXTr3W7iTVhZaXc3Rl1CWRdltHnlVGTwSeG9TQm7PXcuyauzVdbmJpba6eY3Gxp7o7seUFGd2/ouB196t6PrM2o6hZz2k9vc2wukHmRHAUEZkXI7gemM1zeuaXceIdAv7W71I+H9OnKRyOjjbeM3/LIKecNng+9XvDPh+38LaFb2V1CsenwHe4HBkjxgzsw4+XvVPlt5kyk22uhI2lWVv8UdY8RatqVvLstRbpZ+X+9XzB9zA++Bnqc4qHwb4rsvEUOrx6DI2+O+jhxgrvjJxgk8DjPP51pGY3Hj29STQ4U0uK2VX1xLjMjoybkUJ05OBwOKz/C/gtPDeozafYzMunamrzzTnCYBGNuPXJFJTXL729l/X9f8ES0emxP4j13w5Npo0gzNdpAG025kZTHDGDw3J4YqSDjkHFbq6a8WnWHh3Tri4/s+C3CpJJNueWLIzIG9s8dsGuD8U/DiTxvqVlPJrR0zTyDHJZww7lgOMMqj1YZ+Y5x1rpPHs0I8O2lnppEVlBOlrdOuXMduFOASOoYgA46ZpvlbSg9eoru+oieHBp17c6nbxx3QKAbop/v87TvIxk7SxyOQRVfxT4os/C1jZy3v2kpO2GaG28wEqRtBz1HOCTzXJeAtR8QaRHaW+rS2cOlaldyvDYXoKzLDEhkWSE5wykoBgjmvUY55/wBzaxSJdyqPNcmLllchlUdhjDZHtTk2pe9qv6/UcXeOmhzvhewOnQatcWumf2Rf6irXssm9pRdRAfK21iTGo3tkDHUVjeKvBcfi7xba6rBdpawWdvD9ugGQyqOVMa9HDe9dzcQeJbuLU73TrKOy1c250+yFzKJAwZgTKT0woDHbjnimCEWT6ZZXLE3kMJWNyn+ulX/WOT2TJGB70KryyutybKejJ7HT4Fv73WdbZvJKJFZQO2Ssa5+YjqScj6CsHxR4/wBG03xHbWtzLdyXj2qkSWUYnS0ZmIXeCOBzye1ad3cyX0iXlzIJJNjpCLVMiAgDchHowI5puiWWmXGtQQXtjaw3RtSnlqcSvAeRE3P94Z57EUJpPmnqNxduZFPx/cXIfQ7TR9Sh07xLNcmKwEzlFvfL++JWXnBUDb6ntTdb8OiTxbearHr8mlWN5H9nntYQrReeCS0siyBl+9kA4ByM5rC8EXH/AAs/xNNqHjLwidM1/wAPXCraXCM6pnO5YpFJ5IPOenPbvfvPEvhHxR4xu/Ccuqy2816JLaZCoQfaBIQypnoW5wf604ycfdRmmpe9LY6K0sdO0yG5XWdZutb1C+leZ2lOV29RAhXAEQPOOnpjpXN6/wCMPCHhvW7K08TWyrqyQRXYYh5UtSXBTqeWzyW/DpxVa/1VtG1rWF1TTJbWx0ua2stItoQWZhsCqWfkNlcHb1966Dxpp9lfC8tX8OQ69qltZlLWWcbYZkD8IxB/hb0PJ9KuOjWv4jkmo6I6S6ml/tJrl7uUyxwvcRoFBULjAwem7BzioJ45YLG2jtpxDcNEuJxF8ip14Hdj059a5Dxrf3dl8PLzW7qZ7SW02G4hsoi6SsPk2rnJRVzyfapvB2o61r/h3SdQS1nsZrjzDdJeTfJ5JICyKPXnj0pqPu3NOZXsdIrwWssclu80ZmlQzSEE7flYHvz64PApt/JNb3SCO8upUD5iZQNx3EZVePQH6VQube2fQr+3S9ESzs6JdyS8ttHOPUkZ/n2qXSrpUma7S4Mu+3EaPJ8zCJVPEaqBt7kk9aErK5T3JtH02Wz8ceI9XSWEf2hEhgighCHYAAXkc/xAqenrzml0+5sk1GXR/Pd9RW0bV1s5FzE6bwPM346FhwD6cVcv9Lk8R+HLzT9SlNoZ7ZrdFtZMyohwdyt0BIA4xXNXmteEvB+k6LZ6n4gmiEFutpHceVm4u0Df6tiBwqEgkY7jGOczB30Rm3pcteLPDFlr9nb6Tf61c2AkZrpoxIJZJZHGSGUgggDOBjisfRvDPhfwBo8urx6PNJa26ea9zcR+fcSEEBSsX3VJJPOOMV1U9xaSQxXE9rbTW8wzY6lG4Utxz1Bx26+9O0q5UWySpdwRT7Git7iWfcqzPkKNgAyK19pJRtf+v676+RLgneVtTRs9QudR0y01IXG+zu4/PjiuYjbyhDyqkdiPXrWH4i0+3Sx/tqPRbm/1Hch2Wt00ciuTjzFycAeuBzWT8PU8SWGj6nJ8UbxGuLW9MdpPcsHjnUjnCr1xjgVQ8Q+KI4beWS20jVda+zI1zK8zeXFEgJO5lAB8sdB7CiClf3f6/IFKPLqV9X+GN8nxF07XbS9shpEUzXl+8zCSSKYD5s5GXB6YJwOwFdTf2bzIlzDa2kd8Jd0EKPtjt4s+g4DMOWPUZxXJ6B4v8Sa/eKdQ8NCz0m3G55Y1ZASRkJk9etdPql5BBpdzqerARW0WYl8tcNdSfwRoD3J4OetbVOdaSd2KHIk5HrFFFFeecp85+IreKx8MW+m2SeRZR3iRCJDkbRhsc54J6+tc54bg/szxlbNZyzR28ltcA2u8mEblJJ2+55+tFFKGzR2z3Xy/M6DX9Ji0+50lLSe5ji09maKPzMqxMbN82euCOKpXxN/rdtpMrMlvebGnkiYrLIAN20t125HTpiiih7Gq2ZXOhwa7q8xnnubdotSWyJtn2+ZDwdjZB447YrnvCU8lr471DTbJza20+q/Zz5HyMihT90jucck5oorNs26v+ujNj4s6jeP8L7OV7qVma9eF9zZDqCwGR0JxVL4FX1xeWVrYXrJc2FtbyyRW80SMqn5vbJ/E0UVt/wAu38zhk37aK8jotVI8P+DNWk0xEja0gM8WRuG9kDEkHg8k8HtVnww51HRdIubvDyXdlBPLgbQXfOSMfd6dBgUUVHQ6vtW8v1LNqgLywn7kO4RnAyg3Hoeoz3qPTr6b7TBcRFYZVk8pTEoXAYbifc5J5OaKKLIEaduoXRzaD/VRFLtTn5vMJyTn0PpUesYS1KoqqPM28DoS3Lf73vRRSXxDWz/roc94z1KfSLq20+x2RxT7iz7fnAQbgAfQkc+tULuT7Xovhi1lRNupb3upAuZH/wBnceQvsMUUV1QS5Yv+uplU+Jrpb9UdH9pmlvrix8wrbQMDGi9F47Z6dK3tP0ywl1YX9xaJPdw3KwwvIzERBl2lgmdu/DH5iCRmiiuWtolbsU+pi+F9cn1DVdeuJre1W4tb5NNikjQqRENxBPPLf7R55qfVruT/AISbWbUhGhE23BUZwiKw568k8+uB6UUUl8T/AK7BHdFm61CeDTFlyJZLgxyMZfmwR6eg56VyXx5nmtfAHhiCymltYLvUX86OByivgbwcDphiTx3NFFVBLmRlXb5Wdgss154E8K3l3PLNdTRpJJLI25mbcepP0rE0/UW1LxZ4p8N39ta3GloYZ9jxDcWcbjkj0J4oopL4Lm0NdGZnxDd9Qu/Bcl65mNys/mq33WIyc4HGe30rY8AXU+q+FW02+leS1XXW04Dcci3YZMefTnjPSiitpfwl6v8AUyXxv1/Q3dLlebWbhM+XHFdGKNYwAFXzNuB7YrgvCeu6jZftHXGhQXUn9lySzxPAzFlfapIfB4D5A+YYJ6dKKKlLdeX6Dqt8q9T1uG4mm8RNpAleK2YF2eNishwpbG7qASOcdqx/hBrt94g8Ew6hqTxNK9/cxKkcSxxxIhwFVVAAHc9yaKK5vs/cEtkdQltFeSXV7coks9n5Zty6KwiYkjcAR1wSM1mqTZ6vqccRJihs2mRGJI3DJ/LPaiim/wBBnz54p8Wa5rVpe3t/qVwZYfNigWJzEkA2qcoq4APGM88V6NFf3ll4D8I6pBcynUpLQq11IfMcg9vmzj8KKK9OskpRj0v/AJmNJ+8zW0TxPqtotg4ufNFw5DpIoK/hjG38MVobjG5ljEazTyyLJKI13sufu7sZx7UUVzVIpNW/rc6Fs2a/hPULjUdISW4YCUzfZQ8Y2MqZI4I7+9WbbwB4ak8bxa0dLgGo2EeY5FUDexJ+dx/E3+0eaKK55NqbSJrJXZBp91PLqSu8jE3MH2p1JyvmDowB4GOOnpUlmTo1rpVvZsxt0tYj5czGQFsffJbncc8nPNFFaPW/9dQaQaZcG38FwXUkUNzLfrI9x58YKyZzwVGAR2wRVTWLmZ7jTpPMKlvk2qAF27T8uBxj2oorS1pP5/qKn3JI9G0280iXVbuyimu7aYPGWzsBxj7ucdCe1SaNLJda4F3GDfajmH5COc4B9OBxRRTu2n8ykUL/AFC4XTEtYX8mOcmSUxgBn55BPpwK4XUtEtNW8a6dNf8AmSrbWaGOHOIwxlALEdzj1ooropaRk15iqJXS6XO81rVbu2ns7K2k8qKeaWNyvULGBtAHQe/HNM08mbw+t3NiSSJZbtQwBXzOByO4x/D04oorNJLb+txvqVPEHiS78JN4Pt9Ohtpl1GdzI90rOybyM+Wcjb16Cuo8Zu+mz291byOXllWNlkO5duMkbenPf1oopWV4/Myt7zKGr67qF1bWUJm8uK4gikkVFAyWPI55x7VxGs3M+r3E2lX80ktl9qiuChPVuMD6DsB0oorqpRW1imlyfd+p9CUUUV5xwn//2Q==);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Histopathology of a gallbladder with xanthogranulomatous cholecystitis showing the typical foamy macrophages (thin arrow), fibroblasts (double arrows), giant cells (thick arrow), and mononuclear cells.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Salam F Zakko, MD, FACP.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f27_49_28440=[""].join("\n");
var outline_f27_49_28440=null;
var title_f27_49_28441="Molluscum in AIDS 2";
var content_f27_49_28441=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F81275%7EDERM%2F50976&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F81275%7EDERM%2F50976&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Molluscum contagiosum",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 396px; height: 350px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAFeAYwDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD5+BnnkM7vIFUlAzPgk9wO3HrVi0sd6FRvVAwy2P8A0EfpWgba1lk8yKJ52HA3MNkf0X1p88bGGUTMqxqR+7A52/QVHMZ+ztqVnKYaFCFU5DEZ44zjI6k+1MfJSKP97g4U7TgRoBkgemalRoreDzZQBFEhO0dSewH/ANaoLebzdgZgXkGZNowuT0A/rRcXKStJIWZ0KIMEgE4Cr2AqsjeXIy9ZXUfORwpzkj6mp7lxMjRwwBvLwuWHHt9aTSfLsLWG9nVHkJNxF5vJc5woI9MiriTIdbqJ755yqSCEq8jouBk4VEz1NdFqkkVtaWybmMqgxuxOGJ3bpNvvjjPbrWBo0qW8E1zctL5CXIZ5CwETSAFhGB1POSfSpUkmkhe/limlbYSQOVRd3QD1ycE98+1PoSjV05FNg948bCBZPKULx8u3JAJ54BUe5NW9JeVA0ihQWCw7gOgyGbHpnH+c1mS3T/ZLHS4xE7QBt0gH35GJJA9AP6VvabbgaZpqrhWSRmDAkMc46+pzipsao6GeMsYslgkUJJZv423F2x7cCt/w5Ky3rXqjLRIr7c8lcdvTnBrnLl3NiwjieOd4lt3cnkhnyX9jiu20yFbee5gwMhI1Uj1PLKT9MD8KykdEEdDo0m68kupJXdI9oZXIKRliG+X2yRx+VXdWspGURwFf4hlvm5IOSPy4rE0FGkJWPkyTyBkwdoK4UflgmuhuHE0LLIxWToDGcj0yfeueburM64KzuhNNfdZQrOCrnbhW4I9cZqdw0txEysArsAwHJHoSKVVEhiL42nge3GOtKHkZXkB2uCrHueDxipKI53TyfMDBJd3BIwuF4/A0wogZy2VdWUruIO5GGGGf1qe5VWunj/ifMgMg67j3FUCyNbSKVZTnLAfdA44x+HWjqHQjXzIWbcAJAyLlhnjkEk+vNZ7hUUSMxjYnaCRwCByKvXcjLEVRtw3Bcc56E8/n/Ksu7JfyXA/dMzB1POOOMfrV7EbsuWkY8za6r0wD29xn6c1omGQYER3BRtG4YJz6euOtZ9rhHMciO/yB8A4yDWrACTtjG5cn9502f7Q/LrQMsQ21wLZJ0nmhRXwzRorn8c8j8iD3qO6giMYlYybsgSMija7E55wM89v0q+CyDbIsschkyWYFhz6f571BIIpvNYtcMzfeaIlSBkcY/iHHahgismnumQlxbkliqxzwgPkE8fN36elSi2eIMrQOzqB99QcDHPyrjv3Boht8SnfmWPdgsZjgHoPvdPofSpZCnlkbFcKD/AcgdwGX060LYTuea/G9P+LS+INhiZFaA4UHKHz4wV69On518jV9ffHVYl+EeuLGrRHEBCBiysPtEXoMDHqetfINdFJWic9f4gooorUxCiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigD2mewhtbAMkRluR8uN2RuPQVk3dkIofPuAp5LuAdu5uwx6Cu0u9NuLjy5n2RRk4QjgAdz/9eqVxpSyiNo4mXHMS+o/vmue5v7O+pw2w3F5bTXClYTuYxqMliRgLj39Kn0/S/wBzIZFUygAqD0BJ9P0rbgsnS5h8tVVVlKrvP32xUkcBgjk84AlDiTHYnt7mqTujOyTMS+hjImXzCjEBnwMAeuMVQvw9zGrSbFh8kKqxt91F/hGe59egrdu7XbDLtUCSMAys44Rf7uO59qwnYMZzO7ASnZkgEoMdB/QVaZlKJSuZpbgxIzIttH/qYlztQ46gf16mrcTQtA8MavHH50W+XdyEUFjgdMk/lxVELywdTGI1J2E5J7DPrWpY2UlyscaKxbAUnbtUA9B6knqTVtmajrqaOjac0uoxgIUldWVAxzsIK7fxOea6dpoI3tvs7ebD9o43cgKjE5x7nBqpHaCK3gnd2M6QMBuTILvnAP0AzV6TyUt4ZomIUXCb1YZCjaM4HU/d/Wh6IpK7NXyS+rWkTSsy7/MJdiF24Pr9MAV1mnhp7O7njjZ5RNEsfOMhuOvp1NYDQun2W5AbzRKVVHcHO2Pnj/gWR9K6jTldt8TAshCMdvRsAYrnmdlM27XamoukefJiUJuXrkHG4/XFbw4miaPJdX3fL/CM8cVnadEn2+6lYFI2ZYlX8OSfatC5hCJKuVR1X5f9nnrxWDudGgRqrp842qyuxKnr6EU63iG4biqpt+YM3BZTkH+lQmVZHRSckHaoPHH+c09JHkDKw3ZGxMDJHOSPeloVZjCMtA5LKyOzNkZ57AfjRdSolzO8LII2O4K3PAXpk+9TSF4ozLKMBf3ajggMT+pxmqEsamNS0TCNQDg8jnpg/SqRLMm/m8uQN0UuCBjkHGM1FIo2iJScqQNw78Yxj+tXFiD/AOsbI37evA44/KlKRyIpOVkQhRzgD/6+aQDrRS13uBDMU2AHjjtke3P41s2kKIzCRTgLyUBOCehxWNaIXP7tt75x0xn3Jro7VJAChGGYfNsfPb1HOMd6pEy0HwSqJJDHtLOMhd/LcdcVTu4ZLoGNHdHRtwidD7cgnmtM2++LaYtrEqWOMqwz0I6+hyOaV7dmxHNDIcgrlwSBn8aGriUrGVHHEyhHjZgB1ZgCD67u9RykwyDd8pZc9flH0wccj860Y4JTkLFOPYH5V9+ecY9aieAuHJgJTnhHy3HtnApWK5jzL47CU/C3XvkYIDAWZX+XmePgj1yM/rXyNX2H8e0I+EmvhUcJGYFydvGLiPg457/rXx5XTR+E56/xIKKKK1MAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooA+s4bNr8xz3KGO3H+qtMYOB0J/nimanALaGaUqDLIe/b2+grdtg2BcA5I4HNYniK5i80KzcKN2BySevIrk8zuemhxeoR+XKHRQZIl3oCOFPdjWVdTCUfZrSRPlYyS3GM5kPQJ6n+VaWsOzWtw19KFkcZW3Tq5PTcR/Ksa4M0dtEIV+zgJheef8mqizCUdSDX7tSbWxtF814U3yJGdxV+vznuawZYmgkd3YSOXACKcqrn1PftW5Y2otEMioZQGOXYEDJHTPeqqW0eHdlZyckHpu56irTuyJRstTNs7IS3HkSLuLXIWWXPBQc4HfOa6izhjhFktv8AOfNAZGbbhvTP9aowWLPYPdwfIGlIz298fjVmdgZNrhgzgSFzxuOMAe3NaRl3MZR10Nlpm/tC4t5ZGaDC7gTgDKcH6beKjeQW8l/CUIt2YRsx/hKx4GPQkqfrS6LbG4upwbkBGg85CcFguNuB6gHNWLK2XUI7kzQgyzrJJGyMQN0Z+8M9uTwaJOw4K502iESXMjvKWW3t8gOeF3Jjj3P9K6Xwokj6cZZQ677hITxkt0P5ZGK5zwjD9ptpi48sYiVywxz0Jz6YPHua7Tw9CP7KeBdxdJnVN3GMMcN9awm9Tspx0OhtlR4N78M7O2M8gdCKa7Bd25m2MQx43HZ0qvFI4Vd6rHISAwxnJz2HoeeatXIAMjZByBlP7oHH86xNbWKW6aWciMbRnOTwRnpWnapAHaYloI1T5GUZJfA7+p5yaoMxUrhAoZSXcMMcdMDuDyPwqzA4W0VCpkYgMFI5Zs8YojoaN6aD7mdTDGxXy0+UFM55JPANVZsgKhZMoCxU8AHsD+H61YvER3LnDhSAmTuzjg1WIPlvKW3kYRTt5LHkqP0obM7XKMMU8cYiBJLk7sN0OO9EkZC5O5s9FA4J6Zq1esUVotrgqxAB65xyT+lUL1yj5Rm3EqAT3PfilsUk5MmtWhRsKpD5wfLcdQO9b0avcQmPGF2BVbO3PqQa520tIoow5j4Zypzxhsdxj9K6O2SUywjcssRIGXUZIGMge31FNeZdSCWppQyzMrDDeYmOBtwx9s/y/Khp5WiOHbG7kjrnvz7/ANaV449xjYDqQGiXHGf7wBxShRsQRxqWKhc8Buep/Gquzlsipd73k3THJLEkqwDZ9ffp0qKSZlVdjswXGAoOACMnBx2/Q1cnBjDFm+9yNoAAbviqUhLuFxgAbgpyx4PJ+mfyqW9TSKuec/HxHHwr8RNtiAzByXyxUXEf9SK+Pa+zP2gOfhD4iJKsQbcZHXHnx4znn8e9fGddND4Tmr/EFFFFbGIUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAfVl5eS3OUt43iUnA2evrnoKwLlEEnlsxUN/rCjne31b3rf1nUTIz+UpVFXCqBgCsyxsBgS3DZY/MwPYelcR6TS3ZVMECxvMoVWAwvc/596w5le4kYRxgGMEjHcev1rq5baPy1SP+M/MR2Hp9azpYJPLuJlXylIILn+EdlHvTJcEzJ8kzJFZo29GPmsoOB0/U1R1i0aN3z88UalBjjAPb8DXRaDauZ41VgrLkN6gEda0dWs4tgghj3F2bKNz8qjqfxpp9RSp2OS0WLOjzQyfMykyBRx36VPqlmk8kUxdWLwLIojHEeeP5/wA61rfTHsi12zoIWZU2YyR8wHH51oTQw2moXlsgXy4YVSPjruJJJ+lXcw5TjtLAtoC8kDMoiKj5vm28lgPbgGuotx5Wl+fCvyW0G0KMncWGWGfqadLpMNvLp8GQyCIIXJwGUqevvk1c0m3luo49MtwqxljIzE4BXgkD+VVKWgQp2Zp+FrJ4bG+h3qqyCFtzfwADOwfiMV1GhpK1j9pEiL1aRDkYOe/8qr2EKrJM0Sjy942n06EfrmtS0WRraUOgQNI2VHXhsgE/XmueTOpbGhvwfMkYeag54xjj/CoUUyyKZWdFYfMp+vSkmbypEz+8jZckYyS3epiJvlVkBkJG4rnkf54qOobIV5A4VlUFRhF3DtSnaYWYhkfI5Xqe2PrTPLG112bkRjg5+8enbsM1NGZDEisi5/hUn8KbEPdCNix4STGfLUA8npk/SqzRESeZHsMnAJU5CgnH4VMQsKmRlXBIAHUAn+frQkSm3JUFjkZOdoYf40hrQhg3ZZHTJ3kFxyDjtjuaxb9QPnT7oAYA9ev+ea6G4dmXgCIqpYNjIGMgfj1xVJ7ZJC6Bdvy4VBzkd/8APvRa5UHyu5QgSe4TIlIRGzt3HIycY9cnOM11mhiYwRqEVAd5LS8kAcbT7jHWsXTbeTzJBGI1AyMk8cdzn61r2EciMu5o8NjALbt3HPP86uL1uVWmpKxoQo3mYaQK3fH6fUUJ950beJMDKg53c9TimxsRlg4jUj5MdOOy56Ac/Sn7jgHKlR82xW2BR6Zx1z6UzkGyRIm8AEjGcKMHA5z9e1U0AS7YzY3HO0nGY+PXuD6VYMzSEONzIQRtBKhePVucdPrUrJ2JjG0YGATkEcn680kWny7nmv7QuT8IvEZRUWPNuM5ySPPi/r3r4vr7R/aH3H4Qa8VXgfZwW3Y/5bxdhwa+Lq6aOxz1viCiiitTEKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKAPri/hBOQoWEEA4H3j6fSo40MuUROD1Zugx3+grWu4B9oRBlkiwAme/qaY8ZijdpuQeSOg+lcR6FzOnRZQlrBlYly8kgHLk8AA1UvLXfB9mjx5S5J+vv71qxQM4+fKluQTV6OzRbc+WoAYYwe1D1LjoYunacbdbGSMFJFY7zjqMdDUM4SS9klbKo6ugweR61q3D77qKJWIWJdzDoOmKy9YjddLke3BEqAyBSOSByQfwoQTdyPyfM0u6RyuQzMFHbHIqrAserNctZ5WaWRlDN3wvUe2P1q3p8wJn3MrrLskYE8kleB+VQeCo90Oo4x5iXTRjH8I4P9a1t0Oddy9AWn0OK6ii3XESrtU9SUPIb26mn6FYww37wLKWi2bklxgvn5jn0OePpirsMCQ6mRA/yCLbIh6ZJwfocfnU1pkam9t5QjdAAMKMOoGF59fWpZcDUtWMl7howscR8zaf422nH9a0VkXdKisOcDPXkjIqha4WeaUgNgBC2Oen9KsxNiZpChGP7hA/h7e9ZM1saCRqsQ6MrcqB1Jznr2FEmQ0kgLBpB5e38OeajtZimPPRQqBQSc9v/wBdSRTKWhG5nK72Rg3Vj3/KixLuMLhbeRYgVkUE7icqwBHHtVlB5coZndVReRt+h2/qKrSJF5DqxCyZA45z/wDXqR9v2cSM7lSrM+OQTxgfj71Nhk8ZDbASjKCCcdM5JIH4jGfaoonkMZaTapLZK9MnPy49Bg0fwPFls42AFsknpu+tOHIjYOAhIBc9OB97HpTDYkcAlYyRvBLNnpv74/DioYIysTTlvLRO78kg5yMd6SVG+dg7IQ4IYDlt3r6UokKJJuAMYXdtKkYbP86fUXQks1aJV/dH1LHggdMH361etFJmMiKRkZGPX2/DqKo+b5cJb5VR2Ayw5yOM/r1+tXbcAIyqoJBxlmJ6d8d8+tCJZcZ3YEBihKneWfO0f4U3bIpUI6IzDcAGAOBxtGenXuabGZFhyu9eu0qM7QP580sCq4EYHJBBfqT7Y7+/+FUSglQORtAkBO4hR8p7c+mKCUiXy0Z2bI6YwfXjuPSnykLuErM/zbVAACEAdyOg6/XFCqMgoXIAPpx35PUD2xSsM88/aFdW+DfiFd7uy/Z+F5C/6RGBuJ57H2r4qr7/APG3hey8TeHLvRdWkeK1uiu+S3lVHTayuApKkMCQOoPU9DzXmSfs5+Dnwseo+IHc+k8I/wDadbU5qKszGpByd0fJtFfV6fs6eEWGTf68vQZ+1QnB9/3Waa37O/hDY5j1DxA7KMkCaEfqYv6Vp7WJHspHylRX1dN+zr4QRN41LX9uCeZYvwH+qpg/Z48I8b7/AF9MAF1M8J25Hr5WD1o9rEPYyPlSivqdP2ffCB8zdqGv5UjH76IDBHXPleoxiiL9n3wg0wR9R13k44uIcD3J8qj2kQ9jI+WKK+o5P2f/AAihAOo67nft/wBdDjp0/wBXxz36Ukn7P3hcFvLvNdYDuZ4hk9x/qutHtIh7GR8u0V9OyfAPwqiZF7rrOADt8+EZ+n7uqUvwP8LIrFdQ1skc43x8+3+r/Cj2kRqhNnzfRX0KvwW8NNKI11DVOFBZjNGFySe/l8cCop/g34cSOSRLzViix7wTNH6gY/1fvR7WJX1aZ8/0V9AJ8GPD8gZI77VDPvwo86Pawxzzs6ipR8FfDz7BHfaqGJwRJNGM88Y+Sl7WIfVpnz1RX0gvwO8MAqZL/VwCuWUTxZU/9++amb4FeEmhLxalrQxyoeSMb/p+7o9tEX1eZ800V9L2vwH8LTu4TUtWbaQoUTxbpCeyjy/51aX9n7wwjZnu9fWIfebzYgU9MjyqPaxB4eaPl6ivqNf2evC7FSNT1hkYZ3edEAg7Ekx/pxT7j9nvwiiqY9V1aTIydl1E2BjrxF27in7WIvYSPlmivpVvgZ4R+1MialrXlrtyTNEc57g+Virrfs+eGeNl3rPTnfdwoc/TyTS9tEp4aotzu5N6pKsUI+9yR/Fj3qg8czMzSgiP0/rXWXNusMOwKAuOaxLiRmUpn5V7gVhY3i+xXAV5pVxgKF69BUuPmCqNq85PoKbI2JztKrvC5qSQhiRuyD8hUcHPtQykU5rNDwFaR3OGPc56Vi61O0cJaZECuSm3OO2MGukIwyMJwgAAUNz0rnNSgFxe95NwcYboWPeiw27nP6OzWuu38dwoQJHGCMfcfGB+BFamg+RZTanKfMQBT5u0ZDNng4/EVl3Ymtb651uWT5AQLwseFjUADPsK0LEhL3yWIImmQyM391wCMfiK18zm20J1RpdZlWS6mljuZGbzMAFQMAD9RWzOptbnzmEkktmfOA5LOjHDLjv0/Sk+zpb61GzoPJmwgY/wyY5H4gCjUnJuWlX940EiknJG5XPB+nX8qh6amyaehux4tYmG3fHKnUD1wR+VJu2QPJGu4vgMB9SDj0OKht5WTS2WJubZwcd2UHp+VWXjVrtprfcIpmxnuDjH+FS0XF9yxbjfPIHAwxU7Sc8HI59e3FJZIBFl1XKyYIHAAPH/ANalWSHy52AbDNgZ+8pz1x/LFK0Yl2MhTcy4LKuMn+8frU2FcjkeORcr8rghWXt6fnT3BKBGcsMhAynGMdRUUsQERC42s27dnBYdfpRbErj94xViG+YdsdcetSV00Lkly/mPIsA3qfmLnAKghd3HcChQFtYsKxYqScjOR256cYqgJpEdt/zKv3Sw7dfwyM1NBcAwGOJnUKepA5XsD+dF7iZccNK0ZJbAGASBgkg7fwHH+RUNyVWJ45HJUgHcFJwR1H1zT0Vyw+YMCScj34yfaqkMrSvdrLlMgYzznPUj/CmJF238p7ZE/dsTgOrZ4APH4d60C6bQqZYqnDc4yPT057VQtixnjYjajHDFsYGM44qzaDc3y79rFmYquR0oQNF+DLILZewHy78dTyQM8dh+lTiUEtK7GNweCGAOfQ/41kQNNZReSuMu4YndjaD1GT2FXYfLmAKBcKxCL1Ixx1PTufxqkxONi154EDy7SIXyvLZVfcepOaUW7oA52RM7H7xB3ZP3ePWmOzonyrz1VFGTtxn8c9evPSljkSRwElMaMykygc/99EcEHP0qrCtpoFxC0RZpVTJQYLAbcc5U/wCPHalbDwq6FguPlDADeR2Cjt05JpJN3kmVkV0Lb40zlpScc++T3P8Ad7VL5rLOHRmEjHm4Y5BGOnPXHtRYOhTkTy7gM4QyKxwFbvxyff8AyKRzI7I7bymT+8AzhMEgeoycjn0p01rGShYGRlbOP4yFP8Z6A9+M064mjNuQQyqQT5isAnJyCcjnrzUrdlb2sRSKziON0ym8BuccDBBB/nTyoaTnAWRWEh6B+gBHpmiNjL5YeEkkdAwYKf4vwI6VRZ98TKpkZcbYwMbiCDxn29e+aG7AlcsSkIrFI2JIIZN4CnvgfTn3NQiH7PM+7csyNiRCR+GB3JzUiyCVEzb8SIeRjeDgDaP7oyCT796aVM1tC6R7bhyI9rAMCQeuc8Z/ECmGxWWJpLlt+0oiBkdjgs/+1+B/SlnMfmLtkzIPTIwOnToT796kljDuv2gBI5I8MgbDAgkE8dQMEHuM1Xu40uY1LxFmdQU2/Mp5+6Mdcjovrila2wWuVbuQwzHawUiQRvjksfUr1z2qjdiSBnjaMiRVwFByV9SD9DnnpVpmkEqQhFkEedvPUL0zjBDdKgnSW6maKHJkIdjKDtLfL6HjgevUCkbKNim6rMkzIAFUglF/hAxuIz17AemKg8qPy/LYboQ5yox8y9QT/wACxVm3EaIkiYXe2PKbpGoA49QO/wBakVMJgbfMABGRnccYzj8vzouNpmetmD5Ua5DKD5iqcYOc8DoeKlkilcsmxhsUbcDOD6j/AArQEIRyIkxxyGOBnpwfbvViCCMSpiZ95AQ985pb6BcgsQWuHhUIGAGXk438/oavywTYBazedckpGG254/hYfnVSKNZ5YS6mQsBGkgGCM5yAe6k8HPPTFWoowLiW1kKRB8KZDJtTBHykDtyO3XNCV0TLcuWscUgaOS0jCqvyST5WNwOW24GVbp171ZEk0ax+etzcwKT5ctsUZ0PQbx/d6Dt070y5Ebwm1vxdyJEyK8hbKnA/i5z0wcjikjufsTpI1xbLIvyJcAs29B1WY4wUxzxkg/jWiMnqIba5ZWktPIjuztJhjI8tsn5cnPyg9AT3PWnRxwtM/mreWjRjdIoiCxs/JPz/AHSMDBHB5pBLvVbl1R4G/eIbciUMMdo+NwGdpBOOOKdbW5gkRoYnMJyv7slpGY8byN3QZPBHTvSSQ0+5FbytdP59u0H2KeIKYYs5hXJJLFucGo7aziRCLu0lvHLErIkhX5ewI9RVwMJHYRxyIAOUlxskAHA+XGVPqfxpI7W1kBe5eIyMc7SM7P8AZ5PH096Vh8xXv8CIMR8xyMCsC5j/AHhKgnjpW7djJZWcY6g1jrgzOitluRj61W5itDPaFZSPLOWC8/UVLF5jTIoVQFI2sO/FOt1McmCvRttLDgXUavhZFJGVosaXIEG6ORXBOMAYHIyfWsi8ZDqHlRp3YyMTkcenvV67mSK98zcx4BbHcdOnesTTJHvbnWLmVSBboUi4/iPLE/hinGxM7jWt/wDTpbdgGS+hZ0RxkEAfMrA+vFZVlbGLV7O2Znmgu44mUn70LKDkD1HSti7Y6rcW0g+WF5EVJFbDJxk4+oFRXMTQ6lYTtFEX052DlTw0bDk/UZHFUzNas6Vwl0ZLWdElfySjMnGNrcSD/aBxVF7a7maJxCXuIFIZicJcxIOh9GHb3pY5HN7viKs6sY1APDhsE4/CtdJk22khkbeWkhxjozY2+3ak9SkmtjK05mtr2KcO88JJXOMFlwMZHZwMj3FbthsawaCJxJGcm3mU/MGBztI9QOMVX1G0VriJ422yjEpCkckL0I9CM1Yg2bJF2xNDuxkD5sk9c1Br0LIXcrGRcP5eAx5DZHp6g0y0mDOQDzgceuODSBkMiorDdwDu46Z7+44/CjyY45S4HlKwPIPHPak7iVupNHJEoRJXKqGYRgnJXswx27fhVeCTZbTrIoyowB0BbGP5ClkjIyp6kL846D/PQ0+VCfLXHByDgfkakBBHKHgYqA8qlSP7w7darxKxjQxNHtJCMjHkjnH4dM+9TSAErxul2EoQ2MbRnP5Uzd+6DKmPMJ5HGQcAgD9aB2J0fEAL52pkMCQo9M0ZYrhldV3ZJ/vAdMflzUe4i0iVgoBwDxncvPX3p6OY33KuVIDANxtJ6gUCRP5irascsrEEKTyOT61cQtE0pizFuXGM/LjsB261nvMsccaSL82/d16AdavQLG9vJDJHIGVCAWGOcZH1J60DtoTqiF33BniTAAORz6DP0NR/MqmRAqop5j3HoB0A649TUVuXZjvIaXO5WViCR67vzqRXR5FMSoACTlgO/Xg9e/FA0WpJVcIjyFZSSBkkhhjJOOwHAqRpsnY5Riwz5TPnfngDPcHHX2NUE+zxuwxvEhyWxjkHj3A4GR7Yp1hqcMl9e2tvMryWV2sNwURiRuTIXacEjBzx0FVFtg12NiJyirHvX7QQFYyLhypAy3oowfzNJLtSJYkO62icRs4XAJAz17njrVZPOGCCFBADueeMsDnHXtx05FOdnc+W+BbShJNikgdBhunB+XGB16mqI5dRYZVnUFm8iNcxgRKXZTySxA5247+1VJjJcMUcxMjP+8Bzz6FWGeDkH07VFpt8zbxDKFWVlYhXVWVgSAM8dgQR0zxVyaRNMieKWF4pGZ/LYSFt0ZHIbsWA28D19RRa6ua25JW6lezeZLONpG8+dFA8tV2hj3b2BBwfpSpG7zPJMdvlR7SDkMzDkd+QCQCR7c1FpC3JBac7lOUTjIXoSeOw4znHp1q+Z7Z1WW62G1igaE71JLfMoZl9FJxweKErim7SaRBO6RQM0z7ZlAuChbLRjgSE49Dg47ZpiSiRJLaRI47hiwaJoyGUMcAp0GDx34NPubiRWdmEO07VlMr5MoLDt13cAY6DFPeE5MFxK0wGY2kBO4y4yUx7cY96FuR01KTF2RJZlKv5uVKnAWUHaXHqDxn161GyvJHcyQyr58UqxSFTwGXkoFHOff3BqzLFNcpKsMS/a5BkxHA2kjnHbnGc44xUK+SbrzTtWzTYsL7tpGMDkgdie/Zie1TuykUZHE0wgMcQfcBbyOxCuuCxYnqOenqarJHPvhuEAlQEpJ5kRBwvX8yfStwhZEijnX9zIx2bSAYlCkkHtxjOe4rLa4uJ3imikMdvKGiZm+/tB3BuR8r4UEfXmiS7mkXfRGURGbuZoxJIqjaVc4DuOpOfQEfrVjO2FY2uFcbwMHg7iM49uOKa6JFtt/s8cU5xvEqkDJO4vu78Dt3qZm3zmMm0ZZCeR8ir35479OnWszZ6jo3Dpvb5WLb8sMtjHI/E02BJI4lREi+Vxk91ByeMe/61Dpjz3FqbpllUxkqQ2M9cc+mRjGae0rIQRuWFWUMyEMAM8A/jxmncnl1sSW0KsJo45WYzJujUjgNnn35q1by/Y8G4VjDt2qyJvMffK/Q/hznrWYxWCRoQzRuJWKHOFHfn05q3aXixIss8MSRhtxWAMHU4xlsfwg9QOOaE0KUb6mktu80zLEWn2kMd/wB1C2cjbjkHsR070sSqikYuXhyreSsLAxDPIKnjB4G4E5pID5scKtJG7x8o04BRAwwfu/MB6VKILiLaFYI0faeVpIQMDgEtkeuOnvVmL7DxuDhN/wC8JyiviMyoDgEspyee+B05qK5jNulxOsTbMhmZrlj5Zxjh+w9D6kVLCI4o1wiI7Eq0M1rwec8tzjJ5Dcc1GfJV1lu2t0nPEYgdvLBP8J2kjsDzxQJbiBVEQuJ5WmQn94buMMHXHAJXgY+XBAqeE2UKbbgssp5bDEg/QqDkfjUsAO5pTFKQgyzgCTIyc+hx/kUqt9mRFaeeMsofG3Oc9we4p2ByKurLtVHB6SYOe+awrlAr78AOTgYPQ1q3biWxdyxLKMrz3rIucyx784OQ5b1q0jnWhUMnzYbIIII9M5p7FhO7AANuByDjim3DKsxRl3Kw3rn2qteysYFK5LY5Hp6UM0jqVtRx9oZ8BpFQ4BHQ9PzqloLCHQhcXRdPN3yDA+8mSPxrNe8ur9JY44S6x481zxg5xV63trjUNJtYEACRw7IxuzjnoBSRTiUNHdPLtYpd8cp3MAw6o2ApB+lbUkbuszoAVRtw5zu2EHFU9agaOOxuI+Li0YZQcbgOSvp0q2kySTRXUag7WQhV4yCuSMewquhGzuFksT6yltbiSNLnbdQ4ONsmCMf7I9q0JpTBBmREdPNjnwh5xuxhh27nIrL1KF212a7idJIovLKsvb5eDn8TWkyG4tPKhISVt0Su2MZUZqWOOu5umKGSRpFVggn2CXsc8A/TPFQWERhjRZx5ay5aYKfun1/zxUNndSS6BPLvSRVXhSP4wc4z74q/J/pU1uJF2MYxuJAAbAGVH86TQ27aCvt24m2rKBgsDnnsfT6imkGaJlJ/dK+3JHAf0qW5wVUAbD5nJPIOOn0BqFhHFJIzBvLc5bavKMegpMFqRi5bbsPMR+XnqParlrukDgBVA3EYOSxAxj8qy755P3m75XBHmEjgg9D+FP0+7ki+QbVK55AyTn19cUo+ZryXjdFqQqrlQyncPlAPKgDIH15qsA0lrKijZMDwCOh6c+nSn+ZlS8uVLjc2ztg9R7EVXkfdIwDYk80ZI9+P14qWFrCSRFmhxu+TawHGSQcDJ98n8qtwlyGaRCcP9QVJOTj/ADioQXXzy+N+0tlevXqf50kcpRZd+1VfDLxuK9OuO3vTSDce6t+7jdv3asT/ALX0+nAq7bN5ZQBd7Fe7ccc/hVWP97LsdfmX7x9fXHbrU7NCjxyQuwjLbNzDAU5B/LGc/nSH5EiahBHIEdmCyEnBHfjj274q0Jn8iWRsFQ5fH8J7fU1jXds8m0uS0QyxUgcA+h/l7VfQFoAqqu4ArtcYHv0oTYnFdCW2vN+QxUAuAAW4Kng+/wCdW/tEhUuCTKgCLk5A4x1xxxg+tY9vCYCJN+HB3AHJLDofqa1Eddi+Tkbjj5c9Pb0+tCvYcrdC87lbWTarJkYVl5DkEAgHtjt2zVe5nkCys8jwwuxk3bz8ir1BJ+7g9h6+9NZ3ZVPmu0mMB8bgCf8AAHIpsRXdPFLKoSVy4kDH5jjPU9T7e1U2KKsUNTVYFtjHCREgZZEhTcUQkD5Tn5vUjvyetVYWtQrRT+XFHnbuMrgpnoOPu9ScHkGtqFIfsNuXEZmmYELGWRyNpzjHcYyRzxiq0VpGxjtfLiMLRGYoigLhW2sCep65/wDrUWOiNRWsyzHYvPCiTvsiCIIUHzKE3koWBxnnJI4xgEmrlvLd3Mk8uw2szv5f7rLGNFJycnO4kDjoPmzUEMBkuDyokOSzzLuBQbTkA9ecDYPvcdhVxXtoIYGjZUW4cKAJBIJAD1faMDJxnHA6Vol2OWcrsiRxHBuZFtovIYFWXeseTneQeVU8nrk9sVGZ3EcJmaMiaPZkYALoCf1GRu+lLcXkUVwsMt1mZTs5fJCknDHjlc4IHQYqvkeSRHcTNAY3nzIgwhI7kYLdGwPcGkwUe4sKJMzxKqPFHANksiskgbGU79SpJPYArUNx+/vJII41Cuqj5m+bvuAbpxjOcfhSrP8AeDGWFXHnrKluAVLHBX6Y2gfQ54Ip8bSK5aQo0cQYx4Qj5TwEOM/NnJJHb0zUvUqzWpTAKrDbtIwd2MSNKvM6Ic4fHXIJ5wKmCszSmM+TLMsgkgcZBYfdxn7vAGMdaSWKOKJBGzA2ysitIuWdGAAI9cevXBxipVWMT/ZVcyiRYwGGQm7HC5bjnn3B6UhszLqKUXDJA7rgh4vNPCgj7yHnDDHT1NRKkMXmPcj/AI95Cqyk5ULs3A4x1Oc1oBwqhpo/nbazLEhPmhsZI9CDkcdcVQg3s80NxI0cMk42qvJZDwuSeM47denepcTWLuiDT5JMAiFtp5CxuG3MOQQeO3UUk+RkBPMV8SBtoAyfT147UpnEIdIreEiQJI6REMuQ3zHcSMdOPrUr2lz5tsyjy2cnB373VMZ+YdPXpz2qXsaO17jF3M0YaMBY41UsmQCATyR3Pqavx2tuCVeRZFRhIMkp8p4OOwIJ71QKuLeJ42RQGCxkY25JAyfQHOe461oG7CRxtICC78KApU7eDgjHysQcH2oMp36Fq1CIixwzNOWLCOIhV3ZPzLt6hehq6kcYGDZpNaIu0MZDIEIx0jXkgH6VkRX0oVo2kjSQys2NoeRVwOrDjHYZ96abjIPJkmHBkDFdvPOGHCr7cmqTRk4Nm2JFYrHbXFwWiLb0G2QsMfKnOCAc8AjIxzSwRzRotyiRzSFNpjnhWN+MjO4E4OD90+lY0b3ckcLK7jaCyxSqrBgOpXnco64yM5rStmjKGSIskeWLLIhyAwwBk8qc55HHFaK7IcGkSq0S3S7nkaeNDs85dsjZHQEcNjkEGkuhOLmT7Pb2V4ueZXcqc9wR2qpeXZtEjQkyoFyglIDSHOMg8gsPQ/e5q0yXUTssentdR5yssUZII9OvWna+gcttTBsp45bGSLI+VSQTWfZOZzGu7IYbRmorOQbgrgAMcc+9QwIbe8NuhO2MkoSexoizNpak96InkhSRijruXcpxg/1FYl68otGEhDHy2BKnrj2rYnUPFLEw3Mhz0zkViz2qHzdqAHGQcnmmxxMXRb0Wc8kN4skdsAZJFB/jxwa6ywUx2Frt2+dM6kE8YUdjXITWUKLcXXzSsvAgbo2RjOfY1q+F71b2SCymnWOSP90RnksTjr3pKXQ6XT93nNx9t2t6o/1rlZlB5wAf5Vzdk8iaxcv5LKgYMqDjOOOn06V1mpLHbzsE2+fDuRYwfvxjgCqF/EEsYLhFUSbAXJ4wM9PwptM5bpMrCEx3FxKhHlymMuoPykEZOB+JFalnttZ3QlJYwrso9AcBRn+tZ7lUb7D5n72VUUAjJCgklh+GPzqC8eWyvN0ob7I7E7l6ITgbB7ZAI/GjYFqzZgVoEu7fAI87jAwAuzcW+vWttpWmt7eWXMgCebgnG0c8Z9+K5y5nMemTyqxzLGYnbPKnnBGfY4zXTr5EWnBYnEgWJpZE5yy4wuP+BcUWui5KxDPF510FYoQ6p5xHBV8YXHr71HIjmX7RJhRwJMfN2wOKnto5NojvVH2x9sjo3HHTCt9OPqKsXEqrCzjJcMrqQOAM4Bx7VnIE2jOAkllCxxrI6DPHBZR1/HFVjEVGVXnbkEHqOuavSQtLOXwUeRvMA6cc54oIBRHXb8ysrD3A6Ui1K2xUMhhm3Ln7hC+jHsf/AK3tUEyCFEkGEIXa27oOe/rVlkkWV4yw8vAcf7OQM8elMeJl3LIWywzjsxHUfpSHcIJ08t1OSWYAY5+92+lIv7uNYSd7IXC5H8J4INRBIzJGu7MYkCkMuNysO/0OKSGUNbKj8sxZWJUEkjv69f8AGmOxpLHG9z84MgICllyO3J9M+1SW8fkkN8jIRu+Y5Azx0PY1npdI7FVO3aASx/hx/OugmAmit4JIWTfGHk+Xs3Ax6EYzxRa42mtzOdkQIzDBAI4OQAD0P6+9IMq8gQtjzBwp4YdsfSnMFjTkZ3Mfnb3HHPcYyfrVCeUlw0aOQMHAPGemR7+maTdhJXNSOcbMyz7h1EgAGcnGAPy+uaFd2Z1kwgX92XB4yOMn14xxVRFMoVjJtQlSRIuQeSe3OM1NHGxQsAHiBBIRt2WB4z7Uw2JUn82QKAzBMKwzlTg/d+nHbtTwQ4DecEkjZyjeWGEJz0A64xnmqBkjLIJNjyLkkK2EUZySW9c0yYqJEuJF3SF9oRuViT0BPI755pbbmkY3OhsbKWWELBFGxuCrEyMU2Y6BW6gZGTjAxgDOaijSKY/PPZslrmMNbOywo3OcAdTkDOffrTLfWJFVpLhIZo/LJVWyGf5jxkHscY9qqySmZIvNGwj7yiP/AFi4wR8vKkkDp6VpeL2IUZXdzQUXkXkh3aERvvSR5Ngz0BfPPI6KBxkGs+LU5VkkeZLhldgsiFhH5m0/KVGNoU+o65yarRYYoLo29s8hLJ5ceMgD+8xJHHPvTbfiK2gt4oJnClVjaXYIOoVs/wAefmyBjnAod3ojVQXU0rGSd7b7SHiiZlKSoCNzKct8q9s9Pp9antUfyJJIzudVEao5JeKUkjc3b7p29flwcVSWWW1kgjRrRHjCblckAODy0iD5slfujPBxUn+uWZoruZQUCSImWbcGJUYz8rPlgOp4B6nNNIiSuX90UkjpFbyQWwyodpTG5bbhBk9FPzZJ4yBVfTljjtLdTMW3KsQk2bNzOxw+M4OVHGOD1p8s7BPLMM0qzEvbxeaqbQqtyD2XIAA5OTn+I1IsmBNIs2ZSV87buxuyFPJz1GR7EelN6GetrDZTM1zLsjiYGPa0TEBWfdgE56DI6jp61VeSaeCRYpwSo3B5NpAIPXPYdOvIqS4EcarEwjAuioVt28R7eTyT93A6e/qaf5shuIwiIokmaNgFHUnIXb0xgE5ORzWb1GlbUlllaWOzaJt0kbxsR2UoOc+qjnn1rJnRrmAxtH9ot4WBAlYFZS7Ec9upHPfir1wiTqY4bqRrd2Eg+XYJI+QVA5w3XnGOpOKrRQOIpo9vlsQVVxhgoHJye2efrxim7sqCSII9PjjNpHzBIMRFRGCNuCWXZ6kY5P1qpte4tybaNAflk4JJgYuFU/XjntzV6S4jMk2oQx70eIPEBMxVyxxz6AgcDnkYzVWZo7e6uYplJWKPM7N0LD5RjBx36DoRUtJGik+u5DI5YyRyFhGY9hC8g4JH4An2zTr3UGmkbCCMkgKi8iMBduP0rPuLyWNd0qqjtgZ3biw9SfWqWnZu7uKKBgiyEqJZOOv8RJ46jGByalK+g2luzSWRppMSSEAL877BhQBgZx0zwM+prdsI47iZYLOCZrj7O0qzmLcrPgDHmEADBz0HFV4xFbCRA7/Zni8zktHKdpx90Dhc8YPJ69qfcXRFxKWaWOKVcrEzEBQcEk5P3iQB05rSKS3MneWxoGSP7QGd2mlaAeZIx3xq/QhmxuBxngd8VHHBc2ILCJpTbO5VVOZHjwDucHkYAI96zbq+mEwKyK6K21lKndhupBGPXgY9ac8vnSAj5MD5Tt5+mc5A6VTYKm0jS1Pa6TSQx+bl0M6jP3jjJHYMCeg6c5qae7uLaTy4XCrgfLuxjjp71nRXLxM5kOxiBnryc57/AEqA3THqzEdtigDFF1uL2behjSwkhcZ29D7Gq0pQajBJuJBHJIrpYLZZ7N1OMA5z64rm7gKk8atyVYjj0oic0tSe6U+bMi/ccBlPtVC/Ypbq64LDKe9XiC0kXyEYBXBPasiYO15OEOIg/GRzjHIqmKLKDWVtfOy35docbiqPtye1Z2h6VFZXsESM7M0jSguckAe9bl1CsMRnKllUY46g1DYIYr4tMCQkTZbPViRwKhR1udSrNRsnobTXLXd+Un2L5LKA3faoJ3H8TikMgniW2kjwzDawP8A96ztnmapGyjZgFRIejgnkH+VW/tmE1GRdvnu5VARnLD+nStDlZQcqmrRzxSyPDGjKMDLEfxc9yOKh8R3LTWd2jxSTROUMka54UZBOO+M549KetvJ9pt4VBW4gQ7lJ9Tk5qQF4YWiVZEuQWInQ8kEdD7e1SzWmk0VEF7HohaVYLyAW4iUu/luj5GwK/wDGGGT+HWum0q4luSJEhL242yfPyfKVuEx3Bbn8K5C+gl+xRwxmQQof3YI3iLI6AjoM9j0rW0W+uLeZoLLE1y8PlxxNw0Y+8x469+vrS5jfk0ueiWomvrnc2zbIzSw5BXYvXHf6VHKPkbA/eJ8wAI5GcHA/Gk0C4jltOJ952BYEjyS+ACWB7Y9+tJqN0rPNFHG+HJeLcclGJ5AP4Hipa0uYWfNYbAx3XCurhflMbew6f1/Wobz5HkMqAhvmx0DMD1qzp0xnhE0yk4ION23KYwCPxzSXkflyur8qCB83Bx7fUVLWgWs7GZM5XyWY4CkYYHgIT0IomcOGJbb/ABFM8H0+nSnqyorKwBiC5UjgkZ5B9aqD9zG4OPvHG7qjDt75FMtK5Ix3oU+9GwOCR2PX9cVUWdmYxlsEZyWG0qRwQPoenqKvsfMk6n2Cj5eR29O3X0qrdwYk8uTBlYglAcgnGGA9+D9KBxa2ZR01919KC37wKNkbHHmZbBx9B2966WGeJ1ZEOHUsyAynAUnG3B78ZrnptPR2LQq4Kn5JD1cdm+oq5pZcYSdHbyzkYyCwPcf1oWhrNqSubE+JZHUMC8mQpI4yMdPfP+eagkCNbrxwM8dvcEd+9RmVJY0G8k8jJ4ZHz7fhVpWUyMcICHBaTbuAYH+H0z3/AFqWY7FeIqoRUYRnOMFTjGM9f5VODMFlO5Q3IJKjOff3p4jKSlyA0pUhkJDbhjBx+H6ioechiykA4PmAMxA9OmenB6inYV7lC4l24BlEYmUyMwIxkH0P+eahkYXNup2StuP3ypIb1zTLq1Z9TIm+z5VSVTA3Ek52gnovQ5HP5ValuriOVxPbY/hLNMPu9jjvjpS5b7nStLWEaVxE8cm5iQqt3O30Pr9alFwkk0wEgLqoLxHJO3HGAOvqTWTG09zKwvbN0ESlohFJvjY/3sjB4/u9s96u2UMFwySxPHdgIACJGXaCepxyD+hxinaxo4pLUsiSOWV3mkt2kZcGJsjj6HIA+mc57VaijiMRS1e3dZjv2wIWY8ZKcjJ6fdPfJpFgYQMqo8ckTkMfN27h0AIHPOfWnQwvAV82YsisGkSNiMnBx069fvDn2NNaENroT22npDABJO32i6AdjuC7s56kgfKCBweM9OlNhuIUaWWOeaT7VIL15WKyJHt4VUB+7hsEA8AZ61V1C7S3dVZVuI3wiMVyxUtuAH93p+J60txchp3YmV55VKzHPJOOpzweMnsBxTuTyuWrLs0SSR3BuWWMeV9xXwUHIQKOzE9+MD0zTrO6Mkayt5M21Q1w1u++OFujKSMBsnAOM8nHvWR5gms2niQz2yDaotWIDkgYYlhz19hx1q1DP9jnSCVmV4m8tBEGZJSM9hwMc80cw3DSxPcSzXmxlH2ac/vASmMqBnIHZsZ9hk5ptvNIjzzKkUdtMvnxJK26TONoZTn7gHP606aZ54ZFUTSDGHiWQsI4/wC4ScncTztH9ailmmCLNbsxvSzLhmG1DgKoJ7dF46Dkmi4ltaxeic3FwnlkRyFUXzlcBwoXLEEfdHt1OapaozPpk0Ss6rOrHgbZCpYAsW6DsB6d8VIRLb2Fzvjd1ZjkR8kthQzc+pB/+tVfUr1pk2OvmwLtH2fgnK4wgI6KpGWPrjrzR0JiveuiK91IIjTsIE3tGluGXCtJg4KAD7qAE+5wTWBfSxRW58+4d3HJO7GSeQAOw7/rVjUJTLIHlm8xwWlwgAUMwwSPoBj8cjrXLX19Lcz+VHhnOFGeh9/qM1DVzRJLYtJJLd3EaqAhPyuw789fy7+1dDBbSrYv+7juYUjysSzlWXa33yOqjnoMdao6PYf3N8jqNzfu95IA5OPb3rTNxsBWJ/vptYjkMpHPUdxirSsQ5OT0EEz/AGr/AEffHCAzhCxfazYHGevsD9atxhblNu4/KAxyeVHpk9ayoZWkg82A7mRyyqDxjHf+dasSedbRGP7kgwoHYep/GkzZqxYkjLD5dvmbsFe5PY57cVHCdtxJHFl4ycMWOQD3A9q0PMRYlcZLDhSoz2Gc+pqMRSJC8SRKZGYgKQQSp5zn1xRYzT0Muc3MUjPLKoAAVIwhYn2x1NQi6eUlkYYzg5ibr3rVNpblAQrM7MBhTypx69xWbc6RFNMzJNLEBxs3EYP4Gp2NIuPU6mMKY2XbhcYB964q/XFzIEXkP8td3bbvNcFRsxgN6kd65HXLYR3BcEgE5ORWh5q3ZnTSng7TuUZGD+dVC0jRRkKACTlj2NTsc27MvJQ9KzZHllRt7bI1OFTp+JqyUrFtn83yrdBudSXJ7EAVlHFxfoluMxxksx6gE9h9Ktkj7XEJXZY2BULnAAx1qe3jECSujDcxJAxxwOKGrjjKzM5nnMInRkZPMMUSEfeAOfyqnZam8YvLVgUuWkVZHyCFXjoK0baFvMuCpbauCpxwkZ+8R+NZ1zbJeC91K1iaMsPkXbw+3HB9uM5phdPQ2oRJLfz3RR8+aqyN/sbcHn3yD+daDIDcyu/+pj2xKxGeR97H5/pToopLRYJg4C30Hm/OeB/dOO3NRJbldEhhZ8eUjMT74zn8+aQ15CFEeO5VSHWNgg28bx/jzWU1krIwUzgSH5WVip3Drgjmr2iEzaQhffGjy75MnnduGefStmWOOTdGqlnV2yOmDk8/lUSVzWlUs7Ms+GYruGHCTbbdstgyDhhzt56f1qfVEHmW80AYRo4ZsnGVPUH0IP8AKquliVGVXcMiADA48z3PvVmQ+Yt1ghuQisoyMhcnGepBIqehU/iK1oRFMHZDGQTs+bgZPO361pyncU+cuGBOe4X/ABFQ2SZtkJQEGMbsg/IfX8+9Km2OUkGNZFIIcn5W9eTU2E3ch8pfmy33CDkDjH/16Y6EyK74EhwwPdhjhx7jFT3DtFKAyEo6/KV5BHekRV8xRIyrHsyjn+E4P60wTIJ5I0KmZRsaMllU43KD0X0x6elIUTIUESKh2FlXDK45Vh746460t/ZtPJAu/wAvgbj1wx/ix6dPwNSwjcsfnbIpFHzx4xu9DkdxzRe7HsrjVmXeYmAGSsg2qCOvDAdx1yKS5ZlkhkkLKMHAHO4jow9uvFPjifeAVBIcttB3Z+n8sU+VVnsWSPJfb5is2fy+uP5VVydEx5UOTIiqWZsk9CDjkA9OR27060KgN5ihImGBg/Mv/wBeoIXiWIYGAE3dMFMY/MGrLTxeezlvLkRsqQOvtj6/5NKwmxqzzfaJEkjDwr0YDtjhvzzUcpETr5hHmZMmNwIzjsexx2NTySNBcvBJ8giTc7kDCDOcg/Tk1QS5VGkeVZfLc795XcMepHVeMYyMUWBMbIm2RS0fmSY3fMMDH90e1QW+8SP9oDIytwjNlQT+tPl1KKGMKJUlD8JFGhZnHoB2rMGnzzvPJdwoPN/1UK4LBe2/jDN16UJG8b9SzfXMIhfDB5HwskNu5ZyOnboe2Tip9MdiDIyp5oZgFjbIK5zsJ6nHp61Xt90Ef+hFTGp2+WMYOPYckY/Wq0d1ILhsFJI2T7wAJbBPb6Y5zSvY2irqx0pvX+0K/W4jwixuQdmMkgsOvXHtVBtUgZGjZ2i2M2GGADx0X3zVO7u554maRpJJQnSEAM+BwB7nHWoLe48+1815SY3QODtG3/aGOpOe2OKG7jjTVrs0JdSRBC9obouJCWZGbBRhz1H3uCRycdqlt2LW8jR27A7sM8hKq2Rld3c4AzjFR26ywuGQyyYXzfmO3dn27AjNWLQGNkjtiyZOQcHZCe+WPU98jmmJtJaEAZ5bKLz7fIYL5n+kBSJBg9D2P+NaUE0VxukWaKaNFx5iT/PMMYIGOdoz1GapTNG3mlRFEkiBGkReD0+Yk/dzjr78VDa248tbcSiSIIE8wttKepOONvPAx+dO4O0lfY1o9QErLEhaNI87Wi5LocfIrEgEjGcnt+VSW5QO6JHDE0X3ATlIz1DN2Hrxn3qvBp0Buci2VxJnCiNvnb6ngZH8Ix2qx5JgiTaVgWM7Ej2hRFjnavOeM8/zzS1MZOOyGXk7Nay7T5fmfIpA2ZK/xAdeTyT3IFY13eIudoEaBQqiJAoAH949/U+tWbq5Mb/I0rKrMzEsBjtjP+c5Nctrl6ViBLEknaFH8R7KPX6Ur3CKsUNY1LZlIWzPI2V2tknP3QAPzxV3Q9HWG3We7dWkZslSSSAOvPYdf1pPDWlPLdLc3ZC3E7eVHGFyY1P3sHseP0rsIY4IzGUAdGBG1iDyB3Hqe/bmmlYTlfYgihEMG3yCxx0J27+5HqTjHFYGoSYcrG+QuSCoxt6YAz9cYrrnt/Mmu8sFJjZndsMQuegbtzjkdga4zW7d7G58pm3ybVcgDK/gfx605FUmuYtWJKQCOJQoO7+Idc9R71t2Ei2zCMI/lFhtfIIIPPI7HORXJWT+VIDuOxiXzn7p71uQXsaIED4zxj+7n3pI3qHVQBuSEHmcEA8qfT6Yqyse75IyI0kO5pSxyq8hsep3cfQ1zTajDIEUsu4Ajbu4HHINTnWVEJxIOuRjpVI5JXNmWzkeSSNXYblyMkALj0444J59agGh+ZnZhtnynY+MEdj6mqC66JUBkKbSwAI678fyIH6etI90LkiS4ctJgAlX2g4o5UxKUl1Nqe9RJcBdq88ZrA1SRLh3GckpjHrWTea3EkBd5MBRkk1i6Nq7XxlkYkbn+UZ7U4u5EocpNcXZjd0C4z8rADP44rMleZi0hfB28jPQ+pq7cKWvUk25UjDCmq9rtMkewJn5txxt9yK0RjJpGWYLiSLzppTMcYKDrg9xWpLdfZYBCvLkAJjjtjmsbU78W0u+0jDqe5BAJ9QKitop5pvOuY95xuGW/pSuI1zePhrbzD5jQASBDny0Xqn1Na/h2IpohieIh5024/u55zn2rGtYhGs58s+a+WDdQwxyfwroxcrGE2ErHGCdzDjkYyB6U/MjyIPPknWxkVY3cbEPzZG1MjGPc81YuJmvoHWEpHESHYE43HPKLXPtPCqXwMrKY5ljRByScAnA7Dk81qhJZLC8llTYmFYEDiPPC/gam9y7DrARrYPGZAiFmzvOFy33c+noa1LS4RJ5VkYYRfLkYdGUjr9en5VStEBS6ieMb5QxYYyAaNGmSW2nzj7XA+Hj4IwFHyiktStjZ0+RAZZjghZNrHGMYwAQe2aeblIy9tFEhcOxO48kgDLe2c4/Cuatr5UvTBIJBCGXzQo56En6jOOa0tPlWV768kiO1rhCGJz8pTA/IgnFLQuz3ZvIHbNt5bxFQFUSPg7DnHT3HSo0EdzYzxnjYAdrdcDluahFxiJZhs86XlNh+4wwCf0qXaoeMIRhVAA6bjnkmpYJkLK20qclUY7DnpkZ5q2VTDb9mB8pOM/e64/z1qC4kIX92W3MSHA9V9fbrUcc+S8aYB/h54PIwP51Jok5GjGCiFUBd4o9iGX/AJaJng+5we3pVK6jxHEV+dHA2SA/NH82CCPy/DmtlwU2xPt3RuVZs/6voQP5fnWdqTqdPaRRGsgkDRFT1LtjaPpTsSmQAvFLNJ5bJKCNwTjH9449OAeKbebvLgCn55GCgE/K6t1I9MAE1Pey4WNogzSTApsBJ+UKSc9wQRWdeH7Y3nCBXjRHjCRNgTOcbtnoMDb9SfSgV7mgsESzBFUrgbg4YkOuccH2qNCl8FeQl4VYrE5GC/8Atkf3fTP19KZePHJYxOCjRXUqRna3IyScAehA2n8aku5kgSOArC8hH8WfLHPUgdv4cHr2oegIXaWA8zBGMZ3ZDHscH72PSnLcGFwm4HaCG45I7gHvTgjho8KR5pO1Dw3uPT/Co7u6WKVY4jJ5ijcYupA9cngZ6e9LYaM+4NwV3sYzk/OShyOeMkdMjAz3qP7NI/mbnktwuMJE2ML7t1wfanxLNPKZt0caFvmjUEqgX+E+vv6VNN5MsYaGJTlcCSIFcr17np70jVO2hAHAR4oF8oqMbQp2qM9Qfz4psYxZr+6RnQc78AjnPBA60+AIlykLoA7LvC7sbR/UdPepnR3ujgCOMKH2DIDn3J/pVXLvbQzLqKV7iJQyrbhw7Iw9OnPXg84B+tTi3gQk2yopBMhjxgZJ6+9aKkCVtsSoycgt1OfTHeq8xaMrI6JGibQHHGTnPJHX8aQ1Ub0HGaNdkiOwkYAMXwAD3XB6D9ahaO4jY75E8s5IAySp7lgfbv8AjTgY5QwDsCY8AqFQY6kkkY6jB7+lINxukdJUldgpBl4IwMnB9OwzwabKTLFvArlXkuJliUjdtxIQ3JABPykA9jWjFaSRh2j3Op+UNKUZVOMn6de3NRKm0PHMgBbGIywAYEfewOpGRWhEi2/kOGlXynG1pHQbSByPQk8YJ9KEZSmxwQG1dmaZ0JU7YZeSeP4Tzx2A/pWPfFYp5mWKQ7WKDLf6te68jGfWtCe9U7IzIjSDOXSLczd8bhxj3FYGq3DlF4QZONrHjJ6n2FDsTBO+piapIilSyqkZOVO7O7A6nPJB61naVa/2vfpc3KyNAMLBGh2hmJxgn+EH164prQT6zqghaRF43MGOAwB+7x6nn6Cu002yJhYKh8tFypUgck/KQPXg/wA+1StCqkuhL5BSCOKIwxKu1jsHB4xn69ePSraQAmMqq+VgEbl2sEznj0z/AFqXY0cc07FgpKPGAc5JO0hT3wPzzmrkEIlUJIigscso+VlI6bj6YGetO1zPmsiujtGkcPyxBECSNIgJIY8K3bp8oAqvrOjx6nbP5olS72JIzbh5ihTtYg9DkYOPwrQDgSeXMd291QB03I7FumB3wcZ7HFNvJ9wwWgW4cuqrGDlk/iRW7NwMiqS7kpu90eV6xZ3mkSmK5jVkLbVmXLRSZzgqex9Qax5Lq9O4QDIHykngD8q9gstPie3EI3z210jOVufmdc9F2jqCe5zgisLUPC2ngHypWgniCBEnPyzE9dvb1xzTUTf262Z5mtr4hvpMwXFvESflJbBz2460XHgnxll0a/JnOD8kpjHTt23c/Xiu/m8P3EMrK8QYb9rBBlgevT73brVy1s75VBQXbKoLIvDqnXJGfvD/AOvQkh899mjxi78PeNrZHaO41J1A25jbIx/TtWedR8cQsUe8vGIPWSAZ/lX0DDM6xwKRJCCmX8zjJz1z6ZxVoasrKrSWkdwSM75YwxP401p1FJ33ifOnifxW+rTfYNLkbYT88g449q7Lwx+7trccqGAwfeuI0jQfsECzTKA5HPtXa6DH5mlIOd6nK/StuVKJwKrKc22b90Z/mljJJDYOOn41jy20N67yFDv5zk961rMspfIYg8EZ61SkdfMf7JE5bkZPQ1FimxIoRJKJod0jhNuG6JjrT541CeXMzgEjJ35LZ9MdBRDezoDH5CxLyWdxwDVQGechrZoHkclkkVsBO3SmQpamyssNnEiqyAD5SF5wD6n+lWnuAAZbj91CygGSQAEnsAvWseLR2Ch55BLO3zc8hWFSaaVkmjvXj81z8sEbc5A/i9M+9JlJXLgit0ujO9sYXeLfvb+MH5cY7461qrOIXm+zv5iyZhUY4KAYXj9fasF/MvN07yhkt8wpJjhSR/Kr+muJIUkJWNyiwxqT/wAs8ZYn/aNK/RDS6s07BnFos24LtUscnIPynrWfoDsmst56Mi3UG+EKu3DHA3H145IqfUY3k0u5t7JCInfyyW/izzj8hjPvT72VjqulShiFto2DFeu0gBRz6HiktynqjN1qSSy1K63mYiKYTFkXdmFsCUfhnit4xKl48dlIwE8sZi2dCEHGVPSsmbZLd317IWdprh4T6BcDGD6ZHP1qxpsxmu7gJLJJErhIZckOw6NjP5Z9BStcNjoUuw1wsrKWa8kldmAGDgclemBnAqUkpJHHIv7yIOsgB6jHb396zr8bL+0ij+WSJXZPL4HzYUZ/nVzymtVinwP9GYKA7ZzHnr/+ukwS6kMlwHs08sE4+bkZJODx9OvNMsXPkTOxg3uGCjqduOR9M8gjmp5IipkC7GiLZQDggnkrj8yKzwGtZ2CwB03Bt7DPA6j8Pao2ep00mmrHQ2t/AX2us0s7kMJZvp7d6h1Bt0cksgOYpI2kByS+XGCMdxUkbJcYOGCPk78YCnsPYGotZjxYTYZ0YR7lZBySpBwfxxTZMmkLq8ZtL6yuGDea25YwgH7xmQjg9jxk9qeuy0t4mb55goSKKHOM9dqZ6ZOSSemTVBnu7gNci3LmNhLaKkhXaAfmyrf3+R+VW4pJtQ+zXCGO1xHujMZ+fy275PAJAA6Z60zHUgt7UwTCaREnJbcY0PyIOu1VPoeSe5FEYivroNDJvtzIZmlAHzFRgKQeQM57fw0/Wi1jpkptofKVRgLnoTwMevJqn4faS3humLlJVZYwXXGVVRhWHcnJ61PWxrGN43N8WrzWskcPnAkZEoy5GD0A6nHJzxjvUKRxW8fkRwFmQZSRZAd4PUuepJ9T0NXrQEaa10Hkh09FJeUDOSW6AZ5bjnHrTWSOeOOVXWNmUF2XlfYkdOnWqaM7nOaosn2ppA4kWdcy27AqLgqOpPUHscdQOc1MJDcuDZ2kssLR7POeRY1I74B6DOQPoKsXunjUJoxLevFbo+Ssa5E390A+3U/hSvEWJeGc7QuXEa8AjuAeMnvUI0uraFPTYJ2nZr+OIJtAWND9xs8nPf8ADGa0yI2jGFLYzj94dyp3HpmoEiv1UPJJbJECPMjtAQ0mcEDJ4A/WrxKzCRJzIqnG07Su4/7XrVCk3e5TkAkQF5GjYoWDsMgr2OBVbyW2yPOrTHu5IwFx3Xt/Sr4U7ZcrIVDBPlQ4z7H6UjkqjtDKg8ofLvQPvGcZPp1PNLcadimyF7XK+aqsvyhEHzYODyfp2p8ltDC37oqgIwqNKSTjnAx6c8VOEWWVIkiADH/V5wenY9ADnIzTIgwY5j2sxDEmPt03ZB/zigtSLMbxqqQtsihdwzKBuHQgFTnp61ZVbok+VbgDlXaN1dXA/iOcjHToaggeOOJgsiqkR2pLsOFB6qwI4GelU5WEibvL2rjI2wsM454ZiAR+FK5G5VvbydVIDPFuJwqY2jHXAUd65fVrssvBkklY/dx3Pt6Vu30iEZTAZuMwk/N7Z6Yx+dU9O0/7VqG6YMV5JAOMBecZ7Z6fjS3NE0kXfD2kGzs3kkMS3bjmYD/vpQp79j2yDXSWyIJod68gEgZ+RlIwAfcjvikgaPzCYpBHP5YlXywX65XIA4GDkD3yapyXDy2nnQW5SSRSXWT76IxCkE9jwcfWr2MLtvU0WZI2jDxqIwRJg5IBDevQDA3ZFU3nmtLyaXyl/fRq8iZ+4oYhnGPYg468VNr80bhIICS8l0rLGvyghWwQoP8ADhWzmoLmQ3azGIKqkMgYnO5ANwbHbkAfgKb0BarUkiubeSZIi29ZMcxHgDcQpPqCe/bj0qGwkN1bW8KxLHJIJplnfhopN23zB65PPoMVgNOYJ45rts211bli3GIZMiUMuOqHJyOx9jU1tFsS5e4Ej/Yn2RKGJJEbEttcdmDng+3pTQMhm8QzWWkSpdK6MYJpkkKMX3r8ssRA6Yb5gRwAfSumkzcW5WGZsmJSocrtkYgEA5BX2z9civP/ABJNbLrOkFzNJDczNvZz8u14DiVsHkAgZz9cVetNekNtbXbs8JGS6xKBsjVdrZHfnnPo1Un3Jb7Gk2p3thJG2yK4NrKgjRZxFLFlSzqjMAD8ucqxx0weRSW3imzm0JNQEvmMpytu0TmZJScpHtB4JU49DnPY1zi6ysMeoz3IEjNBtESzfKPMXJduoycouBzhfSubtru8srew1KaUo0MyLhxnzVY7UQgcnIAPPThu1Um9iW03c9WF1bA291OS80zr5EbEuFTGQoYffOMcds+1QRbryFJY417hicdckn06Zx+FcIuqT3Gj6FZW7RWmLNF84El4Fc+WRIw4EmFcDGMH6VqR6tp8Ms8c07pEjKsAMhb90EULg457803yt2L52ldHH6ogMJAHT8K0dAeOTTPlHzL2NRamr7T8oOO9Z3h+byLqaN2KjOcZ7Vd9DljpI2zdLbswmQFGI5DdKuS31sqeW1uyjqMDIxWReMZMAAEMeCRyT2qO1a+tbgeaE8ot82RnFSaSRZuNYgaPZGkqEYO9lzmotNhjhmknhjm2SDMgK5B/D3rTvLTzLQSYQ7upC9vWqtnIYCjIwRM7H2gnI9TS6jjG6NiIIwVrZXjWQEqq5OCBzWSEns1d1lIVvlXHy7U7iti680WvMTWqk8Sq+MN2wPesKS0u2lXzp5Rbv95n9c8D2FJj1W5Y0WNL4yKit9gDb22jAJHue1bpia21Jc7ZBIuY4yvQkYDew71QtSlkI44bjzXVSGVeVAHWop7q6utTvYIpfIViqmcsMxoFz8o9STU2sO9zoPN8lzAjLPO2A5A4j9/YUyWB5rp7SFlJQBpty7l5GRgepqO1uLeytVjsYZ3VmUtKy4BPrk8n6Va0OdZLG5v5AsbSO5xjnAO1TjvwKYvMo2WYYJre9cvIW2wyNwAv9046H+dN09PserWomTZDtdMdlYdMjtnnn3rUtytzdNcBQAV5B6bh0+tWYTD9tup2jMoQLH5QP3/lJBP4mp8zS6K0rBtYs22lzy9xgYAbcu1R7AYrV1KNQiQTM+y8PluV67P4lx+QrOVPLgeeRAwMRTyxwWLNn9CB+VLbzMNSVpm82FI1jDDgb2PX36cnvSBos6XFJMT567psPHsx0AHXjv0/I1JZobx5bhCGSIbV28bz/GfoD0pzSn7XJGqBWyrSOrEAj+6Mc5PJ9ga0ERYIk8mLanRGQ/d9AakV7Fe1QxSsVQOhQjcOMEtnn8KtlgkxnUAOF2sfToPp0qnJth1CFpztScMmFONki4P5HmlmhhlukW7MtyhZWjgkfEbZ7gDGfXnpRqDdylazNcmdIcpGzsFdcEZBxlfb5SfrVvZlpUCpG0blhsI3cnOQPQnOaSxdEtIGJURlGYsBkxfMcj69cVC9klzcRmeOMtDGQrtCu52P8JPpjHX1pMZHrDpcW0scDb5JQyxR25DsWxkHHYEjqelVRFcNBI7tFJLdsHYICPLO0ZXHcrjGT1rZjht7ZQyhUiUlG2KEK5Gcce/ep0sBLOZoxK8udu0kbWjxnr/e9adrmkZJHP27SzgRSKojJIJ5+ZQc8en1FdJ9pM6GBFXZyFUZAVB1qkkYF0kMayGTb5rLsydp4C/Unn6AmmWwX7c8aSMwUsX5yI1/hHHUscn8BS2CbUtjRiVpLUuzEMDu2GM4I/oeOKp5hlfZDFLtJxJtHyxkc4HqT3Hap1SeZs73jX0Ubcg543dun0oCpDDGhPluORJ02557daQolvMeyMsyO/ymMgbm55w3b8+RUALGSVSxiiDmNR1JIAyV9vamPE7TbiZEGRnPfHf/AApllJLHbK7h4yCziVG5QsTk478U+YTQ9N3nxxiWVTKoRWkUqM/7SjrmoWUM6SMgaZ8NtC9ccEYBwBU6ySmPzS6sr4di3O0KehHX3GKroxhulKu3yEvycZGc8HuPrSbGhkJluZj9mjYwgvHGFOGIU9R2wOg79akt3mREd45onJ8sMGGwZPfP8xUFufIghBlwUfauVY5U5PmAjjqcEVpIWCxeT5uUJUbGByeqnJ9KXmDYxGDwhUKPIHLOFDnrycEdh61VufMnuPmLMzodu5PnYdc+3GPmx/Orkomu9nmCZ5ySP3rBY0ORk8Yz/L2qnNI7iOFdqo2BkN87ZPOWIyoOKTGkZLWrSs6uz7SR8p69eT7Vp2MJsI4F2gXkkisAThSmcBWPoeTjvio/LewwkyyW+7c3GDwO/wBB/SotTuv7OSzc5muYpIpHBUkrkEZyODhW4B78VUF3Cbb0RPqjXAub2GCXypXRYHIHzSDJUlT0C7ieeoGMDvUk8NvDprRRKT5qeSz9AxVhjgn7vBx3qqJGXUmtlmJ2HILZIwiFmOD3II/WqusXaG5Kt88UdxBGXTjznblV46AHOfpV2M720Ltpd/bNWn1Iq5aztpHjG7Kszdj/AMB7dsio7i9ijVURBK6rKqxnh2BjA2+h+Ynr6VWT/iXaeIJpFbzGZJ5guRvBBJx1PIxn0xWAdT+zXlusbebcSGaLkBzGSW3Mc8Zy4AzxQ9B6GhZyQXdnp5mObOztfIlkxlcyR5KsPZPl/H1qjoF7NZWn2Eo7X1s75Vjw5wCV3YyfYdRz1qjZxzPoItLZo4LYW0YKs2VkKqRkn0IXH4ml1TfcalPeqh/0hUcRZzkjA2nGDgjAJHNF7ahuZWoS+R4kWFv9JjickcBVKyLjqODyApx7+tZ9zeyQ6ZcfZniCWcaoq+YVKGUMpjz7bkYZ7cVLcQCa0RJpGW5zCYpSNu5VAJTjpgAN78+tc8bltT1C8mM6SW7RsIfIj+TPzKHUdTxzjqMegprsZTfQsuYzHFbW5yDKHbIyZY1O0SZ/h+Y8g5zjArbvohe30OlO8cix27o9yqZJlQHac+o5/wC+a5qBrr/QdzQpK0yeWYdqiBBljtHoHA/OrOnXbQXFw0m2WOeQXUYxuZMsVcAnpuycqcjkVorGSlqXNGujbabe3N6EW6S4dJkAwQyoEj4HUEtnPvUV1bWssxF/Ldx3EYEZ8liAcdCR69vwFUtrW2n2nn26nTIpPNQTMTJOrtySR97auFVs9varukPZxwTNqt5HFNJM7IJAZGKZwuT68Y/ClYFVsjTvn3QsGYqPWs0KvmpLyeMEitW7Vm3nGVxgCsqGJ3iGCoy3HtVpg1qaiXCsFiZQGXoeuRVmQxtKhdjyOc9Kpuv7kNIyhoyMGkeaeQNFAmAeS2BzRYq9jYt5ZYbRVtcTwjkh+3tWQyy24Z7iZ9rE5jTg4PpTrCSeHfG10IUYfMGUnn2pbZ0O6Tcbhc7G2jH4UMqD6Fu1uRceWssci7PuSPLu3enHQGtRJlbalzI8almUlQCST0z7Vkm1EQl+y28Uls5IaFmPB7YNWo5wGYbJ7VQo3qI96g/WpuypWL1nbxoxMYl6FGGQCwIp2gadaWgZ4I1aR5DueRTkY4Az36UPcO6ObW4AkK/6wrnv2z0NBunmjIcszMOWUbQrUNCWpuP5tyDK8KRoh2mNWwFPqPrVT7PH9kWGQBYYSXyh5demD61LazC5VUnR94GJAG7D1+opYlJ2xoE2RvmMDnGfWo3HtoWVlSKxVCB5nEUSInAHXr7Cm2nyX1wqYMfmAjJ/gwOT6HNO8vcIWmbMYPXIX5zwCfpS6ZELTf8AaWMis7MTjG1sc/ypX1KVrEzgPftGwbEeD7CQ9M+2KjssTXl5NA+LeOYrC5HG/bjOPTPFU7aS5muLh8MxDknPG89yPZRW1HF5MCraANGxwFYclj2x70hoZAoEcMQ+VmkXO7jpyxPrk8Z961Xl8uKSQjcrjaTx97sD+PGfSslCsbyZ4R2Eau5yQqjLDHU88U+VZpbhWUr5jgiNCPujs596Lia1IdT+0HT5TFCjXUUschQOWDMCOOnQgkde9X7dCXDyljICGQsf9WDyAB29KahTyWtmkZ7lVDeb94hieN3tx09KeXS405blysIkYo4b5cOOCv59KGhJjIo98ccVupdZJCmzI3MhJb65HT3qSC7Ny9xKqh1DMrbjgbgcbR/iO/FY+nySX8rzREw2v+rSYjDEg/My9xnp68VpQFYnaC3jybdiXK8jBJKrnucc/wA+tCY5RsTTRoyiPYQpCvLg5JXqDg9ef5ULqTpM6R7cbQoBXjfj5c/7PqaikmEsM5QKCjhFdf41z8w+tFtGXZ5JY9xcjY+R8wH3T+Io2ehcbNalgwCO2uZppZMsN8hBxuI7+3oPanRomnwpJKHhml+cEDox6IB9OM0jXM1w8ccFq+zcULykRoG7e5XHJ4qR4Ske+7dflDAFQGMfoQvfnpnqDSfkL1HGO/8AtEbRFC7xskkcykKSTuHToc856dfarcMZQJFLJiRBlvMG0gjk/QUwruYEJFGUXa+W3bR0+YfnUdrtkujLKyoJFCAYJIUcAe9Ml7EsBfzFZQhaQkDcwBG3oMnv0GazpG8lj8ypMcDyySwgBbr9c8Ad6fNdefePCkrOAwO7oAOgH55/IDvSwsIo5YS0ZBO6SRuWfshHpgnAFIaGTXSKjM6HzNyuAwI+gHrkVEN24g8luE56jbwDnoOTTdRkaMpscTXIk2osjsdqcAEnHb9elFpbzB0R2KRkE7lHVtp5LdT75+lQy1axYTOSocmcoqCNGKhwOACQeAMfX61P5Ekm+ItbzOQFaZi21ecnuPu8Z65qO0Q28SxRMFDkyMWXlPcnt9anjdlgVBIH80holZf3YHUjHViMZPakhPyGy24jOHA8sMQWbKqOOuPryMDtSxbS2WlCtKo+URjPTPORySB9AOcUu5o9yxkk7cvJnG4ngZI6HufYAUzUZobeGCQO8sO9l3KfmJCEfKfQ88+wppdRXMm5czXt1GHAWdYIwrJgAl5ASPQfL35OKW6nmaGe7eVCsu8/Z0HzNsX5eMeuPpWHJemKee8v5DDBGFSN1XcBHuk+ZieufmGPajTjeS3UEziAzyxu6KyuBFEFwpYA8kkjjtmtIq5MnYoavfl0WBHkeecqguUJygAwzfgcjnjmoI2uLixKspU2Ejalti+5KVZRGFP90KrcHnLAGmNj7bIbp3nmiBaRh+5RwBhUC9MlwWLHmnwwu9tMqNJsU7o3yU82UquQB/cPI9eAe1NEcxf8T3uNkcTRljO/kKIyxZy3AGOvBDAdOea56eSJAIIEMlzLE9tbySZwyAfPKT/f3liV79ecVPdXs+oW9rNGkZn3GEMsgyrFd0MSrnqUzuY54i96rG3RHtliuI2s0nkiLRtu80xjIVT6gk5I4GDSe4ostwXBisZbGK386aZDFBg5zExJDAdsDdkH0q1qtkLBdOS0i2Ps8gzTT58xyxVjux94llwOwFRaTZzy6hLeXFrMy/Ypr0rA3l4DbY1AHUAc4+vSpLwz3ljDEzK9rZ/LczhdwmmcBd688hc7cjqQaDdRtoct4slEsbWsIMEQu2GXbEixAN90deQvUdAR2NZBuZorVLzzU+0ShbyOcgYhZwVZAOuNu0YweTnvS+JreKG7urKKVpVjEso4H7kE/KvHUhQNw7FsdjWy0EYsbA2MW03UYEZj+YRCKVyN+4cllB545QdqpXsc8rLU5dEtr6/t4bePNlAEgSeX5TsA2MzY+6S7sQPRc1TnMsiG4MgN5ZRs10isBHBAoIJB/iZtvHo2PWtjR0muNPudQhgIjuriUQuhAJj4zIzHjAVXw3qeKdYRRQ6JrjwXnmw6fPGTNbw/LdXMmf3EZblkUA8kZI3txxVGL2LNwttJHqmnWChLKC8FsiljKVUIquRnrht3AwOuK56fwVdeLJWvbLVLW1t4iYUS4f5sff49gXx9QatTamNOnvoo/LSaC9mlK4wvnK0mwL3IwVODkdulY5it4IIFvJbVQVZovPbazLvbLY9C+8j2Iq0m9jKUrI9GvHBJVc4IPNV9OVG0qWQ/6xWIFWbtAiEHJ5rNik8uORCxUE5z7UkzqFjmMiqZShUZye9TNPbeXkSlZM9jis4RhHba24NyQeeKvNYW7xBIQUJ6Nng0yUXGa3k2bncDAySMkH1FY/2xobpoVUNAW+/gqf8A9da0aPEpW4kRXj+VlXv71FepHJHutP8AXoSVB5z+NDHF6lFpja3YMUlxMgcFwGJfBret7yRS32SG5kBfBMzgDB9jU+l/Z72wWQL5c+NsgyKicRwTASvNIAdoKnkfhS2K1bLFvDql7mORrWBQdrGNMvjOQea6CKyEEioQvnL/AKxW+Yt7n2IrI0yWLzy26XlQMHuPetqSVWaOfL5UBC2M5FS3pqV1si0eiOApDAhyw546GotMmS8sIblDgvlXBOCCCRUkkghQZBYseGPTPY/Sso3qafDciKyl2u+wiJgNznqBmo6l20Lplfyn+UGHorM3Af1PrSzX80tu6WYjnnb927MN20929CfQdKrJbyXio2oWh+bkRLJ8pPrn1xWsIDbunltFbg5VljG7Ixwc0Ce5LpFowCvlmIXdluvPXJ9as3UgkkV48hkZd+e3+yffuKqI8m2OCD/XuDjP/LPHc+o9KsMqtGEgd0eTjceuc5JPuKTemg0tShIGa7gEG5bdZXLTOcYdugA7dPve9bEEkdtCyqpfzWAiQctJJ/d+vr6DmqT4tbRljiLM5KyRtgK3vmq2kWcobztQkczHKlUHyxj0B757twT0pXsU1dGzYxEJOBt85mPmMpwoP1746VXQRQXj3AhuXd2xIjR4USLxkFumRjPY1ohCCFOfMC7SOik/1B7GoUjRiRsTaQQHx82c8g+9D0JRSAupZg6H7DBIuTsYM+7v833VGPTJ96tKqadCWRQLZAWCrkuHzwD65PWpnjdGIQqykEeXt68dD7+9Zd7cB3KKT5duRvfrmXoCPXaM5/2sUJjepburN1hXTf3Tsy+ZI6nnbnkqe24kj86mu43gRHdDFG5HVhux0GB9OP1qGaQW9lNcO6pcEI/PI252hfwyBUiXT3MTYUeSu4ucgHaB90+hNNpEqTLkMrgCFYgBjOxs5I7Y98ZqvKGmZ1tFSeCF0NypcZ3YyI8k9hyT7AVWjtbm6aFGmlhMm6WQxjGAcAAfhxVow29pZouwx2tvuJRQHJ4yVz357mnuF7A0qzXSrdtEobBSJN3J6jJ4yT6YxRcXSx291cSTiEKGmZGyWIBwFBGMMSMe+ak3ywabLJeTCBJc3DvIAuMrwA3ZQAPxrnozbahD9umV5oWkV4Y3BPkRoQeT3Y9SffFS1YaaLFjcx6fZXDy7ZbmRC94IDu8nI3HLdOOnuacJbgRmSUg3UjI0ECnCQ7gSM4GWIAySfwAqvcTS3c81q0aQwqFNwqgPOQTuVAAcK2F3ewxnrQC/2iJ2ZbO3t4jul3b3zIfl6fxEAAk5PNHkO5qWsIhgMYZpZ5RvlcfeYnox7ZyPwFTk5FyUCBUxICcrkEYJHsP51QFxuEgtLYpCoI3uSm7AySO+PU9c1ctkklvF81wZsfQR56J6c9fUVL8g9SWJXkYpEjSLMvmYc9WxlUBHrg1Zs7cTSs5ZJUYbnVG2hGIz97jC9uM+lMtsybpHYnC/vJD9wbTxgDqN3UVPO4UlmjyQqIW2ZLHG4qF6LwMZoikNt7IiuVDRSLK22VgVeOMDZEzDJY88kLXPa5LumtbVblvKjbPJ4UDAJHQY5rau70WyXUTbbd4H3zouSuQctj3yFX3zxXA+Ib2W5mEJ+V7hfLIZBkE7i0nPQZJUfTNOwm7LUZEbnXYrXzwqWUg/eyCPCoFUyF+cYUrsGT3bjrVprmNJ7i4hKRyiOSK0M+T96SMGUKOMc8Z5G3PSs95Lc6nbwNA0sFvbkSRklxhYyxcjI4VUUAHqSKWJk1HTb1nupPs0kVjczxsACEaV3SJCOhdQzMeoVcY5q0jnbKMTXF1bTSCH7VNKgNpbnPmMWPyezMzc9BtVa1bhoxE5trow6Xaq0ctwCGd0Vj5p2nnJZCoP93ae9ZesSsuqas0zmNreORpp1faA/AOAvQ7SAMdMms7UpLue4v8ASQ8OZiklwwTlZZD5igHttSPJHfApoTYzTHNxexrfI9u14FuTDGwykjHbHt56IqgFvQsAMnjVnQ3movNcPH/olu9uY40CwQNjcdn93IK4GcnPU1FFZFordYYis8tqRKSdxiWNSS+MYbHmrgZ61DerbyXwhtpDLahPKARCsrSiT5PNB6kfMBjqNtLyLjuXzqMqSX6RqDdzWS2xO3ldxye/ylhxirc721poVjptszebbshu2zlIlBDLGHHU5wMDOKlSweXVr6aeNyZWc+Vggxgr8hYDBwFIzjkE1T8SWi6Np8cISEMg81IYXxH5YxsYgjO4kn5fxPNJ3OrQxJ9PtpreCV3jeSVZTJM5JBjcsGO0c8E5Bz1x1rBnuTd6pYWJZ5ENk8lzCylTlZFwNwI5CKMepLDgmrur2xhee1u44rDbKIJHtW5XgtIn4ZC4H90nrS2N1bRT3UFqtrDbSN5xXkNJOFPkruPIOeUToDljkkU1ockrsz2F7dXE2iac8V3fvcpFNcK+POlZcCKMHG3aNgwflUbupo1G0toWh0m3YTaXZ5tROt0YmvLx+J7mIdWXjy1OCNoHrUttAyaAt/KLO5lmMkFpJMpiaMNiS5ueCO58tTxks3OBWb/aNvbLH/YNtf2TmIOkUW9xLGergNkRKSQBt5JIOcVqkr3M5XSsirePMurXLTQRiJFMUiqVVC5iKohdjkklQWCgnGema57UPDmt+I7pr3T4vtNqgEKSzSRrnaADt3EZAORkcZyO1aV9esLuX7UCJLYnh5Q7o7cEDqquSM8ZNZfiG9ga/XfDNPMsSLKsaKywsFwYwTkHHtxkn3q4swcXc9c1DLxBz8oHA71mqqXCt64wRW9rMAiYxZ6nNc4S1u24DPOOKzvodj0Y20U29wI0G4ngd8VclN1ZqskEalS2Co5xVGWQNJ50CES919als7pZbRYmL+aeR35q1sZyeuhYnMi3fJ3o685XGDS28yWdwFuIHlRx8oDZxUsN99sZrZowJCmDnjBHpVS8trhQFmHMZyrfTtU+gJ33Ni1AWbdbRyxKy+nBq5BdqjN5ixyucbdv+etZFsZWASM+XvH8Z+X861bJ2BUtHEF+6XQ5GfWnbQ0TRcSVQ6vGojYEghl2kg/4GtK4DSuZDL5LIRjbnB+v1qpdPEslvFMSrP8Adftn0P1FKl5El3sLBsDYy56L71EvMuKvsXR9peIowDYb5STgg+lWpczrDNMqBzlcB8lG6ZP19aq311FaBVcSOk52hkUtg9jWQ+uS+cqtDsdzseONSzn+g/Gp8izobeR4Y1jB+64CgnID9j9DWh5ilAWRNpZhkDJz3A/GuWtbuZd0dvYTqCSHacgHHYVrw3clpNvVRuX5syDJJHBHpQloTI1lEmIphguoBDAffXvxRIxleTJQiRg3mKeFA6Y+lZCXwlijEQfGN4Mx2hX9ODzTopFEitcs3l4+aNFO1T6gf40mCNUu8kpQq5iDEiQDAYjjj+tXWBjeXbtC/dz1VlPcZ6YrOm1DyWRX+6qZGTlcemavtL5ckYw7SKMqMZ3KR1I9KW4aonimIcxSbmYEFVHII9Aew709wJi5IzgbW7cjofrUF35UVpyFMMvygKfmVu6+2e1SQP8AuknjLpMCrfd4HYUPzGu6J3ZQEj2lgxASQDnpzn2/wrDu7yMXtpZgmCRQ+6KSMP5gHG9COo9fTvWlJKfM8uKE/M42k/3/AEA9zmsELcXC3NzdW0Aj3CO3+0ShcL/HuI6DPT2FNCZDrVxLInkoZFQbJI5igVYGDAlSBwWYAlevQj0zYn1NLK3aBYw0SYY9mkJJw3PUnuPyrm9ZeWWxyubm2ZysgeRm8pFOArM2A+TyB1AAOe1ZelQRFGinSJYZDt82cMJPUN1+b0xSKiu53Y1uAorWlxM87bo3l2sEjJxjr3649x6VLBetrd5tl3ppwuD8xf5pNoG1MDjaMbmJ68CsLVbm0sfB/lwMIbhmDz/u+jKTtOe2CQe/AzVvw7qlpZ2luysrO8J2LxlGI3FmBOAu4rz1PbNX5EyStc0PEV89zqEdgMGV1EfkA8SyZyFz02/dz7BqebDz7aYXl8Et4nAMMMeyMunLM+DliT0BOBnpWPplub4WcAuDFbRyPcSAH947EAEsw+6H7Y5wK1PEV6ljpjWMYW2hlUr+4gaTZHt+d+O2DtAzkk57VD8wS2SEstkNu8aJ9ngRgkkjp87yN12jGWJ4UfTNTTn939kRTBJIoZ0jPyxbf4XPYn8+tZ1u15II5TZfYn24h2FndFzjGW4VuB0yQO9XbCG4dHEU/lwK2UUNtG7nJYgcknPzVLdy7W1ZbXlo4kPkmVAY1JySO7EdunA/HmrVko8t4woFlDNu3MckM2ARn16/nVayhjt7dREgZ5zvaVOOAOdzHkKCcirunGWKEx3LxmQSuSWGAVzuDAdyMgE/lU2FcsR4eWSJoFDcxiN2wrbemw9NvqT7cVDqpSPSy0sjfZ5ZB5nzfOiZAbCjryAM9gc9KmTJihlVo2gUOCWbduzyRjghf8KyPEF3JDpsrWDv9rWRIbeaMhl3tw7gHk4GenTFNDMHVb5S1ztlzaxyNI4gO9UdQQygn73OOemc9MVjzsX1BJbp1A8hMxbg5lIVpPnxyow6rjsSeuKua5EsBOnWyQx27QRIA7bURQHdtz+jCPluvJrEgRbHQbvVyZf3yCVbiNcTO0xAVUB6MeFXOSuVPrWiiYVZ9C7pl4EgBkV2vtQUXLQhd3lW5bZEu7oxYqo29+c4qaNE09rc3CiK6k1IXTlhlHgiCRMGA6kecce9V9P3Lr9y0kUU1olzHYAhtsYliRnbauMlYyHUHuQDnmqN3OZmsjqB8lZNFitZZVPIeVS7E9h8zIzHsEq47XMetiGRHiC2920QgWSWKWHbh53EhIDHuWfbu7bUxUf21tO1H7UJA0EbMt2wBdQXwQSBwQAoXjrzioPEVysXieSCWMCS3vJZZXByUJiTc+T05lwAeMc96R1MRtUIKiOMtIGIA83AI6dcDGB6mi1ilrqdF9qi0yxvreOWOOdFgSCQvl1BeMlsDjYWVMHvmtPRrKwubm9vruMu95Kr8vjAOSZFUD7wfDHP8JwBXFaVJb29hpsc8Pmi2SMCO6QHysgkRseygtkIc7X56HFami6hbWsEkU73BliIO1ZmVgDkYxnHp7YpLc1prqelaXqsEVg1lcW7zzODEZYZT86MMHKk8jtwehJ4NeZ+IZFF/wCSrIbe1QKkUBIBbcXwCeSckDceelVL/wAS3MSmG3xtJxuPJAHYH045PeuZu72c3O+MjzWYMZT6jpj6Ek/l6USfNY6FT5btdS7eMtzdW3G6eWGe5uFDbollMjFNmeg27dzHJJ/Kq2q3KJp3nQfPNakSQJgFiwO5nJ6BjgAHkgYwKLNedhjkK524PPA449uKTUL2FYjCpRdjgMQ3QdcfyqrJInkexT1jTbNb29hjhtHWVg0BEpQCJhvHmSdAoDcoAckEnHSq0225vQmp3N/qNxPIz3Fy0h8soVwMBhucgiMDIAAHT0stdiWSMF1JiRYwq85UdMnucUfJJd5RzhgAxJzjuefXJqlYh0TPFpHJDDbDkROZZHWID96VChVBHCIAfqxzTU0y42KLcTLGMgZCqTz1IA4roePLwp24HXqT9TUoiR1Byc45Jk2598Umrm1OlFI7vxLGGILBAegxXD6o4tdyHPmZ+X3r0PXLTzrJXGDIpyPeuM8QWy3drHMq4cDDAdqiLujnqKxnypue3l25Ujnb2NUXlNi4SQbhu4yfWrdqTJbbIsl4+SCfSquqsl5bbmwDGQ2B39q1Od6luGb/AE4sFPTIGec1JdX3kzbZi6q4wcDJBrH1CSFYHezUyblBWQk7kI6iorcG+jDPIVlbqpP9arQi7vc6SzZFt1VJyxJyd/Q1d04+XK0Uqxq3JVlb7/4VzP2CWAoqKGA6HdTkM1w628zb0DZGeGQ/Wpdi1JnfRyW0lqFlJaEAhs84z7VhJMWu3KQNOQdpEnAK/WlSe9gCl8OchMD+tW7q8utoFzZeWB95l6kHuKmSNqc7bmjYTyyFk8tbZI2DiKXMhYUkO+2uX+xsHMnOxVxz/vGoLS5W7CgoAV4b/aHqatWNhCIZmkMzOshK/PkbPYVNjSUkW2N1OhRo3jc8kB8nIqw1xfTbore23NbgbpJMbceoAHzGmIfMRV3uocgja3cd6uQRXMchE0nz5KkHnj1pAiTT7fH7x186U/MxZeCPUDtT3V7zY0TbwrbYXOcFe+fxp1ojrKU3DeVJUZwMjrUlvDDCqmBmMUg+ZN+ArjuKlpj2dxbm0MqMFG+6mISPHCg9S30wMmrmmOls8wLuWjUCSSQMoYfU8celVPNeS9KKVlSJcowB2qWPP48VNJE92xku2DxIwxEMkFvU+tKyWqBu+jLoP2q4+0BCbdSTGGXBK9C+PWore58uV7Qu0bLIxE8owHTqVA7/AMqsWUsjR4IGRlgz85+o7ZFU3K+cy28agTMRBkA5yOQPUelFwt0Gz3s1wqRww3ElmGKSxu/lGckYESkDIGOSRyeKzLrSZopkLMs1/I3y85SBRjLZOc4HA9TWyliJwHk8yQRPltxIIc/Kxz69qtSi1hl8tiY1fcokAyQMZ57/AI0biWhnw6dFDZIHVPJiXcrHuMenTPWuQux9nuGHlb4MqgZuWVm+6o9TXSpfyMFMm0MT+6IOWP8AdP04z9BVbzrMzwzzXChLeKS73ABmaXkBsDsAOM9zVLULuJw51CbUZT9gR8oJZF8sFzgMY1ZiQFUfe5q1p2iy2NjHcL5EgnhjKROpmRN4yRnIYPxxwVAJ6V2mjWJTw0ofKXEluuxXXHlDHyg/mWJ9Saq6Td26xTNGWYW4VlikbaI4jxnPuTgDrjkUrXFzl7w/cT2cM0MhswEH2m6mil8xmkYcLgqMNxn2GPWpGkhnu43kf9xEodoiN7NxxjjopJb6+uKvXMkEU5uLpY45nBn2BOxGOnXGBkZrAv5ptWaT7NIIbCFyUJU+bNjjJXooB6A8n0qX5jWuxf1LV44kiFuhuJ3lDIrMNyEjAL46/Qc+1V9OdIYc3lyPN8zcUCnHJPGOnHbNJZwWmlIs17IquVyJmPmSHJztQdz7D+laFvOxijCxMCQGKovbJ+XJx81O3Ue2hdtb57mHbYQcruy867ImUgLkA8yYyfl4qzYr5IghE3mXuCxlIyz9grseFGegHas60Ety0m5Y4YYzujjjbo3Ys/Y89B+Oa1Ey0TQs7eUoDDy8gxuTyT+IpPUXUp39wlvEXVszlOFjGAWYgH8c96yvFq/ZvDyTh40t7TYGmyVK/MFfHc4ySe5wa09deUWjSBw0WQm9XG4HIPI7f41R8UPHIyRtuu7u5ZY4LWQkqTgseOyAAFiOSBjvSiht9TjPGTPfaumgWnyXOoHdco4ES2tovO9v7odQWO45CsB1cCptadrmxhkhmmZoybyFJIQojnkYR27tHnAIAd1Xk4APGRWfam31K6vlDMLJmknuZ3JWS8IDNGH7gO4ZwvRQuT/CA66kuY7i1Mnlxwq66pKqfOpuJIxHbxk9jFCpfHrtJrW19DkkyfRkj/tMWWnoo+w2+1Gk+ZXOHLOx7ks4J9qwPEVyzaVZy3GydJftscak/IkccgUJxyQxOQp5OTzitDR7iaFtSntWdZrbS7gxbeSXnXZGnuSdvPbFc9fhbPR9TsohOtvDPFEGC5ZkhgAZj7lgTkcFsVfQS3JddaGCfU766uYgs1hbAM3y7pG+zpIWHY8c+3Sq76rHaHzbxmQwlpSJUKszlcRgg+vBA9Bk8Dneu7CCXUb5JoCUF0FijdQVAjjWNACcjJdDwf7pNTat4RupLi2E8cc80/7xfLcztnABMjnocDjPUD0pTeuh0UaXMtdDiLTXBHZz3d3M0kEcSLKq4LyM6YwvsSWf1Gym3D39vfXFvHbySOjKplUZE6kZVlP9wghh9a6KXQZY9qtAAI3OPlwMgYPPc9varNvEpghjlaXNqNkL7cqYyc7D3AVidvoCR6VCaOyFBp36HKpa6vNhvs6K3UGWUYH4VDdaVr80LRi7sY424IVG347jJr0a1WF3ijRZZ5Gj/eJIBGEbnlT3GAOv0qWKK2nhV0jcqFZpGUYAI5OfTqPzqr2N3RT3PMP7O1YosdxJGNp5mRzvYdgfYfSr1t4ahkQEXUZbuO+a9Dm05Wy2F2Bd/wAo3Ac4HPaqp0mOWNSeC6lh8nUZ5OcU1VS3RzzwPNtNnCSeF5N7+SwkCjG7JGDVC6069slySwQdO4rvZdDlUGS2Zo/9wlc/0rIvrW+ZWjkkZwOoIGRT9pTe6MPqeIg7wlc5aPxbZWzLFeQGJ1HDoSw46nHrVv8A4TLSHJYz5J/vDBrM1TwfHdNvLzKwGcrjBJ9qzR4Ii7zyg+4Ap80e5Vq8dGkfSs8weCONcYPHpXI61ALZZYxlZM5GOldRFbIYyzE7hyAaxtWtt2xnOI2PD46HtWEGKokedozRSpKG2sX2yKPSpLh0tbiRQu5JR91h3qLXrE/bC0Mh3E54OPxq1aMt/bmKcAXCDnNbrY4paMorbnzC9t8kYXDLiokmNosYaHaQcB/UH1q8RLaSb5lLQEFSy8kH/OKSR7a5jkUuQy/MjHj8DVJktF/TZYLiF1O8ENncTwKgv0dZJWjOR6hcE+4qC2iaR/MiwHOCxTofpVu9cSiLcJFnXjJHDCk7WCNyaynSOFGu3eN+xB5ep7TVVdER3nMquWQlchl/Godu6KKZI2XGVJUZH1NQypLBGSAJIx8yhug9aGjRSNQzTzzbYSkQA+6E+YitC1tpLc7pnBBX5HOfyb3rOaSGWKBoreSN1ORIh4IPUVZecqsi7ppYJRyccfU+9RYu5o6dOzyLZxzJGYwQ7u2dvpz6Vavrm9n8uGC4eRQflDNhQR1AI/OuXMscMm51ZQFwGKAKf94f1retNRkkiC25hiduACoYbumc5pblKVifTzdLMr+fGCR9+KM4P4nrW5DKkTDcSHU7ZOS7/UD+GsKM3DKvm/ZVCYLEZOPpk4rV8+CFy0s1zIzAAjZhX44C460ti+a5sF5YwDFAYoWQNl25I74Aqw93F5CS7woPynediPnjr1zWbZ7ZtjmSI+XkxReZgReufVqdfXUDWcoMscBZgAWH3DkYIzzSZJdjuZJpTBCyAov7yZs7foB3NKXS1kMxleabeI1dl2hE67QOgHfNNtruBo1SzPmwBhufOee4zU9/NDBdQbnURvFJtjxuaTkDGBzn0pWKTLjNCiwRPksU2oepwef8msnXrlraNEDhx5ThoidxPoF+vTjsDVlRCIQwRlkAB25PzYPA2/0FUomSLVpLmV9806CKyjVSBGo+8wBHUk8n0pFIyr6zLafPLd3AEjEQQQgA4JwoAJ6DnrTpLe0U3mm2lskNqPNkmzwQipsRPxIY89fxqXVE1A2Estlbu6xOshuJF5BXkLgH24PQ1lWUFy9rf6lrKeVDO5vNowsW5gF5b1BG3HbrSQ2bs2oNeTWlrZFRp8FurXl4W+VflH7oY5JA5IHrismxgvdQvpJruZpAHilVIP3CbEGBkjlmx0wcdutWTCdW+wabp0P2fRwVeaXZtW4JUnag4IQYPLYzkY4rasZdPtjNLeXEe2HcDsHmeWicAKF744AqtzO1txt3AovUhjMey4AnnVSUGzPy7nb5m5PQn2pv26ztbDdPPboIAf30hUAsCckgZyc9B34rC+0veW81zqtvFF9pcO6lPNIBHyRhQDjjr1rOkuLSze0sJ4Nlsk2RGYXDMFHCOAB82SOc4OKWhVmbem3t1qU32mO0McoykctymwQo/ZE6lj3PHpmr0oSOT7Hc3LyyyrvkRm4TB+Uuq42j0Geaw5NTv7q7eCKGO1sIXPzQ5eR8n7m/oCOpVc/XNT22kwxxut2bVEfJkDEyMx9WZiVB/M0waNq2uIHcsZlmUDYsMBzFCV4GSOM8euB2q7NLPGYJlZSw2444IJ+6w7j3NM09PNiEnn5jiUgkptTGOu0e1Mu7jyIomDq003ESqOgHOWB7AdfQ8daiQ4otXcttcRSJLtZVAyMErn29MD9a5LxHfPbiUwyOqRxPa2wI/wBSxGbhwOu4jEY9ya2ypkNrH82xnEku5v3jsuSZCDwBwPl7cfSuC8X6kIxcjT1jWZIWDXjsWaNWOGCr/e+Yncegzj1poUhlzt0nwzqNkIF+1ItuzwiQH9/IEZoTj+JiBkdFUgckmsi+VpfE17aSkrbxyNdSzhMFSArSsX6kn5EGe3SpXT7LFaRFY7JVMc10wLSNthwWkIAJ37Wi465B9KZrYlgl1VbeKI3N1FLeyMp3CKIOfItw3TiMEt33HvitrdTjuX47uS3e1vHjktWupWugIiodIUUKkR7Akyb8HkKQeD0owWqTpptnJKVdQEmdudwR3Z8epwwGT6e1PmsTHe2Fg0xkgaFoybdhlgGaXzFJ+8cL97uCT0xWpY20j3Sx3kUbzbpZkWUYVC+SoHQnjafT1qW7GkI3Or8PQQah9qne3mkSV5JYht2w9eEdunzAluMnr0zXV2tlAUjjZra2td2wQwRZwc87e/zYyQPvdPWszQPLsbO2jjilMcrCRJDCSNwHQD7uOvT2rTmZrp4d05aeIAecwOMAbiVI6dhjjtUuVjqUehl3ejWV+JJA0qzAlpIwoBiwSRnt2yT6kDtWRL4ch2b4LrzHJLZzldqjLHI4zu+UAA+vNdE0VzGuI7RnZCSvmTBtu45YhehJPOKDGFeEzWsfkBg8fzFgf7zccDnoPXmpumbRbjszkNQ0C8tnjjuLeSHzo2mZHAG1VHJz/wACwPWsmAXJjMZNwZQoiaFZSCQDwAOhwQDivSYryzLS/aLa5muzIqRKYjKzAjqpztAHcHnqaqanpls6Qw3sTRyzNyhIGF3DB47bcnP96qa7Gsa7WkkcXZ3zKYxfyXMlos7qDwEMhO7Eueu4gnn8Kv6ekKweZqDSW7Jsh/djCRowysjckkDJJ7nAqxeaO0F2y27oxvbeVpVnIc7csVMi9AwyMMMEelV106aG/WMxGHzYTGrR7fMjkRA3zc/O2Sfl6kHvijXqX7SL2GxyRGCFJVcXOMgMMJKD0Kn0NUbm3U7m3BgAdrNj5sdQK0bO5uprO206ckrHbC6tomhyHVxjOOSQAeDnjFBt7mzvo7q9CIY7iKG52EOIlchDvxwON3y9e9O1ylNI5mSyHmkDA45x0ye1Z8tj8/O38a6i/hWz1iWziJuCjtG21c85ONuOvGMVlSRoXPysPpzSQ3Lm1O3SIbAMjGcdetZepQOLOaPcNvY+lXoZURwu0kMeKW7bdE0fllgeCetQjgkmeYarHyd+GYdsVko0bTAc7+2O1dnrlgsREioCFP6VyerabslS4VgkT8Y6EVvB3OSrG2qLelvFI7xysSByNx61V1O1WBmltxuQcHIqjbRwW9x5J1JfKY53sOUq7DdWkgubVLqO6kU5BzjNa8rOfmRVs7iSLZ9kOxs4IxwRWmNXkZjiLeyjDKRWPE63cZ8s+RKmeAe9RW08iTKQ4Ljru/lmgPQ6GG9AiM0T5cAllYcLTreW4mkZHcFGHAZvl/CueSdWuNyqG3n7hPGafc+chVVHk47Kcj6UMd9dDo7e2kt22sfMg+8gDH5WHatIvatCVeN8/wASx9xXPafqEscKZjR+x+baVPrVy4vJghVG8sj+JDuNQ1Y1TubdraxvCw87zVIA2g4fHY/hVSa0CSpa3EjrC3y78hcH39qo2t7uXeJwWHZ8DPrxVm5vHuilzaXSeYvyMRhj06kGk0WmdDY6ZPHAyRCbzQCyfP8AK2Oo5qC2MckseY5pGdA6MSSyj0H0rI0+cyjbbyyzGPkHzfl+nNaAvppFjeMpEYzu4PIOeSAP5VMkWtDYhsdPuAfPVHJGQSu08deOvStOCxs4JY50kYY/vzFiDjHGe9ZR1ZJTlU3sc4YOu7d67TjAp1pqKxy/v7Z4w5yX8osVb2x2NKyQ3Jm2ltBcRAKCAxADunC+/uatrDDpdvFKT+/b51cjkgH5uRzWFca1tZEjUqGP35EYjj+6O9aOnXcc9mUnldyAVXHb6mpHrYtQ6iJLxjYW7K7EEPdY+Vh1wuat29vawOU82KS4dCS7Zd2H932x7Vl3WnfaZCDCBBIPMEG3hip5yf8ACprefZIv2G3CGLIMqv8AIB3X1akvMoiu5p5plwkohjdYEjj+ZriYAjPsoH9TVSTw7NqF5HcalPK0MBLpblgkAcH7+0feA7M3U9q05LxdOgCQxbpnI8pU6AehPp16c0ht1lVjM/mOF3eXuyq+5A/TPpSH1J20iG4867857madFy8xyGKg4wOmME+lYflxvAlrE5eNDwY0Ch4x1+Xgtjpzx9a1bzz7mzECs7RlhtKKD/4736cdvaqFzcm2muFtbdmuthcNMcu6nGSSMksP5cUnYLMlmSVyfKWMIyiTzQCegAwBgfN/LPFVp9F+1NHvdAkEbo6hNzYOCGJOct9atXk80qMLmdrWFipjjs0O6bj+E8uuRyc4+tWIbSyjjVYwFVCSYEY5Ix/FznPuarUV7GRbaPDZKkFlNcSxElFM025MdcBTyTnsMD3rTFmIrYTMwlCsWXEY2Qk9ggIUH3qwqxx7mjjjyclmd9pBHuee1JJcwxyybbmDe5HyA73APYDvn0OKPIPMrJNcNcbN6eXnfJiLkjI9+Rnn8KlS48yV4kkZ5ZHbzpJn++o/hPoAO/4VVvyRJMqY+2DKgByojA9jyAOfrUVksTzLCLgxxzLmWdFyzIOAiDHOc8+2SetTZ7F3RoXk+6SBoxGtsiO8cgYDfnCkgdl54B64zXBaza29xqbXmpo4ViZZVcfMsKAkA9M5Ud+7V0etrMdSa2tEntQVEL5hZQS2SFV2GN5AJJHQVyurLDA1tCjjcW8u5dVO3ah3FQSSwC7ck+i+9Wl3MZuy0FMqrbyJdqj3zRG4ckmPyg7Fwgfs5aRCSM4VR7VmaVbGfVL+WeztvkG5bKMkom/MKIemCqEHrkncT7zwmGXR2kmF8DqjM9xMYECwxHMqx5ZyIwUYfMRkqMYBxT4YoGgkSBJHBQnz5ZQEYEAxsqqQWDJl+SML8x9K0OUXwvDHdaxJf3KRyWtpGXdV+XbhTHFGAeAMBQB3GTW9anzpXnneGSSNxmMudzyseQo69R0OOKrW5itbUW1yyMkTR3G1VMQRjyjBRySewPPOeK0tLkWTX7IzPEscsbm6jZAyZ3bnO3rjHPJzk1m+x204acx1lhp91Gq/Z7qaKPb5QJJzhuT8n8IwSc1Zjuo18sQXCGNIztBQ7VO7blv73T8zWXBdCaxiSHz2PnuXfdtItzkKn1IP1Har+xIlEgZoxFhQ3VUC4I+h/TpUehtJPqOkngPmJkyIFbCqhdt4Gcs3b6VSFy7vshbCkDzgTs2tj7oUcH3JrRE20nMMpQkvgP5ed33Sc8HHUiuf1VWmXG/bJ1dguCx/xHYnqKTLpJN6kx8R2MlsbR4AlxGpWSTyjteTghc9uO2PxqlaX4aRntoIYo8EKUQrj3Ckn8qxrr7Q6ZdYMwoyCQMQxBHPHTJz15NPsbcIkKrIzEHPyg4bj9fX8KlOXU65QhGOhrzASybywiEmC0UYxGMAY5POcjNRsLmaeAXFxK0UJ85QRks3TPGM4HT0xSRzrl3lkVsKSAxP6e3tUocEDzA+4fMRu4/z7VSOVuxAWBvJLpVaRVjlghKjb5e5FjQ/htyMd6br4uAl3b6u8x1CX77NJv8Al2AJkDguOfn684qvd3LIxOxZSgOQ2drfiP6VQSYPg3DyTEAKSSRgY4474quZ2sUrbmpLqV1ealHOYQlzJbxyyHdkhwoU4OPlztU4yfrzSWduk0l25khjJnYkXSlHyQCcheB1rJvNQSVwFxtXgbjnyxxgjHf3qjd3lr57iZ2aQHBPmcn6+9VfuK69DvBHtjQ8MM9T1FWcN5bhuFI7/wCFQoSpYEAq3PXvTN0rMRwEPoKkwkyleojqQ6D5uPpXCeIdPMChJc4QgqB0xXpUqosZLAHHX2rmfElsl9AAflZehFVF2MJq55/dWVrKhljRd3UqetRah4fsp7YyQ7opwNwZTj+VWJ7CaQG3XAbPDj0rOddQ0+4wJRLH93DdPzrWNjnkn1M+1jnQhYx5ikYP+NQW081nfSRSIZFY5IY9BWtas0Msyy7YwfmDiotRKXIDrtVk4JXv9a08zFbhEqukj+WVQ/cY9VNSxTOLWRwAZQOcGobd7qOPABliHUCo/JVpXbzirE/d7j/61FuwX7mjGPtiycb5QAVA+U//AF6u2NxPFDtVY4UcZypyzf7OKxJL3UI32NCpRPuMB8yj2PcexqvJqLJcK6MsgznJ+Ugd8ehosUnpqdTaxaXDPHPq9nLcxkNuihkCSNxxlu3NRLodtcHc8KrvHyFnzj06dapaTrtjcFoJLcRqXAMsgO4575qfUkhS4aO1ju/vfK4UlSf9k0OOg4zVy5/wj5sGViIlj6kMTjP51rWMsvDRLAqoPlYLtyO/FZlvqkio9s1u06MRtkcAN+R9K0ra8gMaq0Fw74yQcYX8B2qbPoXzI0raeyVC88W+XOCDHuzx1B9K1bTVoZgIIRJGSPXCgjp2rK0qQKwMgeI87Dnqp/wrWhMUhETJgZzuUYGaizRpdPc1Ps+4yLOyuGO7BXgEdvep7eW3jQcIrAenXHoO31qoCXXHmE4GQAOCenA9ar28uHG5UaIviJNoLMR/ET6Z9ahmkdjVXUJ5SDChgt2J2/8APQg9cHsf6Uktv/Z+ns1qPLMWNkBJO8HsSetKCwt5AuftDIQC5DbT+PFZUv8AaLvFcNeSKqfJkqoUeoPH5HtUspI04l8w4i2m7IONxK/KfvZHY9qkguILFXXezzsGyFTlwem4D7gHPvWUs1pcMonaZ4wwLGRjsc/7LDqPfitS3vNOgHlxHeFX7kILyA56nA6e9Hmhshubm5aLyk84I47bY0U4PqMn8Kz5La+fY63V1HIhAXbIUj9OcgEj2rqHkM8cYjP2hWO/YUA2MByTnr0pJ5dylrjKvwrCbksOxA9v1qWUmuxzVjp9ja/aVuIbpihZGDyuzqccD5T09OxFXkUW8OUS0t7dUG4iM5H91hj7x9uasarFDIJZIi8N2MFZIORs/wBw8FPrxmuVM1/A0V3NNuW3YOsjyrHCxPAKR7STj2496a8xM0f7XllMgvbrZEpPyEhGdQobcSORkEDHXPGaZFeQIf3rsZ2IVYwpCKeqr8vVsev51zVncar9tup7mUrcXKq/mPArDchyiAAAhMZwDkknJ5pga8CfaPtQgIRlWWO0MbDnczOW68dzjrTE7pbHV6lqNkrzW6LF9ojfypIVkPkqu3cenLZ6kL07nBqtda1eyzrDHex2lum1meNFjGw8DoVBGe3JGOa4/S7iJ7tLu+iW8eSMIvkKrRJ8x48w+vBO0c7fvHArcvdWRYcaTaW3mIyiK5gRFkROrKWYEgE/jj3ptW2M+ZvfckZL9oLm5uXNnYMjIjahJ5PmLuG4KHyWJ44A5HArPv0t5L4afbub+5uJDYtAkZtoychjEGb5towN5wMnIzxUthuknTUNQuo7eZV83zvLaWfAG0FN2WeRjwgPYbugrN+y/abm8i/d2kBj23Uys0y2lqD88aMPvOc4eQZLO5C9zTRnLXQdptwfEHiv7BM4kae0lMbR5EZfgtIAeFIBCq7e5GM4rRe3sY9O8uSGCdFAZUiICM/mqcAcFowqKue65HRqb4Yms2W91O5hltdNmnSINKm0yRDucfxOx2xoOFEbMScZOIt3LJuleL7PDJJ9vKBQ7RxkFIkUZ4ChQ2Oeo+lU9EZx1Z2Gh+de3kkm6J3mYh5HXIRs5MnHXrjH4VYuI4F1K1+0uht5FxCpQGRjuO5m9WZsdOAMdKytKkluWigt5J40eI+WN/kRlcfNyRySOgHvitrRzEPIkMiqsX2hxFnISJmX5hI3IUkEkn6AVnLU7oytqdPaqxZNqJtjYS5Ztqs+CMAe3HvTvtGFVHkB4JCMAOP7xUfkPTvVG3uBJbgW6lbfLBS3Hner89FPb27UrTlIwJpGlilYyEMwKh8chfTOBz7VLdi9yZppZ0V5ETMnTzM5VeevuetUZlfGSkYjlHyptOcdv5daR9St7S+DXKzyvJGTGuD9/PRsc9OcVFcXa3PJkSV2Clth3BvRQPXsT0PaloaK66EGoNJLFGsiRx26HK4QEt26jk/SiTatsqozJK5KkINo24xj8ana8a6ZmjUgopQgYJB/uqP5ntUEpRUbJ2KMAnPCjrgE9SfbpTFz6akbuxnV2j3HcTt65AwMfQCohqF07lokC28PEKu+CQOSST/KlkTzg6KWBB2ts6ewB6/Ws64RDG6lCScqFZsAE8d+aaJWqIvtEjoArDI5Y54BJyc+tRXKoxDNI3yqSwIwfYVG8wE1ykA+0QWsDTOWXbu24Xkd/mbA/Osp7iR7sedK5JkCOTy2MjJ/DIH4VaRlKoQ6gyBmEbBFVgHGM8nvmpNG0KW/s/tE0k0G5jsCdGX1/mPwpUkQW9490m/zoUG0EfLLE5DE/UAfnWrbapHY6PpcN3C9xN9n3F0lAABkcgY7YGB+FaqKWpyzrSfU7dpQqlcHng8dKIMjC5yo4OSadO3kfPgEDkiobiTdKhQY3DNc52PUl4dyU5QjBzWTqMZVCNudp6DnNajSCC2DKDhjgj8cVUuG3Fck8U7EXOI1SN7a5juYIj5WfmB7UahHbyAPCq+VIOQD0NdJeFDNLFJGrRsMAelcvfWohMhgOzb2PPatE9DCa1uc3qdhJGzPCp3pw6nvVRowNkkPydmAGRXXQyi8to5ioBX5SPWqFxp5hLSQuAjj7hFXcycTloHlgaV53CCU5XZ938fSqGo3M0d0s8L4dSMsBnI+lbsqjMaPyCSelUL+JllQLsAPTiqvYysQQ397eD/RFVmA5I4IP40gllubZo754Q65BCrg/nTo5HtjJgKe5xxTmgW9UbB5ZY59abYJWHGwt2ijdgz8ABo25H1FSNf3ttBiMNMY3+UA9V9/Smw2nlIdrkOD1FNbDP5UhZ16+lNMTVzatNTW9iQ25jSUHLbhjb/9etG2+xxgsLQtOBzILrI+uP6VxkdjBLeRhS8blsAqc1fjtnhbzZ7h3VDtJUcsKLXHc6y31t4rlEMUTRMdmfM3MCR6dBWta60pLxy2s3mAYEQwScdCK4K+vFLE2okQquSxOCcVt6ZqVy22QbGRmTDH5XUHtkVMkXCR2ianIsPmi3ljdnAQOQCSR6jpUulXIt5ngmIhd0I3yDhhnOMfjXOXKXovoY5LhWZGG1iM4LEjPvgCtWRisSzqE88fMWK534/vGs2jWLOgiuEfiwe4dEX/AFqkqm4HuD3pkrNDdmK9d2mLAqkZG1j2OKyILxmlkMpOSASo6c1pzzxR20ZUPmRthxgcjkEnms2mbxdi/IhcYYzuvAMIAUKfQ461oQzTSW5iVvLVVyqqMufw9K5uTWhbRK8/mSZBVgqgZ9Oa0LcXsoilBgMeNxTlSTj+8ByKRa8zVL42SNHlyAxbB+bHU4+npTby/h2fOp3bQCA/BbsST0+npXN3jXkAlktJ/skUBOfKJYn/AGQpOAOev6VCtpeXaw/bLtUtwQ/lQxjLf7zH71SPzOts43hM0U87o0qBZeCrE+4P8Pt0qhLZXGWUqjyR/K3mEA4z0UntWeLV0s1mS+vUUOpQ+ZuYdsZPQcdOlOuLbUZLaS7W+jlQHYTcw7nLf8BKjH4U2kJNjp7Xy/kkgZZUO0q5ywIP3smsXXbVNQF3BJLIiCw+VmIwGctznsASOT0qfWNZSDTkmuUMbb9v+jr97I/2j8vTtmue1PWphBYzpGkcC2xM0ed5kVXwqc4GDwTkHuOaaCT0uxulb7mxt4bWweWbysz7sxRgDj5sc7cg/MMZxUunwSvdkTOp06BFeWGxUDg5AwDw5PPBOT3NYxa4F/FbX95dzw3EiKIzKSofgYI4BT0yDjAA611djaNLLpULpEtnczsYIwxOwAMWZuhLkJjOe4AwBVLXVGbi72Zn3+ozapNbxWtvLa2UYMcHzruz/EzuOS5xz+QAUCqtytvHHLZGeCLT3aNLtATumCgnJZehLYXauCeeR1rp9JhhvrOVolCTSIUknZQWcHnaV6Y6j1I6muKsrj+0Y9SiuYY1WxVbuZIzhHhLCNI19CWPJPRc4ycYEtSZJJF2wmlnuHu7lSwZVW3SRtnEuEBIHCDacj0EagcdWKbez0eRgvmnALPCRlbcDbEMvzuKkMevXFV4Zli0nVLu+hWe5nvf3ioxRH2IgK+qr84UAdFBFbungtrVkLlle6uGZ5H8sFQynjapOBzgfQVb2RFOGrLOiZvYIUCkRkYDF3kOF6BSfu+uAAOtaNnHwFScCOKRQB5AIaZvu788nGRjt06mrMcc/mb5J2ZyyoAvyht394j1I5wKyteFzbtDaW8oQyyBZZQSH65YD69Ae1ZPudSXRGzHrU+rzidoVSQP9mVIPmEuwY3jI5LAFsGtGZyJoizMVDAO33So7jPr05/KsDT7ixtLGCyj+0xMVLQpAFRVwePm5Kn3HNb9jJ5MS2kqIzyRnyyo+WLvnnlie5JqN9WWl0QSW7ShVSEbkHmMEkywyex6jHGcVTnLmCYqSsk7bfNT7sajoFHUtjPPbNathG99JFFZ7AHI4m6s+CclgDwMHjHXFU7kRNKII0IBHO49XPXJ9OKW2pol3KaJFbREJIVYjGwKWPPQZHbqeKiZ9kIuNwVgFVFIBCN1zg9sH88Uy9Rksla1+QISeW7d+PxqzNBALKNZFZ5nAVDnCr749T3poT8yus8tukakv5KSLJsJAJHqD6nmsy6Z483E0hKcMWJxtPP5njFX45hbRuoijlZw8ZMuW2gjgr6Edqz4lhvtPV7iP5YBmRAciRvug+3Az9TVLUfLZXMm4uVFvqiWqKiXKQwnzfmYKr72Ye5bH4VBFapC6qwVXgClj1O8nPT2/nVPVEdvs7BvlbccD5c845x34p5Uw4Cli0sojB3kdsnJ/GrjJHNUhy3Kl7KkupPGWAiWV5tx42sx5X3rLnuxFKy3csUtxkl90edvPA/LFW9MZvtkpjwrB2XJ+bkD37U3UUtobgFo2laRRIWbg5PXp71qmcjgf//Z);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Note the double and \"giant lesions\" on the face of a patient with acquired immunodeficiency syndrome.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Goodheart, HP. Goodheart's Photoguide of Common Skin Disorders, 2nd ed, Lippincott Williams &amp; Wilkins 2003. Copyright &copy; 2003 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Molluscum in AIDS",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 305px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Confluent nodules of molluscum contagiosum are present on the eyelids in this patient with AIDS.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Henry Perry, MD. Photo from Gold DH, Weingeist TA. Color Atlas of the Eye in Systemic Disease. Baltimore: Lippincott Williams &amp; Wilkins, 2001. Copyright &copy; 2001.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f27_49_28441=[""].join("\n");
var outline_f27_49_28441=null;
var title_f27_49_28442="Cystic fibrosis: Clinical manifestations and diagnosis";
var content_f27_49_28442=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"0\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Cystic fibrosis: Clinical manifestations and diagnosis",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?27/49/28442/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?27/49/28442/contributors\">",
"     Julie P Katkin, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?27/49/28442/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?27/49/28442/contributors\">",
"     George B Mallory, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?27/49/28442/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?27/49/28442/contributors\">",
"     Alison G Hoppin, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?27/49/28442/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Mar 22, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cystic fibrosis (CF) is the most common fatal autosomal recessive disease among Caucasian populations, with a frequency of 1 in 2000 to 3000 live births. The usual presenting symptoms and signs include persistent pulmonary infection, pancreatic insufficiency, and elevated sweat chloride levels. However, many patients demonstrate mild or atypical symptoms, and clinicians should remain alert to the possibility of CF even when only a few of the usual features are present [",
"    <a class=\"abstract\" href=\"UTD.htm?27/49/28442/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    An overview of the clinical manifestations and diagnosis of CF will be presented here. The genetics, pathogenesis, and treatment of CF are reviewed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/11/39095?source=see_link\">",
"     \"Cystic fibrosis: Genetics and pathogenesis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/22/39274?source=see_link\">",
"     \"Cystic fibrosis: Overview of the treatment of lung disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/22/41322?source=see_link\">",
"     \"Cystic fibrosis: Antibiotic therapy for lung disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/15/19706?source=see_link\">",
"     \"Cystic fibrosis: Overview of gastrointestinal disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the United States, cystic fibrosis (CF) occurs in approximately 1:3000 Caucasians, 1:9200 Hispanics, 1:10,900 Native Americans, 1:15,000 African Americans, and 1:30,000 Asian Americans [",
"    <a class=\"abstract\" href=\"UTD.htm?27/49/28442/abstract/2\">",
"     2",
"    </a>",
"    ]. CF is increasingly recognized in nonwhite populations not only in regions familiar with CF but also in South and East Asia, Africa, and Latin America. Prevalence estimates are likely to rise with increasing use of newborn screening and increasing recognition of individuals with mild disease or disease limited to one organ system.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     DEFINITIONS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Classic CF",
"    </span>",
"    &nbsp;&mdash;&nbsp;The classic or typical form of cystic fibrosis (CF) is diagnosed if a patient demonstrates clinical disease in one or more organ systems (as described below) and has elevated sweat chloride (&ge;60",
"    <span class=\"nowrap\">",
"     mmol/L).",
"    </span>",
"    Most of these patients have disease manifestations in multiple organ systems (pancreas, upper and lower respiratory tract, and male reproductive tract). (See",
"    <a class=\"local\" href=\"#H7\">",
"     'Overview of clinical features'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Nonclassic CF",
"    </span>",
"    &nbsp;&mdash;&nbsp;About 2 percent of patients fulfill diagnostic criteria for CF but have a normal or intermediate sweat chloride result. In these patients, the diagnosis of CF depends upon DNA analysis (two copies of a disease-causing mutation in the cystic fibrosis transmembrane conductance regulator [CFTR] gene) or on measurement of nasal potential difference. This disease pattern has often been termed \"nonclassic\" CF [",
"    <a class=\"abstract\" href=\"UTD.htm?27/49/28442/abstract/3,4\">",
"     3,4",
"    </a>",
"    ]. However, current guidelines emphasize that there is a wide spectrum of severity in CF and that there is no clear distinction between \"classic\" and \"nonclassic\" types [",
"    <a class=\"abstract\" href=\"UTD.htm?27/49/28442/abstract/5\">",
"     5",
"    </a>",
"    ]. The estimated prevalence and disease manifestations of nonclassic CF may change in the future, as diagnostic methods for CFTR mutations and dysfunction become more sensitive and are more broadly applied.",
"   </p>",
"   <p>",
"    The term \"nonclassic\" has also been used to describe patients with clinical disease limited to only one organ system (eg, isolated obstructive azoospermia or chronic pancreatitis). However, this definition depends upon the stringency of the diagnostic methods used to determine clinical disease. Therefore, the sweat test-based definition of nonclassic disease can be applied more consistently and is preferred [",
"    <a class=\"abstract\" href=\"UTD.htm?27/49/28442/abstract/3,4\">",
"     3,4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Patients who are first diagnosed with CF as adults are more likely to have nonclassic features, with normal or intermediate sweat chloride results, milder lung disease,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    little or no gastrointestinal disease [",
"    <a class=\"abstract\" href=\"UTD.htm?27/49/28442/abstract/6\">",
"     6",
"    </a>",
"    ]. This group of patients also has a lower frequency of delta F508 mutations as compared to patients diagnosed with CF during childhood; they also have a higher frequency of unusual CFTR mutations, which are not included in the standard CF screening panel. (See",
"    <a class=\"local\" href=\"#H22\">",
"     'Molecular diagnosis'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     CFTR-related disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;A number of diseases can be influenced by the CFTR genotype but do not fit the criteria for diagnosing CF and depend upon non-CFTR genes and environmental exposures [",
"    <a class=\"abstract\" href=\"UTD.htm?27/49/28442/abstract/4\">",
"     4",
"    </a>",
"    ]. These illnesses include chronic rhinosinusitis, idiopathic bronchiectasis, chronic idiopathic pancreatitis, and allergic bronchopulmonary aspergillosis. The risk for allergic bronchopulmonary aspergillosis is increased among individuals in whom only one CFTR mutation is identified, and also among patients with CF itself. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/48/33545?source=see_link\">",
"     \"Allergic bronchopulmonary aspergillosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H49145351\">",
"    <span class=\"h2\">",
"     CFTR-related metabolic syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;CFTR-related metabolic syndrome (CRMS) is a term that describes infants and children with an equivocal diagnosis following newborn screening for CF. In particular, CRMS describes asymptomatic infants with positive newborn screening results and one of the following patterns [",
"    <a class=\"abstract\" href=\"UTD.htm?27/49/28442/abstract/7\">",
"     7",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Intermediate sweat chloride results (on two occasions) and fewer than two CF-causing mutations",
"     </li>",
"     <li>",
"      Normal sweat chloride results and two CFTR mutations, at least one of which is not clearly categorized as CF causing",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Because the natural history of infants with these characteristics is unpredictable, CRMS is a provisional diagnosis. Some may go on to develop a positive sweat test and clinical characteristics of CF (although the disease is often mild) [",
"    <a class=\"abstract\" href=\"UTD.htm?27/49/28442/abstract/8\">",
"     8",
"    </a>",
"    ]; others may develop symptoms of nonclassic CF including isolated male infertility, and others may remain entirely asymptomatic. Consensus statements for evaluation and management of infants with CRMS have been published in Europe and in the United States [",
"    <a class=\"abstract\" href=\"UTD.htm?27/49/28442/abstract/7,9\">",
"     7,9",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     OVERVIEW OF CLINICAL FEATURES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cystic fibrosis (CF) is caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) protein, a complex chloride channel and regulatory protein found in all exocrine tissues [",
"    <a class=\"abstract\" href=\"UTD.htm?27/49/28442/abstract/10-12\">",
"     10-12",
"    </a>",
"    ]. Deranged transport of chloride",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    other CFTR-affected ions, such as sodium and bicarbonate, leads to thick, viscous secretions in the lungs, pancreas, liver, intestine, and reproductive tract, and to increased salt content in sweat gland secretions [",
"    <a class=\"abstract\" href=\"UTD.htm?27/49/28442/abstract/1,11,13\">",
"     1,11,13",
"    </a>",
"    ]. The typical CF patient develops multisystem disease involving several or all of these organs (",
"    <a class=\"graphic graphic_table graphicRef76253 \" href=\"UTD.htm?5/7/5244\">",
"     table 1",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/11/39095?source=see_link\">",
"     \"Cystic fibrosis: Genetics and pathogenesis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    An overview of these clinical features is presented below, and details of the pathogenesis, diagnosis, and management are discussed in the linked topic reviews.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H59098960\">",
"    <span class=\"h2\">",
"     Presentation",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the past, most patients were diagnosed with CF after presenting with symptoms. Because of the expansion of newborn screening programs during the past decade, there has been a dramatic increase in the number of CF cases identified before presenting with symptoms. In 2001, less than 10 percent of CF cases were diagnosed on the basis of newborn screening programs [",
"    <a class=\"abstract\" href=\"UTD.htm?27/49/28442/abstract/14\">",
"     14",
"    </a>",
"    ]; by 2011, nearly 60 percent were diagnosed by newborn screening (",
"    <a class=\"graphic graphic_figure graphicRef68042 \" href=\"UTD.htm?26/28/27085\">",
"     figure 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?27/49/28442/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Symptomatic presentation in infants and children &ndash; Prior to the implementation of widespread newborn screening in the United States, infants and children were typically diagnosed with CF after presenting with one or more of the following symptoms [",
"      <a class=\"abstract\" href=\"UTD.htm?27/49/28442/abstract/16\">",
"       16",
"      </a>",
"      ]:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Meconium ileus &ndash; 20 percent of patients",
"     </li>",
"     <li>",
"      Respiratory symptoms &ndash; 45 percent of patients",
"     </li>",
"     <li>",
"      Failure to thrive &ndash; 28 percent of patients",
"      <br/>",
"      <br/>",
"      For infants presenting with meconium ileus, the median age of diagnosis was two weeks. For those presenting with other symptoms, the median age of diagnosis was 14.5 months (interquartile range, 4.2 to 65 months).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Prenatal presentation &ndash; Some cases of CF present with abnormal findings on routine prenatal ultrasonography, including hyperechogenic bowel. The risk of CF is highest if there is evidence of meconium peritonitis (scattered calcifications are seen throughout the fetal peritoneum), bowel dilatation, or absent gallbladder (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?35/20/36166?source=see_link\">",
"       \"Fetal echogenic bowel\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?31/44/32456?source=see_link\">",
"       \"Overview of echogenic masses and calcification in the fetal abdomen\"",
"      </a>",
"      ). If these findings are present on fetal ultrasonography, we suggest offering the parents prenatal CF carrier screening. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?21/62/22503?source=see_link\">",
"       \"Cystic fibrosis: Prenatal genetic screening\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Symptomatic presentation in adulthood &ndash; Patients presenting with CF later in life are more likely to have atypical symptoms [",
"      <a class=\"abstract\" href=\"UTD.htm?27/49/28442/abstract/17-19\">",
"       17-19",
"      </a>",
"      ]. One large retrospective cohort study of more than 1000 patients with CF found that 7 percent were diagnosed at age &ge;18 years [",
"      <a class=\"abstract\" href=\"UTD.htm?27/49/28442/abstract/18\">",
"       18",
"      </a>",
"      ]. Patients diagnosed in adulthood were more likely than children to present with gastrointestinal symptoms, diabetes mellitus, and infertility. In addition, adults presenting with CF were more likely than children to have unusual genetic mutations, normal pancreatic function, and equivocal results on sweat chloride tests.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Respiratory tract involvement",
"    </span>",
"    &nbsp;&mdash;&nbsp;Typical respiratory manifestations of CF include a persistent, productive cough, hyperinflation of the lung fields on chest radiograph, and pulmonary function tests that are consistent with obstructive airway disease. The onset of clinical symptoms varies widely, due to differences in CFTR genotype and other individual factors, but pulmonary function abnormalities often are detectable even in the absence of symptoms. As an example, in a cohort of infants largely identified by newborn screening, 35 percent had respiratory symptoms (cough, wheezing, or any breathing difficulty); mean pulmonary function scores were abnormal by six weeks of age and declined during the subsequent two years [",
"    <a class=\"abstract\" href=\"UTD.htm?27/49/28442/abstract/20\">",
"     20",
"    </a>",
"    ]. As the disease progresses, chronic bronchitis with or without bronchiectasis develops and is accompanied by acute exacerbations characterized by increased cough, tachypnea, dyspnea, increased sputum production, malaise, anorexia, and weight loss. Digital clubbing is often seen in patients with moderate to advanced disease (",
"    <a class=\"graphic graphic_figure graphicRef52839 \" href=\"UTD.htm?42/58/43951\">",
"     figure 2",
"    </a>",
"    ). The clinical manifestations of pulmonary disease in CF are discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/45/27351?source=see_link\">",
"     \"Cystic fibrosis: Clinical manifestations of pulmonary disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Colonization of the airway with pathogenic bacteria often occurs early in life. Staphylococcus aureus and Haemophilus influenzae are common pathogens during early childhood, but Pseudomonas aeruginosa is ultimately isolated from the respiratory secretions of most patients. This predisposition to infection may be in part because of impaired clearance directly induced by a defect in CFTR. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/11/39095?source=see_link\">",
"     \"Cystic fibrosis: Genetics and pathogenesis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/22/41322?source=see_link&amp;anchor=H9942753#H9942753\">",
"     \"Cystic fibrosis: Antibiotic therapy for lung disease\", section on 'Pseudomonas aeruginosa'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The treatment of CF lung disease is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/22/39274?source=see_link\">",
"     \"Cystic fibrosis: Overview of the treatment of lung disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/22/41322?source=see_link\">",
"     \"Cystic fibrosis: Antibiotic therapy for lung disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Sinus disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;The majority of CF patients develop sinus disease. Radiographs reveal pan-opacification of the paranasal sinuses in 90 to 100 percent of patients older than eight months of age [",
"    <a class=\"abstract\" href=\"UTD.htm?27/49/28442/abstract/21\">",
"     21",
"    </a>",
"    ]. Nasal polyposis is seen in 10 to 32 percent of patients [",
"    <a class=\"abstract\" href=\"UTD.htm?27/49/28442/abstract/22\">",
"     22",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Chronic rhinosinusitis may be associated with mutations in the CFTR gene even among patients who do not meet the diagnostic criteria for CF; these patients are said to have \"CFTR-related disease,\" as described above. One case-control study of patients with chronic rhinosinusitis found a significantly higher proportion of patients with a single CFTR mutation among patients with chronic rhinosinusitis than in the general population (7 versus 2 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?27/49/28442/abstract/23\">",
"     23",
"    </a>",
"    ]. Evaluation of a child with rhinosinusitis is discussed in a separate topic review. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/0/11273?source=see_link\">",
"     \"Acute bacterial rhinosinusitis in children: Clinical features and diagnosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Pancreatic disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;CF is associated with several different types of pancreatic disease:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Pancreatic insufficiency &ndash; Insufficiency of the exocrine pancreas is present from birth in about two-thirds of patients with CF, and up to 90 percent have laboratory evidence of fat malabsorption by one year of age [",
"      <a class=\"abstract\" href=\"UTD.htm?27/49/28442/abstract/24\">",
"       24",
"      </a>",
"      ]. Pancreatic disease tends to be progressive; many of the patients with apparently normal or marginal pancreatic function at birth will develop overt evidence of pancreatic insufficiency in childhood or adulthood. Clinically significant pancreatic insufficiency eventually develops in about 85 percent of individuals with CF [",
"      <a class=\"abstract\" href=\"UTD.htm?27/49/28442/abstract/25\">",
"       25",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      Common symptoms and signs of pancreatic insufficiency include steatorrhea, characterized by frequent, bulky, foul-smelling stools that may be oily, and failure to thrive or poor weight gain due to malabsorption of fat and protein. In a patient with a clear diagnosis of CF, the diagnosis of pancreatic insufficiency usually can be established based upon these clinical symptoms, a clinical response to pancreatic enzyme replacement therapy (PERT),",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      laboratory testing (eg, fecal elastase). Infants with severe untreated pancreatic insufficiency occasionally present with a syndrome of edema, with hypoproteinemia, electrolyte loss, and anemia, due to malabsorption of macro- and micronutrients. Such patients also may present with symptoms caused by deficiencies of the fat-soluble vitamins A, D, E, and K. Vitamin K deficiency can present as a coagulopathy, and vitamin D deficiency with rickets. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?28/26/29095?source=see_link\">",
"       \"Cystic fibrosis: Assessment and management of pancreatic insufficiency\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?15/24/15754?source=see_link\">",
"       \"Cystic fibrosis: Nutritional issues\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Pancreatitis &ndash; The defective ductular and acinar pancreatic secretion causes progressive pancreatic damage. This can lead to acute or recurrent pancreatitis. Pancreatitis develops in about 10 percent of CF patients with pancreatic sufficiency and is rare among those with pancreatic insufficiency [",
"      <a class=\"abstract\" href=\"UTD.htm?27/49/28442/abstract/26\">",
"       26",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?19/15/19706?source=see_link&amp;anchor=H21#H21\">",
"       \"Cystic fibrosis: Overview of gastrointestinal disease\", section on 'Pancreatitis'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      CF-related diabetes &ndash; Patients with exocrine pancreatic insufficiency often develop dysfunction of the endocrine pancreas, leading to glucose intolerance and CF-related diabetes (CFRD). Approximately 25 percent of patients develop CFRD by 20 years of age. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?19/15/19706?source=see_link&amp;anchor=H22#H22\">",
"       \"Cystic fibrosis: Overview of gastrointestinal disease\", section on 'CF-related diabetes'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Meconium ileus and distal ileal obstruction",
"    </span>",
"    &nbsp;&mdash;&nbsp;Meconium ileus is characterized by obstruction of the bowel by meconium in a newborn infant. It is the presenting problem in 10 to 20 percent of newborns with CF [",
"    <a class=\"abstract\" href=\"UTD.htm?27/49/28442/abstract/27\">",
"     27",
"    </a>",
"    ]. Conversely, 80 to 90 percent of infants with meconium ileus have CF, although premature infants may be more likely to have meconium ileus without CF [",
"    <a class=\"abstract\" href=\"UTD.htm?27/49/28442/abstract/27,28\">",
"     27,28",
"    </a>",
"    ]. Meconium ileus can occur in patients with a variety of CFTR mutations. A high familial recurrence rate suggests that other genetic modifiers predispose to the development of meconium ileus [",
"    <a class=\"abstract\" href=\"UTD.htm?27/49/28442/abstract/29,30\">",
"     29,30",
"    </a>",
"    ]. In about 40 percent of cases, there is associated perforation, or jejunal or ileal atresia. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/15/19706?source=see_link&amp;anchor=H11986089#H11986089\">",
"     \"Cystic fibrosis: Overview of gastrointestinal disease\", section on 'Meconium ileus'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Episodes of small bowel obstruction may also occur in older children and adults and are known as distal intestinal obstructive syndrome (DIOS) (or \"meconium ileus equivalent\"). DIOS occurs in about 15 percent of adult patients with CF and is more common in patients with severe CFTR genotypes and advanced lung disease. Pancreatic insufficiency is present in many, but not all, affected patients. When identified early, DIOS can usually be controlled medically. Surgical intervention is sometimes required to alleviate severe obstruction and may be complicated by recurrent symptoms caused by adhesions. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/15/19706?source=see_link&amp;anchor=H10#H10\">",
"     \"Cystic fibrosis: Overview of gastrointestinal disease\", section on 'Distal intestinal obstruction syndrome'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Rectal prolapse occurs in about 20 percent of children with classic CF. It appears to be related to constipation and is more likely if effective pancreatic enzyme therapy has not been established. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/15/19706?source=see_link&amp;anchor=H18#H18\">",
"     \"Cystic fibrosis: Overview of gastrointestinal disease\", section on 'Rectal prolapse'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/48/32519?source=see_link&amp;anchor=H7#H7\">",
"     \"Overview of rectal prolapse in children\", section on 'Cystic fibrosis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Biliary disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Focal biliary cirrhosis caused by inspissated bile is present in many patients, and this may cause elevations of serum alkaline phosphatase and lobular hepatomegaly. Asymptomatic liver disease is a common finding at autopsy. In a minority of patients, the liver disease is progressive, with periportal fibrosis, cirrhosis, symptomatic portal hypertension, and variceal bleeding. CF is the third leading cause for liver transplantation in late childhood. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/15/19706?source=see_link&amp;anchor=H23#H23\">",
"     \"Cystic fibrosis: Overview of gastrointestinal disease\", section on 'Hepatobiliary disease'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Cholelithiasis has been reported in up to 12 percent of patients, which may result from excessive loss of bile acids in the stool with consequent production of lithogenic bile [",
"    <a class=\"abstract\" href=\"UTD.htm?27/49/28442/abstract/31\">",
"     31",
"    </a>",
"    ]. Asymptomatic cholelithiasis generally does not require treatment, although prophylactic cholecystectomy is performed in such patients prior to lung transplantation in some centers.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Infertility",
"    </span>",
"    &nbsp;&mdash;&nbsp;More than 95 percent of men with CF are infertile because of defects in sperm transport, although spermatogenesis is not affected [",
"    <a class=\"abstract\" href=\"UTD.htm?27/49/28442/abstract/32\">",
"     32",
"    </a>",
"    ] (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/54/11114?source=see_link\">",
"     \"Causes of male infertility\"",
"    </a>",
"    ). Most of these men have incompletely developed Wolffian structures, most commonly, absent vas deferens. These anomalies probably reflect a critical role for CFTR in the organogenesis of these structures. Nearly half of all men with congenital bilateral absence of the vas deferens and normal lung function have two CFTR mutations [",
"    <a class=\"abstract\" href=\"UTD.htm?27/49/28442/abstract/33\">",
"     33",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Microsurgical epididymal sperm aspiration and intracytoplasmic sperm injection can permit affected men to become biological fathers [",
"    <a class=\"abstract\" href=\"UTD.htm?27/49/28442/abstract/34\">",
"     34",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/33/3610?source=see_link\">",
"     \"Treatment of male infertility\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The incidence of female infertility may be as high as 20 percent. It is related to secondary amenorrhea (induced primarily by malnutrition) and the production of abnormally tenacious cervical mucus [",
"    <a class=\"abstract\" href=\"UTD.htm?27/49/28442/abstract/35\">",
"     35",
"    </a>",
"    ]. When patients with CF become pregnant, maternal and fetal outcomes are generally favorable if the prepregnancy FEV1 exceeds 50 to 60 percent of the predicted value [",
"    <a class=\"abstract\" href=\"UTD.htm?27/49/28442/abstract/36-39\">",
"     36-39",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Careful genetic counseling is essential for prospective parents with CF since all offspring of such individuals will be carriers of CF mutations and the risk of children affected with CF is high.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Musculoskeletal disorders",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with CF have reduced bone mineral content and increased rates of fractures and kyphoscoliosis. Clinically significant reductions in bone density are present in up to 30 percent of patients with CF across all age groups and up to 75 percent of adults with CF [",
"    <a class=\"abstract\" href=\"UTD.htm?27/49/28442/abstract/40,41\">",
"     40,41",
"    </a>",
"    ]. Several different mechanisms appear to contribute to the bone disease, including malabsorption of vitamin D, poor nutritional status, physical activity, glucocorticoid therapy, and delayed pubertal maturation or hypogonadism [",
"    <a class=\"abstract\" href=\"UTD.htm?27/49/28442/abstract/41\">",
"     41",
"    </a>",
"    ]. Limited evidence suggests that patients homozygous for the delta F508 mutation are at particularly high risk of decreased bone mineral density [",
"    <a class=\"abstract\" href=\"UTD.htm?27/49/28442/abstract/42\">",
"     42",
"    </a>",
"    ]. The pathogenesis, assessment, and prevention of bone disease in patients with CF are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/24/15754?source=see_link&amp;anchor=H8#H8\">",
"     \"Cystic fibrosis: Nutritional issues\", section on 'Bone disease'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Hypertrophic osteoarthropathy is a syndrome characterized by abnormal proliferation of the skin and osseous tissue at the distal parts of the extremities, occurring in association with radiographically confirmed periosteal new bone formation. Clubbing of the digits and hypertrophic osteoarthropathy appear to be different manifestations of the same disease process (",
"    <a class=\"graphic graphic_figure graphicRef52839 \" href=\"UTD.htm?42/58/43951\">",
"     figure 2",
"    </a>",
"    ). Although clubbed fingers and toes are common in patients with long-standing CF, hypertrophic osteoarthropathy is uncommon (5 percent of patients) [",
"    <a class=\"abstract\" href=\"UTD.htm?27/49/28442/abstract/43\">",
"     43",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/42/35496?source=see_link&amp;anchor=H13#H13\">",
"     \"Malignancy and rheumatic disorders\", section on 'Hypertrophic osteoarthropathy'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A CF-associated arthropathy occurs in 2 to 9 percent of patients and is characterized by brief episodes of pain and swelling of joints [",
"    <a class=\"abstract\" href=\"UTD.htm?27/49/28442/abstract/44\">",
"     44",
"    </a>",
"    ]. These features are occasionally accompanied by painful nodular skin lesions and purpura.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Recurrent venous thrombosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;CF appears to be a risk factor for recurrent venous thrombosis [",
"    <a class=\"abstract\" href=\"UTD.htm?27/49/28442/abstract/45,46\">",
"     45,46",
"    </a>",
"    ]. In a review of 120 children and young adults with acute venous thromboembolism, recurrent thrombosis occurred in 19. Among these, six had CF (compared to none of the patients without recurrence), and five of the six were colonized with Burkholderia cepacia [",
"    <a class=\"abstract\" href=\"UTD.htm?27/49/28442/abstract/47\">",
"     47",
"    </a>",
"    ]. Most, but not all, of the recurrent thrombosis events occurred in the presence of a central venous catheter. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/57/14234?source=see_link\">",
"     \"Diagnosis and treatment of venous thrombosis and thromboembolism in infants and children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Nephrolithiasis and nephrocalcinosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Nephrolithiasis and nephrocalcinosis are common in patients with CF [",
"    <a class=\"abstract\" href=\"UTD.htm?27/49/28442/abstract/48-50\">",
"     48-50",
"    </a>",
"    ]. The reported prevalence of microscopic nephrocalcinosis ranges from 27 to 92 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?27/49/28442/abstract/50,51\">",
"     50,51",
"    </a>",
"    ], and 3 and 6 percent of individuals with CF develop nephrolithiasis, compared to 1 to 2 percent of age-matched controls without CF [",
"    <a class=\"abstract\" href=\"UTD.htm?27/49/28442/abstract/52\">",
"     52",
"    </a>",
"    ]. Enteric hyperoxaluria (due to fat malabsorption resulting from decreased secretion of pancreatic enzymes) and hypocitraturia (due to chronic metabolic acidosis) are putative risk factors [",
"    <a class=\"abstract\" href=\"UTD.htm?27/49/28442/abstract/49\">",
"     49",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/60/6090?source=see_link&amp;anchor=H12#H12\">",
"     \"Epidemiology of and risk factors for nephrolithiasis in children\", section on 'Hypocitraturia'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/53/33626?source=see_link&amp;anchor=H9#H9\">",
"     \"Risk factors for calcium stones in adults\", section on 'Hypocitraturia'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H59099793\">",
"    <span class=\"h1\">",
"     NEWBORN SCREENING",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H49141214\">",
"    <span class=\"h2\">",
"     Techniques",
"    </span>",
"    &nbsp;&mdash;&nbsp;Newborn screening typically employs two serial assays; infants with abnormal results for the first assay are retested with a second assay. The two assays used for newborn screening are serum immunoreactive trypsin (IRT) and DNA analysis for mutations in CFTR. IRT is used as the initial screening test in many protocols and is followed by a second IRT test on a different sample from the infant",
"    <span class=\"nowrap\">",
"     (IRT/IRT",
"    </span>",
"    protocol) or a DNA test on the initial sample",
"    <span class=\"nowrap\">",
"     (IRT/DNA",
"    </span>",
"    protocol). An",
"    <span class=\"nowrap\">",
"     IRT/IRT",
"    </span>",
"    screening protocol has somewhat lower costs but more delayed or missed diagnoses as compared with an",
"    <span class=\"nowrap\">",
"     IRT/DNA",
"    </span>",
"    screening protocol [",
"    <a class=\"abstract\" href=\"UTD.htm?27/49/28442/abstract/53\">",
"     53",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      IRT assay &ndash; Most infants with cystic fibrosis (CF) have elevated blood levels of IRT, which can be quantified by radioimmunoassay or by an enzyme&ndash;linked immunoassay [",
"      <a class=\"abstract\" href=\"UTD.htm?27/49/28442/abstract/54-56\">",
"       54-56",
"      </a>",
"      ]. IRT levels fall rapidly during infancy. After eight weeks of age, negative result is not informative, although a positive result still strongly supports a diagnosis of CF [",
"      <a class=\"abstract\" href=\"UTD.htm?27/49/28442/abstract/55,56\">",
"       55,56",
"      </a>",
"      ]. The initial IRT test is approximately 80 percent sensitive for detecting CF using typical cutoff values, and additional patients are not diagnosed through the",
"      <span class=\"nowrap\">",
"       IRT/IRT",
"      </span>",
"      protocol if a second sample is not returned for testing. In addition, the rates of false-positive and false-negative results are relatively high in many series [",
"      <a class=\"abstract\" href=\"UTD.htm?27/49/28442/abstract/56-58\">",
"       56-58",
"      </a>",
"      ]. The test is primarily used for neonatal screening but also may be useful for small or malnourished infants, in whom the sweat chloride test cannot be successfully performed.",
"     </li>",
"     <li>",
"      DNA assay &ndash; DNA analysis for mutations in the CF gene is used for newborn screening in most US states. This may be used as a secondary screen to confirm the diagnosis in patients with abnormal initial IRT assays",
"      <span class=\"nowrap\">",
"       (IRT/DNA",
"      </span>",
"      protocol), or it may be used as a primary method of screening. Many",
"      <span class=\"nowrap\">",
"       IRT/DNA",
"      </span>",
"      protocols use a floating IRT cutoff that improves sensitivity to as high as 96 percent [",
"      <a class=\"abstract\" href=\"UTD.htm?27/49/28442/abstract/53\">",
"       53",
"      </a>",
"      ]. The DNA assay tests for the 23 most common CFTR mutations, and infants with one or more mutations are referred for sweat testing.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Infants with positive CF newborn screening results should undergo sweat chloride testing to determine whether they have CF [",
"    <a class=\"abstract\" href=\"UTD.htm?27/49/28442/abstract/5\">",
"     5",
"    </a>",
"    ]. For optimal accuracy, sweat testing should be performed when the infant is at least two weeks of age and weighs &gt;2 kg, using laboratory techniques stipulated by the Cystic Fibrosis Foundation. (See",
"    <a class=\"local\" href=\"#H19\">",
"     'Sweat chloride'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H49141221\">",
"    <span class=\"h2\">",
"     Rationale",
"    </span>",
"    &nbsp;&mdash;&nbsp;The rationale for newborn screening is that early detection of CF may lead to earlier intervention and improved outcomes because affected individuals are diagnosed, referred, and treated earlier in life as compared with individuals who are diagnosed after presenting with symptomatic CF. This perspective is supported by the following evidence:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A meta-analysis of randomized trials examining newborn screening in Europe and Australia demonstrated a 5 to 10 percent reduction in mortality by 10 years of age in children with CF without meconium ileus [",
"      <a class=\"abstract\" href=\"UTD.htm?27/49/28442/abstract/59\">",
"       59",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Several observational studies have shown that children with CF detected via screening demonstrate better lung function and improved growth parameters and require less intensive treatment than children diagnosed with CF on clinical grounds [",
"      <a class=\"abstract\" href=\"UTD.htm?27/49/28442/abstract/13,60-66\">",
"       13,60-66",
"      </a>",
"      ]. Improved pulmonary function and outcome has not yet been definitively confirmed in randomized trials [",
"      <a class=\"abstract\" href=\"UTD.htm?27/49/28442/abstract/56,67\">",
"       56,67",
"      </a>",
"      ]. However, improved growth and nutritional outcomes through adolescence have been documented in a randomized trial in which outcomes of children identified by newborn screening were compared with those diagnosed as infants based upon symptoms [",
"      <a class=\"abstract\" href=\"UTD.htm?27/49/28442/abstract/68\">",
"       68",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Early nutritional intervention appears to improve neurocognitive outcome in infants and young children diagnosed with CF through newborn screening [",
"      <a class=\"abstract\" href=\"UTD.htm?27/49/28442/abstract/64,68-71\">",
"       64,68-71",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Screening programs also may be cost effective because of improved clinical outcomes. A study using the UK Cystic Fibrosis database compared the yearly costs of long-term therapies and intravenous antibiotics for children whose CF was identified through a newborn screening program as compared to those identified by clinical symptoms after two months of age [",
"      <a class=\"abstract\" href=\"UTD.htm?27/49/28442/abstract/72\">",
"       72",
"      </a>",
"      ]. Treatment costs were significantly lower in the group identified by newborn screening. Similar trends were seen when the analysis was restricted to children with the common mutation associated with severe classic CF, delta F508, suggesting that the reduction in cost was not due to finding only milder cases of CF.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In addition to allowing early identification and treatment of individuals with CF, neonatal screening identifies a population for studying the mechanism of early (preclinical) lung injury. In the future, the effectiveness of novel therapies to delay or prevent the onset of lung disease could be assessed in these patients with preclinical disease.",
"   </p>",
"   <p>",
"    Concerns were initially raised that newborn screening might be associated with earlier acquisition of Pseudomonas aeruginosa because of earlier exposure to other CF patients within the medical system [",
"    <a class=\"abstract\" href=\"UTD.htm?27/49/28442/abstract/73\">",
"     73",
"    </a>",
"    ]. However, several subsequent studies showed that newborn screening is not a risk factor [",
"    <a class=\"abstract\" href=\"UTD.htm?27/49/28442/abstract/74-76\">",
"     74-76",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H49141207\">",
"    <span class=\"h2\">",
"     Regional variation in screening",
"    </span>",
"    &nbsp;&mdash;&nbsp;National programs for newborn screening with various combinations of IRT and DNA testing are currently in place in Australia, New Zealand, Northern Ireland, Wales, Scotland, France, and England [",
"    <a class=\"abstract\" href=\"UTD.htm?27/49/28442/abstract/56,77-80\">",
"     56,77-80",
"    </a>",
"    ]. Updated information about the screening programs in the United Kingdom is available at",
"    <a class=\"external\" href=\"file://newbornbloodspot.screening.nhs.uk/\">",
"     file://newbornbloodspot.screening.nhs.uk/",
"    </a>",
"    .",
"   </p>",
"   <p>",
"    In the United States, the Centers for Disease Control and Prevention (CDC) concluded in 2004 that CF screening programs were justified on the basis of moderate benefit and low risk of harm but noted that the decision to implement these programs was dependent upon the resources and priorities of individual states [",
"    <a class=\"abstract\" href=\"UTD.htm?27/49/28442/abstract/81,82\">",
"     81,82",
"    </a>",
"    ]. Statewide testing programs are in place in all states in the United States. An updated list of state screening programs and the years in which each was first implemented is available on the Cystic Fibrosis Foundation website:",
"    <a class=\"external\" href=\"file://www.cff.org/\">",
"     www.cff.org",
"    </a>",
"    (",
"    <a class=\"graphic graphic_figure graphicRef68042 \" href=\"UTD.htm?26/28/27085\">",
"     figure 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?27/49/28442/abstract/56,81-83\">",
"     56,81-83",
"    </a>",
"    ]. The technique employed, and therefore the specificity of the screen, varies among states.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H59100333\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of cystic fibrosis (CF) is based upon compatible clinical findings with biochemical or genetic confirmation (",
"    <a class=\"graphic graphic_algorithm graphicRef50886 \" href=\"UTD.htm?32/19/33073\">",
"     algorithm 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?27/49/28442/abstract/17,84,85\">",
"     17,84,85",
"    </a>",
"    ]. The sweat chloride test is the mainstay of laboratory confirmation, although tests for specific mutations, nasal potential difference, immunoreactive trypsin, stool fecal fat, or pancreatic enzyme secretion may also be useful in some cases.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5359539\">",
"    <span class=\"h2\">",
"     Diagnostic criteria",
"    </span>",
"    &nbsp;&mdash;&nbsp;BOTH of the following criteria must be met to diagnose cystic fibrosis (CF) [",
"    <a class=\"abstract\" href=\"UTD.htm?27/49/28442/abstract/3\">",
"     3",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Clinical symptoms consistent with CF in at least one organ system, AND",
"     </li>",
"     <li>",
"      Evidence of cystic fibrosis transmembrane conductance regulator (CFTR) dysfunction (any of the following):",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Elevated sweat chloride &ge;60",
"      <span class=\"nowrap\">",
"       mmol/L",
"      </span>",
"      (on two occasions)",
"     </li>",
"     <li>",
"      Presence of two disease-causing mutations in CFTR",
"     </li>",
"     <li>",
"      Abnormal nasal potential difference",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The criterion of clinical symptoms is not required for newborns identified through a screening program or for siblings of patients with CF who are diagnosed by shared genotype (",
"    <a class=\"graphic graphic_table graphicRef72741 \" href=\"UTD.htm?31/51/32571\">",
"     table 2",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    The accuracy of sweat chloride and nasal potential difference measurements are operator dependent, so it is critical that testing be performed in experienced centers, following standard guidelines (see",
"    <a class=\"local\" href=\"#H21\">",
"     'Technique'",
"    </a>",
"    below). Interpretation of intermediate results of sweat chloride levels is discussed below. (See",
"    <a class=\"local\" href=\"#H20\">",
"     'Interpretation'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5359711\">",
"    <span class=\"h2\">",
"     Laboratory testing",
"    </span>",
"    &nbsp;&mdash;&nbsp;Evidence of CFTR dysfunction can be provided by sweat chloride testing, molecular testing for CFTR mutations, or measurements of nasal potential difference. In most cases, sweat chloride testing is the first and most important test. DNA testing is used for confirmation or for further investigation of patients with intermediate sweat chloride results and for prognostic and epidemiologic purposes in individuals with positive results of sweat chloride testing. The diagnostic approach is outlined in the algorithm (",
"    <a class=\"graphic graphic_algorithm graphicRef50886 \" href=\"UTD.htm?32/19/33073\">",
"     algorithm 1",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h3\">",
"     Sweat chloride",
"    </span>",
"    &nbsp;&mdash;&nbsp;The sweat chloride test remains the primary test for the diagnosis of CF; sweat testing is performed by the collection of sweat with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/36/33344?source=see_link\">",
"     pilocarpine",
"    </a>",
"    iontophoresis and by chemical determination of the chloride concentration [",
"    <a class=\"abstract\" href=\"UTD.htm?27/49/28442/abstract/86\">",
"     86",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H59099179\">",
"    <span class=\"h4\">",
"     Indications",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with the following characteristics should undergo sweat testing to clarify a diagnosis of CF:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Infants with positive CF newborn screening results (perform after two weeks of age and &gt;2 kg if asymptomatic)",
"     </li>",
"     <li>",
"      Infants with symptoms suggestive of CF (eg, meconium ileus)",
"     </li>",
"     <li>",
"      Older children and adults with symptoms suggestive of CF (eg, male infertility, chronic respiratory infections, or chronic sinusitis)",
"     </li>",
"     <li>",
"      Siblings of a patient with confirmed CF",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Infants with positive CF newborn screening results should undergo sweat chloride testing to determine whether they have CF [",
"    <a class=\"abstract\" href=\"UTD.htm?27/49/28442/abstract/5\">",
"     5",
"    </a>",
"    ]. For optimal accuracy, sweat testing should be performed when the infant is at least two weeks of age and weighs &gt;2 kg. In symptomatic newborns (eg, those presenting with meconium ileus), sweat testing may be performed as early as the second day of life if adequate quantities of sweat can be collected, but the results are more likely to be inconclusive at this age.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h4\">",
"     Interpretation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Interpretation of sweat chloride results depend upon the age of the patient (",
"    <a class=\"graphic graphic_table graphicRef88515 \" href=\"UTD.htm?11/30/11756\">",
"     table 3",
"    </a>",
"    ) (US guidelines [",
"    <a class=\"abstract\" href=\"UTD.htm?27/49/28442/abstract/5\">",
"     5",
"    </a>",
"    ]).",
"   </p>",
"   <p>",
"    For newborns and infants younger than six months of age:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      &le;29",
"      <span class=\"nowrap\">",
"       mmol/L:",
"      </span>",
"      Normal (CF very unlikely)",
"     </li>",
"     <li>",
"      30 to 59",
"      <span class=\"nowrap\">",
"       mmol/L:",
"      </span>",
"      Intermediate (Possible CF)",
"     </li>",
"     <li>",
"      &ge;60",
"      <span class=\"nowrap\">",
"       mmol/L:",
"      </span>",
"      Abnormal (Diagnosis of CF)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    For infants &ge;6 months, children, and adults:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      &le;39",
"      <span class=\"nowrap\">",
"       mmol/L:",
"      </span>",
"      Normal (CF very unlikely)",
"     </li>",
"     <li>",
"      40 to 59",
"      <span class=\"nowrap\">",
"       mmol/L:",
"      </span>",
"      Intermediate (Possible CF)",
"     </li>",
"     <li>",
"      &ge;60",
"      <span class=\"nowrap\">",
"       mmol/L:",
"      </span>",
"      Abnormal (Diagnosis of CF)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The diagnostic ranges above reflect the physiologic increases in sweat chloride concentrations with advancing age. For newborns and young infants, a wide intermediate range is used. This is because sweat chloride concentrations in healthy newborns gradually decrease during the first weeks of life [",
"    <a class=\"abstract\" href=\"UTD.htm?27/49/28442/abstract/87\">",
"     87",
"    </a>",
"    ], then rise slightly throughout childhood. Median sweat chloride concentrations in a healthy population rise from 13",
"    <span class=\"nowrap\">",
"     mMol/L",
"    </span>",
"    in mid-childhood to 23",
"    <span class=\"nowrap\">",
"     mMol/L",
"    </span>",
"    in young adults [",
"    <a class=\"abstract\" href=\"UTD.htm?27/49/28442/abstract/88\">",
"     88",
"    </a>",
"    ]. It may be appropriate to use lower cutoff values for defining disease in young children, but such age-based reference ranges have not been adopted. Of note, European guidelines use the lower cutoff for the intermediate range (30",
"    <span class=\"nowrap\">",
"     mmol/L)",
"    </span>",
"    for all ages, but this does not change the classification of most patients [",
"    <a class=\"abstract\" href=\"UTD.htm?27/49/28442/abstract/4,89\">",
"     4,89",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Normal &ndash; A normal sweat chloride result is sufficient to rule out CF in most individuals. Nonetheless, a normal sweat chloride concentration is observed in approximately 1 percent of patients with CF, who have unusual genotypes such as the 3849 + 10kb C-T or poly-T defects [",
"      <a class=\"abstract\" href=\"UTD.htm?27/49/28442/abstract/90\">",
"       90",
"      </a>",
"      ]. In patients with suggestive symptoms, repeating sweat chloride",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      DNA testing may be warranted (",
"      <a class=\"graphic graphic_algorithm graphicRef50886 \" href=\"UTD.htm?32/19/33073\">",
"       algorithm 1",
"      </a>",
"      ). Similarly, infants with two CFTR mutations and abnormal newborn screening results occasionally have normal sweat chloride results [",
"      <a class=\"abstract\" href=\"UTD.htm?27/49/28442/abstract/91\">",
"       91",
"      </a>",
"      ]. In this case, analysis of parental DNA can be performed to determine the nature of the CFTR mutation and clarify the diagnosis [",
"      <a class=\"abstract\" href=\"UTD.htm?27/49/28442/abstract/5\">",
"       5",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Intermediate &ndash; For patients with intermediate sweat chloride results, sweat chloride testing should be repeated. For asymptomatic infants with intermediate results, the sweat chloride test should be repeated at one to two months of age, and then at 6- to 12-month intervals until the diagnosis is clear. In symptomatic infants or children, or for infants who were younger than two weeks old when first tested, it may be appropriate to repeat the sweat chloride test sooner. Intermediate results of sweat testing also should be investigated with DNA analysis, using a CFTR multimutation method (",
"      <a class=\"graphic graphic_algorithm graphicRef50886 \" href=\"UTD.htm?32/19/33073\">",
"       algorithm 1",
"      </a>",
"      ) [",
"      <a class=\"abstract\" href=\"UTD.htm?27/49/28442/abstract/5\">",
"       5",
"      </a>",
"      ]. Approximately 20 percent of children with intermediate sweat chloride results will have DNA evidence of CF on expanded analysis [",
"      <a class=\"abstract\" href=\"UTD.htm?27/49/28442/abstract/92\">",
"       92",
"      </a>",
"      ]. (See",
"      <a class=\"local\" href=\"#H22\">",
"       'Molecular diagnosis'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      Abnormal &ndash; A sweat chloride value of 60",
"      <span class=\"nowrap\">",
"       meq/L",
"      </span>",
"      or greater (on two occasions) is sufficient to confirm the diagnosis of CF in patients with clinical symptoms of CF. This value distinguishes most patients with CF from those with other forms of chronic pulmonary disease [",
"      <a class=\"abstract\" href=\"UTD.htm?27/49/28442/abstract/93,94\">",
"       93,94",
"      </a>",
"      ]. Despite the slight variations in sweat chloride concentrations with age that are described above, the cutoff of &ge;60",
"      <span class=\"nowrap\">",
"       mmol/L",
"      </span>",
"      is highly specific for diagnosing CF in all age groups. A variety of other clinical conditions may be associated with elevated sweat chloride levels, but none of these are readily confused with CF (",
"      <a class=\"graphic graphic_table graphicRef78885 \" href=\"UTD.htm?25/39/26235\">",
"       table 4",
"      </a>",
"      ). Very rarely, apparently healthy individuals have sweat chloride values &ge;60",
"      <span class=\"nowrap\">",
"       mmol/L",
"      </span>",
"      [",
"      <a class=\"abstract\" href=\"UTD.htm?27/49/28442/abstract/88\">",
"       88",
"      </a>",
"      ]. Therefore, positive results of sweat testing should be further evaluated by DNA analysis",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      repeat sweat chloride testing (",
"      <a class=\"graphic graphic_algorithm graphicRef50886 \" href=\"UTD.htm?32/19/33073\">",
"       algorithm 1",
"      </a>",
"      ) [",
"      <a class=\"abstract\" href=\"UTD.htm?27/49/28442/abstract/5\">",
"       5",
"      </a>",
"      ]. We also suggest DNA analysis because the results may affect treatment choices as well as confirm the diagnosis. Emerging treatment strategies target specific CFTR mutations, using CFTR modulators. (See",
"      <a class=\"local\" href=\"#H22\">",
"       'Molecular diagnosis'",
"      </a>",
"      below and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?38/22/39274?source=see_link&amp;anchor=H20592751#H20592751\">",
"       \"Cystic fibrosis: Overview of the treatment of lung disease\", section on 'CFTR modulators'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Asymptomatic infants with equivocal results of the diagnostic process (sweat chloride test and DNA analysis) are given a provisional diagnosis of CFTR-related metabolic syndrome (CRMS). This is because the sweat chloride results and symptoms may change with age and because the clinical consequences of some CFTR mutations are unclear. Consensus statements describing the evaluation and management of these patients have been published [",
"    <a class=\"abstract\" href=\"UTD.htm?27/49/28442/abstract/7,9\">",
"     7,9",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H49145351\">",
"     'CFTR-related metabolic syndrome'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Among older individuals, a few will also fail to have a clear diagnosis despite this evaluation. In this case, further clinical assessment performed at a specialized CF center contributes to a provisional diagnosis (",
"    <a class=\"graphic graphic_algorithm graphicRef50886 \" href=\"UTD.htm?32/19/33073\">",
"     algorithm 1",
"    </a>",
"    ). (See",
"    <a class=\"local\" href=\"#H25\">",
"     'Other tests'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h4\">",
"     Technique",
"    </span>",
"    &nbsp;&mdash;&nbsp;Sweat testing is performed by the collection of sweat with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/36/33344?source=see_link\">",
"     pilocarpine",
"    </a>",
"    iontophoresis and by chemical determination of the chloride concentration [",
"    <a class=\"abstract\" href=\"UTD.htm?27/49/28442/abstract/86\">",
"     86",
"    </a>",
"    ]. The test is performed by applying pilocarpine to the skin to encourage sweat formation. A small collection system is applied at the same spot to the surface of the skin, and the whole is covered in plastic wrap to promote sweating and allow collection of the sweat. A sufficient amount of fluid is usually obtained within about an hour. The test is painless but difficult to perform properly. The sweat chloride test must be carried out with extreme care and should be obtained by a laboratory that performs the assay regularly. Guidelines for diagnostic sweat testing are published by the Cystic Fibrosis Foundation, and adherence to these guidelines is required for accreditation as a CF center [",
"    <a class=\"abstract\" href=\"UTD.htm?27/49/28442/abstract/95\">",
"     95",
"    </a>",
"    ]. Improper technique can cause factitious elevation or depression in the sweat chloride level. Collection of insufficient quantities of sweat is a common problem, particularly in young infants; at least 50 mg of sweat must be collected within a 45-minute period for the test to be valid. Hypoproteinemic edema and concurrent administration of steroids or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?5/27/5561?source=see_link\">",
"     topiramate",
"    </a>",
"    can lead to a false decrease in the sweat chloride concentration [",
"    <a class=\"abstract\" href=\"UTD.htm?27/49/28442/abstract/96\">",
"     96",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h3\">",
"     Molecular diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Intermediate results of sweat testing should be clarified by DNA analysis using a CFTR multimutation method, and sweat chloride testing should be repeated (",
"    <a class=\"graphic graphic_algorithm graphicRef50886 \" href=\"UTD.htm?32/19/33073\">",
"     algorithm 1",
"    </a>",
"    ). Many experts also suggest DNA analysis in individuals with positive sweat testing for prognostic and epidemiologic purposes [",
"    <a class=\"abstract\" href=\"UTD.htm?27/49/28442/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Molecular diagnosis is usually carried out by direct mutation analysis. Most diagnostic laboratories in the United States screen for at least 23 of the most common mutations, using a panel developed for population screening by the American College of Medical Genetics (ACMG) (",
"    <a class=\"graphic graphic_table graphicRef65637 \" href=\"UTD.htm?35/38/36459\">",
"     table 5",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?27/49/28442/abstract/97\">",
"     97",
"    </a>",
"    ]. If two CF-causing mutations are detected and the sweat test is intermediate or positive, the diagnosis of CF is confirmed. If two CF-causing mutations are not identified, the sweat test should be repeated [",
"    <a class=\"abstract\" href=\"UTD.htm?27/49/28442/abstract/5\">",
"     5",
"    </a>",
"    ]. If only one disease-causing mutation (or one disease-causing mutation and another mutation that is not clearly categorized) is identified in an asymptomatic infant with normal or intermediate sweat chloride results, the infant is given the provisional diagnosis of CRMS. (See",
"    <a class=\"local\" href=\"#H49145351\">",
"     'CFTR-related metabolic syndrome'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    The ACMG panel identifies approximately 90 percent of CF-causing mutations (and 97 percent of mutations in families of Ashkenazi Jewish ancestry) [",
"    <a class=\"abstract\" href=\"UTD.htm?27/49/28442/abstract/84\">",
"     84",
"    </a>",
"    ]. However, the panel may be less sensitive for other ethnic groups; in one study, it detected only 68.5 percent of CF-causing mutations in a Hispanic population [",
"    <a class=\"abstract\" href=\"UTD.htm?27/49/28442/abstract/98\">",
"     98",
"    </a>",
"    ]. Several state screening programs have therefore expanded or modified the ACMG panel to suit multiethnic populations.",
"   </p>",
"   <p>",
"    For individuals with an intermediate or positive sweat chloride test result but in whom two mutations are not detected by the standard genetic screen, more extensive methods should be used to detect CFTR mutations. These tests include an expanded panel of CFTR mutations, evaluation for deletions or duplications (using multiplex ligation-dependent probe amplification, MLPA),",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    direct sequencing. These techniques are better able to identify rare mutations and are now readily available in several commercial laboratories at fairly reasonable cost. A list of testing laboratories is available through the GeneTests website (",
"    <a class=\"external\" href=\"file://www.genetests.org/\">",
"     www.genetests.org",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Additional information on genetic testing for carriers can be obtained from the Cystic Fibrosis Foundation (",
"    <a class=\"external\" href=\"file://www.cff.org/\">",
"     www.cff.org",
"    </a>",
"    ). Linkage analysis can be performed for prenatal diagnosis or carrier detection in CF families carrying unidentified mutations [",
"    <a class=\"abstract\" href=\"UTD.htm?27/49/28442/abstract/99\">",
"     99",
"    </a>",
"    ]. The indications for genetic screening and prenatal testing in the diagnosis of CF are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/62/22503?source=see_link\">",
"     \"Cystic fibrosis: Prenatal genetic screening\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The Cystic Fibrosis Mutation database lists more than 1500 different mutations in the CFTR gene with potential to cause disease (",
"    <a class=\"external\" href=\"file://www.genet.sickkids.on.ca/cftr/\">",
"     www.genet.sickkids.on.ca/cftr/",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/11/39095?source=see_link\">",
"     \"Cystic fibrosis: Genetics and pathogenesis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h3\">",
"     Nasal potential difference measurements",
"    </span>",
"    &nbsp;&mdash;&nbsp;Abnormalities in epithelial chloride secretion can be demonstrated in most CF patients by evaluating the nasal transepithelial potential difference (NPD). The test provides supportive evidence of CFTR dysfunction and can be helpful in evaluating a patient in whom sweat chloride testing and DNA testing are inconclusive [",
"    <a class=\"abstract\" href=\"UTD.htm?27/49/28442/abstract/100\">",
"     100",
"    </a>",
"    ] (",
"    <a class=\"graphic graphic_algorithm graphicRef50886 \" href=\"UTD.htm?32/19/33073\">",
"     algorithm 1",
"    </a>",
"    ); in these patients, nonclassic (atypical) CF may be suspected because of CF-like disease in one or more organ systems. (See",
"    <a class=\"local\" href=\"#H5\">",
"     'Nonclassic CF'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Using electrodes placed in the nasal cavity, voltage measurements are taken in the basal state, after nasal perfusion with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?37/12/38085?source=see_link\">",
"     amiloride",
"    </a>",
"    to block sodium transport (the major component of NPD) and after nasal perfusion with a chloride-free solution containing a cAMP agonist, such as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?22/31/23029?source=see_link\">",
"     isoproterenol",
"    </a>",
"    , to stimulate CFTR-dependent chloride transport [",
"    <a class=\"abstract\" href=\"UTD.htm?27/49/28442/abstract/85,101-103\">",
"     85,101-103",
"    </a>",
"    ]. Patients with CFTR dysfunction have a high potential difference in the basal state, a greater decline than controls to amiloride, and minimal response to low chloride-isoproterenol perfusion (",
"    <a class=\"graphic graphic_figure graphicRef67877 \" href=\"UTD.htm?27/25/28050\">",
"     figure 3",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    This test is not widely available and should be performed in experienced centers because standardization of both solution preparation and potential difference measurement is necessary [",
"    <a class=\"abstract\" href=\"UTD.htm?27/49/28442/abstract/102,104\">",
"     102,104",
"    </a>",
"    ]. The presence of nasal polyps or inflammation may result in false-negative results. Only a few centers performing this test have adapted the technique for use in infants [",
"    <a class=\"abstract\" href=\"UTD.htm?27/49/28442/abstract/5,105\">",
"     5,105",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The degree of abnormality in NPD is not correlated with the severity of CF lung disease [",
"    <a class=\"abstract\" href=\"UTD.htm?27/49/28442/abstract/106\">",
"     106",
"    </a>",
"    ]. However, specific abnormalities in NPD are associated with distinct phenotypes of CF. In general, abnormal chloride secretion is associated with pancreatic insufficiency, while sodium hyperabsorption is more common among patients with severe of lung disease [",
"    <a class=\"abstract\" href=\"UTD.htm?27/49/28442/abstract/103\">",
"     103",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h3\">",
"     Other tests",
"    </span>",
"    &nbsp;&mdash;&nbsp;For a few individuals, the diagnosis of CF remains unclear even after repeated sweat chloride testing and expanded DNA analysis. Such patients are not diagnosed with CF because they do not have two CF-causing mutations on expanded DNA analysis. However, there is an ongoing clinical suspicion of CF either because of intermediate sweat chloride test results on repeated testing or because they have clinical features that are compatible with CF but normal sweat chloride on repeated testing.",
"   </p>",
"   <p>",
"    For these patients, measurement of nasal potential difference provides an additional laboratory measure of CFTR function, as discussed above. In addition, a detailed evaluation should be performed to look for clinical evidence of CFTR-related disease (",
"    <a class=\"graphic graphic_algorithm graphicRef50886 \" href=\"UTD.htm?32/19/33073\">",
"     algorithm 1",
"    </a>",
"    ). The choice of tests depends upon the patient's age and clinical presentation, but may include the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Pancreatic exocrine function may be evaluated indirectly by measurement of fecal elastase, which is clinically practical but has limited accuracy [",
"      <a class=\"abstract\" href=\"UTD.htm?27/49/28442/abstract/107\">",
"       107",
"      </a>",
"      ]. Low levels of fecal elastase suggest pancreatic insufficiency and support a diagnosis of CF. Normal levels of fecal elastase do not exclude the diagnosis because pancreatic function is sufficient in a substantial fraction of individuals with CF.",
"      <br/>",
"      <br/>",
"      Pancreatic exocrine function also can be measured directly by collecting duodenal fluid after stimulation with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?27/49/28435?source=see_link\">",
"       secretin",
"      </a>",
"      and cholecystokinin. Decreased levels of pancreatic enzymes provide support for a diagnosis of CF. The technique is time consuming, technically demanding, costly, and uncomfortable for the patient, so it is rarely performed for patients with CF.",
"      <br/>",
"      <br/>",
"      Similar information can be gathered by calculating the percentage of ingested fat in a 72-hour stool collection; the value is elevated in individuals with pancreatic insufficiency. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?28/26/29095?source=see_link&amp;anchor=H5#H5\">",
"       \"Cystic fibrosis: Assessment and management of pancreatic insufficiency\", section on 'Diagnosis'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      A detailed pulmonary evaluation may include pulmonary function testing (in infants, children and adults), respiratory tract culture for CF-associated pathogens, bronchoalveolar lavage for cytology and microbial cultures, and exclusionary testing for ciliary dyskinesia and immune deficiency [",
"      <a class=\"abstract\" href=\"UTD.htm?27/49/28442/abstract/5\">",
"       5",
"      </a>",
"      ]. Most of these tests will not be appropriate for evaluation of an infant.",
"     </li>",
"     <li>",
"      Evidence of azoospermia (in sexually mature males), bronchiectasis, or recurrent or chronic pancreatitis also provides supportive evidence for a CFTR-related disorder.",
"     </li>",
"     <li>",
"      Computerized tomography of the nasal sinuses. The presence of chronic pansinusitis provides support for CF or a CFTR-related disorder.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    If this evaluation fails to provide convincing evidence of CF and the sweat chloride results are in the intermediate range, the individuals are at risk for CF and should be monitored periodically for the appearance of symptoms.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1966215\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Symptoms of the following disorders may mimic symptoms of cystic fibrosis (CF):",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Immunologic abnormalities, especially severe combined immunodeficiency, may present with recurrent sinopulmonary infections, similar to CF. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?23/48/24326?source=see_link\">",
"       \"Primary humoral immune deficiencies: An overview\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?41/30/42471?source=see_link\">",
"       \"Severe combined immunodeficiency (SCID): An overview\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Primary ciliary dyskinesia (PCD) also causes recurrent sinopulmonary infections as well as male infertility. Affected patients are also prone to recurrent otitis media, and 50 percent have situs inversus. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?9/37/9817?source=see_link\">",
"       \"Primary ciliary dyskinesia (immotile-cilia syndrome)\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Shwachman-Diamond syndrome can cause pancreatic insufficiency but is substantially less common than CF. The disorder is associated with chronic or recurrent hematologic abnormalities. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?32/39/33400?source=see_link\">",
"       \"Shwachman-Diamond syndrome\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Diagnostic evaluation for these disorders should be considered when the diagnosis of apparent CF cannot be confirmed by laboratory testing.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, \"The Basics\" and \"Beyond the Basics.\" The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on \"patient info\" and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topic (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?19/57/20371?source=see_link\">",
"       \"Patient information: Cystic fibrosis (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Cystic fibrosis (CF) is caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) protein. Deranged chloride transport leads to thick, viscous secretions in the lungs, pancreas, liver, intestine, and reproductive tract. The typical CF patient presents with multisystem disease involving several or all of these organs (",
"      <a class=\"graphic graphic_table graphicRef76253 \" href=\"UTD.htm?5/7/5244\">",
"       table 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Overview of clinical features'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The diagnosis of CF requires clinical symptoms consistent with CF in at least one organ system AND evidence of CFTR dysfunction (elevated sweat chloride, presence of two disease-causing mutations in CFTR, or abnormal nasal potential difference). Clinical symptoms are not required for infants identified through newborn screening or siblings of patients with CF (",
"      <a class=\"graphic graphic_table graphicRef72741 \" href=\"UTD.htm?31/51/32571\">",
"       table 2",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H5359539\">",
"       'Diagnostic criteria'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Sweat chloride testing is the most important diagnostic test and should be performed to clarify a diagnosis of CF in infants with positive CF newborn screening results, in any patient with symptoms suggestive of CF, and in siblings of a patient with confirmed CF. (See",
"      <a class=\"local\" href=\"#H19\">",
"       'Sweat chloride'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For most individuals, a normal sweat chloride result is sufficient to rule out CF. A sweat chloride value of 60",
"      <span class=\"nowrap\">",
"       mmol/L",
"      </span>",
"      or greater is sufficient to confirm the diagnosis of CF, provided that it is confirmed by a second sweat test or DNA testing (",
"      <a class=\"graphic graphic_algorithm graphicRef50886 \" href=\"UTD.htm?32/19/33073\">",
"       algorithm 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H20\">",
"       'Interpretation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For patients with intermediate sweat chloride results, sweat chloride testing should be repeated, and DNA analysis should be performed (",
"      <a class=\"graphic graphic_algorithm graphicRef50886 \" href=\"UTD.htm?32/19/33073\">",
"       algorithm 1",
"      </a>",
"      and",
"      <a class=\"graphic graphic_table graphicRef88515 \" href=\"UTD.htm?11/30/11756\">",
"       table 3",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H20\">",
"       'Interpretation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      DNA analysis should be performed for patients with intermediate or positive sweat chloride results. A standard panel is sufficient to confirm the diagnosis for most patients (",
"      <a class=\"graphic graphic_table graphicRef65637 \" href=\"UTD.htm?35/38/36459\">",
"       table 5",
"      </a>",
"      ); those with equivocal results should undergo an expanded DNA analysis (",
"      <a class=\"graphic graphic_algorithm graphicRef50886 \" href=\"UTD.htm?32/19/33073\">",
"       algorithm 1",
"      </a>",
"      ). We also suggest that patients with positive sweat chloride results also have DNA analysis to confirm the diagnosis and because the results occasionally affect treatment choices. (See",
"      <a class=\"local\" href=\"#H22\">",
"       'Molecular diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients in whom the diagnosis remains uncertain should be further evaluated at a CF center with specialized testing, including measurement of nasal potential difference",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      consideration of other diagnoses. (See",
"      <a class=\"local\" href=\"#H23\">",
"       'Nasal potential difference measurements'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/49/28442/abstract/1\">",
"      Ratjen F, D&ouml;ring G. Cystic fibrosis. Lancet 2003; 361:681.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/49/28442/abstract/2\">",
"      Hamosh A, FitzSimmons SC, Macek M Jr, et al. Comparison of the clinical manifestations of cystic fibrosis in black and white patients. J Pediatr 1998; 132:255.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/49/28442/abstract/3\">",
"      Boyle MP. Nonclassic cystic fibrosis and CFTR-related diseases. Curr Opin Pulm Med 2003; 9:498.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/49/28442/abstract/4\">",
"      De Boeck K, Wilschanski M, Castellani C, et al. Cystic fibrosis: terminology and diagnostic algorithms. Thorax 2006; 61:627.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/49/28442/abstract/5\">",
"      Farrell PM, Rosenstein BJ, White TB, et al. Guidelines for diagnosis of cystic fibrosis in newborns through older adults: Cystic Fibrosis Foundation consensus report. J Pediatr 2008; 153:S4.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/49/28442/abstract/6\">",
"      Keating CL, Liu X, Dimango EA. Classic respiratory disease but atypical diagnostic testing distinguishes adult presentation of cystic fibrosis. Chest 2010; 137:1157.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/49/28442/abstract/7\">",
"      Cystic Fibrosis Foundation, Borowitz D, Parad RB, et al. Cystic Fibrosis Foundation practice guidelines for the management of infants with cystic fibrosis transmembrane conductance regulator-related metabolic syndrome during the first two years of life and beyond. J Pediatr 2009; 155:S106.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/49/28442/abstract/8\">",
"      Ren CL, Desai H, Platt M, Dixon M. Clinical outcomes in infants with cystic fibrosis transmembrane conductance regulator (CFTR) related metabolic syndrome. Pediatr Pulmonol 2011; 46:1079.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/49/28442/abstract/9\">",
"      Mayell SJ, Munck A, Craig JV, et al. A European consensus for the evaluation and management of infants with an equivocal diagnosis following newborn screening for cystic fibrosis. J Cyst Fibros 2009; 8:71.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/49/28442/abstract/10\">",
"      Rowe SM, Miller S, Sorscher EJ. Cystic fibrosis. N Engl J Med 2005; 352:1992.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/49/28442/abstract/11\">",
"      Gibson RL, Burns JL, Ramsey BW. Pathophysiology and management of pulmonary infections in cystic fibrosis. Am J Respir Crit Care Med 2003; 168:918.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/49/28442/abstract/12\">",
"      Collins FS. Cystic fibrosis: molecular biology and therapeutic implications. Science 1992; 256:774.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/49/28442/abstract/13\">",
"      Robinson P. Cystic fibrosis. Thorax 2001; 56:237.",
"     </a>",
"    </li>",
"    <li>",
"     Cystic Fibrosis Foundation Patient Registry. 2001 Annual data report to the center directors. Bethesda, MD: Cystic Fibrosis Foundation; 2002.",
"    </li>",
"    <li>",
"     Cystic Fibrosis Foundation Patient Registry: annual data report 2011. file://www.cff.org/UploadedFiles/research/ClinicalResearch/2011-Patient-Registry.pdf (Accessed on December 18, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/49/28442/abstract/16\">",
"      Accurso FJ, Sontag MK, Wagener JS. Complications associated with symptomatic diagnosis in infants with cystic fibrosis. J Pediatr 2005; 147:S37.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/49/28442/abstract/17\">",
"      Yankaskas JR, Marshall BC, Sufian B, et al. Cystic fibrosis adult care: consensus conference report. Chest 2004; 125:1S.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/49/28442/abstract/18\">",
"      Gilljam M, Ellis L, Corey M, et al. Clinical manifestations of cystic fibrosis among patients with diagnosis in adulthood. Chest 2004; 126:1215.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/49/28442/abstract/19\">",
"      Rodman DM, Polis JM, Heltshe SL, et al. Late diagnosis defines a unique population of long-term survivors of cystic fibrosis. Am J Respir Crit Care Med 2005; 171:621.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/49/28442/abstract/20\">",
"      Pillarisetti N, Williamson E, Linnane B, et al. Infection, inflammation, and lung function decline in infants with cystic fibrosis. Am J Respir Crit Care Med 2011; 184:75.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/49/28442/abstract/21\">",
"      Yung MW, Gould J, Upton GJ. Nasal polyposis in children with cystic fibrosis: a long-term follow-up study. Ann Otol Rhinol Laryngol 2002; 111:1081.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/49/28442/abstract/22\">",
"      Ramsey B, Richardson MA. Impact of sinusitis in cystic fibrosis. J Allergy Clin Immunol 1992; 90:547.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/49/28442/abstract/23\">",
"      Wang X, Moylan B, Leopold DA, et al. Mutation in the gene responsible for cystic fibrosis and predisposition to chronic rhinosinusitis in the general population. JAMA 2000; 284:1814.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/49/28442/abstract/24\">",
"      Bronstein MN, Sokol RJ, Abman SH, et al. Pancreatic insufficiency, growth, and nutrition in infants identified by newborn screening as having cystic fibrosis. J Pediatr 1992; 120:533.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/49/28442/abstract/25\">",
"      Nousia-Arvanitakis S. Cystic fibrosis and the pancreas: recent scientific advances. J Clin Gastroenterol 1999; 29:138.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/49/28442/abstract/26\">",
"      De Boeck K, Weren M, Proesmans M, Kerem E. Pancreatitis among patients with cystic fibrosis: correlation with pancreatic status and genotype. Pediatrics 2005; 115:e463.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/49/28442/abstract/27\">",
"      Fakhoury K, Durie PR, Levison H, Canny GJ. Meconium ileus in the absence of cystic fibrosis. Arch Dis Child 1992; 67:1204.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/49/28442/abstract/28\">",
"      Gorter RR, Karimi A, Sleeboom C, et al. Clinical and genetic characteristics of meconium ileus in newborns with and without cystic fibrosis. J Pediatr Gastroenterol Nutr 2010; 50:569.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/49/28442/abstract/29\">",
"      Picard E, Aviram M, Yahav Y, et al. Familial concordance of phenotype and microbial variation among siblings with CF. Pediatr Pulmonol 2004; 38:292.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/49/28442/abstract/30\">",
"      Blackman SM, Deering-Brose R, McWilliams R, et al. Relative contribution of genetic and nongenetic modifiers to intestinal obstruction in cystic fibrosis. Gastroenterology 2006; 131:1030.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/49/28442/abstract/31\">",
"      Bass S, Connon JJ, Ho CS. Biliary tree in cystic fibrosis. Biliary tract abnormalities in cystic fibrosis demonstrated by endoscopic retrograde cholangiography. Gastroenterology 1983; 84:1592.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/49/28442/abstract/32\">",
"      Dodge JA. Male fertility in cystic fibrosis. Lancet 1995; 346:587.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/49/28442/abstract/33\">",
"      Chill&oacute;n M, Casals T, Mercier B, et al. Mutations in the cystic fibrosis gene in patients with congenital absence of the vas deferens. N Engl J Med 1995; 332:1475.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/49/28442/abstract/34\">",
"      McCallum TJ, Milunsky JM, Cunningham DL, et al. Fertility in men with cystic fibrosis: an update on current surgical practices and outcomes. Chest 2000; 118:1059.",
"     </a>",
"    </li>",
"    <li>",
"     Brugman SM, Taussig LM. The reproductive system. In: Cystic Fibrosis, Taussig LM (Ed), Thieme-Stratton, New York 1984. p.232.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/49/28442/abstract/36\">",
"      Gilljam M, Antoniou M, Shin J, et al. Pregnancy in cystic fibrosis. Fetal and maternal outcome. Chest 2000; 118:85.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/49/28442/abstract/37\">",
"      Edenborough FP, Stableforth DE, Webb AK, et al. Outcome of pregnancy in women with cystic fibrosis. Thorax 1995; 50:170.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/49/28442/abstract/38\">",
"      Frangolias DD, Nakielna EM, Wilcox PG. Pregnancy and cystic fibrosis: a case-controlled study. Chest 1997; 111:963.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/49/28442/abstract/39\">",
"      Boyd JM, Mehta A, Murphy DJ. Fertility and pregnancy outcomes in men and women with cystic fibrosis in the United Kingdom. Hum Reprod 2004; 19:2238.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/49/28442/abstract/40\">",
"      Grey V, Atkinson S, Drury D, et al. Prevalence of low bone mass and deficiencies of vitamins D and K in pediatric patients with cystic fibrosis from 3 Canadian centers. Pediatrics 2008; 122:1014.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/49/28442/abstract/41\">",
"      Aris RM, Merkel PA, Bachrach LK, et al. Guide to bone health and disease in cystic fibrosis. J Clin Endocrinol Metab 2005; 90:1888.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/49/28442/abstract/42\">",
"      King SJ, Topliss DJ, Kotsimbos T, et al. Reduced bone density in cystic fibrosis: DeltaF508 mutation is an independent risk factor. Eur Respir J 2005; 25:54.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/49/28442/abstract/43\">",
"      Lipnick RN, Glass RB. Bone changes associated with cystic fibrosis. Skeletal Radiol 1992; 21:115.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/49/28442/abstract/44\">",
"      Merkel PA. Rheumatic disease and cystic fibrosis. Arthritis Rheum 1999; 42:1563.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/49/28442/abstract/45\">",
"      Williams V, Griffiths AB, Yap ZL, et al. Increased thrombophilic tendency in pediatric cystic fibrosis patients. Clin Appl Thromb Hemost 2010; 16:71.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/49/28442/abstract/46\">",
"      Takemoto CM. Venous thromboembolism in cystic fibrosis. Pediatr Pulmonol 2012; 47:105.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/49/28442/abstract/47\">",
"      Raffini LJ, Raybagkar D, Blumenstein MS, et al. Cystic fibrosis as a risk factor for recurrent venous thrombosis at a pediatric tertiary care hospital. J Pediatr 2006; 148:659.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/49/28442/abstract/48\">",
"      Hoppe B, Hesse A, Br&ouml;mme S, et al. Urinary excretion substances in patients with cystic fibrosis: risk of urolithiasis? Pediatr Nephrol 1998; 12:275.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/49/28442/abstract/49\">",
"      Hoppe B, von Unruh GE, Blank G, et al. Absorptive hyperoxaluria leads to an increased risk for urolithiasis or nephrocalcinosis in cystic fibrosis. Am J Kidney Dis 2005; 46:440.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/49/28442/abstract/50\">",
"      Oz&ccedil;elik U, Be��ba�� N, G&ouml;&ccedil;men A, et al. Hypercalciuria and nephrocalcinosis in cystic fibrosis patients. Turk J Pediatr 2004; 46:22.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/49/28442/abstract/51\">",
"      Katz SM, Krueger LJ, Falkner B. Microscopic nephrocalcinosis in cystic fibrosis. N Engl J Med 1988; 319:263.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/49/28442/abstract/52\">",
"      Gibney EM, Goldfarb DS. The association of nephrolithiasis with cystic fibrosis. Am J Kidney Dis 2003; 42:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/49/28442/abstract/53\">",
"      Wells J, Rosenberg M, Hoffman G, et al. A decision-tree approach to cost comparison of newborn screening strategies for cystic fibrosis. Pediatrics 2012; 129:e339.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/49/28442/abstract/54\">",
"      Crossley JR, Elliott RB, Smith PA. Dried-blood spot screening for cystic fibrosis in the newborn. Lancet 1979; 1:472.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/49/28442/abstract/55\">",
"      Farrell MH, Farrell PM. Newborn screening for cystic fibrosis: ensuring more good than harm. J Pediatr 2003; 143:707.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/49/28442/abstract/56\">",
"      Wagener JS, Sontag MK, Sagel SD, Accurso FJ. Update on newborn screening for cystic fibrosis. Curr Opin Pulm Med 2004; 10:500.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/49/28442/abstract/57\">",
"      Durie PR, Forstner GG, Gaskin KJ, et al. Age-related alterations of immunoreactive pancreatic cationic trypsinogen in sera from cystic fibrosis patients with and without pancreatic insufficiency. Pediatr Res 1986; 20:209.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/49/28442/abstract/58\">",
"      Fritz A, Farrell P. Estimating the annual number of false negative cystic fibrosis newborn screening tests. Pediatr Pulmonol 2012; 47:207.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/49/28442/abstract/59\">",
"      Grosse SD, Rosenfeld M, Devine OJ, et al. Potential impact of newborn screening for cystic fibrosis on child survival: a systematic review and analysis. J Pediatr 2006; 149:362.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/49/28442/abstract/60\">",
"      Khoury MJ, McCabe LL, McCabe ER. Population screening in the age of genomic medicine. N Engl J Med 2003; 348:50.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/49/28442/abstract/61\">",
"      Waters DL, Wilcken B, Irwing L, et al. Clinical outcomes of newborn screening for cystic fibrosis. Arch Dis Child Fetal Neonatal Ed 1999; 80:F1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/49/28442/abstract/62\">",
"      Sims EJ, McCormick J, Mehta G, et al. Newborn screening for cystic fibrosis is associated with reduced treatment intensity. J Pediatr 2005; 147:306.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/49/28442/abstract/63\">",
"      Dankert-Roelse JE, M&eacute;relle ME. Review of outcomes of neonatal screening for cystic fibrosis versus non-screening in Europe. J Pediatr 2005; 147:S15.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/49/28442/abstract/64\">",
"      Siret D, Bretaudeau G, Branger B, et al. Comparing the clinical evolution of cystic fibrosis screened neonatally to that of cystic fibrosis diagnosed from clinical symptoms: a 10-year retrospective study in a French region (Brittany). Pediatr Pulmonol 2003; 35:342.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/49/28442/abstract/65\">",
"      Sims EJ, Clark A, McCormick J, et al. Cystic fibrosis diagnosed after 2 months of age leads to worse outcomes and requires more therapy. Pediatrics 2007; 119:19.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/49/28442/abstract/66\">",
"      Dijk FN, McKay K, Barzi F, et al. Improved survival in cystic fibrosis patients diagnosed by newborn screening compared to a historical cohort from the same centre. Arch Dis Child 2011; 96:1118.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/49/28442/abstract/67\">",
"      Farrell PM, Li Z, Kosorok MR, et al. Bronchopulmonary disease in children with cystic fibrosis after early or delayed diagnosis. Am J Respir Crit Care Med 2003; 168:1100.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/49/28442/abstract/68\">",
"      Farrell PM, Kosorok MR, Rock MJ, et al. Early diagnosis of cystic fibrosis through neonatal screening prevents severe malnutrition and improves long-term growth. Wisconsin Cystic Fibrosis Neonatal Screening Study Group. Pediatrics 2001; 107:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/49/28442/abstract/69\">",
"      Koscik RL, Farrell PM, Kosorok MR, et al. Cognitive function of children with cystic fibrosis: deleterious effect of early malnutrition. Pediatrics 2004; 113:1549.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/49/28442/abstract/70\">",
"      Milla CE. Association of nutritional status and pulmonary function in children with cystic fibrosis. Curr Opin Pulm Med 2004; 10:505.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/49/28442/abstract/71\">",
"      Koscik RL, Lai HJ, Laxova A, et al. Preventing early, prolonged vitamin E deficiency: an opportunity for better cognitive outcomes via early diagnosis through neonatal screening. J Pediatr 2005; 147:S51.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/49/28442/abstract/72\">",
"      Sims EJ, Mugford M, Clark A, et al. Economic implications of newborn screening for cystic fibrosis: a cost of illness retrospective cohort study. Lancet 2007; 369:1187.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/49/28442/abstract/73\">",
"      Kosorok MR, Jalaluddin M, Farrell PM, et al. Comprehensive analysis of risk factors for acquisition of Pseudomonas aeruginosa in young children with cystic fibrosis. Pediatr Pulmonol 1998; 26:81.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/49/28442/abstract/74\">",
"      Rosenfeld M, Emerson J, McNamara S, et al. Risk factors for age at initial Pseudomonas acquisition in the cystic fibrosis epic observational cohort. J Cyst Fibros 2012; 11:446.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/49/28442/abstract/75\">",
"      Wang SS, FitzSimmons SC, O'Leary LA, et al. Early diagnosis of cystic fibrosis in the newborn period and risk of Pseudomonas aeruginosa acquisition in the first 10 years of life: A registry-based longitudinal study. Pediatrics 2001; 107:274.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/49/28442/abstract/76\">",
"      Baussano I, Tardivo I, Bellezza-Fontana R, et al. Neonatal screening for cystic fibrosis does not affect time to first infection with Pseudomonas aeruginosa. Pediatrics 2006; 118:888.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/49/28442/abstract/77\">",
"      Farriaux JP, Vidailhet M, Briard ML, et al. Neonatal screening for cystic fibrosis: France rises to the challenge. J Inherit Metab Dis 2003; 26:729.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/49/28442/abstract/78\">",
"      Price JF. Newborn screening for cystic fibrosis: do we need a second IRT? Arch Dis Child 2006; 91:209.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/49/28442/abstract/79\">",
"      Sarles J, Berth&eacute;z&egrave;ne P, Le Louarn C, et al. Combining immunoreactive trypsinogen and pancreatitis-associated protein assays, a method of newborn screening for cystic fibrosis that avoids DNA analysis. J Pediatr 2005; 147:302.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/49/28442/abstract/80\">",
"      Munck A, Dhondt JL, Sahler C, Roussey M. Implementation of the French nationwide cystic fibrosis newborn screening program. J Pediatr 2008; 153:228.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/49/28442/abstract/81\">",
"      Grosse SD, Boyle CA, Botkin JR, et al. Newborn screening for cystic fibrosis: evaluation of benefits and risks and recommendations for state newborn screening programs. MMWR Recomm Rep 2004; 53:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/49/28442/abstract/82\">",
"      Wilfond BS, Gollust SE. Policy issues for expanding newborn screening programs: the cystic fibrosis newborn screening experience in the United States. J Pediatr 2005; 146:668.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/49/28442/abstract/83\">",
"      Balfour-Lynn IM. Newborn screening for cystic fibrosis: evidence for benefit. Arch Dis Child 2008; 93:7.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/49/28442/abstract/84\">",
"      Stern RC. The diagnosis of cystic fibrosis. N Engl J Med 1997; 336:487.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/49/28442/abstract/85\">",
"      Rosenstein BJ, Cutting GR. The diagnosis of cystic fibrosis: a consensus statement. Cystic Fibrosis Foundation Consensus Panel. J Pediatr 1998; 132:589.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/49/28442/abstract/86\">",
"      Denning CR, Huang NN, Cuasay LR, et al. Cooperative study comparing three methods of performing sweat tests to diagnose cystic fibrosis. Pediatrics 1980; 66:752.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/49/28442/abstract/87\">",
"      Parad RB, Comeau AM, Dorkin HL, et al. Sweat testing infants detected by cystic fibrosis newborn screening. J Pediatr 2005; 147:S69.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/49/28442/abstract/88\">",
"      Mishra A, Greaves R, Smith K, et al. Diagnosis of cystic fibrosis by sweat testing: age-specific reference intervals. J Pediatr 2008; 153:758.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/49/28442/abstract/89\">",
"      Ooi CY, Dupuis A, Ellis L, et al. Comparing the American and European diagnostic guidelines for cystic fibrosis: same disease, different language? Thorax 2012; 67:618.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/49/28442/abstract/90\">",
"      Dreyfus DH, Bethel R, Gelfand EW. Cystic fibrosis 3849+10kb C &gt; T mutation associated with severe pulmonary disease and male fertility. Am J Respir Crit Care Med 1996; 153:858.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/49/28442/abstract/91\">",
"      Parad RB, Comeau AM. Diagnostic dilemmas resulting from the immunoreactive trypsinogen/DNA cystic fibrosis newborn screening algorithm. J Pediatr 2005; 147:S78.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/49/28442/abstract/92\">",
"      Lebecque P, Leal T, De Boeck C, et al. Mutations of the cystic fibrosis gene and intermediate sweat chloride levels in children. Am J Respir Crit Care Med 2002; 165:757.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/49/28442/abstract/93\">",
"      Davis PB, Del Rio S, Muntz JA, Dieckman L. Sweat chloride concentration in adults with pulmonary diseases. Am Rev Respir Dis 1983; 128:34.",
"     </a>",
"    </li>",
"    <li>",
"     Goodchild MC, Watson E. Diagnostic methods and screening. In: Cystic Fibrosis, Hodson ME, Geddes DM (Eds), Chapman and Hall Medical, London 1995. p.179.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/49/28442/abstract/95\">",
"      LeGrys VA, Yankaskas JR, Quittell LM, et al. Diagnostic sweat testing: the Cystic Fibrosis Foundation guidelines. J Pediatr 2007; 151:85.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/49/28442/abstract/96\">",
"      Guglani L, Sitwat B, Lower D, et al. Elevated sweat chloride concentration in children without cystic fibrosis who are receiving topiramate therapy. Pediatr Pulmonol 2012; 47:429.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/49/28442/abstract/97\">",
"      Watson MS, Cutting GR, Desnick RJ, et al. Cystic fibrosis population carrier screening: 2004 revision of American College of Medical Genetics mutation panel. Genet Med 2004; 6:387.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/49/28442/abstract/98\">",
"      Wong LJ, Wang J, Zhang YH, et al. Improved detection of CFTR mutations in Southern California Hispanic CF patients. Hum Mutat 2001; 18:296.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/49/28442/abstract/99\">",
"      Beaudet AL, Feldman GL, Fernbach SD, et al. Linkage disequilibrium, cystic fibrosis, and genetic counseling. Am J Hum Genet 1989; 44:319.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/49/28442/abstract/100\">",
"      Sermet-Gaudelus I, Girodon E, Sands D, et al. Clinical phenotype and genotype of children with borderline sweat test and abnormal nasal epithelial chloride transport. Am J Respir Crit Care Med 2010; 182:929.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/49/28442/abstract/101\">",
"      Alton EW, Currie D, Logan-Sinclair R, et al. Nasal potential difference: a clinical diagnostic test for cystic fibrosis. Eur Respir J 1990; 3:922.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/49/28442/abstract/102\">",
"      Boyle MP, Diener-West M, Milgram L, et al. A multicenter study of the effect of solution temperature on nasal potential difference measurements. Chest 2003; 124:482.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/49/28442/abstract/103\">",
"      Fajac I, Hubert D, Guillemot D, et al. Nasal airway ion transport is linked to the cystic fibrosis phenotype in adult patients. Thorax 2004; 59:971.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/49/28442/abstract/104\">",
"      Knowles MR, Paradiso AM, Boucher RC. In vivo nasal potential difference: techniques and protocols for assessing efficacy of gene transfer in cystic fibrosis. Hum Gene Ther 1995; 6:445.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/49/28442/abstract/105\">",
"      Sermet-Gaudelus I, Girodon E, Roussel D, et al. Measurement of nasal potential difference in young children with an equivocal sweat test following newborn screening for cystic fibrosis. Thorax 2010; 65:539.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/49/28442/abstract/106\">",
"      Wallace HL, Barker PM, Southern KW. Nasal airway ion transport and lung function in young people with cystic fibrosis. Am J Respir Crit Care Med 2003; 168:594.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/49/28442/abstract/107\">",
"      Daftary A, Acton J, Heubi J, Amin R. Fecal elastase-1: utility in pancreatic function in cystic fibrosis. J Cyst Fibros 2006; 5:71.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6367 Version 12.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-122.72.76.133-AC55A795B2-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f27_49_28442=[""].join("\n");
var outline_f27_49_28442=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H26\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      DEFINITIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Classic CF",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Nonclassic CF",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      CFTR-related disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H49145351\">",
"      CFTR-related metabolic syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      OVERVIEW OF CLINICAL FEATURES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H59098960\">",
"      Presentation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Respiratory tract involvement",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Sinus disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Pancreatic disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Meconium ileus and distal ileal obstruction",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Biliary disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Infertility",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Musculoskeletal disorders",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Recurrent venous thrombosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Nephrolithiasis and nephrocalcinosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H59099793\">",
"      NEWBORN SCREENING",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H49141214\">",
"      Techniques",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H49141221\">",
"      Rationale",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H49141207\">",
"      Regional variation in screening",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H59100333\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5359539\">",
"      Diagnostic criteria",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5359711\">",
"      Laboratory testing",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      - Sweat chloride",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H59099179\">",
"      Indications",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Interpretation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Technique",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      - Molecular diagnosis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      - Nasal potential difference measurements",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      - Other tests",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1966215\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PEDS/6367\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/6367|ALG\">",
"      <a href=\"#\" title=\"ALGORITHMS\">",
"       ALGORITHMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"UTD.htm?32/19/33073\" title=\"algorithm 1\">",
"      Algorithm CF Dx",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/6367|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?26/28/27085\" title=\"figure 1\">",
"      Newborn screen trends",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?42/58/43951\" title=\"figure 2\">",
"      Clubbing of the fingers",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?27/25/28050\" title=\"figure 3\">",
"      CF nasal PD",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/6367|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?5/7/5244\" title=\"table 1\">",
"      Symptoms of cystic fibrosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?31/51/32571\" title=\"table 2\">",
"      Diagnosis of cystic fibrosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?11/30/11756\" title=\"table 3\">",
"      Interpretation of sweat chloride",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?25/39/26235\" title=\"table 4\">",
"      Causes elevated sweat chloride",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?35/38/36459\" title=\"table 5\">",
"      Cystic fibrosis screening panel",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/0/11273?source=related_link\">",
"      Acute bacterial rhinosinusitis in children: Clinical features and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/48/33545?source=related_link\">",
"      Allergic bronchopulmonary aspergillosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/54/11114?source=related_link\">",
"      Causes of male infertility",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/22/41322?source=related_link\">",
"      Cystic fibrosis: Antibiotic therapy for lung disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/26/29095?source=related_link\">",
"      Cystic fibrosis: Assessment and management of pancreatic insufficiency",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/45/27351?source=related_link\">",
"      Cystic fibrosis: Clinical manifestations of pulmonary disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/11/39095?source=related_link\">",
"      Cystic fibrosis: Genetics and pathogenesis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/24/15754?source=related_link\">",
"      Cystic fibrosis: Nutritional issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/15/19706?source=related_link\">",
"      Cystic fibrosis: Overview of gastrointestinal disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/22/39274?source=related_link\">",
"      Cystic fibrosis: Overview of the treatment of lung disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/62/22503?source=related_link\">",
"      Cystic fibrosis: Prenatal genetic screening",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/57/14234?source=related_link\">",
"      Diagnosis and treatment of venous thrombosis and thromboembolism in infants and children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/60/6090?source=related_link\">",
"      Epidemiology of and risk factors for nephrolithiasis in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/20/36166?source=related_link\">",
"      Fetal echogenic bowel",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/42/35496?source=related_link\">",
"      Malignancy and rheumatic disorders",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/44/32456?source=related_link\">",
"      Overview of echogenic masses and calcification in the fetal abdomen",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/48/32519?source=related_link\">",
"      Overview of rectal prolapse in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?19/57/20371?source=related_link\">",
"      Patient information: Cystic fibrosis (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/37/9817?source=related_link\">",
"      Primary ciliary dyskinesia (immotile-cilia syndrome)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/48/24326?source=related_link\">",
"      Primary humoral immune deficiencies: An overview",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/53/33626?source=related_link\">",
"      Risk factors for calcium stones in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/30/42471?source=related_link\">",
"      Severe combined immunodeficiency (SCID): An overview",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/39/33400?source=related_link\">",
"      Shwachman-Diamond syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/33/3610?source=related_link\">",
"      Treatment of male infertility",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f27_49_28443="Worldwide TB burden";
var content_f27_49_28443=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F68082&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F68082&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    The 22 highest tuberculosis-burden countries",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td>",
"        Afghanistan",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Bangladesh",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Brazil",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cambodia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        China",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Democratic Republic of the Congo",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Ethiopia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        India",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Indonesia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Kenya",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Mozambique",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Myanmar",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Nigeria",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Pakistan",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Philippines",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Russian Federation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        South Africa",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Tanzania",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Thailand",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Uganda",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Vietnam",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Zimbabwe",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     <p>",
"      World Health Organization. Global tuberculosis control: WHO report 2011.",
"      <a href=\"file://www.who.int/tb/country/en/index.html\">",
"       file://www.who.int/tb/country/en/index.html",
"      </a>",
"     </p>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f27_49_28443=[""].join("\n");
var outline_f27_49_28443=null;
var title_f27_49_28444="Results of phlebotomy in HH";
var content_f27_49_28444=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F68740&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F68740&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Results of therapeutic phlebotomy in patients with hemochromatosis",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Complications of iron overload",
"       </td>",
"       <td class=\"subtitle1\">",
"        Expected treatment outcome",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        None",
"       </td>",
"       <td>",
"        Prevention of complications of iron overload; normal life expectancy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Weakness, fatigue, lethargy",
"       </td>",
"       <td>",
"        Improvement in majority of patients",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Elevated serum concentrations of hepatic enzymes",
"       </td>",
"       <td>",
"        Resolution or marked improvement",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hepatomegaly",
"       </td>",
"       <td>",
"        Resolution often occurs",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hepatic cirrhosis",
"       </td>",
"       <td>",
"        No change",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Increased risk for primary liver cancer",
"       </td>",
"       <td>",
"        No change*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Right upper quadrant pain",
"       </td>",
"       <td>",
"        Resolution or marked improvement&bull;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Arthropathy",
"       </td>",
"       <td>",
"        Improvement in arthralgias sometimes occurs; change in joint deformity is rare; progression is sometimes seen",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hypogonadotrophic hypogonadism",
"       </td>",
"       <td>",
"        Resolution is rare",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Diabetes mellitus",
"       </td>",
"       <td>",
"        Occasional improvement, often temporary",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hypothyroidism, hypogonadism",
"       </td>",
"       <td>",
"        Resolution is rare",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cardiomyopathy",
"       </td>",
"       <td>",
"        Resolution sometimes occurs",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hyperpigmentation",
"       </td>",
"       <td>",
"        Resolution usually occurs",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hyperferritinemia",
"       </td>",
"       <td>",
"        Resolution",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Excess absorption and storage of nonferrous metals&Delta;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Infection with Vibrio vulnificus or other bacteria",
"       </td>",
"       <td>",
"        Little or no change",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * Increased risk occurs only in persons with cirrhosis.",
"     <br>",
"      <span class=\"bullet\">",
"       &bull;",
"      </span>",
"      Right upper quadrant pain in persons with hemochromatosis is often related to hepatic iron overload. In these cases, therapeutic phlebotomy usually results in marked improvement or resolution. However, right upper quadrant pain may also be caused by primary liver cancer, portal vein thrombosis, gallbladder disease, lesions in the hepatic flexure, or nephrolithiasis. Iron depletion alone will not alleviate right upper quadrant pain due to these causes.",
"      <br>",
"       &Delta; Cobalt, maganese, zinc, and lead.",
"      </br>",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from: Barton JC, et al. Ann Intern Med 1998; 129:932.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f27_49_28444=[""].join("\n");
var outline_f27_49_28444=null;
var title_f27_49_28445="Parenteral rx severe malaria";
var content_f27_49_28445=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F79194&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F79194&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Therapeutic options for parenteral treatment of severe malaria*",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\" colspan=\"2\">",
"        I. Artemisinin derivative",
"        <sup>",
"         &bull;",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Artesunate",
"       </td>",
"       <td>",
"        2.4 mg/kg intravenously as first dose, followed by 2.4 mg/kg at 12 and 24 hours, followed by 2.4 mg/kg once daily",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\" colspan=\"2\">",
"        II. Quinine or quinidine",
"        <sup>",
"         &Delta;",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Quinine dihydrochloride",
"        <sup>",
"         &loz;",
"        </sup>",
"       </td>",
"       <td>",
"        16.7 mg base/kg (= 20 mg salt/kg) in 5 percent dextrose loading dose over 4 hours, followed by 25 mg base/kg/day (20 to 30 mg salt/kg/day) divided into 2 to 3 equal administrations of 8.35 mg base/kg (= 10 mg salt/kg) over 2 hours at 8 or 12 hr intervals (maximum 1800 mg salt/day)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"2\">",
"        Quinidine gluconate",
"        <sup>",
"         &sect;",
"        </sup>",
"       </td>",
"       <td>",
"        6.25 mg base/kg (= 10 mg salt/kg) loading dose intravenously (maximum 600 mg salt) in normal saline over 1-2 hrs, followed by 0.0125 mg base/kg/min (= 0.02 mg salt/kg/minute) continuous infusion for at least 24 hours",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Alternative: 15 mg base/kg (= 24 mg salt/kg) loading dose intravenously in normal saline over 4 hrs, followed by 7.5 mg base/kg (= 12 mg salt/kg) infused over 4 hrs every 8 hrs, starting 8 hrs after the beginning of the loading dose",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"2\">",
"        <strong>",
"         PLUS",
"        </strong>",
"        * one of the following: Doxycycline, Tetracycline or Clindamycin",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        Doxycycline",
"       </td>",
"       <td>",
"        Adults: 100 mg orally twice daily. Children: 2.2 mg/kg (up to 100 mg) orally twice daily. Intravenous dosing acceptable if oral medication not tolerated; switch to oral dosing once patient is able to swallow. Treatment course is 7 days.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        Tetracycline",
"       </td>",
"       <td>",
"        Adults: 250 mg orally four times daily. Children: 25 mg/kg/day (up to 1000 mg) divided into 4 equal doses. Treatment course is 7 days.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        Clindamycin",
"        <sup>",
"         &yen;",
"        </sup>",
"       </td>",
"       <td>",
"        Adults and children: 20 mg base/kg/day orally (maximum 1800 mg) divided into 3 equal doses. Treatment course is 7 days.",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * In general, parenteral therapy is administered for severe disease. Once the patient is able to tolerate oral medications, treatment may be completed orally. Options include:",
"     <strong>",
"      1.",
"     </strong>",
"     Parenteral artesunate followed by atovaquone-proguanil (for adults: 4 adult tabs orally for 3 days), mefloquine (for adults: 750 mg salt orally as initial dose followed by 500 mg salt orally 6 to 12 hrs later), doxycycline or clindamycin.",
"     <strong>",
"      2.",
"     </strong>",
"     Parenteral quinine (or quinidine) with doxycycline, tetracycline or clindamycin (7 days therapy total); this is common practice for patients with malaria acquired in SE Asia, if artesunate is not available.",
"     <strong>",
"      3.",
"     </strong>",
"     Parenteral quinine (at least three doses) until the patient is able to swallow, followed by oral therapy with an artemisinin combination drug such as artemether-lumefantrine (3 days therapy total; see separate table summarizing oral artemisinin combination therapy); this is common practice for children with malaria acquired in Africa, if artesunate is not available.",
"     <br>",
"      <span class=\"bullet\">",
"       &bull;",
"      </span>",
"      Artesunate can also be administered intramuscularly, orally, or via rectal suppository (100 mg for children 6 months to 6 years of age; 400 mg for children &gt;6 years). In the United States intravenous artesunate is not approved by the Food and Drug Administration but is available for emergency use under an investigational protocol by enrollment with the Centers for Disease Control (CDC). Artesunate is unstable in solution so is dispensed as a dry powder of artesunic acid together with an ampule of diluent (5 percent sodium bicarbonate solution or sodium phosphate solution as supplied by US CDC). The powder and liquid are mixed to provide a concentration of 10 mg/mL; the artesunate solution should be administered within one hour of preparation. Once the patient has received four doses of intravenous artesunate and is able to swallow, the treatment can be completed with a course of an active oral antimalarial drug based on known susceptibility data.",
"      <br>",
"       &Delta; Important adverse effects include hypoglycemia, QT prolongation, tinnitus, reversible hearing loss, nausea, vomiting, dizziness and visual disturbances. To avoid cardiotoxicity, a loading dose of quinine/quinidine should not be administered to patients who received mefloquine or other quinine derivatives within the previous 12 hours.",
"       <br>",
"        <span class=\"lozenge\">",
"         &loz;",
"        </span>",
"        Quinine should be given by rate controlled intravenous infusion and never by intravenous injection (which can be lethal). Quinine can also be administered via intramuscular injection if intravenous infusions cannot be given: two injections of 10 mg/kg quinine (diluted to 60 mL) should be administered four hours apart. The anterior thigh is preferred over the gluteal region to minimize the risk of sciatic nerve damage.",
"        <br>",
"         &sect; In the United States, intravenous quinidine is available for treatment of severe malaria. Quinidine can cause QT prolongation and should be administered by rate controlled intravenous infusion with continuous electrocardiographic and hemodynamic monitoring in an intensive care unit. Quinidine may be significantly absorbed to PVC tubing; tubing length should be minimized to approximately 12 inches.",
"         <br>",
"          &yen; Clindamycin should be administered for pregnant women; doxycycline and tetracycline are contraindicated.",
"         </br>",
"        </br>",
"       </br>",
"      </br>",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     CDC Malaria Hotline: (770) 488-7788 Monday-Friday 8a to 4:30p EST; (770) 488-7100 after hours, weekends and holidays.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f27_49_28445=[""].join("\n");
var outline_f27_49_28445=null;
var title_f27_49_28446="Doses antiemetic drugs";
var content_f27_49_28446=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F68894&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F68894&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Recommended adult doses of antiemetic drugs",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\" rowspan=\"2\">",
"        Drug",
"       </td>",
"       <td class=\"subtitle1\" rowspan=\"2\">",
"        Trade name&nbsp;",
"       </td>",
"       <td class=\"subtitle1\" colspan=\"2\">",
"        Dose and schedule",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2\">",
"        Prechemotherapy",
"       </td>",
"       <td class=\"subtitle2\">",
"        Postchemotherapy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"4\">",
"        Agents with a higher therapeutic index",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle3_left\" colspan=\"4\">",
"        5-HT3 receptor antagonists*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        Ondansetron IV",
"       </td>",
"       <td class=\"indent2\">",
"        Zofran",
"        <sup>",
"         &reg;",
"        </sup>",
"        &nbsp;",
"       </td>",
"       <td>",
"        8 mg or 0.15 mg/kg IV once",
"       </td>",
"       <td>",
"        &nbsp;&nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        Ondansetron oral",
"       </td>",
"       <td class=\"indent2\">",
"        Zofran",
"        <sup>",
"         &reg;",
"        </sup>",
"       </td>",
"       <td>",
"        8 mg by mouth twice daily",
"       </td>",
"       <td>",
"        8 mg by mouth twice daily on days 2 and 3 for moderately emetogenic chemotherapy with the potential for delayed emesis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        Ondansetron oral dissolving tablet (ODT)",
"       </td>",
"       <td class=\"indent2\">",
"        Zofran ODT",
"        <sup>",
"         &reg;",
"        </sup>",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        8 mg dissolved in mouth every 12 hours as needed",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        Ondansetron oral soluble film",
"       </td>",
"       <td class=\"indent2\">",
"        Zuplenz",
"        <sup>",
"         &reg;",
"        </sup>",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        8 mg dissolved in mouth every 12 hours as needed",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        Granisetron IV",
"       </td>",
"       <td class=\"indent2\">",
"        Kytril",
"        <sup>",
"         &reg;",
"        </sup>",
"       </td>",
"       <td>",
"        1 mg or 0.01 mg/kg IV&nbsp;once",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        Granisetron oral",
"       </td>",
"       <td class=\"indent2\">",
"        Granisol",
"        <sup>",
"         &reg;",
"        </sup>",
"       </td>",
"       <td>",
"        2 mg by mouth once",
"       </td>",
"       <td>",
"        1 mg by mouth twice daily on days 2 and 3 for moderately emetogenic chemotherapy with the potential for delayed emesis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        Granisetron transdermal patch",
"       </td>",
"       <td class=\"indent2\">",
"        Sancuso",
"        <sup>",
"         &reg;",
"        </sup>",
"       </td>",
"       <td>",
"        Apply 24 to 48 hours prior to chemotherapy. Releases 3.1 mg per 24 hours.&nbsp;",
"       </td>",
"       <td>",
"        Remove 24 hours or more after last chemotherapy dose. Maximum seven days depending on regimen.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        Dolasetron oral ONLY",
"        <sup>",
"         &bull;",
"        </sup>",
"       </td>",
"       <td class=\"indent2\">",
"        Anzemet",
"        <sup>",
"         &reg;",
"        </sup>",
"       </td>",
"       <td>",
"        100 mg by mouth once",
"       </td>",
"       <td>",
"        100 mg by mouth&nbsp;daily on days 2 and 3 for moderately emetogenic chemotherapy with potential for delayed emesis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        Palonosetron IV",
"       </td>",
"       <td class=\"indent2\">",
"        Aloxi",
"        <sup>",
"         &reg;",
"        </sup>",
"       </td>",
"       <td>",
"        0.25 mg IV once",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        Palonosetron oral",
"       </td>",
"       <td class=\"indent2\">",
"        Aloxi",
"        <sup>",
"         &reg;",
"        </sup>",
"       </td>",
"       <td>",
"        0.5 mg by mouth&nbsp;once",
"       </td>",
"       <td>",
"        0.5 mg by mouth daily on days 2 and 3 for moderately emetogenic chemotherapy with potential for delayed emesis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        Tropisetron IV",
"        <sup>",
"         &Delta;",
"        </sup>",
"       </td>",
"       <td class=\"indent2\">",
"        Navoban",
"        <sup>",
"         &reg;",
"        </sup>",
"       </td>",
"       <td>",
"        5 mg IV once",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        Tropisetron oral",
"        <sup>",
"         &Delta;",
"        </sup>",
"       </td>",
"       <td class=\"indent2\">",
"        Navoban",
"        <sup>",
"         &reg;",
"        </sup>",
"       </td>",
"       <td>",
"        &nbsp;&nbsp;&nbsp;",
"       </td>",
"       <td>",
"        5 mg by mouth daily for up to 5 days",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        Ramosetron",
"        <sup>",
"         &Delta;",
"        </sup>",
"       </td>",
"       <td class=\"indent2\">",
"        Nasea",
"        <sup>",
"         &reg;",
"        </sup>",
"       </td>",
"       <td>",
"        300 mcg IV&nbsp;once",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle3_left\" colspan=\"4\">",
"        Glucocorticoids",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist3_start\" colspan=\"4\">",
"        Dexamethasone",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist3\" colspan=\"2\" rowspan=\"2\">",
"        With a Neurokinin-1 antagonist",
"       </td>",
"       <td class=\"sublist_other\">",
"        12 mg IV or orally for highly emtogenic chemotherapy",
"       </td>",
"       <td class=\"sublist_other\">",
"        8 mg by mouth on days 2, 3, and 4 for highly emetogenic chemotherapy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist_other\">",
"        8 mg IV or orally for for moderately emetogenic chemotherapy",
"       </td>",
"       <td class=\"sublist_other\">",
"        8 mg by mouth on days 2 and 3 for moderately emetogenic chemotherapy with the potential for delayed emesis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist3\" colspan=\"2\" rowspan=\"2\">",
"        Without a Neurokinin-1 antagonist",
"       </td>",
"       <td class=\"sublist_other\">",
"        20 mg IV for highly emetogenic chemotherapy",
"       </td>",
"       <td class=\"sublist_other\">",
"        16 mg by mouth on days 2, 3, and 4 for highly emetogenic chemotherapy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist_other\">",
"        8 mg&nbsp;orally for moderately emetogenic chemotherapy",
"       </td>",
"       <td class=\"sublist_other\">",
"        8 mg by mouth on days 2 and 3 for moderately emetogenic chemotherapy with the potential for delayed emesis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle3_left\" colspan=\"4\">",
"        Neurokinin-1 antagonists",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        Aprepitant oral",
"       </td>",
"       <td class=\"indent2\">",
"        Emend",
"        <sup>",
"         &reg;",
"        </sup>",
"       </td>",
"       <td>",
"        125 mg by mouth&nbsp;once",
"       </td>",
"       <td>",
"        80 mg by mouth daily for two days starting 24 hours after the start of chemotherapy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        Fosaprepitant IV (single dose)",
"       </td>",
"       <td class=\"indent2\">",
"        Emend IV",
"        <sup>",
"         &reg;",
"        </sup>",
"       </td>",
"       <td>",
"        150 mg IV once",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td class=\"subtitle2_left\" colspan=\"4\">",
"        Agents with a lower therapeutic index",
"        <sup>",
"         &loz;",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle3_left\" colspan=\"4\">",
"        Dopaminergic antagonists",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        Metoclopramide IV (high dose)",
"       </td>",
"       <td class=\"indent2\">",
"        Reglan",
"        <sup>",
"         &reg;",
"        </sup>",
"       </td>",
"       <td>",
"        1 to 2 mg/kg IV",
"       </td>",
"       <td>",
"        Repeat IV dose 2 hours postchemotherapy; oral 0.5 mg/kg every 6 hours on days 2 to 4, starting 24 hours after start of chemotherapy, for moderately emetogenic chemotherapy, with the potential for delayed emesis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        Prochlorperazine IV",
"       </td>",
"       <td class=\"indent2\">",
"        Compazine",
"        <sup>",
"         &reg;",
"        </sup>",
"       </td>",
"       <td>",
"        5 to 10 mg IV every 3 to 4 hours as needed (maximum 40 mg per day)",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        Prochlorperazine oral",
"       </td>",
"       <td class=\"indent2\">",
"        Compazine",
"        <sup>",
"         &reg;",
"        </sup>",
"       </td>",
"       <td>",
"        10 mg by mouth",
"       </td>",
"       <td>",
"        10 mg by mouth every 3 to 4 hours as needed",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        Nabilone oral",
"       </td>",
"       <td class=\"indent2\">",
"        Cesamet",
"        <sup>",
"         &reg;",
"        </sup>",
"       </td>",
"       <td>",
"        <p>",
"         1 to 2 mg by mouth once",
"        </p>",
"       </td>",
"       <td>",
"        1 to 2 mg twice daily or as needed (maximum 6 mg divided in 3 doses per day)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        Dronabinol oral",
"       </td>",
"       <td class=\"indent2\">",
"        Marinol",
"        <sup>",
"         &reg;",
"        </sup>",
"       </td>",
"       <td>",
"        5 mg/m",
"        <sup>",
"         2",
"        </sup>",
"        by mouth",
"       </td>",
"       <td>",
"        5 mg/m",
"        <sup>",
"         2",
"        </sup>",
"        by mouth every 2 to 4 hours as needed (maximum 15 mg/m",
"        <sup>",
"         2",
"        </sup>",
"        per dose up to 6 doses per day)",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    IV: intravenous",
"    <div class=\"footnotes\">",
"     * Prechemotherapy dosing of 5-HT3 receptor antagonists shown is based on a three-drug combination including dexamethasone and a neurokinin-1 antagonist for highly emetogenic chemotherapy or the combination of palonosetron with dexamethasone for moderately emetogenic chemotherapy.&nbsp;See text.",
"     <br>",
"      <sup>",
"       &bull;",
"      </sup>",
"      IV use of dolasetron is contraindicated because of the potential for fatal cardiac arrhythmias.&nbsp;",
"      <br>",
"       <sup>",
"        &Delta;",
"       </sup>",
"       Not available in US.",
"       <br>",
"        <sup>",
"         &loz;",
"        </sup>",
"        In general, use of agents with a low therapeutic index&nbsp;is reserved for patients intolerant or refractory to first line agents. If used, they should be combined with more effective higher therapeutic index antiemetics.",
"       </br>",
"      </br>",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     Modified from: Hesketh PJ. Chemotherapy-Induced Nausea and Vomiting. N Engl J Med 2008; 358:2482.",
"     <br>",
"      Additional data from: Basch E, Prestrud AA, Hesketh PJ, et al. Antiemetics: American Society of Clinical Oncology Clinical Practice Guideline Update. J Clin Oncol 2011; 21:4189.",
"     </br>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f27_49_28446=[""].join("\n");
var outline_f27_49_28446=null;
var title_f27_49_28447="Percutaneous transtracheal ventilation catheter adapters";
var content_f27_49_28447=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F52559&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F52559&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Percutaneous transtracheal ventilation catheter adapters",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 209px; height: 432px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A 3-mL syringe with the plunger removed may be used as an adapter between the catheter and a 7.5 mm ID endotracheal tube. Alternately, a 3.0 mm ID endotracheal tube connector can be inserted directly into the catheter hub. Both methods can be used to connect the catheter to a standard self-inflating resuscitation bag.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Mittal MK, Baren JM. Percutaneous Transtracheal Ventilation. In: Textbook of Pediatric Emergency Procedures, 2nd ed, King C, Henretig FM (Eds), Lippincott Williams &amp; Wilkins, Philadelphia 2008. Copyright &copy; 2008 Lippincott Williams &amp; Wilkins.",
"    </div>",
"    <div class=\"contractual\">",
"     <br/>",
"     <a href=\"file://www.lww.com\">",
"      file://www.lww.com",
"     </a>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f27_49_28447=[""].join("\n");
var outline_f27_49_28447=null;
